
<html lang="en"     class="pb-page"  data-request-id="c7469467-07ec-4bab-8734-04082b3917c8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00610;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" /></meta><meta name="dc.Creator" content="Annachiara  Gandini" /></meta><meta name="dc.Creator" content="Manuela  Bartolini" /></meta><meta name="dc.Creator" content="Daniele  Tedesco" /></meta><meta name="dc.Creator" content="Loreto  Martinez-Gonzalez" /></meta><meta name="dc.Creator" content="Carlos  Roca" /></meta><meta name="dc.Creator" content="Nuria E.  Campillo" /></meta><meta name="dc.Creator" content="Josefa  Zaldivar-Diez" /></meta><meta name="dc.Creator" content="Concepción  Perez" /></meta><meta name="dc.Creator" content="Giampaolo  Zuccheri" /></meta><meta name="dc.Creator" content="Andrea  Miti" /></meta><meta name="dc.Creator" content="Alessandra  Feoli" /></meta><meta name="dc.Creator" content="Sabrina  Castellano" /></meta><meta name="dc.Creator" content="Sabrina  Petralla" /></meta><meta name="dc.Creator" content="Barbara  Monti" /></meta><meta name="dc.Creator" content="Martina  Rossi" /></meta><meta name="dc.Creator" content="Fabio  Moda" /></meta><meta name="dc.Creator" content="Giuseppe  Legname" /></meta><meta name="dc.Creator" content="Ana  Martinez" /></meta><meta name="dc.Creator" content="Maria Laura  Bolognesi" /></meta><meta name="dc.Description" content="Several findings propose the altered tau protein network as an important target for Alzheimer’s disease (AD). Particularly, two points of pharmacological intervention can be envisaged: inhibition o..." /></meta><meta name="Description" content="Several findings propose the altered tau protein network as an important target for Alzheimer’s disease (AD). Particularly, two points of pharmacological intervention can be envisaged: inhibition o..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 4, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00610" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00610" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00610" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00610" /></link>
        
    
    

<title>Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00610" /></meta><meta property="og:title" content="Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0001.jpeg" /></meta><meta property="og:description" content="Several findings propose the altered tau protein network as an important target for Alzheimer’s disease (AD). Particularly, two points of pharmacological intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process. On the basis of this consideration and on our interest in multitarget paradigms in AD, we report on the discovery of 2,4-thiazolidinedione derivatives endowed with such a profile. 28 and 30 displayed micromolar IC50 values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, respectively. In addition, they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. 30 also displayed inhibition of both K18 and full-length tau aggregations. Finally, both compounds were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model. To the best of our knowledge, 28 and 30 are the first balanced, nontoxic, dual-acting compounds hitting tau cascade at two different hubs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00610"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00610">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00610&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00610&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00610&amp;href=/doi/10.1021/acs.jmedchem.8b00610" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7640-7656</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00592" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00614" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Annachiara Gandini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annachiara Gandini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div><div class="loa-info-affiliations-info">Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annachiara++Gandini">Annachiara Gandini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuela Bartolini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuela Bartolini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++Bartolini">Manuela Bartolini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniele Tedesco</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniele Tedesco</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Tedesco">Daniele Tedesco</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Loreto Martinez-Gonzalez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Loreto Martinez-Gonzalez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Loreto++Martinez-Gonzalez">Loreto Martinez-Gonzalez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlos Roca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlos Roca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Roca">Carlos Roca</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nuria E. Campillo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nuria E. Campillo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nuria+E.++Campillo">Nuria E. Campillo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9948-2665" title="Orcid link">http://orcid.org/0000-0002-9948-2665</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Josefa Zaldivar-Diez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Josefa Zaldivar-Diez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Josefa++Zaldivar-Diez">Josefa Zaldivar-Diez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Concepción Perez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Concepción Perez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Quimica Medica, CSIC, Calle Juan de la Cierva 3, 28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Concepci%C3%B3n++Perez">Concepción Perez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giampaolo Zuccheri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giampaolo Zuccheri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div><div class="loa-info-affiliations-info">S3 Center of the Institute of Nanosciences, Italian National Research Council (CNR), I-41125 Modena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giampaolo++Zuccheri">Giampaolo Zuccheri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrea Miti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea Miti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div><div class="loa-info-affiliations-info">S3 Center of the Institute of Nanosciences, Italian National Research Council (CNR), I-41125 Modena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Miti">Andrea Miti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2730-1861" title="Orcid link">http://orcid.org/0000-0002-2730-1861</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessandra Feoli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessandra Feoli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EpigeneticMedChemLab, Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessandra++Feoli">Alessandra Feoli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sabrina Castellano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sabrina Castellano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">EpigeneticMedChemLab, Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sabrina++Castellano">Sabrina Castellano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sabrina Petralla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sabrina Petralla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sabrina++Petralla">Sabrina Petralla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Monti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Monti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Monti">Barbara Monti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Rossi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Rossi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Rossi">Martina Rossi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabio Moda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabio Moda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Fondazione IRCCS Istituto Neurologico Carlo Besta, via Celoria 11, I-20133 Milan, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Moda">Fabio Moda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giuseppe Legname</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giuseppe Legname</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Legname">Giuseppe Legname</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Martinez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Martinez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Martinez">Ana Martinez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2707-8110" title="Orcid link">http://orcid.org/0000-0002-2707-8110</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Maria Laura Bolognesi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Laura Bolognesi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +39 0512099717. E-mail: <a href="/cdn-cgi/l/email-protection#ec818d9e858d808d999e8dc28e8380838b82899f85ac9982858e83c28598"><span class="__cf_email__" data-cfemail="066b67746f676a677374672864696a69616863756f4673686f6469286f72">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Laura++Bolognesi">Maria Laura Bolognesi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1289-5361" title="Orcid link">http://orcid.org/0000-0002-1289-5361</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00610&amp;href=/doi/10.1021%2Facs.jmedchem.8b00610" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7640–7656</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 4, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 April 2018</li><li><span class="item_label"><b>Published</b> online</span>4 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7640%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnnachiara%2BGandini%252C%2BManuela%2BBartolini%252C%2BDaniele%2BTedesco%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D17%26contentID%3Dacs.jmedchem.8b00610%26title%3DTau-Centric%2BMultitarget%2BApproach%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%253A%2BDevelopment%2Bof%2BFirst-in-Class%2BDual%2BGlycogen%2BSynthase%2BKinase%2B3%25CE%25B2%2Band%2BTau-Aggregation%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7656%26publicationDate%3DSeptember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00610"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3492</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00610" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Annachiara&quot;,&quot;last_name&quot;:&quot;Gandini&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Bartolini&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Tedesco&quot;},{&quot;first_name&quot;:&quot;Loreto&quot;,&quot;last_name&quot;:&quot;Martinez-Gonzalez&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Roca&quot;},{&quot;first_name&quot;:&quot;Nuria&quot;,&quot;last_name&quot;:&quot;E. Campillo&quot;},{&quot;first_name&quot;:&quot;Josefa&quot;,&quot;last_name&quot;:&quot;Zaldivar-Diez&quot;},{&quot;first_name&quot;:&quot;Concepción&quot;,&quot;last_name&quot;:&quot;Perez&quot;},{&quot;first_name&quot;:&quot;Giampaolo&quot;,&quot;last_name&quot;:&quot;Zuccheri&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Miti&quot;},{&quot;first_name&quot;:&quot;Alessandra&quot;,&quot;last_name&quot;:&quot;Feoli&quot;},{&quot;first_name&quot;:&quot;Sabrina&quot;,&quot;last_name&quot;:&quot;Castellano&quot;},{&quot;first_name&quot;:&quot;Sabrina&quot;,&quot;last_name&quot;:&quot;Petralla&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Monti&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Rossi&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Moda&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Legname&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Martinez&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Laura Bolognesi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;7640-7656&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00610&quot;},&quot;abstract&quot;:&quot;Several findings propose the altered tau protein network as an important target for Alzheimer’s disease (AD). Particularly, two points of pharmacological intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process. On the basis of this consideration and on our interest in multitarget paradigms in AD, we report on the discovery of 2,4-thiazolidinedione derivatives endowed with such a profile. 28 and 30 displayed micromolar IC50 values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, respectively. In addition, they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. 30 also displayed inhibition of both K18 and full-length tau aggregations. Finally, both compounds were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model. To the best of our knowledge, 28 and 30 are the first balanced, nontoxic, dual-acting compounds hitting tau cascade at two different h&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00610&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00610" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00610&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00610" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00610&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00610" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00610&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00610&amp;href=/doi/10.1021/acs.jmedchem.8b00610" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00610" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00610" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26pmid%3D30078314%26genre%3Darticle%26aulast%3DGandini%26date%3D2018%26atitle%3DTau-Centric%2BMultitarget%2BApproach%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%253A%2BDevelopment%2Bof%2BFirst-in-Class%2BDual%2BGlycogen%2BSynthase%2BKinase%2B3%25CE%25B2%2Band%2BTau-Aggregation%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/jmcmar.2018.61.issue-17/20180913/jmcmar.2018.61.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Several findings propose the altered tau protein network as an important target for Alzheimer’s disease (AD). Particularly, two points of pharmacological intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process. On the basis of this consideration and on our interest in multitarget paradigms in AD, we report on the discovery of 2,4-thiazolidinedione derivatives endowed with such a profile. <b>28</b> and <b>30</b> displayed micromolar IC<sub>50</sub> values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, respectively. In addition, they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. <b>30</b> also displayed inhibition of both K18 and full-length tau aggregations. Finally, both compounds were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model. To the best of our knowledge, <b>28</b> and <b>30</b> are the first balanced, nontoxic, dual-acting compounds hitting tau cascade at two different hubs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drug development for Alzheimer’s disease (AD) has proven to be very difficult. A 0.4% success rate for approval is among the lowest for any therapeutic area, and it has been 15 years since the last drug, memantine, was launched.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> What is even more discouraging is that despite the enormous social and economic rewards of a successful treatment, big pharma are pulling out of AD research.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a></div><div class="NLM_p">Over the years, some of the complications of AD drug discovery have been related to its multifactorial nature. Advances in systems biology have been revealing a phenotypic robustness and a network structure for AD pathology, strongly implying that single-target compounds are inadequate in curing AD and preventing its progression.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Conversely, a polypharmacological approach appears better suited to confront such a complex disease and to provide disease-modifying effects.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> In light of this, the development of multitarget directed ligands (MTDLs), i.e., small molecules able to hit multiple targets responsible for AD pathogenesis, has been pursued as a new therapeutic opportunity in recent years, leading to the discovery of different promising compounds.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> In spite of the clear preclinical success, no rationally designed multitarget compound has been approved so far for the treatment of AD.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Indeed, AD multitarget drug discovery combines the hurdles of an extremely challenging area with those of novel pharmaceutical tools.</div><div class="NLM_p">Clearly, to develop clinically effective MTDLs, the selection of appropriate targets is of utmost importance. They should be causally linked to the most relevant AD pathological processes, and their “networking” is critical for determining the final properties of the MTDL.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">The amyloid hypothesis<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> has long been the central dogma in AD drug discovery, leading to many (either single or multitarget)<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> drug candidates. However, recently, this hypothesis has been questioned on the basis of the repeating failures of amyloid-β (Aβ)-based drugs.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18−22)</a> In parallel, several findings are suggesting that the altered tau network is more significant than the Aβ one from a pathogenic point of view.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Strikingly, the very close spatial correlation between neuronal loss and tau aggregates in patients’ brains, and the genetic evidence for the role of tau aggregation in a wide range of neurodegenerative disorders due to mutations in the tau gene, provides a strong foundation to a tau-targeted therapy.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Tau is a microtubule-associated protein (MAP), predominantly expressed in the neuronal axons where it promotes microtubule stabilization and facilitates axonal transport of proteins, trophic factors, and other cellular constituents, including neurotransmitters.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Under physiological conditions, tau is in a dynamic equilibrium between the microtubule-bound and -unbound states, regulated by specific kinases and phosphatases. However, under pathological conditions, hyperphosphorylated tau loses its microtubule-stabilizing and axonal transport functions. Particularly, hyperphosphorylated tau becomes prone to misfolding and aggregation, ultimately resulting in the formation of neurofibrillary tangles (NFTs) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The tau aggregation cascade, once initiated, is self-replicating, depleting the physiological tau pool in the neuron and converting it to toxic NFTs which continue to accumulate, leading to neuronal death.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> In view of all these evidence, tau cascade is being recognized as a promising target for the development of drug candidates for the treatment of AD.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic depiction of tau cascade, tau structure, and points of pharmacological intervention.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Building on these considerations, we aimed to identify novel MTDLs able to hit tau cascade at two validated hubs, namely by inhibiting glycogen synthase kinase 3β (GSK-3β) and the tau aggregation process (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><div class="NLM_p">GSK-3β is a multifunctional serine/threonine kinase that phosphorylates tau mainly at the Ser199, Ser396, and Ser413 sites.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In AD, GSK-3β overexpression induces tau hyperphosphorylation and, consequently, its disjunction from the microtubules and its aggregation. Moreover, GSK-3β has an important role in other AD key features such as inflammation and apoptosis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Over the past decade, an increased interest in GSK-3β led to the discovery of several inhibitors, with different chemical scaffolds and mechanisms of action (i.e., ATP competition, allosteric modulation, and irreversible inhibition).<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> There was considerable rationale from preclinical models that GSK-3β inhibitors could be disease-modifying drugs.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Importantly, the ATP noncompetitive GSK-3β inhibitor tideglusib (<b>1</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is currently under clinical development for AD and other tauopathies and has demonstrated no safety concerns even after long-term treatments.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of tau-directed AD investigational drugs <b>1</b>–<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the other side, agents capable of preventing tau self-assembly represent another attractive strategy for the treatment of AD.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Importantly, phenothiazine derivatives methylene blue (<b>2</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and LMTX (<b>3</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) are in the clinical phase of AD drug development.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></div><div class="NLM_p">Herein, we report on the development of the first-in-class MTDLs <b>4</b>–<b>38</b> (general structure in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) which, by simultaneously inhibiting GSK-3β and the tau aggregation process, may pave the way for a completely novel AD treatment. In contrast with the available single-targeted drug candidates, their superior potential efficacy is based on the assumption that, by targeting two points of the tau network, they could trigger a synergistic response and eliminate compensatory reactions and feedback controls, thereby overcoming the pathway robustness. Furthermore, in principle, such dual inhibitors should possess a lower target-related toxicity. Because most links in neuronal networks are weak, it can be inferred that even low-affinity dual inhibitors should be sufficient to achieve a significant antitau effect. If the concentration required to obtain the desired effect is lower with respect to single-targeted drugs, the risk for toxicity is reduced.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This greatly eases the constraints of druggability, which is a key issue for GSK-3β.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General chemical structures of TDZD, 2-iminothiazolidin-4-one, hydantoin, rhodanine, thiohydantoin, and TZD-derivatives <b>4</b>–<b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is noteworthy that although interesting examples of MTDLs that combine antitau activity with a second one beneficial for AD treatment have been recently reported (e.g., antiamyloid, antioxidant, anti-inflammatory activity),<a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46">(36−46)</a><b>4</b>–<b>38</b> are the first compounds able to hit tau cascade at two hubs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Design of Dual GSK-3β/Tau Aggregation Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Designing a ligand able to simultaneously bind two targets sharing no similarity in the binding sites, as it is the case of GSK-3β and tau protein, could be very challenging.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Likewise, combining the molecular frameworks of two CNS-directed single-target ligands (or the corresponding underlying pharmacophores) in one small molecule might not be an easy task, especially in terms of pharmacokinetics optimization.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">In this context, five-membered heterocyclic fragments caught our attention. Several known GSK-3β inhibitors carry five-membered heterocyclic rings (i.e., 2-iminothiazolidin-4-one and hydantoin, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) with hydrogen bond acceptor and donor functionalities.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> Thiadiazolidinediones (TDZDs, exemplified by <b>1</b>) have been reported as the first class of non-ATP competitive inhibitors of GSK-3β.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Intriguingly, rhodanine, thiohydantoin, and hydantoin isosters (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) were discovered by Mandelkow and Waldmann as effective tau antiaggregation motifs.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> These derivatives inhibited the formation of tau aggregates in a dose-dependent fashion as well as destabilized preformed tau aggregates. The ability of rhodanines and thiohydantoins to directly interact with tau aggregates has been confirmed by the tau imaging properties of derivatives RH1 ((<i>Z</i>)-ethyl 2-(5-((5-(3-iodophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetate) and TH2 ((<i>Z</i>)-ethyl 2-(4-((5-(3-iodophenyl)furan-2-yl)methylene)-5-oxo-2-thioxoimidazolidin-1-yl) acetate).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Thus, we reasoned that the cross-talk between all these fragments could be favorably exploited to identify MTDLs directed to the two selected targets (i.e., GSK-3β and tau protein).</div><div class="NLM_p">In principle, being prone to bind a large number of targets with weak or moderate affinity, rhodanines might be an optimal starting point for ligand-based multitarget endeavors.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Nevertheless, the validity of rhodanine scaffold is questionable because of its notorious pan assay interference compounds (PAINS) behavior.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Although it is hard to draw the line between true multitarget activity and aggregation effects or potential reactivity, which may or may not<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> lead to assay interference, we considered it safer to disregard the rhodanine scaffold.</div><div class="NLM_p">Conversely, among the five-membered heterocycle isosters, we selected the 2,4-thiazolidinedione (TZD, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) scaffold, which has never been explored as either GSK-3β or tau antiaggregation fragment. As highlighted by Baell and Pouliot,<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57−59)</a> the TZD core itself does not aggressively drive assay interference in the same way as rhodanine does. Indeed, TZD is not identified as a PAIN by computational filters (see “<a class="ref internalNav" href="#sec6_1_1" aria-label="PAINS Analysis">PAINS Analysis</a>” in <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). To support the drug-likeness of the TZD scaffold in AD, the TZD-based antidiabetic drug pioglitazone (PIO) is currently under evaluation in a phase 3 clinical trial as an anti-inflammatory drug in mild cognitive impaired patients.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p last">Starting from the TZD, as a first step, we decided to decorate it at position 5 with different aromatic and heteroaromatic substituents, affording a 35-membered library of 5-arylidene-2,4-thiazolidinediones (<b>4</b>–<b>38</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This was based on previous studies showing that (i) 5-arylidene substitution improved affinity in a series of 2-iminothiazolidin-4-one competitive GSK-3β inhibitors, and (ii) due to their volume and size, they do not fit in similar regions of homologous kinases, therefore showing selectivity for GSK-3β.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In addition, this would allow to maintain the planarity and aromaticity features, critical for interaction with tau fibrils.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Among the possible aromatic and heteroaromatic substituents, we included those (e.g., indoles, benzofurans, and benzothiophenes) reported as effective antiamyloid scaffolds.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of <b>4</b>–<b>38</b> was easily achieved through a one-pot, optimized version of the Knoevenagel condensation. The conventional protocol based on the reaction of equimolar amounts of TZD and an aromatic aldehyde,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> in the presence of catalytic amounts of pyridine and acetic acid, suffers from several disadvantages, such as long reaction times, low to moderate yields, use of toxic solvents. To overcome these drawbacks, a solvent-free procedure using ethylenediamine diacetate (EDDA) as an inexpensive and effective Brönsted acid–base catalyst has been proposed.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Clearly, there are several advantages in using a solvent-free reaction, such as reduced pollution, lower costs, simplicity in process and handling, shorter reaction times, and higher yields. With the aim of further improving the green chemistry aspects, we performed the reaction under microwave (MW) irradiation. Thus, a newly optimized procedure based on the solvent-free condensation of aromatic aldehydes with TZD (1:1) in the presence of EDDA (0.5 equiv), under MW irradiation at 80 °C for 30 min (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), was developed. It was successfully applied to the vast array of aldehydes <b>4a</b>–<b>38a</b> (with electron-withdrawing and electron-donating groups, heteroaromatic, conjugated, and planar rings) to obtain target compounds <b>4</b>–<b>38</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for structures). To the best of our knowledge, microwave-mediated EDDA-catalyzed Knoevenagel condensation has never been exploited so far for the synthesis of 5-arylidene-2,4-thiazolidinediones.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Optimized Knoevenagel Reaction for the Synthesis of TZD Derivatives <b>4</b>–<b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All the aromatic aldehydes were purchased from commercial vendors, except <b>14a</b> and <b>15a</b>. These were synthesized by slightly modified reported procedures (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> In the first case, 2-fluorobenzaldehyde (<b>39</b>) was reacted with dimethylamine in the presence of potassium carbonate to provide aldehyde <b>14a</b>. In the second case, the commercially available 3-(dimethylamino)benzyl alcohol (<b>40</b>) was oxidized under Swern conditions, affording aldehyde <b>15a</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0017.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Procedure for the Synthesis of Aldehydes <b>14a</b> and <b>15a</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">All compounds were characterized using analytical (HPLC) and spectroscopic data (<sup>1</sup>H and <sup>13</sup>C NMR, ESI-MS), which are collected in the <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">4.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To verify the capability of the synthesized molecules to simultaneously hit the two targets and to make a judicious use of resources, we designed a screening pipeline whose main goals were: (i) to make a preliminary screening of all synthesized molecules for GSK-3β activity, (ii) to predict blood–brain barrier (BBB) permeability of the active GSK-3β inhibitors, (iii) to filter out toxic compounds, (iv) to assess the most promising compounds for their antitau activity, and (iv) to confirm the antitau activity in a cellular model.</div><div id="sec4_0_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> GSK-3β Inhibition Assays</h3><div class="NLM_p">GSK-3β biochemical inhibition for <b>4</b>–<b>38</b> was first assessed using the Kinase-Glo luminescent assay, which quantifies the decrease in ATP levels following the kinase reaction.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> All compounds were first tested at 10 μM, and hits with percentage inhibition ≥50% were further tested to obtain IC<sub>50</sub> values (determined by using the linear regression parameter). TDZD8 (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> was used as reference compound. Encouragingly, 16 out of the starting 35 TZDs inhibited GSK-3β with IC<sub>50</sub> values in the single-digit micromolar range (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>30</b> ((<i>Z</i>)-5-((5-methoxy-1-methyl-1<i>H</i>-indol-3-yl)methylene)thiazolidine-2,4-dione) was the most active, with a submicromolar IC<sub>50</sub> of 0.89 ± 0.21 μM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. GSK-3β Inhibition Evaluation of TZD Derivatives <b>4</b>–<b>38</b> (Values Are the Mean of Three Independent Experiments)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0018.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0019.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">From the data reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, preliminary structure–activity relationships (SAR) can be drawn. In comparison with unsubstituted <b>4</b> (IC<sub>50</sub> > 10 μM), hydroxyl substituents in <i>ortho</i> and <i>meta</i> positions of the phenyl ring did not increase enzyme inhibition, as evident for <b>5</b> and <b>6</b>. On the other side, −OH substitution in <i>para</i> improved the inhibitory activity, as shown by <b>7</b> (8.99 ± 0.78 μM). Disubstituted <b>8</b>–<b>10</b> did not show any significant enhancement with respect to <b>7</b>. Addition of the fluorine atom (<b>11</b>–<b>13</b>) seemed not to affect the activity. Regarding the dimethylamino substituent, the favored positions are the <i>ortho</i> and <i>meta</i>, as shown by <b>14</b> (9.22 ± 0.89 μM) and <b>15</b> (8.54 ± 0.81 μM). Replacement of the phenyl of <b>4</b> with a 4-pyridyl ring, as in <b>19</b>, led to an IC<sub>50</sub> of 1.42 ± 0.12 μM. Thiophene and benzothiophene substitutions (<b>22</b>, <b>23</b>) also resulted in a good inhibitory activity. In contrast, substitution with bulky moieties such as naphthyl, anthracene, phenylpropylene, or biphenyl, as in <b>24</b>–<b>27</b>, <b>33</b>, and <b>34</b>, resulted in compounds inactive at 10 μM. Interestingly, bicyclic <i>N</i>-heterocycles, such as <b>28</b>–<b>32</b>, showed different behaviors. More hydrophilic <b>28</b> and <b>32</b> are better GSK-3β inhibitors than <b>29</b>. Moreover, the insertion of a methyl group on the nitrogen atom of the indole, as in <b>30</b>, resulted in an important improvement in the inhibitory profile (0.89 ± 0.21 μM). This trend in activity had already been described for the previously reported indolyl-maleimide series of GSK-3β inhibitors.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> A retrospective computational study was performed to rationalize these results and predict compound binding mode (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">The GSK-3β inhibitory activity of selected inhibitors <b>28</b> and <b>30</b> (vide infra) was also confirmed in a time-resolved fluorescence energy transfer (TR-FRET) assay. <b>28</b> and <b>30</b> were tested at 10 different concentrations, and the resulting dose–response curves are depicted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The obtained IC<sub>50</sub> values for both <b>28</b> (21.0 ± 2.4 μM) and <b>30</b> (5.5 ± 0.8 μM) were in agreement with the ones obtained with the Kinase-Glo luminescent assay. Thus, we were able to prove the genuine GSK-3β inhibitory activity of <b>28</b> and <b>30</b>. In addition, because of the presence of the alkylidene moiety, prone to potential covalent reactions (see “<a class="ref internalNav" href="#sec6_1_1" aria-label="PAINS Analysis">PAINS Analysis</a>” for further discussion), we aimed to assess the reversibility of GSK-3β inhibition. Thus, we performed a jump-dilution experiment on <b>30</b>, demonstrating that the enzymatic activity was restored after dilution, pointing to a reversible inhibition by <b>30</b> (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">Figure S7</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response curves of GSK-3β activity in the presence of <b>28</b> and <b>30</b>. Values are the means ± SD determined for at least two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further investigate the mechanism of action, <b>28</b> and <b>30</b> were subjected to kinetic analysis. Particularly, we determined the competition with the ATP. We varied both ATP and <b>28</b> and <b>30</b> concentrations with a constant concentration of GS-2, the substrate used in the enzymatic reaction. The double-reciprocal plot of data (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) indicates that both <b>28</b> and <b>30</b> act as competitive inhibitors of ATP binding. In light of this, TZD derivatives represent a new chemical class of ATP-competitive GSK-3β inhibitors.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinetic data for the TZD derivatives <b>28</b> and <b>30</b>. ATP concentration in the reaction mixture varied from 1 to 50 μM. Compounds concentrations used are depicted in the plot, and the concentration of GS-2 was kept constant at 25 μM. Each point is the mean of two different experiments, both analyzed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_0_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Blood–Brain Barrier Permeation</h3><div class="NLM_p last">One of the main obstacles for CNS drug discovery is the drug penetration into the BBB at therapeutic concentrations.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Parallel artificial membrane permeability assay (PAMPA)-BBB is a high throughput technique developed to predict BBB passive permeability. To preliminarily explore the capacity of GSK-3β inhibitors <b>7</b>–<b>10</b>, <b>14</b>, <b>15</b>, <b>18</b>, <b>19</b>, <b>22</b>, <b>23</b>, <b>28</b>, <b>30</b>, <b>32</b>, <b>35</b>, <b>37</b>, and <b>38</b> to penetrate into the brain, we used the PAMPA-BBB method,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> which employs a brain lipid porcine membrane. The in vitro effective permeability (<i>P</i><sub>e</sub>) of commercial drugs through lipid membrane extract together with TZD derivatives was determined. An assay validation was made comparing the reported permeability values of commercial drugs with the experimental data. A good correlation between experimental-described values was obtained (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">Figure S6</a>). From this equation and following the pattern established in the literature for BBB permeation prediction,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> we could classify compounds as CNS+ when they present a permeability >3.07 × 10<sup>–6</sup> cm/s. On the basis of these results, only compounds <b>14</b>, <b>15</b>, <b>23</b>, <b>28</b>, and <b>30</b> are predicted to cross the BBB by passive permeation (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">Table S2</a>) and thus were progressed for toxicity and tau antiaggregation analysis.</div></div><div id="sec4_0_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Neuro- and Hepatotoxicity Assessment</h3><div class="NLM_p">The failure of several AD drug discovery approaches has been attributed not only to the lack of efficacy but also to the toxicity of the drug candidates after a chronic treatment.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In consideration of this, and motivated by the promising in vitro results, we first tested neurotoxicity on the five GSK-3β inhibitors predicted to cross the BBB, in comparison to PIO (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Neurotoxicity on primary rat cerebellar granule neurons (CGNs) after 24 h treatment. (B) Hepatotoxicity on human hepatoma cells (HepG2) after 24 h treatment. Results are expressed as percentage of controls and are the mean ± SE of at least three different experiments, each run in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Primary cultures of cerebellar granule neurons (CGNs) are useful in vitro models to study neuronal death.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assessment of CGNs viability after 24 h treatment with <b>14</b>, <b>15</b>, and <b>23</b> showed a clear toxic effect for all the three compounds, as well as PIO, even at 5 μM concentration. Notably, <b>28</b> and <b>30</b> showed a very low neurotoxicity only at the highest tested concentrations (50 μM).</div><div class="NLM_p last">In AD patients, aging, comorbidity, and subsequent polytherapy significantly contribute to increase the risk of drug–drug interactions and, consequently, hepatotoxicity. Moreover, although being effective therapeutic agents, some TZD derivatives have been reported to show hepatotoxicity.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> To this end, parallel experiments were performed on <b>14</b>, <b>15</b>, <b>23</b>, <b>28</b>, and <b>30</b> in a human hepatoma cell line (HepG2) in comparison with PIO (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). After 24 h incubation at 0–50 μM, a concentration-dependent decrease in cell viability was observed for PIO, <b>14</b>, and <b>15</b>. Encouragingly, compounds <b>23</b>, <b>28</b>, and <b>30</b> showed no hepatotoxicity, even at 50 μM. On the basis of the toxicity profiles, indole derivatives <b>28</b> and <b>30</b> emerged as the most drug-like compounds.</div></div><div id="sec4_0_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> AcPHF6 Aggregation and Inhibition Studies by Thioflavin T (ThT) Fluorescence, Circular Dichroism Spectroscopy, and Atomic Force Microscopy</h3><div class="NLM_p">In parallel, the ability of PAMPA-BBB permeable <b>14</b>, <b>15</b>, <b>23</b>, <b>28</b>, and <b>30</b> to interfere with tau aggregation in vitro was investigated by using the AcPHF6 peptide (<sub>306</sub>VQIVYK<sub>311</sub>) as a model system. Indeed, AcPHF6 is a short segment found in the third repeat of the microtubule-binding region of tau protein (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). As recently highlighted by cryoelectron microscopy of tau filaments, <sub>306</sub>VQIVYK<sub>311</sub> spatially arranges into a β-strand conformation and contributes to the formation of the C-shaped cross-β structure representing the filament core of PHFs.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> As AcPHF6 undergoes spontaneous fibrillation, it has been proposed as a suitable model for screening small molecule inhibitors of tau aggregation.<a onclick="showRef(event, 'ref75 ref76 ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77 ref78 ref79 ref80">(75−80)</a> As for other β-sheet proteins, the aggregation process can be monitored by fluorescence in the presence of ThT, which displays a characteristic change in the emission spectrum in the presence of β-rich structures.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The antiaggregating activity of <b>14</b>, <b>15</b>, <b>23</b>, <b>28</b>, and <b>30</b> was therefore monitored in phosphate buffer 50 mM, pH 7.4, using ThT as detection dye. In agreement with previous studies,<a onclick="showRef(event, 'ref75 ref76 ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref77 ref78 ref79 ref80">(75−80)</a> when incubated alone, AcPHF6 rapidly aggregated, as confirmed by the increase in the fluorescence intensity over a period of 80 min (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Co-incubation of AcPHF6 with the selected compounds led to a significant (>50%) decrease of the fluorescence intensities, indicating that all compounds could significantly interfere with AcPHF6 aggregation, even if at different extents (from 54.7% to 79.8%). In particular, derivatives <b>15</b> and <b>30</b> showed the highest inhibitory potencies reducing the fluorescence signal at plateau by almost 80% (79.5 and 79.8%, respectively) and resulting in being only slightly less potent than the known inhibitor myricetin.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a><a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B shows the details of the kinetics of aggregation of AcPHF6 incubated alone and in the presence of compounds <b>28</b> and <b>30</b>, namely the derivatives endowed with the best safety profile (see above).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Inhibition of AcPHF6 peptide (50 μM) aggregation in the presence of selected derivatives (10 μM) after 80 min incubation. The data are the mean of at least three repeats. (B) Kinetics of the AcPHF6 aggregation in the absence and in the presence of compounds <b>28</b> and <b>30</b> monitored by ThT fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Circular dichroism (CD) studies were then carried out to gain further insights into the mechanism of inhibition of <b>28</b> and <b>30</b> and to exclude false positive outcomes due to the possible displacement of bound ThT by the tested compounds. The CD spectrum of AcPHF6 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) shows a negative band at 221 nm followed by a positive band at shorter wavelengths, both of which are typical features of β-sheet structures. A decrease in intensity was observed for the CD spectrum of AcPHF6 in the presence of <b>28</b>, suggesting that the abundance of β-sheet structures is lower. On the other hand, the CD profile of AcPHF6 in the presence of <b>30</b> lacks for the typical bands of β-sheet structures, with the peptide displaying an unordered conformation. Both behaviors are consistent with the inhibitory trends highlighted by the fluorescence-based assay; therefore, CD data confirm the inhibitory capacity of derivatives <b>28</b> and <b>30</b> and suggest that their antiaggregating activity is related to their ability to stabilize the AcPHF6 peptide in a less fibrillogenic conformation, with derivative <b>30</b> being much more effective in doing so.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. CD spectra of AcPHF6 (100 μM) in the absence (blue solid line) and in the presence of <b>28</b> (20 μM, green dashed line) or <b>30</b> (20 μM, red dotted line), measured after 2 h incubation. Solvent: phosphate buffer (50 mM pH 7.4)/water/methanol/DMSO 89:10:0.95:0.05 (v/v/v/v). Pathlength: 1 mm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Atomic force microscopy (AFM) studies were also performed to examine the morphology of the fibrils formed by a 50 μM phosphate buffer solution of AcPHF6 peptide alone and in the presence of <b>28</b> and <b>30</b> when prepared in the same conditions employed for the above-described ThT studies (but in the absence of ThT). After incubation, aliquots of the solutions were subjected to ultrafiltration to separate the low molecular weight unpolymerized hexapeptide fraction from the high molecular weight (HMW) fiber fraction, and such HMW fraction was adsorbed on the surface of mica for AFM imaging. We believe that filtering out unpolymerized peptides at the time of AFM specimen preparation could avoid some confusing results sometimes found in AFM data. As evident in the micrographs in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, long and thick amyloid fibrils were imaged after adsorbing on mica the solution of AcPHF6 incubated in the absence of inhibitors (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). Here, fibers with individual diameters of 10 nm or more (and lengths of several hundreds of nanometers) were found in bundles and higher-order aggregates. On the other hand, only much smaller structures (possibly oligomers or protofibrils) were observed from the adsorption of the hexapeptide incubated in the presence of the inhibitors <b>28</b> and <b>30</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B,C). We can hypothesize that such lower molecular weight aggregated structures could be responsible for the small but nonzero fluorescence signal recorded in the ThT-based assay when the hexapeptide was incubated in the presence of <b>28</b> and <b>30</b>.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. AFM micrographs of amyloid fibers obtained from the aggregation of 50 μM AcPHF6 peptide in phosphate buffer in the absence (A) and in the presence of 10 μM compound <b>28</b> (B) and compound <b>30</b> (C). The height of fibers on the mica substrate is coded according to the common included color table (ranging from 0 to 50 nm of heights) as to allow visual comparison of the different size of the adsorbed structures. Insets of B and C: the rectangular portions of B and C situated at the inset location in the micrograph (and of the size of the inset) are displayed according to the reported magnified 0–5 nm color look-up table in order to better show the smaller and thinner adsorbed structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_0_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> K18 and Full-Length Tau Aggregation and Inhibition Studies</h3><div class="NLM_p">Encouraged by the results obtained with the AcPHF6 peptide, we decided to confirm the antiaggregating properties of the most active <b>30</b> in more clinically relevant models of tau aggregation. The tau fibrillization process can be replicated in vitro, however, recombinant tau shows very little intrinsic tendency to aggregate due to the lack of a series of post-translational modifications required for its aggregation. Indeed, during the last years, recombinant truncated tau isoforms are more frequently used for in vitro tau aggregation, where the addition of anionic cofactors (e.g., heparin, arachidonic acid) results in the formation of fibrils that resemble those observed in the brains of AD patients.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> Thus, <b>30</b> was first evaluated in a heparin-induced tau assembly assay in which the fibrillization of the truncated K18 tau fragment (comprising four microtubules-binding repeats, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was monitored by ThT. The aggregation of the tau fragment K18 was achieved through the real-time quaking-induced conversion (RT-QuIC) technique.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, K18 alone was completely aggregated after 11–12 h and the fluorescence intensity reached the highest value, while the treatment with <b>30</b> (1, 5, 10 μM) resulted in a delay of K18 self-aggregation. Moreover, the analysis of the averaged fluorescence intensities at the plateau of the kinetic showed a 35% inhibition of the aggregation process.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. RT-QuIC analysis of <b>30</b> activity on tau K18 self-aggregation monitored by ThT fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Motivated by the promising results, we also tested the inhibitory activity of <b>30</b> toward the heparin-induced self-aggregation of full-length 2N4R tau through RT-QuIC technique. Treatment of 2N4R tau with <b>30</b> (10 μM) did not show a delay in the aggregation process (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). However, coincubation with <b>30</b> led to a lower amount of formed aggregates, as indicated by a 30% lower plateau signal. Importantly, this result is in agreement with that obtained with K18 fragment, confirming the potential of <b>30</b> as tau antiaggregating compound.</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. RT-QuIC analysis of <b>30</b> activity on full-length tau self-aggregation monitored by ThT fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_0_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Okadaic Acid-Induced Tau Hyperphosphorylation Cell Model</h3><div class="NLM_p">Increasing evidence has suggested that inhibition of phosphatases by okadaic acid (OA) represents the most robust way to induce tau hyperphosphorylation. Thus, OA-treated cell lines and primary neuronal cultures have been used as established cellular models of hyperphosphorylated tau-induced neurodegeneration.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> In addition, OA-treated rodents recapitulate the morphological hallmarks of AD.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">To confirm the antitau profile of <b>28</b> and <b>30</b> in a cellular context, we further explored their rescue potential in the OA-induced neurodegeneration cell model, in comparison with TDZD8.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">We studied the effect of <b>28</b> and <b>30</b> and TDZD8, at two different concentrations (10 and 20 μM), in a human neuroblastoma cell line (SH-SY5Y) treated with OA (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). As expected, OA induced a decrease in cell viability higher than 50%. Importantly, both <b>28</b> and <b>30</b> were able to increase the cell viability, probably due to the decrease on tau phosphorylation by GSK-3β inhibition. Particularly, <b>28</b> was only slightly less effective than TDZD8. To note, other indole derivatives have been reported as effective in counteracting OA-induced neurotoxicity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><figure id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. OA-induced neurodegeneration cell model. Effects of treatment with <b>28</b> and <b>30</b>. Results are mean value ± SEM, represented as relatives to control value (= 100), of six replicates from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_0_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Inhibitory Activity Profile toward Casein Kinase 1 (CK1) δ and ε, and Cell Division Cycle 7 (Cdc7)</h3><div class="NLM_p">Finally, to preliminarily address kinase promiscuity issues of ATP competitive inhibitors,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> we tested <b>28</b> and <b>30</b> on three selected kinases, i.e., casein kinase 1 (CK1) δ and ε, and cell division cycle 7 (Cdc7) kinase, available in our laboratories. Cdc7 is another representative cell cycle regulation kinase,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> which should show low binding affinity toward new GSK-3β hits to avoid possible toxicities. CK1δ and CK1ε represent GSK-3β phylogenetically diverse kinases, able to phosphorylate tau.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><div class="NLM_p">Therefore, the inhibition of <b>28</b> and <b>30</b> toward CK1δ, CK1ε, Cdc7, and GSK-3β were assessed at 10 μM. Encouragingly, <b>28</b> and <b>30</b> only poorly, or not inhibited at all, CK1δ, CK1ε, and Cdc7 (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), while they inhibited GSK-3β by 95% and 100%, respectively. This reveals a preliminary selectivity of both <b>28</b> and <b>30</b> toward GSK-3β.</div><figure id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Inhibitory activity profile of <b>28</b> (blue) and <b>30</b> (purple) toward human CK1δ, CK1ε, Cdc7, and GSK-3β kinases, at a fixed concentration of 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">5.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have been interested in MTDLs that can confront the multifactorial nature of AD for years. Recently, in accordance with the drug discovery trends, we argued that a single molecule able to act at two validated targets belonging to the tau cascade might have clinical benefit and show higher therapeutic potential than those addressing amyloid cascade.</div><div class="NLM_p">Although in principle very promising, this approach must deal with the problem of targeting two proteins with no binding site similarity.</div><div class="NLM_p">On the basis of structural resemblances, as well as the available SAR data for GSK-3β and amyloid aggregation inhibitors, we were able to select the thiazolidinedione as a starting scaffold and to design a novel, first-in-class chemical series of dual inhibitors.</div><div class="NLM_p">A library of 35 derivatives was synthesized and tested in a pipeline tailored to our academic setting. This has delivered two hit molecules (<b>28</b> and <b>30</b>) that display features we consider relevant in terms of MTDL drug discovery principles: (i) they are low molecular weight fragment hits with evident advantages in terms of intended “promiscuity” and pharmacokinetic properties, (ii) their activity is balanced, and (iii) they show no significant toxicity, even toward mammalian primary neuronal cells.</div><div class="NLM_p">Thus, although very preliminary, the collected results show that it is possible to design small molecules that act specifically at two structurally different tau targets, like a kinase and a fibrillar protein, with a good potency and in the same concentration range to yield compounds effective at a cellular level.</div><div class="NLM_p last">These hits, targeting two independent but interrelated activities, might serve as tools to validate a completely new tau-centric network approach as a potential new disease-modifying strategy to treat AD.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">6.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">All the commercial available reagents and solvents were purchased from Sigma-Aldrich, Alpha Aesar, VWR, and TCI and used without further purification. Reactions were followed by analytical thin layer chromatography (TLC) on precoated TLC plates (layer 0.20 mm silica gel 60 with a fluorescent indicator UV254, from Sigma-Aldrich). Developed plates were air-dried and analyzed under a UV lamp (UV 254/365 nm). CEM Discover SP focused microwave reactor was used for microwave mediated reactions. Nuclear magnetic resonance (NMR) experiments were run on Varian VXR 400 (400 MHz for <sup>1</sup>H, 100 MHz for <sup>13</sup>C). <sup>1</sup>H and <sup>13</sup>C NMR spectra were acquired at 300 K using deuterated dimethyl sulfoxide ((CD<sub>3</sub>)<sub>2</sub>SO) and chloroform (CDCl<sub>3</sub>) as solvents. Chemical shifts (δ) are reported in parts per million (ppm) relative to tetramethylsilane (TMS) as internal reference, and coupling constants (<i>J</i>) are reported in hertz (Hz). The spin multiplicities are reported as s (singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). Mass spectra were recorded on a VG707EH-F apparatus, and electrospray ionization (ESI) both in positive and negative mode was applied. Compounds were named following IUPAC rules as applied by ChemBioDraw Ultra (version 14.0). All of the final compounds showed ≥95% purity by analytical HPLC (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">Table S3</a>). As reported in literature,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> the TZD-derivatives <b>4</b>–<b>38</b> were obtained as single <i>Z</i> isomers. Indeed, their <sup>1</sup>H NMR spectra show only one signal attributable to the resonance of the 5-methylidene proton in the range 7.50–8.70 ppm, while in their <sup>13</sup>C NMR spectra the 5-methylidene carbon and the C5 of the TZD ring resonated in the ranges 130.5–140.7 and 117.5–128.0 ppm, respectively.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> PAINS Analysis</h4><div class="NLM_p">Aware of the liabilities that might arise from the alkylidene-TZD scaffold, we have analyzed <b>4</b>–<b>38</b> for known classes of assay interference compounds.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> First, <b>4</b>–<b>38</b> were not recognized as PAINS according to the Free ADME-Tox Filtering Tool (FAF-Drugs4) program (<a href="http://fafdrugs4.mti.univ-paris-diderot.fr/" class="extLink">http://fafdrugs4.mti.univ-paris-diderot.fr/</a>) and to the “False Positive Remover” software (<a href="http://www.cbligand.org/PAINS/" class="extLink">http://www.cbligand.org/PAINS/</a>), neither as aggregators according to the software “Aggregator Advisor” (<a href="http://advisor.bkslab.org/" class="extLink">http://advisor.bkslab.org/</a>). However, FAF-Drugs4 labeled them as covalent inhibitors due to their electrophilic nature. Thus, we provided evidence that the activities reported herein are highly likely not caused by pan assay interference.</div><div class="NLM_p">The genuine GSK-3β inhibitory activity of <b>28</b> and <b>30</b> has been confirmed in two assays (i.e., Kinase-Glo and TR-FRET). Possible promiscuous kinase inhibition was preliminary ruled out by the fact that <b>28</b> and <b>30</b> do not inhibit similar kinases (CK1δ, CK1ε) and Cdc7.</div><div class="NLM_p">As regards tau aggregation inhibition, activities of <b>28</b> and <b>30</b> have been evaluated in three different assays (i.e., ThT-based fluorometric assay, CD, and AFM), which show consistent results.</div><div class="NLM_p">The potential unspecific covalent reaction of alkylidene-TZD with proteins was ruled out by the negative jump dilution assay.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> In addition, we investigated the thiol-trapping reactivity of <b>28</b> and <b>30</b> in a simple NMR-based assay.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Reaction of Michael acceptor-bearing compounds with two equivalents of 2-aminoethanethiol (cysteamine), a biologically relevant model thiol,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> in DMSO should lead to the instantaneous formation of the corresponding Michael adduct and the simultaneous disappearance of the olefin signals. In contrast to what is reported for 5-benzylidene barbiturates,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> reaction of <b>28</b> and <b>30</b> (0.01 mmol) with cysteamine (0.02 mmol), after 30 min, did not lead to the formation of the Michael adduct (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). The same was observed after 24 h. Thus, we can expect that the double bond of <b>28</b> and <b>30</b> did not react covalently with sulfur nucleophiles with indiscriminate reactivity. In addition, on the basis of the results of the jump-dilution and the ATP-competition assays, we are confident that they did not react covalently with GSK-3β kinase.</div><figure id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0015.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Thiol trapping assay. <sup>1</sup>H NMR spectrum of <b>28</b> (A) and <b>30</b> (B) in DMSO-<i>d</i><sub>6</sub> and in DMSO-<i>d</i><sub>6</sub> with cysteamine (1:2). In the squares, the olefin signal is highlighted. No reaction occurs, even after 30 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure for the Synthesis of Compounds <b>4</b>–<b>38</b></h4><div class="NLM_p">The corresponding aldehydes (1 mmol) were reacted with 2,4-thiazolidinedione (1 mmol), using EDDA (0.5 mmol) under microwave irradiation at 80 °C for 30 min. The reaction mixture was diluted with water, and the solid was collected by filtration. After washing with water, all of the final compounds were purified through crystallization from ethanol/water.</div><div id="sec6_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (<i>Z</i>)-5-Benzylidenethiazolidine-2,4-dione (<b>4</b>)</h5><div class="NLM_p last">The title compound <b>4</b> was obtained as a light-yellow solid according to general procedure using benzaldehyde (<b>4a</b>). Yield 87%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.61 (br s, 1H); δ 7.79 (s, 1H); δ 7.61–7.46 (m, 5H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.37; δ 167.89; δ 133.49; δ 132.10; δ 130.81; δ 130.41; δ 129.74; δ 124.11. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 204 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (<i>Z</i>)-5-(2-Hydroxybenzylidene)thiazolidine-2,4-dione (<b>5</b>)</h5><div class="NLM_p last">The title compound <b>5</b> was obtained as a yellow solid according to general procedure using 2-hydroxybenzaldehyde (<b>5a</b>). Yield 56%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.48 (br s, exch, 1H); δ 10.48 (s, exch, 1H); δ 8.02 (s, 1H); δ 7.33–7.28 (m, 2H); δ 6.96–6.92 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.60; δ 167.97; δ 157.69; δ 132.66; δ 128.73; δ 127.41; δ 122.36; δ 120.37; δ 120.11; δ 116.55. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 220 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (<i>Z</i>)-5-(3-Hydroxybenzylidene)thiazolidine-2,4-dione (<b>6</b>)</h5><div class="NLM_p last">The title compound <b>6</b> was obtained as a white solid according to general procedure using 3-hydroxybenzaldehyde (<b>6a</b>). Yield 43%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.58 (br s, exch, 1H); δ 9.82 (s, exch, 1H); δ 7.68 (s, 1H); δ 7.32 (t, <i>J</i> = 7.9, 1H); δ 7.03 (d, <i>J</i> = 7.6, 1H); δ 6.97(s, 1H); δ 6.87 (d, <i>J</i> = 8, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.38; δ 167.81; δ 158.29; δ 134.63; δ 132.37; δ 130.78; δ 123.78; δ 121.73; δ 118.14; δ 116.32. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 220 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (<i>Z</i>)-5-(4-Hydroxybenzylidene)thiazolidine-2,4-dione (<b>7</b>)</h5><div class="NLM_p last">The title compound <b>7</b> was obtained as a yellow solid according to general procedure using 4-hydroxybenzaldehyde (<b>7a</b>). Yield 69%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.42 (br s, exch, 1H); δ 10.28 (s, exch, 1H); δ 7.69 (s, 1H); δ 7.45 (s, 1H); δ 6.91 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.48; δ 167.94; δ 160.30; δ 132.79; δ 132.70; δ 124.36; δ 119.43; δ 116.73. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 220 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> <i>(</i><i>Z</i>)-5-(2-Hydroxy-4-methoxybenzylidene)thiazolidine-2,4-dione (<b>8</b>)</h5><div class="NLM_p last">The title compound <b>8</b> was obtained as a yellow solid according to general procedure using 2-hydroxy-4-methoxybenzaldehyde (<b>8a</b>). Yield 75%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.39 (br s, exch, 1H); δ 10.64 (s, exch, 1H); δ 7.98 (s, 1H); δ 7.27 (d, <i>J</i> = 8.8, 1H); δ 6.59 (dd, <i>J</i> = 8.8, 2.5, 1H); δ 6.51 (d, <i>J</i> = 2.5, 1H); δ 3.77 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.24; δ 167.63; δ 162.66; δ 159.13; δ 129.72; δ 126.96; δ 118.38; δ 113.07; δ 106.56; δ 101.13; δ 55.32. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 274 [M + Na]<sup>+</sup>.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (<i>Z</i>)-5-(4-Hydroxy-3-methoxybenzylidene)thiazolidine-2,4-dione (<b>9</b>)</h5><div class="NLM_p last">The title compound <b>9</b> was obtained as a light-yellow solid according to general procedure using 4-hydroxy-3-methoxybenzaldehyde (<b>9a</b>). Yield 62%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.43 (br s, exch, 1H); δ 9.90 (s, exch, 1H); δ 7.71 (s, 1H); δ 7.17 (s, 1H); δ 7.08–7.05 (m, 1H); δ 6.94–6.90 (m, 1H); δ 3.83 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.51; δ 167.99; δ 149.84; δ 148.40; δ 132.96; δ 124.83; δ 124.54; δ 119.73; δ 116.60; δ 114.58; δ 56.07. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 250 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (<i>Z</i>)-5-(4-Hydroxy-3-nitrobenzylidene)thiazolidine-2,4-dione (<b>10</b>)</h5><div class="NLM_p last">The title compound <b>10</b> was obtained as a light-yellow solid according to general procedure using 4-hydroxy-3-nitrobenzaldehyde (<b>10a</b>). Yield 79%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.14 (d, <i>J</i> = 2.3 Hz, 1H); δ 7.76 (s, 1H); δ 7.72 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H); δ 7.22 (d, <i>J</i> = 8.8 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.88; δ 168.61; δ 155.86; δ 137.81; δ 135.78; δ 130.09; δ 128.19; δ 123.16; δ 122.55; δ 121.57. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 265 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (<i>Z</i>)-5-(2-Fluorobenzylidene)thiazolidine-2,4-dione (<b>11</b>)</h5><div class="NLM_p last">The title compound <b>11</b> was obtained as a pale-yellow solid according to general procedure using 2-fluorobenzaldehyde (<b>11a</b>). Yield 49%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.73 (br s, 1H); δ 7.79 (s, 1H); δ 7.56 (t, <i>J</i> = 6.9, 2H); δ 7.39 (t, <i>J</i> = 8.3, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.05; δ 167.51; δ 160.93; δ 129.24; δ 126.81; δ 125.85; δ 123.10; δ 121.36; δ 116.66. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 246 [M + Na]<sup>+</sup>.</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>Z</i>)-5-(3-Fluorobenzylidene)thiazolidine-2,4-dione (<b>12</b>)</h5><div class="NLM_p last">The title compound <b>12</b> was obtained as a yellow solid according to general procedure using 3-fluorobenzaldehyde (<b>12a</b>). Yield 60%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.73 (br s, 1H); δ 7.83 (s, 1H); δ 7.62 (dd, <i>J</i> = 14.5, 7.5, 1H); δ 7.48 (t, <i>J</i> = 9.9, 2H); δ 7.37 (t, <i>J</i> = 8.5, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.67; δ 167.27; δ 162.28; δ 135.46; δ 131.41; δ 130.32; δ 125.56; δ 125.37; δ 117.19; δ 116.74. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 222 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (<i>Z</i>)-5-(4-Fluorobenzylidene)thiazolidine-2,4-dione (<b>13</b>)</h5><div class="NLM_p last">The title compound <b>13</b> was obtained as a yellow solid according to general procedure using 4-fluorobenzaldehyde (<b>13a</b>). Yield 76%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.63 (br s, exch, 1H); δ 7.81 (s, 1H); δ 7.67 (m, 2H); δ 7.39 (t, <i>J</i> = 8.7, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.79; δ 167.32; δ 162.86; δ 132.48; δ 130.70; δ 129.74; δ 123.31; δ 116.51. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 222 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (<i>Z</i>)-5-(2-(Dimethylamino)benzylidene)thiazolidine-2,4-dione (<b>14</b>)</h5><div class="NLM_p last">The title compound <b>14</b> was obtained as a yellow solid according to general procedure using 2-(<i>N</i>,<i>N</i>-dimethylamino)benzaldehyde (<b>14a</b>). Yield 70%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.45 (br s, exch, 1H); δ 7.86 (s, 1H); δ 7.43 (dd, <i>J</i> = 12.9, 7.3, 2H); δ 7.18 (d, <i>J</i> = 8.1, 1H); δ 7.10 (t, <i>J</i> = 7.5, 1H); δ 2.68 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.65; δ 167.88; δ 153.28; δ 131.38; δ 130.53; δ 129.83; δ 125.65; δ 122.82; δ 122.08; δ 118.81; δ 44.15. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 247 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> (<i>Z</i>)-5-(3-(Dimethylamino)benzylidene)thiazolidine-2,4-dione (<b>15</b>)</h5><div class="NLM_p last">The title compound <b>15</b> was obtained as a yellow solid according to general procedure using 3-(<i>N</i>,<i>N</i>-dimethylamino)benzaldehyde (<b>15a</b>). Yield 78%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.55 (br s, exch, 1H); δ 7.73 (s, 1H); δ 7.31 (t, <i>J</i> = 7.9, 1H); δ 6.87–6.81 (m, 3H); δ 2.93 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.45; δ 167.74; δ 151.06; δ 134.00; δ 133.51; δ 130.16; δ 123.16; δ 117.73; δ 114.79; δ 113.99; δ 40.33. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 247 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (<i>Z</i>)-5-(4-(Dimethylamino)benzylidene)thiazolidine-2,4-dione (<b>16</b>)</h5><div class="NLM_p last">The title compound <b>16</b> was obtained as an orange solid according to general procedure using 4-(<i>N</i>,<i>N</i>-dimethylamino)benzaldehyde (<b>16a</b>). Yield 88%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.29 (br s, exch, 1H); δ 7.66 (s, 1H); δ 7.42 (d, <i>J</i> = 8.9, 2H); δ 6.81 (d, <i>J</i> = 9, 2H); δ 3.01 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.10; δ 167.52; δ 151.42; δ 132.83; δ 132.06; δ 119.80; δ 115.71; δ 112.01; δ 30.63. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 247 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> (<i>Z</i>)-5-(Pyridin-2-ylmethylene)thiazolidine-2,4-dione (<b>17</b>)</h5><div class="NLM_p last">The title compound <b>17</b> was obtained as a yellow solid according to general procedure using 2-pyridinecarbaldehyde (<b>17a</b>). Yield 55%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.43 (br s, 1H); δ 8.75 (d, <i>J</i> = 4.7, 1H); δ 7.93 (t, <i>J</i> = 7.6, 1H); δ 7.86–7.82 (m, 2H); δ 7.42 (dd, <i>J</i> = 6.7, 5.6, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.13; δ 167.55; δ 151.33; δ 149.44; δ 137.61; δ 128.12; δ 127.88; δ 127.83; δ 124.03. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 205 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (<i>Z</i>)-5-(Pyridin-3-ylmethylene)thiazolidine-2,4-dione (<b>18</b>)</h5><div class="NLM_p last">The title compound <b>18</b> was obtained as a pale-yellow solid according to general procedure using 3-pyridinecarbaldehyde (<b>18a</b>). Yield 34%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.68 (br s, 1H); δ 8.80 (s, 1H); δ 8.59 (d, <i>J</i> = 4.7, 1H); δ 7.93 (d, <i>J</i> = 8.1, 1H); δ 7.80 (s, 1H); δ 7.52 (d, <i>J</i> = 5.6, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.57; δ 167.20; δ 151.31; δ 150.53; δ 135.98; δ 129.24; δ 128.38; δ 126.02; δ 124.23. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 205 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (<i>Z</i>)-5-(Pyridin-4-ylmethylene)thiazolidine-2,4-dione (<b>19</b>)</h5><div class="NLM_p last">The title compound <b>19</b> was obtained as a pale-pink solid according to general procedure using 4-pyridinecarbaldehyde (<b>19a</b>). Yield 59%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.79 (br s, 1H); δ 8.72 (d, <i>J</i> = 5.1, 2H); δ 7.75 (s, 1H); δ 7.54 (d, <i>J</i> = 5.2, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.82; δ 167.71; δ 150.81; δ 149.72; δ 140.50; δ 128.65; δ 123.59. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 205 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (<i>Z</i>)-5-(Furan-2-ylmethylene)thiazolidine-2,4-dione (<b>20</b>)</h5><div class="NLM_p last">The title compound <b>20</b> was obtained as a brown solid according to general procedure using 2-furaldehyde (<b>20a</b>). Yield 65%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.44 (br s, exch, 1H); δ 8.05 (s, 1H); δ 7.61 (d, <i>J</i> = 5.3, 1H); δ 7.09 (d, <i>J</i> = 3.5 1H); δ 6.76–6.75 (m, not resolved, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.59; δ 167.05; δ 149.21; δ 147.46; δ 120.39; δ 118.55; δ 118.40; δ 113.48. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 194 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (<i>Z</i>)-5-(Benzofuran-2-ylmethylene)thiazolidine-2,4-dione (<b>21</b>)</h5><div class="NLM_p last">The title compound <b>21</b> was obtained as a dark-yellow solid according to general procedure using 2-benzofurancarboxaldehyde (<b>21a</b>). Yield 59%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.58 (br s, exch, 1H); δ 7.78–7.75 (m, not resolved, 2H); δ 7.70–7.67 (m, not resolved, 1H); δ 7.51 (s, 1H); δ 7.45 (dd, <i>J</i> = 14.0, 7.3, 1H); δ 7.33 (dd, <i>J</i> = 13.7, 7.0, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.57; δ 166.97; δ 155.33; δ 150.89; δ 127.82; δ 127.11; δ 124.21; δ 123.98; δ 122.46; δ 118.54; δ 114.14; δ 111.50. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 244 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (<i>Z</i>)-5-(Thiophen-2-ylmethylene)thiazolidine-2,4-dione (<b>22</b>)</h5><div class="NLM_p last">The title compound <b>22</b> was obtained as a gray solid according to general procedure using 2-thiophenecarboxaldehyde (<b>22a</b>). Yield 92%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.56 (br s, exch, 1H); δ 8.06 (s, 1H); δ 8.02 (d, <i>J</i> = 5.0, 1H); δ 7.68 (d, <i>J</i> = 3.6, 1H); δ 7.30–7.28 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.99; δ 166.94; δ 137.15; δ 134.31; δ 132.89; δ 128.80; δ 125.00; δ 120.98. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 210 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (<i>Z</i>)-5-(Benzothiophen-2-ylmethylene)thiazolidine-2,4-dione (<b>23</b>)</h5><div class="NLM_p last">The title compound <b>23</b> was obtained as a dark-yellow solid according to general procedure using benzo[<i>b</i>]thiophene-2-carboxaldehyde (<b>23a</b>). Yield 54%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.61 (br s, exch, 1H); δ 8.14 (s, 1H); δ 8.12–8.08 (m, 1H); δ 8.00–7.96 (m, 2H); δ 7.50–7.45 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.37; δ 167.34; δ 141.28; δ 138.83; δ 137.04; δ 131.29; δ 126.47; δ 125.46; δ 125.23; δ 125.02; δ 124.35; δ 122.90. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 260 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> (<i>Z</i>)-5-(Naphthalen-2-ylmethylene)thiazolidine-2,4-dione (<b>24</b>)</h5><div class="NLM_p last">The title compound <b>24</b> was obtained as a yellow solid according to general procedure using 2-naphthaldehyde (<b>24a</b>). Yield 37%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.65 (br s, exch, 1H); δ 8.18 (s, 1H); δ 8.06–8.04 (m, 2H); δ 7.98–7.94 (m, 2H); δ 7.69 (d, <i>J</i> = 8.6, 1H); δ 7.64–7.58 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.38; δ 167.81; δ 133.68; δ 133.16; δ 132.18; δ 131.26; δ 131.06; δ 129.37; δ 129.13; δ 128.41; δ 128.13; δ 127.57; δ 126.42; δ 124.30. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 254 [M + Na]<sup>+</sup>.</div></div><div id="sec6_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> (<i>Z</i>)-5-(Anthracen-9-ylmethylene)thiazolidine-2,4-dione (<b>25</b>)</h5><div class="NLM_p last">The title compound <b>25</b> was obtained as an orange solid according to general procedure using anthracene-9-carbaldehyde (<b>25a</b>). Yield 18%. <sup>1</sup>H NMR (401 MHz, CDCl<sub>3</sub>): δ 8.79 (s, 1H); δ 8.55 (s, 1H); δ 8.07 (d, <i>J</i> = 8.2, 2H); δ 7.98 (d, <i>J</i> = 8.8, 2H); 7.60–7.52 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.87; δ 165.04; δ 133.38; δ 131.32; δ 131.11; δ 129.82; δ 129.41; δ 128.70; δ 127.23; δ 126.81; δ 125.89; δ 125.04. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 304 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (<i>Z</i>)-5-((<i>E</i>)-3-Phenylallylidene)thiazolidine-2,4-dione (<b>26</b>)</h5><div class="NLM_p last">The title compound <b>26</b> was obtained as a pale-yellow solid according to general procedure using cinnamaldehyde (<b>26a</b>). Yield 36%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.31 (br s, 1H); δ 7.67–7.65 (m, 2H); δ 7.47–7.35 (m, 4H); δ 7.27 (d, <i>J</i> = 15.3, 1H); δ 6.91 (dd, <i>J</i> = 15.3, 11.4, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.61; δ 143.33; δ 136.07; δ 131.94; δ 130.03; δ 129.34; δ 128.13; δ 124.09; δ 109.95. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 230 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>Z</i>)-5-((<i>E</i>)-3-(4-(Dimethylamino)phenyl)allylidene)thiazolidine-2,4-dione (<b>27</b>)</h5><div class="NLM_p last">The title compound <b>27</b> was obtained as a dark-red solid according to general procedure using (<i>E</i>)-3-(4-(dimethylamino)phenyl)acrylaldehyde (<b>27a</b>). Yield 58%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.23 (br s, 1H); δ 7.47 (dd, <i>J</i> = 19.7, 10.2, 3H); δ 7.16 (d, <i>J</i> = 15.0, 1H); δ 6.72 (d, <i>J</i> = 8.9, 2H); δ 6.61 (dd, <i>J</i> = 15.0, 11.6, 1H); δ 2.99 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.23; δ 167.32; δ 151.79; δ 145.30; δ 133.96; δ 129.97; δ 123.61; δ 120.93; δ 118.50; δ 112.31; δ 40.13. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 273 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>Z</i>)-5-((1<i>H</i>-Indol-3-yl)methylene)thiazolidine-2,4-dione (<b>28</b>)</h5><div class="NLM_p last">The title compound <b>28</b> was obtained as a yellow solid according to general procedure using 1<i>H</i>-indole-3-carbaldehyde (<b>28a</b>). Yield 45%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.29 (br s, 1H); δ 12.12 (s, exch, 1H); δ 8.06 (s, 1H); δ 7.89 (d, <i>J</i> = 7.8, 1H); δ 7.74 (s, 1H); δ 7.50 (d, <i>J</i> = 7.9, 1H); δ 7.27–7.18 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.09; δ 167.69; δ 136.62; δ 129.06; δ 127.19; δ 124.93; δ 123.49; δ 121.47; δ 118.75; δ 116.59; δ 112.82; δ 110.83. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 243 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (<i>Z</i>)-5-((5-Methoxy-1<i>H</i>-indol-3-yl)methylene)thiazolidine-2,4-dione (<b>29</b>)</h5><div class="NLM_p last">The title compound <b>29</b> was obtained as a dark-yellow solid according to general procedure using 5-methoxy-1<i>H</i>-indole-3-carbaldehyde (<b>29a</b>). Yield 47%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.25 (br s, 1H); δ 12.00 (s, 1H); δ 8.09 (s, 1H); δ 7.66 (d, <i>J</i> = 3.0, 1H), δ 7.40 (dd, <i>J</i> = 18.0, 5.5, 2H); δ 6.86 (dd, <i>J</i> = 8.8, 2.3, 1H); δ 3.82 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.19; δ 167.77; δ 155.36; δ 131.43; δ 129.19; δ 128.05; δ 125.43; δ 115.76; δ 113.80; δ 113.59; δ 110.86; δ 100.47; δ 55.88. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 273 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (<i>Z</i>)-5-((5-Methoxy-1-methyl-1<i>H</i>-indol-3-yl)methylene)thiazolidine-2,4-dione (<b>30</b>)</h5><div class="NLM_p last">The title compound <b>30</b> was obtained as an orange solid according to general procedure using 5-methoxy-1-methyl-1<i>H</i>-indole-3-carbaldehyde (<b>30a</b>). Yield 44%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.25 (br s, 1H); δ 8.07 (s, 1H); δ 7.73 (s, 1H); δ 7.52–7.44 (m, 2H); δ 6.92 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H); δ 3.89 (s, 3H); δ 3.84 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.20; δ 167.73; δ 155.68; δ 132.72; δ 132.20; δ 128.56; δ 124.96; δ 115.48; δ 113.73; δ 112.10; δ 109.72; δ 100.71; δ 55.95; δ 33.85. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 287 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> (<i>Z</i>)-5-((1-Methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)methylene)thiazolidine-2,4-dione (<b>31</b>)</h5><div class="NLM_p last">The title compound <b>31</b> was obtained as an orange solid according to general procedure using 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>31a</b>). Yield 48%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.57 (br s, 1H); δ 7.84 (s, 1H); δ 7.75 (d, <i>J</i> = 8.0, 1H); δ 7.67 (d, <i>J</i> = 8.0, 1H); δ 7.34 (dt, <i>J</i> = 26.1, 7.1, 2H); δ 3.99 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.21; δ 167.41; δ 147.97; δ 143.15; δ 136.28; δ 131.34; δ 124.48; δ 123.49; δ 120.04; δ 115.69; δ 111.43; δ 30.25. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 260 [M + Na]<sup>+</sup>.</div></div><div id="sec6_2_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> (<i>Z</i>)-5-((2-Phenyl-1<i>H</i>-indol-3-yl)methylene)thiazolidine-2,4-dione (<b>32</b>)</h5><div class="NLM_p last">The title compound <b>32</b> was obtained as an orange solid according to general procedure using 2-phenyl-1<i>H</i>-indole-3-carbaldehyde (<b>32a</b>). Yield 22%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.31 (br s, 1H); δ 12.27 (s, exch 1H); δ 7.96 (s, 1H); δ 7.78 (d, <i>J</i> = 7.9, 1H); 7.63–7.49 (m, 6H); δ 7.29–7.19 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.44; δ 142.21; δ 136.91; δ 131.44; δ 129.56; δ 129.44; δ 128.09; δ 126.01; δ 123.47; δ 121.18; δ 120.40; δ 120.28; δ 112.68; δ 107.31. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 319 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (<i>Z</i>)-5-([1,1′-Biphenyl]-4-ylmethylene)thiazolidine-2,4-dione (<b>33</b>)</h5><div class="NLM_p last">The title compound <b>33</b> was obtained as a white solid according to general procedure using [1,1′-biphenyl]-4-carbaldehyde (<b>33a</b>). Yield 55%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.64 (br s, 1H); δ 7.86–7.83 (m, 3H); δ 7.72 (dd, <i>J</i> = 21.4, 8.0, 4H); δ 7.50 (t, <i>J</i> = 7.6, 2H); δ 7.41 (t, <i>J</i> = 7.3, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.28; δ 167.88; δ 142.15; δ 139.25; δ 132.52; δ 131.66; δ 131.10; δ 129.50; δ 128.63; δ 127.81; δ 127.21; δ 123.94. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 280 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (<i>Z</i>)-5-(2-(Benzyloxy)benzylidene)thiazolidine-2,4-dione (<b>34</b>)</h5><div class="NLM_p last">The title compound <b>34</b> was obtained as a pale-yellow solid according to general procedure using 2-(benzyloxy)benzaldehyde (<b>34a</b>). Yield 61%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.58 (br s, 1H); δ 8.03 (s, 1H); δ 7.48–7.42 (m, 6H); δ 7.36 (t, <i>J</i> = 6.5, 1H); δ 7.24 (d, <i>J</i> = 8.4, 1H); δ 7.11 (t, <i>J</i> = 7.5, 1H); δ 5.25 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.43; δ 167.77; δ 157.61; δ 136.94; δ 132.66; δ 128.98; δ 128.81; δ 128.47; δ 128.10; δ 126.64; δ 124.02; δ 122.35; δ 121.63; δ 113.73; δ 70.35. MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 334 [M + Na]<sup>+</sup>.</div></div><div id="sec6_2_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (<i>Z</i>)-5-((2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methylene)thiazolidine-2,4-dione (<b>35</b>)</h5><div class="NLM_p last">The title compound <b>35</b> was obtained as a pale-yellow solid according to general procedure using 2,3-dihydrobenzo[<i>b</i>][1,4]dioxine-6-carbaldehyde (<b>35a</b>). Yield 75%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.52 (br s, 1H); δ 7.69 (s, 1H); δ 7.12–7.10 (m, 2H); δ 7.02 (dd, <i>J</i> = 7.6, 1.2, 1H); δ 4.30–4.25 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.40; δ 168.01; δ 146.04; δ 144.13; δ 131.99; δ 126.78; δ 124.21; δ 121.60; δ 119.16; δ 118.42; δ 64.89; δ 64.41. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 262 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (<i>Z</i>)-5-((7-Methoxybenzo[<i>d</i>][1,3]dioxol-5-yl)methylene)thiazolidine-2,4-dione (<b>36</b>)</h5><div class="NLM_p last">The title compound <b>36</b> was obtained as a yellow solid according to general procedure using 7-methoxybenzo[<i>d</i>][1,3]dioxole-5-carbaldehyde (<b>36a</b>). Yield 58%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.55 (br s, 1H); δ 7.72 (s, 1H); δ 6.97 (s, 1H); δ 6.82 (s, 1H); δ 6.11 (s, 2H); δ 3.87 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.33; δ 167.98; δ 149.56; δ 143.91; δ 137.43; δ 132.28; δ 128.02; δ 122.08; δ 111.80; δ 103.44; δ 102.68; δ 56.82. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 278 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (<i>Z</i>)-5-((2-Chloroquinolin-3-yl)methylene)thiazolidine-2,4-dione (<b>37</b>)</h5><div class="NLM_p last">The title compound <b>37</b> was obtained as a pale-yellow solid according to general procedure using 2-chloroquinoline-3-carbaldehyde (<b>37a</b>). Yield 45%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.87 (br s, 1H); δ 8.55 (s, 1H); δ 8.24 (d, <i>J</i> = 8.1, 1H); δ 8.00–7.88 (m, 3H); δ 7.73 (t, <i>J</i> = 7.2, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.91; δ 167.26; δ 149.81; δ 146.90; δ 138.45; δ 132.88; δ 129.42; δ 128.63; δ 128.11; δ 126.92; δ 126.29; δ 125.85. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 290 [M – H]<sup>−</sup>.</div></div><div id="sec6_2_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (<i>Z</i>)-5-((2-Chloro-6-methoxyquinolin-3-yl)methylene)thiazolidine-2,4-dione (<b>38</b>)</h5><div class="NLM_p last">The title compound <b>38</b> was obtained as a yellow solid, according to general procedure using 2-chloro-6-methoxyquinoline-3-carbaldehyde (<b>38a</b>). Yield 32%. <sup>1</sup>H NMR (401 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.85 (br s, 1H); δ 8.44 (s, 1H); δ 7.94 (s, 1H); δ 7.89 (d, <i>J</i> = 9.2, 1H); δ 7.69 (d, <i>J</i> = 2.5, 1H); δ 7.52 (dd, <i>J</i> = 9.1, 2.7, 1H); δ 3.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.96; δ 167.33; δ 158.75; δ 147.17; δ 142.93; δ 137.08; δ 129.52; δ 129.19; δ 128.33; δ 126.21; δ 125.88; δ 125.19; δ 107.20; δ 56.26. MS (ESI<sup>–</sup>) <i>m</i>/<i>z</i>: 320 [M – H]<sup>−</sup>.</div></div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Biology</h3><div id="sec6_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Inhibition of GSK-3β (Kinase-Glo Luminescent Assay)</h4><div class="NLM_p last">Human recombinant GSK-3β was purchased from Millipore (Millipore Iberica SAU). The prephoshorylated polypeptide substrate was purchased from Millipore (Millipore Iberica SAU). Kinase-Glo luminescent kinase assay was obtained from Promega (Promega Biotech Iberica, SL). ATP and all other reagents were from Sigma-Aldrich (St. Louis, MO). Assay buffer contained 50 mM HEPES (pH 7.5), 1 mM EDTA, 1 mM EGTA, and mM magnesium acetate. The method of Baki et al.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> was followed to analyze the inhibition of GSK-3β. Kinase-Glo assays were performed in assay buffer using white 96-well plates. In a typical assay, 10 μL (10 μM) of the tested compound (dissolved in DMSO at mM concentration and diluted in advance in assay buffer to the desired concentration), and 10 μL (20 ng) of enzyme were added to each well followed by 20 μL of assay buffer containing 25 μM substrate (GS-2 peptide) and 1 μM ATP. The final DMSO concentration in the reaction mixture did not exceed 1%. After a 30 min incubation at 30 °C, the enzymatic reaction was stopped with 40 μL of Kinase-Glo reagent. Glow-type luminescence was recorded after 10 min using a Fluoroskan Ascent multimode reader. The activity is proportional to the difference of the total and consumed ATP. The inhibitory activities were calculated on the basis of maximal kinase and luciferase activities measured in the absence of inhibitor and in the presence of a reference compound inhibitor (TDZD8, Sigma-Aldrich, IC<sub>50</sub> = 0.69 μM) at total inhibition concentration, respectively. The linear regression parameters were determined and the IC<sub>50</sub> extrapolated (GraphPad Prism 4.0, GraphPad Software Inc.).</div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Mechanism of Action on GSK3β: Kinetic Studies</h4><div class="NLM_p last">To investigate the inhibitory mechanism of <b>28</b> and <b>30</b> on GSK-3β, kinetic experiments were performed. Lineweaver–Burk plots of enzyme kinetics varying both ATP (from 1 to 50 μM) and inhibitor concentrations were performed. Double-reciprocal plotting of the data is depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. The intercept of the plot in the vertical axis (1/V) does not change when the inhibitors concentration increases. These results would suggest that inhibitors act as competitive inhibitors of ATP binding.</div></div><div id="sec6_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Inhibition of GSK-3β (TR-FRET Assay)</h4><div class="NLM_p last">The assays were performed in white Optiplate-384 at room temperature (22 °C) in a final volume of 25 μL, using the following kinase buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 10 mM MgCl<sub>2</sub>, 2 mM DTT, and 0.01% Tween-20. The compounds were dissolved in DMSO and then diluted in kinase buffer, keeping constant the concentration of DMSO (3%) in each well. In each assay, the compound SB216763 was used as a positive control (IC<sub>50</sub> 11.4 ± 2.1 nM), while DMSO was used as reference. GSK-3β (0.5 nM, final concentration) was first incubated with the two compounds for 30 min, then a mixture of ATP (10 μM, final concentration) and U<i>Light</i>-GS (Ser641/pSer657) peptide (50 nM, final concentration) was added. The reaction was incubated for 1 h; afterward, the kinase reaction was stopped by adding 24 mM EDTA and 2 nM (final concentration) of Eu-antiphospho-GS (Ser641) antibody, both diluted in detection buffer 1×. After an incubation of 1 h, the TR-FRET signal was read with the EnSight multimode plate reader (excitation at 320 nm and emissions at 615 and 665 nm). The compounds were tested in 10-dose IC<sub>50</sub> mode with 2-fold serial dilutions. Data were analyzed using Excel and GraphPad Prism software (version 6.0, GraphPad) for IC<sub>50</sub> curve fits using sigmoidal dose–response (variable slope) equation. Values obtained for each compound are the means ± SD determined for at least two separate experiments. Compounds <b>28</b> and <b>30</b> are soluble in the assay conditions as determined at the maximum concentration tested (nephelometry determination) and do not interfere with the readout of the assay (no absorption at 320 nm and no emission at 615 and 665 nm).</div></div><div id="sec6_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Inhibition of Casein Kinase 1 (CK1) δ and ε</h4><div class="NLM_p last">Human recombinant CK1δ and CK1ε were purchased from Millipore (Millipore Iberica SAU). Casein solution from bovine milk, 5%, was purchased from Sigma-Aldrich (St. Louis, MO). ATP and all other reagents were from Sigma-Aldrich (St. Louis, MO). Assay buffer contained 50 mM HEPES, pH 7.5, 0.01% Brij-35, 10 mM Cl<sub>2</sub>Mg, 1 mM EGTA, and 0.01% NaN<sub>3</sub>. Kinase-Glo Kit from Promega was used to test compounds <b>28</b> and <b>30</b> for activity against CK-1. The Kinase-Glo assays were performed in the above mentioning assay buffer using black 96-well plates. Typically, 10 μL of test compound (dissolved in DMSO at 1 mM concentration and diluted in advance in assay buffer to 10 μM) and 10 μL (16 ng) of enzyme were added to each well followed by 20 μL of assay buffer containing 0.1% casein as substrate and 4 μM ATP. The final DMSO concentration in the reaction mixture did not exceed 1%. After 60 min incubation at 30 °C, the enzymatic reaction was stopped with 40 μL of Kinase-Glo reagent. Glow-type luminescence was recorded after 10 min using a FLUOstar Optima (BMG Labtechnologies GmbH, Offenburg, Germany) multimode reader. The activity is proportional to the difference of the total and consumed ATP. The inhibitory activities were calculated on the basis of maximal activities measured in the absence of inhibitor. The IC<sub>50</sub> was defined as the concentration of each compound that reduces to 50% the enzymatic activity with respect to that without inhibitors. Each value is the mean of two independent experiments.</div></div><div id="sec6_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Inhibition of Cell Division Cycle 7 (Cdc7)</h4><div class="NLM_p last">The ADP-Glo kinase assay + CDC7/DBF4 kinase enzyme system (catalogue no. V5089) from Promega was used to screen compounds for activity against Cdc7. ATP and other reagents were purchased from Sigma-Aldrich (St. Louis, MO). The assays were performed in a buffer solution using 96-well plates. Compounds <b>28</b> and <b>30</b> (5 μL, 40 μM dissolved in 4% DMSO) were added to each well followed by the enzyme (5 μL, 25 ng/well), ATP (5 μL, final concentration in the well 10 μM), and PDKtidE (5 μL, 4 μg/well) as substrate. Then it was allowed to incubate for 60 min at room temperature and ADP-Glo reagent (20 μL) was added allowing to incubate again for 40 min at room temperature. After the incubation, the kinase detection agent (40 μL) was added and allowed to incubate for 30 min at room temperature. Finally, the luminescence was recorded using a FLUOstar Optima (BMG Labtechnologies GmbH, Offenburg, Germany) multimode reader. The inhibition activities were calculated based on the maximum activity, measured in the absence of inhibitor.</div></div><div id="sec6_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Blood–Brain Barrier Permeation</h4><div class="NLM_p last">Prediction of the brain penetration was evaluated using a PAMPA-BBB.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Ten commercial drugs, phosphate buffer saline solution at pH 7.4 (PBS), ethanol, and dodecane were purchased from Sigma-Aldrich, Acros Organics, Merck, and Fluka. The porcine polar brain lipid (PBL) (catalogue no. 141101) was from Avanti Polar Lipids. The donor plate was a 96-well filtrate plate (Multiscreen IP sterile plate PDVF membrane, pore size is 0.45 μM, catalogue no. MAIPS4510), and the acceptor plate was an indented 96-well plate (Multiscreen, catalogue no. MAMCS9610), both from Millipore. Filter PDVF membrane units (diameter 30 mm, pore size 0.45 μm) from Symta were used to filter the samples. A 96-well plate UV reader (Thermoscientific, Multiskan spectrum) was used for the UV measurements. Test compounds [(3–5 mg of caffeine, enoxacine, hydrocortisone, desipramine, ofloxacine, piroxicam, and testosterone), (12 mg of promazine) and 25 mg of verapamil and atenolol] were dissolved in EtOH (1000 μL). Then 100 μL of this compound stock solution was taken; 1400 μL of EtOH and 3500 μL of PBS pH = 7.4 buffer were then added to reach 30% of EtOH concentration in the experiment. These solutions were filtered. The acceptor 96-well microplate was filled with 180 μL of PBS/EtOH (70/30). The donor 96-well plate was coated with 4 μL of porcine brain lipid in dodecane (20 mg/mL), and after 5 min, 180 μL of each compound solution was added. Then 1–2 mg of each compound were dissolved in 1500 μL of EtOH and 3500 μL of PBS pH = 7.4 buffer, filtered, and then added to the donor 96-well plate to be determined their ability to pass the brain barrier. Then the donor plate was carefully put on the acceptor plate to form a “sandwich”, which was left undisturbed for 2 h and 30 min at 25 °C. During this time, the compounds diffused from the donor plate through the brain lipid membrane into the acceptor plate. After incubation, the donor plate was removed. UV plate reader determined the concentration of compounds and commercial drugs in the acceptor and the donor wells. Every sample was analyzed at three to five wavelengths, in three wells, and in two independent runs. Results are given as the mean [standard deviation (SD)], and the average of the two runs is reported. Ten quality control compounds (previously mentioned) of known BBB permeability were included in each experiment to validate the analysis set.</div></div><div id="sec6_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Neuro- and Hepatotoxicity Assessment</h4><div class="NLM_p">Primary cultures of CGNs were prepared from 7 day-old pups of the same rat strain, as previously described.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98,99)</a> All animal experiments were authorized by the University of Bologna bioethical committee (Protocol no. 17-72-1212) and performed according to Italian and European Community laws on the use of animals for experimental purposes. For cerebellar granule cultures, cells were dissociated from cerebella and plated on 96-well plates, previously coated with 10 μg/mL poly-<span class="smallcaps smallerCapital">l</span>-lysine, at a density of 3 × 105 cells/0.2 mL medium/well in BME supplemented with 100 mL/L heat-inactivated FBS (Life technologies), 2 mM glutamine, 100 μM gentamicin sulfate, and 25 mM KCl (all from Sigma-Aldrich). Then 16 h later, 10 μM cytosine arabino-furanoside (Sigma-Aldrich) was added to avoid glial proliferation. After 7 days in vitro, differentiated neurons were shifted to serum-free BME medium containing 25 mM KCl without serum and different treatments were performed.</div><div class="NLM_p">HepG2 cells (human hepatocellular liver carcinoma cell line from American Type Culture Collection, ATCC) were grown in DMEM supplemented with 10% FBS and 50 units/mL of penicillin/streptomycin (Life Technologies) at 37 °C in a humidified atmosphere containing 5% CO<sub>2</sub>. For the experiments, cells (0.5 × 105 cells/well) were seeded in 96-well plate in complete medium; after 24 h, the medium was removed and cells were exposed to the increasing concentrations of previously selected non-neurotoxic compounds (0, 10, 25, and 50 μM) in DMEM with no serum for further 24 h, and survival was measured through MTT assay.</div><div class="NLM_p last">The viability of the different cell types (CGNs and HepG2) exposed to increasing concentrations of the studied compounds (0, 5, 25, and 50 μM) for 24 h was evaluated through the MTT assay. Briefly, thiazolyl blue was added to the culture medium at a final concentration of 0.1 mg/mL. Following a 20 min incubation for CGNs and 10 min for HepG2 cells at 37 °C in the dark, the MTT precipitate was dissolved in 0.1 M Tris-HCl pH 7.5 buffer containing 5% Triton X-100 (all from Sigma-Aldrich) and absorbance was read at 570 nm in a multiplate spectophotometric reader (Bio-Rad).</div></div><div id="sec6_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> AcPHF6 Aggregation and Inhibition Studies by ThT Fluorescence</h4><div class="NLM_p last">ThT fluorescence assays were performed as described previously by Lunven et al.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> with some variations. AcPHF6 (Celtek Peptides) was initially dissolved in 1,1,1,3,3,3,-hexafluoro-2-propanol, kept at room temperature overnight, aliquoted, and dried. Stock solutions of AcPHF6 (0.5 mM) were then prepared in ultrapure water immediately prior to fluorescence assays. Stock solutions of all tested compounds (2 mM) were prepared in DMSO, while stock solution of ThT (0.5 mM) was prepared in 50 mM phosphate buffer pH 7.4. AcPHF6 aggregation was monitored using standard 96-well plates and an EnSpire plate reader (PerkinElmer) setting the excitation and emission wavelengths at 446 and 490 nm, respectively. Samples were prepared by diluting stock solutions in 50 mM phosphate buffer pH 7.4 to a final AcPHF6 concentration of 50 μM with 20 μM ThT and 10 μM test compound (maximum final DMSO content: 0.5%, v/v); the final volume was 100 μL. Assays were performed at 25 °C. Fluorescence data were recorded every minute over 120 min with 10 s shaking (400 rpm) prior to each reading. Each condition was assayed at least in triplicate, and values were averaged. Estimation of the inhibitory potency (%) was carried out by comparing fluorescence values at the plateau (average fluorescence intensity value in the 70–80 min range).</div></div><div id="sec6_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> CD Spectroscopy</h4><div class="NLM_p last">CD spectra were measured in the 260–200 nm spectral range on a Jasco J-810 spectropolarimeter (Tokyo, Japan) equipped with a PTC-423S Peltier-type temperature control system. Measurements were carried out at 25 °C using quartz cells with 1 mm path length (Hellma, Milan, Italy), a 50 nm min<sup>–1</sup> scanning speed, a 2 nm response, a 2 nm spectral bandwidth, and an accumulation cycle of 3. Stock solutions of AcPHF6 (1 mM) were prepared in water immediately prior to CD measurements, while stock solutions of compounds <b>28</b> and <b>30</b> (2 mM) were prepared in methanol/DMSO (95:5, v/v). Samples were prepared by diluting stock solutions in phosphate buffer 50 mM (pH 7.4) to a final AcPHF6 concentration of 100 μM with 20 μM test compound (final DMSO content: 0.05%, v/v). The spectral contribution of solvents and test compounds was subtracted to derive the CD spectra of AcPHF6, then data were converted to molar units per residue (Δε<sub>res</sub>) and plotted using the Bezier smoothing algorithm provided by the Gnuplot software (version 5.2.2, <a href="http://gnuplot.sourceforge.net" class="extLink">http://gnuplot.sourceforge.net</a>).</div></div><div id="sec6_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Atomic Force Microscopy</h4><div class="NLM_p last">Atomic force microscopy imaging was performed in PeakForce tapping-mode on a Nanoscope Multimode 8 (Bruker, USA) with ScanAsyst Air probes (Bruker). Peptide specimens were prepared by quickly diluting a freshly prepared 500 μM aliquot of AcPHF6 peptide in water to 50 μM concentration in 50 mM phosphate buffer (pH 7.4) or in the same buffer additionally containing 10 μM of either compound <b>28</b> or <b>30</b>, briefly vortexing and then subjecting the specimens to the same incubation procedure detailed for ThT fluorescence measurements (briefly, incubation at 25 °C for 80 min with 400 rpm shaking for 10 s every minute). At the end of the incubation, the peptide solutions were immediately filtered through Microcon centrifuge ultrafiltration devices (MWCO 30 kDa, Millipore) to separate the small MW fraction from the polymerized peptide fraction. Additional runs on the same Microcons were performed in order to exchange the different buffers with ultrapure water. Then 5 μL aliquots of the high molecular weight retentate fractions were layered on discs of freshly cleaved muscovite mica (EMS, USA) and allowed to dry while protected from ambient contamination. The recorded micrographs were only processed by flattening with Bruker’s Nanoscope Analysis software (version 1.8).</div></div><div id="sec6_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> K18 Aggregation and Inhibition Studies</h4><div class="NLM_p last">K18 aggregations were performed in a black 96-well optical flat bottom plate (Thermoscientific) with a basic reaction mix (BRM) prepared as follows: 21 μM K18, heparin 0.015 mg/mL, 0.1 mM DTT, and 10 μM ThT in PBS 1×. Five different experimental conditions were assessed: (1) BRM alone to assess the kinetic of tauK18 self-assembly, BRM supplemented with <b>30</b> at the final concentration of (2) 1 μM, (3) 5 μM, and (4) 10 μM, and (5) BRM supplemented with 1% DMSO. Each experimental condition was prepared and analyzed in triplicate. The plate was sealed with a sealing film, inserted into a FLUOstar OPTIMA microplate reader (BMG Labtech), and subjected to cycles of shaking (1 min at 300 rpm, double orbital) and incubation (14 min) at 37 °C. Fluorescence readings (480 nm) were taken every 15 min (30 flashes per well at 450 nm).</div></div><div id="sec6_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Full-Length 2N4R Tau Aggregation and Inhibition Studies</h4><div class="NLM_p last">TauFL 2N4R aggregation was performed in a black 96-well optical flat-bottom plate (Thermoscientific) with a basic reaction mix (BRM) prepared as follows: 20 μM tauFL (2N4R), heparin 0.02 mg/mL, 0.5 mM DTT, and 10 μM ThT in PBS 1×. Three different experimental conditions were assessed: (1) BRM alone to assess the kinetic of TauFL 2N4R self-assembly, (2) BRM supplemented with <b>30</b> at the final concentration of 10 μM, and (3) BRM supplemented with 1% DMSO as control for the reaction. The plate was then inserted into a FLUOstar OPTIMA microplate reader (BMG Labtech) and subjected to cycles of shaking (1 min at 600 rpm, single orbital) and incubation (1 min) at 42 °C. Fluorescence readings (480 nm) were taken every 2 min (100 flashes per well at 450 nm).</div></div><div id="sec6_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Okadaic Acid-Induced Tau Hyperphosphorylation Cell Model</h4><div class="NLM_p last">Human SH-SY5Y cells were grown in DMEM supplemented with 10% FBS and 1% penicillin–streptomycin at 37 °C and 5% CO<sub>2</sub> in an incubator. SH-SY5Y cells were seeded onto 96-well plate at 60000 cells per well. Then 48 h later, cells were preincubated with the compounds at the desired concentration for 1 h and after that time OA (acquired from Sigma-Aldrich, catalogue no. 09381) was added at a concentration of 30 nM and incubated for another 24 h. Afterward, cells were incubated with 0.5 mg/mL MTT solution for at least 4 h at 37 °C and 5% CO<sub>2.</sub> Then culture media was removed and the formazan crystals attached to the bottom of the plate were dissolved with 200 μL of DMSO. Finally, UV-absorbance was measured at 595 nM in a microplate reader (Varioskan Flash Microplate reader, Thermo Scientific).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00610" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00610" class="ext-link">10.1021/acs.jmedchem.8b00610</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Retrospective computational studies; PAMPA-BBB assay data; jump dilution assay; synthetic details for compounds <b>14a</b> and <b>15a</b>; compounds purity by HPLC; <sup>1</sup>H and <sup>13</sup>C NMR spectra of all synthesized compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and GSK-3β data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf">jm8b00610_si_001.pdf (4.35 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_002.csv">jm8b00610_si_002.csv (1.73 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00610" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Laura Bolognesi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1289-5361" title="Orcid link">http://orcid.org/0000-0002-1289-5361</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cea3afbca7afa2afbbbcafe0aca1a2a1a9a0abbda78ebba0a7aca1e0a7ba"><span class="__cf_email__" data-cfemail="751814071c1419140007145b171a191a121b10061c35001b1c171a5b1c01">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annachiara Gandini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Bartolini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Tedesco</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loreto Martinez-Gonzalez</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Roca</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nuria E. Campillo</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9948-2665" title="Orcid link">http://orcid.org/0000-0002-9948-2665</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josefa Zaldivar-Diez</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Concepción Perez</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Quimica Medica, CSIC, Calle Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giampaolo Zuccheri</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">S3
Center of the Institute of Nanosciences, Italian National Research
Council (CNR), I-41125 Modena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Miti</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">S3
Center of the Institute of Nanosciences, Italian National Research
Council (CNR), I-41125 Modena, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2730-1861" title="Orcid link">http://orcid.org/0000-0002-2730-1861</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandra Feoli</span> - <span class="hlFld-Affiliation affiliation">EpigeneticMedChemLab,
Department of Pharmacy, University of Salerno,  Via Giovanni Paolo II 132, I-84084 Fisciano, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabrina Castellano</span> - <span class="hlFld-Affiliation affiliation">EpigeneticMedChemLab,
Department of Pharmacy, University of Salerno,  Via Giovanni Paolo II 132, I-84084 Fisciano, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabrina Petralla</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Monti</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Rossi</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Moda</span> - <span class="hlFld-Affiliation affiliation">Fondazione
IRCCS Istituto Neurologico Carlo Besta, via Celoria 11, I-20133 Milan, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Legname</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Martinez</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biologica, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2707-8110" title="Orcid link">http://orcid.org/0000-0002-2707-8110</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3985-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the University of Bologna (RFO2015_2016), European Cooperation of Science and Technology (EUCOST) Action CA15135, Ministerio de Economia y Competitividad (CTQ2015-66313-R), Italian Ministry of Health (GR-2013-02355724), MJFF, ALZ, Alzheimer’s Research UK and the Weston Brain Institute (BAND2015). The authors thank E. De Cecco (PhD candidate, SISSA) for providing K18 and 2N4R protein samples for the in vitro assays.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AFM</td><td class="NLM_def"><p class="first last">atomic force microscopy</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CD</td><td class="NLM_def"><p class="first last">circular dichroism</p></td></tr><tr><td class="NLM_term">Cdc7</td><td class="NLM_def"><p class="first last">cell division cycle 7</p></td></tr><tr><td class="NLM_term">CGNs</td><td class="NLM_def"><p class="first last">cerebellar granule neurons</p></td></tr><tr><td class="NLM_term">CK1</td><td class="NLM_def"><p class="first last">casein kinase 1</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">EDDA</td><td class="NLM_def"><p class="first last">ethylenediamine diacetate</p></td></tr><tr><td class="NLM_term">GSK-3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3β</p></td></tr><tr><td class="NLM_term">HepG2</td><td class="NLM_def"><p class="first last">human hepatoma cell line</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">microtubule-associated protein</p></td></tr><tr><td class="NLM_term">MTDLs</td><td class="NLM_def"><p class="first last">multitarget directed ligands</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">NFTs</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">okadaic acid</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interference compounds</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>e</sub></td><td class="NLM_def"><p class="first last">effective permeability</p></td></tr><tr><td class="NLM_term">PIO</td><td class="NLM_def"><p class="first last">pioglitazone</p></td></tr><tr><td class="NLM_term">RT-QuIC</td><td class="NLM_def"><p class="first last">real-time quaking-induced conversion</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TDZDs</td><td class="NLM_def"><p class="first last">thiadiazolidinediones</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavin T</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence energy transfer</p></td></tr><tr><td class="NLM_term">TZD</td><td class="NLM_def"><p class="first last">2,4-thiazolidinedione</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 99 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morstorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYATer9mSj1bbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uliassi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perone, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer’s disease drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.4155%2Ffmc-2017-0038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28632448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=995-1013&author=E.+Uliassiauthor=A.+Gandiniauthor=R.+C.+Peroneauthor=M.+L.+Bolognesi&title=Neuroregeneration+versus+neurodegeneration%3A+toward+a+paradigm+shift+in+Alzheimer%E2%80%99s+disease+drug+discovery&doi=10.4155%2Ffmc-2017-0038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery</span></div><div class="casAuthors">Uliassi, Elisa; Gandini, Annachiara; Perone, Rosaria Carmela; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">995-1013</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease represents an enormous global burden in terms of human suffering and economic cost.  To tackle the current lack of effective drugs and the continuous clin. trial failures might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting neural stem cells (NSCs) regeneration.  In this context, small mols. have come to the forefront for their potential to manipulate NSCs, provide therapeutic tools and unveil NSCs biol.  Classically, these mols. have been generated either by target-based or phenotypic approaches.  To circumvent specific liabilities, nanomedicines emerge as a feasible alternative.  However, this review is not intended to be comprehensive.  Its purpose is to focus on recent examples that could accelerate development of neuroregenerative drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6M7MV2M7NbVg90H21EOLACvtfcHk0lh0Guj0TrDHjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7nN&md5=bbbe7af9d8f6b0e7ad76e9c9a2561b5a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0038%26sid%3Dliteratum%253Aachs%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DPerone%26aufirst%3DR.%2BC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DNeuroregeneration%2520versus%2520neurodegeneration%253A%2520toward%2520a%2520paradigm%2520shift%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D995%26epage%3D1013%26doi%3D10.4155%2Ffmc-2017-0038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolsten, M.</span></span> <i>Learn more about our neuroscience R&D decision</i>; <span class="NLM_publisher-name">Pfizer Worldwide Research and Development</span>, January 11, <span class="NLM_year">2018</span>; <a href="https://www.pfizer.com/news/featured_stories/featured_stories_detail/learn_more_about_our_neuroscience_r_d_decision" class="extLink">https://www.pfizer.com/news/featured_stories/featured_stories_detail/learn_more_about_our_neuroscience_r_d_decision</a> (accessed July 12, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Dolsten&title=Learn+more+about+our+neuroscience+R%26D+decision"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DDolsten%26aufirst%3DM.%26jtitle%3DLearn%2520more%2520about%2520our%2520neuroscience%2520R%2526D%2520decision%26pub%3DPfizer%2520Worldwide%2520Research%2520and%2520Development%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M.
P.</span></span> <span> </span><span class="NLM_article-title">Pathways towards and away from Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">631</span>, <span class="refDoi"> DOI: 10.1038/nature02621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnature02621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=15295589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=631&author=M.%0AP.+Mattson&title=Pathways+towards+and+away+from+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature02621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways towards and away from Alzheimer's disease</span></div><div class="casAuthors">Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7000</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Slowly but surely, Alzheimer's disease (AD) patients lose their memory and their cognitive abilities, and even their personalities may change dramatically.  These changes are due to the progressive dysfunction and death of nerve cells that are responsible for the storage and processing of information.  Although drugs can temporarily improve memory, at present there are no treatments that can stop or reverse the inexorable neurodegenerative process.  But rapid progress towards understanding the cellular and mol. alterations that are responsible for the neuron's demise may soon help in developing effective preventative and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQHWKtbjr0cLVg90H21EOLACvtfcHk0lh0Guj0TrDHjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D&md5=796c7f13ce37cf041c62266bad2f7218</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature02621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02621%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DPathways%2520towards%2520and%2520away%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D631%26doi%3D10.1038%2Fnature02621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span> <span> </span><span class="NLM_article-title">Alzheimer disease, a multifactorial disorder seeking multi-therapies</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2010.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.jalz.2010.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20813343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqtrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=420-424&author=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Alzheimer+disease%2C+a+multifactorial+disorder+seeking+multi-therapies&doi=10.1016%2Fj.jalz.2010.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease, a multifactorial disorder seeking multitherapies</span></div><div class="casAuthors">Iqbal, Khalid; Grundke-Iqbal, Inge</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-424</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is multifactorial and apparently involves several different etiopathogenic mechanisms.  There are at least five subgroups of AD based on cerebrospinal fluid levels of Aβ1-42, a marker of beta-amyloid (Aβ) plaques, and tau and ubiquitin, two markers of neurofibrillary tangles.  These different AD subgroups may respond differently to a given disease-modifying drug, and hence, different therapeutic drugs for different disease subgroups might be required.  Stratification of AD patients by disease subgroups in clin. trials is crit. to the successful development of potent disease-modifying drugs.  Levels of disease markers in the cerebrospinal fluid are promising, both in identifying various subgroups of AD and in monitoring the response to therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfMb_FH8t4rVg90H21EOLACvtfcHk0lh0Guj0TrDHjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqtrnN&md5=fe74812223b2952b3a63bc9a703a2903</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DAlzheimer%2520disease%252C%2520a%2520multifactorial%2520disorder%2520seeking%2520multi-therapies%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3D420%26epage%3D424%26doi%3D10.1016%2Fj.jalz.2010.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Human disease and drug pharmacology, complex as real life</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.2174/0929867311320130002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F0929867311320130002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=23410162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1623-1634&author=E.+Viaynaauthor=I.+Solaauthor=O.+Di+Pietroauthor=D.+Munoz-Torrero&title=Human+disease+and+drug+pharmacology%2C+complex+as+real+life&doi=10.2174%2F0929867311320130002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Human disease and drug pharmacology, complex as real life</span></div><div class="casAuthors">Viayna, E.; Sola, I.; Di Pietro, O.; Munoz-Torrero, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1623-1634</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past decades drug discovery practice has escaped from the complexity of the formerly used phenotypic screening in animals to focus on assessing drug effects on isolated protein targets in the search for drugs that exclusively and potently hit one selected target, thought to be crit. for a given disease, while not affecting at all any other target to avoid the occurrence of side-effects.  However, reality does not conform to these expectations, and, conversely, this approach has been concurrent with increased attrition figures in late-stage clin. trials, precisely due to lack of efficacy and safety.  In this context, a network biol. perspective of human disease and treatment has burst into the drug discovery scenario to bring it back to the consideration of the complexity of living organisms and particularly of the (patho)physiol. environment where protein targets are (mal)functioning and where drugs have to exert their restoring action.  Under this perspective, it has been found that usually there is not one but several disease-causing genes and, therefore, not one but several relevant protein targets to be hit, which do not work on isolation but in a highly interconnected manner, and that most known drugs are inherently promiscuous.  In this light, the rationale behind the currently prevailing single-target-based drug discovery approach might even seem a Utopia, while, conversely, the notion that the complexity of human disease must be tackled with complex polypharmacol. therapeutic interventions constitutes a difficult-to-refuse argument that is spurring the development of multitarget therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBt1iV-z6TT7Vg90H21EOLACvtfcHk0lgoWj6g2IDK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jtLo%253D&md5=6f57be001cdbd82e7b57d09149759022</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867311320130002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320130002%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DHuman%2520disease%2520and%2520drug%2520pharmacology%252C%2520complex%2520as%2520real%2520life%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1623%26epage%3D1634%26doi%3D10.2174%2F0929867311320130002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buccafusco, J. J.</span></span> <span> </span><span class="NLM_article-title">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.tips.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=15629202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktV2m" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=27-35&author=M.+B.+Youdimauthor=J.+J.+Buccafusco&title=Multi-functional+drugs+for+various+CNS+targets+in+the+treatment+of+neurodegenerative+disorders&doi=10.1016%2Fj.tips.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span></div><div class="casAuthors">Youdim, Moussa B. H.; Buccafusco, Jerry J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-35</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Individuals with neurodegenerative diseases such as Parkinson's disease or Alzheimer's disease are benefiting from drugs developed to act on a single mol. target.  However, current pharmacol. approaches are limited in their ability to modify significantly the course of the disease, and offer incomplete and transient benefit to patients.  New therapeutic strategies comprise drug candidates designed specifically to act on multiple neural and biochem. targets for the treatment of cognition impairment, motor dysfunction, depression and neurodegeneration.  Examples include the development of single mol. entities that combine 2 or more of the following properties: (i) cholinesterase inhibition; (ii) activation or inhibition of specific subtypes of acetylcholine receptors or α-adrenoceptors; (iii) anti-inflammatory activity; (iv) monoamine oxidase inhibition; (v) catechol-O-Me transferase inhibition; (vi) nitric oxide prodn.; (vii) neuroprotection; (viii) anti-apoptotic activity; and (ix) activation of mitochondrial-dependent cell-survival genes and proteins.  These bi- or multi-functional compds. might provide greater symptomatic efficacy, and better utility as potential neuroprotective disease-modifying drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreBPSKLWPfGLVg90H21EOLACvtfcHk0lgoWj6g2IDK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktV2m&md5=0f2bd02614627d98b7e17a7a49905d1a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DMulti-functional%2520drugs%2520for%2520various%2520CNS%2520targets%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D27%26epage%3D35%26doi%3D10.1016%2Fj.tips.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Network pharmacology: the next paradigm in drug discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1038/nchembio.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnchembio.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=18936753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=682-690&author=A.+L.+Hopkins&title=Network+pharmacology%3A+the+next+paradigm+in+drug+discovery&doi=10.1038%2Fnchembio.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology: the next paradigm in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets.  However, many effective drugs act via modulation of multiple proteins rather than single targets.  Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy.  This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity.  Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets.  However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties.  Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHy4FqkK-h7Vg90H21EOLACvtfcHk0lgoWj6g2IDK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.118%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520pharmacology%253A%2520the%2520next%2520paradigm%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D682%26epage%3D690%26doi%3D10.1038%2Fnchembio.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lhA_qkxIO-0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzior, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignasik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands in Alzheimer’s disease treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4949</span>– <span class="NLM_lpage">4975</span>, <span class="refDoi"> DOI: 10.2174/092986711797535245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F092986711797535245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=22050745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4949-4975&author=M.+Bajdaauthor=N.+Guziorauthor=M.+Ignasikauthor=B.+Malawska&title=Multi-target-directed+ligands+in+Alzheimer%E2%80%99s+disease+treatment&doi=10.2174%2F092986711797535245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed ligands in Alzheimer's disease treatment</span></div><div class="casAuthors">Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4949-4975</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs).  This methodol. has been specifically developed for treatment of disorders with complex pathol. mechanisms.  One such disorder is Alzheimer's disease (AD), currently the most common multifactorial neurodegenerative disease.  AD is related to increased levels of the amyloid β peptide (Aβ) and the hyperphosphorylated tau protein, along with loss of neurons and synapses.  Moreover, there is some evidence pointing to the role of oxidative stress, metal ion deregulation, inflammation and cell cycle regulatory failure in its pathogenesis.  There are many attractive targets for the development of anti-AD drugs, and the multi-factor nature of this disease calls for multi-target-directed compds. which can be beneficial for AD treatment.  This review presents the discovery of dual- and multi-acting anti-AD drug candidates, focusing on the novel design strategy and the compds. it yields - particularly hybrids obtained by linking structurally active moieties interacting with different targets.  The first group of compds. includes cholinesterase inhibitors acting as dual binding site inhibitors and/or inhibitors with addnl. properties.  These compds. are characterized by increased potency against acetylcholinesterase (AChE) and Aβ plaque formation with addnl. properties such as antioxidant activity, neuroprotective, and metal-complexing property, voltage-dependent calcium channel antagonistic activity, inhibitory activity against glutamate-induced excitotoxicity, histamine H3 receptor antagonism, cannabinoid CB1 receptor antagonism and β-secretase (BACE1) inhibition.  A novel class of compds. represents the combination of dual BACE1 inhibitors with metal chelators, and dual modulators of γ-secretase with peroxisome proliferator-activated receptor γ (PPARγ).  We have reviewed the latest reports (2008-2011) presenting new multi-target-directed compds. in Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZHSluHvxy4bVg90H21EOLACvtfcHk0lhA_qkxIO-0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F&md5=c8f35f849c399d43c90570f71ca10e13</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986711797535245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535245%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DIgnasik%26aufirst%3DM.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DMulti-target-directed%2520ligands%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4949%26epage%3D4975%26doi%3D10.2174%2F092986711797535245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lhA_qkxIO-0ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tranches
Dias, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Multi-target directed drugs: a modern approach for design of new drugs for the treatment of Alzheimer’s disease</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2174/1570159X1203140511153200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F1570159X1203140511153200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=24851088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Whtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=239-255&author=K.+S.+Tranches%0ADiasauthor=C.+Viegas&title=Multi-target+directed+drugs%3A+a+modern+approach+for+design+of+new+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1570159X1203140511153200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimerμs Disease</span></div><div class="casAuthors">Tranches Dias, Kris Simone; Viegas, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-255</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multi-faceted pathogenesis.  So far, the therapeutic paradigm "one-compd.-one-target" has failed and despite enormous efforts to elucidate the pathophysiol. of AD, the disease is still incurable. ; The multiple factors involved in AD include amyloid aggregation to form insol. neurotoxic plaques of A, hyperphosphorylation of tau protein, oxidative stress, calcium imbalance, mitochondrial dysfunction and deterioration of synaptic transmission.  These factors together, accentuate changes in the CNS homeostasis, starting a complex process of interconnected physiol. damage, leading to cognitive and memory impairment and neuronal death. ; A recent approach for the rational design of new drug candidates, also called multitarget-directed ligand (MTDL) approach, has gained increasing attention by many research groups, which have developed a variety of hybrid compds. acting simultaneously on diverse biol. targets.  This review aims to show some recent advances and examples of the exploitation of MTDL approach in the rational design of novel drug candidate prototypes for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm9_SZfQyuGLVg90H21EOLACvtfcHk0lipSCM8CbETyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Whtrc%253D&md5=98863e70218492e508d306284e93da4c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1570159X1203140511153200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X1203140511153200%26sid%3Dliteratum%253Aachs%26aulast%3DTranches%2BDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMulti-target%2520directed%2520drugs%253A%2520a%2520modern%2520approach%2520for%2520design%2520of%2520new%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2014%26volume%3D12%26spage%3D239%26epage%3D255%26doi%3D10.2174%2F1570159X1203140511153200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer’s disease</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">466</span>, <span class="refDoi"> DOI: 10.3390/molecules21040466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.3390%2Fmolecules21040466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=27070562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=466&author=F.+Pratiauthor=A.+Cavalliauthor=M.+L.+Bolognesi&title=Navigating+the+chemical+space+of+multitarget-directed+ligands%3A+from+hybrids+to+fragments+in+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules21040466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease</span></div><div class="casAuthors">Prati, Federica; Cavalli, Andrea; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466/1-466/12</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Multitarget drug discovery is one of the hottest topics and most active fields in the search for new mols. against Alzheimer's disease (AD).  Over the last 20 years, many promising multitarget-directed ligands (MTDLs) have been identified and developed at a pre-clin. level.  However, how to design them in a rational way remains the most fundamental challenge of medicinal chemists.  This is related to the foundational question of achieving an optimized activity towards multiple targets of interest, while preserving drug-like properties.  In this respect, large hybrid mols. and small fragments are poles apart.  In this review article, our aim is to appraise what we have accomplished in the development of both hybrid- and fragment-like mols. directed to diverse AD targets (i.e., acetylcholinesterase, NMDA receptors, metal chelation, BACE-1 and GSK-3β).  In addn., we attempt to highlight what are the persistent needs that deserve to be improved and cared for, with the ultimate goal of moving an MTDL to AD clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAXsoof4raqbVg90H21EOLACvtfcHk0lipSCM8CbETyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI&md5=3653a0ef6b41711663e8d2f2d4ae74f6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21040466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21040466%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DNavigating%2520the%2520chemical%2520space%2520of%2520multitarget-directed%2520ligands%253A%2520from%2520hybrids%2520to%2520fragments%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D466%26doi%3D10.3390%2Fmolecules21040466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lipSCM8CbETyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, M. S.</span></span> <span> </span><span class="NLM_article-title">Introduction to special issue on Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8977</span>– <span class="NLM_lpage">8978</span>, <span class="refDoi"> DOI: 10.1021/jm301426y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301426y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKmtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8977-8978&author=M.+S.+Wolfe&title=Introduction+to+special+issue+on+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301426y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction to Special Issue on Alzheimer's Disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8977-8978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtrVvr47zTWrVg90H21EOLACvtfcHk0lipSCM8CbETyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKmtbjN&md5=d89975521800c43d5621f0a69690845b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301426y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301426y%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DIntroduction%2520to%2520special%2520issue%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8977%26epage%3D8978%26doi%3D10.1021%2Fjm301426y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0lj64OCUqOUWPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=619-637&author=F.+Pratiauthor=G.+Bottegoniauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=BACE-1+inhibitors%3A+from+recent+single-target+molecules+to+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Prati, Federica; Bottegoni, Giovanni; Bolognesi, Maria Laura; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer's disease (AD), leading to many small-mol. and biol. drug candidates.  One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors.  The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment.  It also suggests new possibilities for discovering BACE-1-targeted compds. with more complex mechanisms of actions and improved efficacy.  Herein, the authors review the major advances in BACE-1 drug discovery, from single-target small mol. inhibitors to multitarget compds.  The authors discuss these compds. as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqIKti01PzWrVg90H21EOLACvtfcHk0lj64OCUqOUWPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO&md5=a30fe7a54f34206355c6380eb9eacbe4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DBACE-1%2520inhibitors%253A%2520from%2520recent%2520single-target%2520molecules%2520to%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D619%26epage%3D637%26doi%3D10.1021%2Facs.jmedchem.7b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, A.</span></span> <span> </span><span class="NLM_article-title">Neuroscience: the plaque plan</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>456</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1038/456161a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2F456161a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=19005527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=456&publication_year=2008&pages=161-164&author=A.+Abbott&title=Neuroscience%3A+the+plaque+plan&doi=10.1038%2F456161a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroscience: The plaque plan</span></div><div class="casAuthors">Abbott, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">456</span>
        (<span class="NLM_cas:issue">7219</span>),
    <span class="NLM_cas:pages">161-164</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroscientists are pretty sure they know what causes Alzheimer's disease, but their theory has not yet given rise to effective drugs.  Alison Abbott asks what's wrong.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBBdgBQowASrVg90H21EOLACvtfcHk0lj64OCUqOUWPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtLzL&md5=58988985203c90e130a2b6f451e0a165</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F456161a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F456161a%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DA.%26atitle%3DNeuroscience%253A%2520the%2520plaque%2520plan%26jtitle%3DNature%26date%3D2008%26volume%3D456%26spage%3D161%26epage%3D164%26doi%3D10.1038%2F456161a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, D. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">γ-secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1021/jm101168r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.+C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs&doi=10.1021%2Fjm101168r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer's Drugs</span></div><div class="casAuthors">Oehlrich, Daniel; Berthelot, Didier J.-C.; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvn89jnxR8U7Vg90H21EOLACvtfcHk0lhBdxCdW9rpzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO&md5=91dfeb6984c718e941635e7b3f60f59f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2BC.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698%26doi%3D10.1021%2Fjm101168r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrup, K.</span></span> <span> </span><span class="NLM_article-title">The case for rejecting the amyloid cascade hypothesis</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">794</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1038/nn.4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnn.4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=26007212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=794-799&author=K.+Herrup&title=The+case+for+rejecting+the+amyloid+cascade+hypothesis&doi=10.1038%2Fnn.4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The case for rejecting the amyloid cascade hypothesis</span></div><div class="casAuthors">Herrup, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">794-799</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a biol. complex neurodegenerative dementia.  Nearly 20 years ago, with the combination of observations from biochem., neuropathol. and genetics, a compelling hypothesis known as the amyloid cascade hypothesis was formulated.  The core of this hypothesis is that it is pathol. accumulations of amyloid-β, a peptide fragment of a membrane protein called amyloid precursor protein, that act as the root cause of AD and initiate its pathogenesis.  Yet, with the passage of time, growing amts. of data have accumulated that are inconsistent with the basically linear structure of this hypothesis.  And while there is fear in the field over the consequences of rejecting it outright, clinging to an inaccurate disease model is the option we should fear most.  This Perspective explores the proposition that we are over-reliant on amyloid to define and diagnose AD and that the time has come to face our fears and reject the amyloid cascade hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIDjilDJZlrVg90H21EOLACvtfcHk0lhBdxCdW9rpzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN&md5=e7513943fd2fa3fe7c6d9e1cb3f859b2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnn.4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4017%26sid%3Dliteratum%253Aachs%26aulast%3DHerrup%26aufirst%3DK.%26atitle%3DThe%2520case%2520for%2520rejecting%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D794%26epage%3D799%26doi%3D10.1038%2Fnn.4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkes, N.</span></span> <span> </span><span class="NLM_article-title">Merck ends trial of potential Alzheimer’s drug verubecestat</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">j845</span>, <span class="refDoi"> DOI: 10.1136/bmj.j845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1136%2Fbmj.j845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28202490" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2017&pages=j845&author=N.+Hawkes&title=Merck+ends+trial+of+potential+Alzheimer%E2%80%99s+drug+verubecestat&doi=10.1136%2Fbmj.j845"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fbmj.j845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.j845%26sid%3Dliteratum%253Aachs%26aulast%3DHawkes%26aufirst%3DN.%26atitle%3DMerck%2520ends%2520trial%2520of%2520potential%2520Alzheimer%25E2%2580%2599s%2520drug%2520verubecestat%26jtitle%3DBMJ.%26date%3D2017%26volume%3D356%26spage%3Dj845%26doi%3D10.1136%2Fbmj.j845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Castillo-Frias, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthoumieu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasica-Labouze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterpone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derreumaux, P.</span></span> <span> </span><span class="NLM_article-title">Why is research on amyloid-beta failing to give new drugs for Alzheimer’s disease?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1435-1437&author=A.+J.+Doigauthor=M.+P.+Del+Castillo-Friasauthor=O.+Berthoumieuauthor=B.+Tarusauthor=J.+Nasica-Labouzeauthor=F.+Sterponeauthor=P.+H.+Nguyenauthor=N.+M.+Hooperauthor=P.+Fallerauthor=P.+Derreumaux&title=Why+is+research+on+amyloid-beta+failing+to+give+new+drugs+for+Alzheimer%E2%80%99s+disease%3F&doi=10.1021%2Facschemneuro.7b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?</span></div><div class="casAuthors">Doig, Andrew J.; del Castillo-Frias, Maria P.; Berthoumieu, Olivia; Tarus, Bogdan; Nasica-Labouze, Jessica; Sterpone, Fabio; Nguyen, Phuong H.; Hooper, Nigel M.; Faller, Peter; Derreumaux, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1435-1437</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two hallmarks of Alzheimer's disease (AD) are the presence of neurofibrillary tangles (NFT) made of aggregates of the hyperphosphorylated tau protein and of amyloid plaques composed of amyloid-β (Aβ) peptides, primarily Aβ1-40 and Aβ1-42.  Targeting the prodn., aggregation, and toxicity of Aβ with small mol. drugs or antibodies is an active area of AD research due to the general acceptance of the amyloid cascade hypothesis, but thus far all drugs targeting Aβ have failed.  From a review of the recent literature and our own experience based on in vitro, in silico, and in vivo studies, we present some reasons to explain this repetitive failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrimFSfyVV9VrVg90H21EOLACvtfcHk0lhBdxCdW9rpzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D&md5=26bc5126993b4d8df4eaf9ddf81e981a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00188%26sid%3Dliteratum%253Aachs%26aulast%3DDoig%26aufirst%3DA.%2BJ.%26aulast%3DDel%2BCastillo-Frias%26aufirst%3DM.%2BP.%26aulast%3DBerthoumieu%26aufirst%3DO.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DNasica-Labouze%26aufirst%3DJ.%26aulast%3DSterpone%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DDerreumaux%26aufirst%3DP.%26atitle%3DWhy%2520is%2520research%2520on%2520amyloid-beta%2520failing%2520to%2520give%2520new%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1435%26epage%3D1437%26doi%3D10.1021%2Facschemneuro.7b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodero-Tavoletti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span> <span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(14)70252-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions&doi=10.1016%2FS1474-4422%2814%2970252-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2ebPmZ9pHNR_9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124%26doi%3D10.1016%2FS1474-4422%2814%2970252-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, J.</span></span> <span> </span><span class="NLM_article-title">Tau-based therapies in neurodegeneration: opportunities and challenges</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnrd.2017.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28983098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sqt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=863-883&author=C.+Liauthor=J.+G%C3%B6tz&title=Tau-based+therapies+in+neurodegeneration%3A+opportunities+and+challenges&doi=10.1038%2Fnrd.2017.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-based therapies in neurodegeneration: opportunities and challenges</span></div><div class="casAuthors">Li, Chuanzhou; Gotz, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">863-883</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Aggregates of the microtubule-assocd. protein tau are a defining feature of several neurodegenerative diseases that are collectively known as tauopathies, and constitute one of the hallmark lesions of Alzheimer disease (AD).  Given the lack of efficacy to date of amyloid-β-targeted therapies for AD, interest is growing in tau as a potential alternative target.  Several drug candidates, which are now in clin. trials, aim to reduce tau levels or to prevent the aggregation or pathol. post-translation modifications of this protein.  In this Review, we discuss preclin. and clin. studies in light of an increased understanding of the physiol. and pathol. roles of tau, advances in animal models of tauopathy, the identification of novel targets and the availability of novel tracers to track tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSC7Md8i-637Vg90H21EOLACvtfcHk0limsvavdJ6blQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sqt7jF&md5=389b4be6419498344b5e53ca1be9c22e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.155%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DG%25C3%25B6tz%26aufirst%3DJ.%26atitle%3DTau-based%2520therapies%2520in%2520neurodegeneration%253A%2520opportunities%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D863%26epage%3D883%26doi%3D10.1038%2Fnrd.2017.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span> <span> </span><span class="NLM_article-title">Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrn2194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnrn2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=17684513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Crt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=663-672&author=C.+Ballatoreauthor=V.+M.+Y.+Leeauthor=J.+Q.+Trojanowski&title=Tau-mediated+neurodegeneration+in+Alzheimer%E2%80%99s+disease+and+related+disorders&doi=10.1038%2Fnrn2194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-mediated neurodegeneration in Alzheimer's disease and related disorders</span></div><div class="casAuthors">Ballatore, Carlo; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">663-672</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Advances in the understanding of the mechanisms of tau-mediated neurodegeneration in Alzheimer's disease (AD) and related tauopathies, which are characterized by prominent CNS accumulations of fibrillar tau inclusions, are rapidly moving this previously underexplored disease pathway to center stage for disease-modifying drug discovery efforts.  However, controversies abound concerning whether or not the deleterious effects of tau pathologies result from toxic gains-of-function by pathol. tau or from crit. losses of normal tau function in the disease state.  This review summarizes the most recent advances in the authors' knowledge of the mechanisms of tau-mediated neurodegeneration to forge an integrated concept of those tau-linked disease processes that drive the onset and progression of AD and related tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8-k_a3SnV7bVg90H21EOLACvtfcHk0ljFSkhOF1rVIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Crt78%253D&md5=eef3cc99033075b3215b739521d672f6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrn2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2194%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTau-mediated%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2007%26volume%3D8%26spage%3D663%26epage%3D672%26doi%3D10.1038%2Fnrn2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spillantini, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span> <span> </span><span class="NLM_article-title">Tau pathology and neurodegeneration</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70090-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS1474-4422%2813%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=23684085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=609-622&author=M.+G.+Spillantiniauthor=M.+Goedert&title=Tau+pathology+and+neurodegeneration&doi=10.1016%2FS1474-4422%2813%2970090-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Tau pathology and neurodegeneration</span></div><div class="casAuthors">Spillantini, Maria Grazia; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-622</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathway leading from sol. and monomeric to hyperphosphorylated, insol. and filamentous tau protein is at the center of many human neurodegenerative diseases, collectively referred to as tauopathies.  Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia.  However, most cases of tauopathy are not inherited in a dominant manner.  The first tau aggregates form in a few nerve cells in discrete brain areas.  These become self propagating and spread to distant brain regions in a prion-like manner.  The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-Mr15hi3grVg90H21EOLACvtfcHk0ljFSkhOF1rVIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D&md5=532220e2bfffdb228277e80868bdde65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DTau%2520pathology%2520and%2520neurodegeneration%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D609%26epage%3D622%26doi%3D10.1016%2FS1474-4422%2813%2970090-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span> <span> </span><span class="NLM_article-title">Microtubule stabilizing agents as potential treatment for Alzheimer’s disease and related neurodegenerative tauopathies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8979</span>– <span class="NLM_lpage">8996</span>, <span class="refDoi"> DOI: 10.1021/jm301079z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301079z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8979-8996&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=D.+M.+Hurynauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Leeauthor=A.+B.+Smith&title=Microtubule+stabilizing+agents+as+potential+treatment+for+Alzheimer%E2%80%99s+disease+and+related+neurodegenerative+tauopathies&doi=10.1021%2Fjm301079z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule Stabilizing Agents as Potential Treatment for Alzheimer's Disease and Related Neurodegenerative Tauopathies</span></div><div class="casAuthors">Ballatore, Carlo; Brunden, Kurt R.; Huryn, Donna M.; Trojanowski, John Q.; Lee, Virginia M.-Y.; Smith, Amos B., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8979-8996</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The microtubule (MT) assocd. protein tau, which is highly expressed in the axons of neurons, is an endogenous MT-stabilizing agent that plays an important role in axonal transport.  Loss of MT-stabilizing tau function, caused by misfolding, hyperphosphorylation, and sequestration of tau into insol. aggregates, leads to axonal transport deficits with neuropathol. consequences.  Several in vitro and preclin. in vivo studies have shown that MT-stabilizing drugs can be utilized to compensate for the loss of tau function and to maintain/restore effective axonal transport.  These findings indicate that MT-stabilizing compds. hold considerable promise for the treatment of Alzheimer disease and related tauopathies.  The present article provides a synopsis of the key findings demonstrating the therapeutic potential of MT-stabilizing drugs in the context of neurodegenerative tauopathies, as well as an overview of the different classes of MT-stabilizing compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB8zgmxRqAj7Vg90H21EOLACvtfcHk0ljFSkhOF1rVIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfE&md5=f995701a74a9d4b6d831ef208891177a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301079z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301079z%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DMicrotubule%2520stabilizing%2520agents%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520neurodegenerative%2520tauopathies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8979%26epage%3D8996%26doi%3D10.1021%2Fjm301079z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Progress and developments in tau aggregation inhibitors for Alzheimer disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4135</span>– <span class="NLM_lpage">4155</span>, <span class="refDoi"> DOI: 10.1021/jm3017317</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3017317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVCks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4135-4155&author=B.+Bulicauthor=M.+Pickhardtauthor=E.+Mandelkow&title=Progress+and+developments+in+tau+aggregation+inhibitors+for+Alzheimer+disease&doi=10.1021%2Fjm3017317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease</span></div><div class="casAuthors">Bulic, Bruno; Pickhardt, Marcus; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4135-4155</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacol. approaches directed toward Alzheimer disease are diversifying in parallel with a growing no. of promising targets.  Investigations on the microtubule-assocd. protein tau yielded innovative targets backed by recent findings about the central role of tau in numerous neurodegenerative diseases.  In this review, we summarize the recent evolution in the development of nonpeptidic small mols. tau aggregation inhibitors (TAGIs) and their advancement toward clin. trials.  The compds. are classified according to their chem. structures, providing correlative insights into their pharmacol.  Overall, shared structure-activity traits are emerging, as well as specific binding modes related to their ability to engage in hydrogen bonding.  Medicinal chem. efforts on TAGIs together with encouraging in vivo data argue for successful translation to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-MCCWng61lLVg90H21EOLACvtfcHk0ljFSkhOF1rVIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVCks7w%253D&md5=35aa968d078ff044e0d353fca4f13e42</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3017317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3017317%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProgress%2520and%2520developments%2520in%2520tau%2520aggregation%2520inhibitors%2520for%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4135%26epage%3D4155%26doi%3D10.1021%2Fjm3017317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1259412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1080%2F13543776.2017.1259412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=27828716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFegtbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=657-666&author=V.+Palomoauthor=A.+Martinez&title=Glycogen+synthase+kinase+3+%28GSK-3%29+inhibitors%3A+a+patent+update+%282014%E2%80%932015%29&doi=10.1080%2F13543776.2017.1259412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)</span></div><div class="casAuthors">Palomo, Valle; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-666</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Glycogen synthase kinase (GSK-3) is a serine/threonine kinase that phosphorylates more than one hundred different sequences within proteins in a variety of different pathways.  It is a key component of a remarkably large no. of cellular processes and diseases.  Imbalance of GSK-3 activity is involved in various prevalent pathol. diseases, such as diabetes, neurodegenerative diseases and cancer.  Understanding its role in different disorders has been central in the last several decades and there has been a significantly large development of GSK-3 inhibitors, some of which, show promising results for the treatment of these devastating diseases.:.  This review covers patent literature on GSK-3 inhibitors and their applications published and/or granted between 2014 and 2015.:.  GSK-3 inhibitors have gained a prominent role in regenerative medicine based in their ability to modulate stem cells.  Moreover, some allosteric modulators of GSK-3 emerge as safe compds. for chronic treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiR4jwEmZaLLVg90H21EOLACvtfcHk0lgr6ojAIO8mBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFegtbnP&md5=a919f64e1136af3b4901ff2929d1bf58</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1259412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1259412%26sid%3Dliteratum%253Aachs%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520%2528GSK-3%2529%2520inhibitors%253A%2520a%2520patent%2520update%2520%25282014%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D657%26epage%3D666%26doi%3D10.1080%2F13543776.2017.1259412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandosell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, F.</span></span> <span> </span><span class="NLM_article-title">Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1586/ern.10.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1586%2Fern.10.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20420491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=703-710&author=J.+Avilaauthor=F.+Wandosellauthor=F.+Hernandez&title=Role+of+glycogen+synthase+kinase-3+in+Alzheimer%E2%80%99s+disease+pathogenesis+and+glycogen+synthase+kinase-3+inhibitors&doi=10.1586%2Fern.10.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors</span></div><div class="casAuthors">Avila, Jesus; Wandosell, Francisco; Hernandez, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">703-710</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase (GSK)-3 has been proposed as the link between the two histopathol. hallmarks of Alzheimer's disease, the extracellular senile plaques composed of β-amyloid and the intracellular neurofibrillary tangles formed from hyperphosphorylated tau.  Thus, GSK-3 is one of the main tau kinases and it modifies several sites of the tau protein present in neurofibrillary tangles.  Furthermore, GSK-3 is able to modulate the generation of amyloid-β, as well as to respond to this peptide.  In several transgenic models, overexpression of GSK-3 has been assocd. with neuronal death, tau hyperphosphorylation and a decline in cognitive performance.  Lithium, a widely used drug for affective disorders, inhibits GSK-3 at therapeutically relevant concns. and it has been demonstrated that this is able to prevent tau phosphorylation.  In the present review, we summarize all these data and discuss the potential of GSK-3 inhibitors for Alzheimer's disease therapy, as well as some of their potential problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9AMLoLImff7Vg90H21EOLACvtfcHk0lgr6ojAIO8mBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWls7s%253D&md5=4add8e9d6a932f16b0209442033c3f61</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1586%2Fern.10.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.10.40%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DWandosell%26aufirst%3DF.%26aulast%3DHernandez%26aufirst%3DF.%26atitle%3DRole%2520of%2520glycogen%2520synthase%2520kinase-3%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathogenesis%2520and%2520glycogen%2520synthase%2520kinase-3%2520inhibitors%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2010%26volume%3D10%26spage%3D703%26epage%3D710%26doi%3D10.1586%2Fern.10.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Muela, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timchenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Subtly modulating glycogen synthase kinase 3 beta: allosteric inhibitor development and their potential for the treatment of chronic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4983</span>– <span class="NLM_lpage">5001</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00395</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00395" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4983-5001&author=V.+Palomoauthor=D.+I.+Perezauthor=C.+Rocaauthor=C.+Andersonauthor=N.+Rodriguez-Muelaauthor=C.+Perezauthor=J.+A.+Morales-Garciaauthor=J.+A.+Reyesauthor=N.+E.+Campilloauthor=A.+M.+Perez-Castilloauthor=L.+L.+Rubinauthor=L.+Timchenkoauthor=C.+Gilauthor=A.+Martinez&title=Subtly+modulating+glycogen+synthase+kinase+3+beta%3A+allosteric+inhibitor+development+and+their+potential+for+the+treatment+of+chronic+diseases&doi=10.1021%2Facs.jmedchem.7b00395"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00395%26sid%3Dliteratum%253Aachs%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DRoca%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DC.%26aulast%3DRodriguez-Muela%26aufirst%3DN.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DReyes%26aufirst%3DJ.%2BA.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DPerez-Castillo%26aufirst%3DA.%2BM.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DTimchenko%26aufirst%3DL.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DSubtly%2520modulating%2520glycogen%2520synthase%2520kinase%25203%2520beta%253A%2520allosteric%2520inhibitor%2520development%2520and%2520their%2520potential%2520for%2520the%2520treatment%2520of%2520chronic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4983%26epage%3D5001%26doi%3D10.1021%2Facs.jmedchem.7b00395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Development of tau aggregation inhibitors for Alzheimer’s disease</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1740</span>– <span class="NLM_lpage">1752</span>, <span class="refDoi"> DOI: 10.1002/anie.200802621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.200802621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlaltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1740-1752&author=B.+Bulicauthor=M.+Pickhardtauthor=B.+Schmidtauthor=E.+M.+Mandelkowauthor=H.+Waldmannauthor=E.+Mandelkow&title=Development+of+tau+aggregation+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fanie.200802621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Development of tau aggregation inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Bulic, Bruno; Pickhardt, Marcus; Schmidt, Boris; Mandelkow, Eva-Maria; Waldmann, Herbert; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1740-1752</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  A variety of human diseases are suspected to be directly linked to protein misfolding.  Highly organized protein aggregates, called amyloid fibrils, and aggregation intermediates are obsd.; these are considered to be mediators of cellular toxicity and thus attract a great deal of attention from investigators.  Neurodegenerative pathologies such as Alzheimer's disease account for a major part of these protein misfolding diseases.  The last decade has witnessed a renaissance of interest in inhibitors of tau aggregation as potential disease-modifying drugs for Alzheimer's disease and other "tautopathies".  The recent report of a phase II clin. trial with the tau aggregation inhibitor MTC could hold promise for the validation of the concept.  This review summarizes the available data concerning small-mol. inhibitors of tau aggregation from a medicinal chem. point of view.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotlDVfG5fTwrVg90H21EOLACvtfcHk0lgRVH58_UkRGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlaltb0%253D&md5=99fae786e20252e4139283ce4943e37c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.200802621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200802621%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DDevelopment%2520of%2520tau%2520aggregation%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D1740%26epage%3D1752%26doi%3D10.1002%2Fanie.200802621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span> </span><span class="NLM_article-title">Cognitive
and Functional Connectivity Effects of Methylene Blue in
Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
(MB2)</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2015</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT02380573" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02380573</a> (accessed July 12, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cognitive%0Aand+Functional+Connectivity+Effects+of+Methylene+Blue+in%0AHealthy+Aging%2C+Mild+Cognitive+Impairment+and+Alzheimer%27s+Disease%0A%28MB2%29.+ClinicalTrials.gov%3B+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02380573+%28accessed+July+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DCognitive%250Aand%2520Functional%2520Connectivity%2520Effects%2520of%2520Methylene%2520Blue%2520in%250AHealthy%2520Aging%252C%2520Mild%2520Cognitive%2520Impairment%2520and%2520Alzheimer%2527s%2520Disease%250A%2528MB2%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2015%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilcock, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisoni, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardlund, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelter, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staff, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuksanovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahearn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracoud, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamsi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, J. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, C. M.</span></span> <span> </span><span class="NLM_article-title">Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer’s disease: cohort analysis as modified primary outcome in a phase III clinical trial</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.3233/JAD-170560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.3233%2FJAD-170560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=29154277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=435-457&author=G.+K.+Wilcockauthor=S.+Gauthierauthor=G.+B.+Frisoniauthor=J.+Jiaauthor=J.+H.+Hardlundauthor=H.+J.+Moebiusauthor=P.+Benthamauthor=K.+A.+Kookauthor=B.+O.+Schelterauthor=D.+J.+Wischikauthor=C.+S.+Davisauthor=R.+T.+Staffauthor=V.+Vuksanovicauthor=T.+Ahearnauthor=L.+Bracoudauthor=K.+Shamsiauthor=K.+Marekauthor=J.+Seibylauthor=G.+Riedelauthor=J.+M.+D.+Storeyauthor=C.+R.+Harringtonauthor=C.+M.+Wischik&title=Potential+of+low+dose+leuco-methylthioninium+bis%28hydromethanesulphonate%29+%28LMTM%29+monotherapy+for+treatment+of+mild+Alzheimer%E2%80%99s+disease%3A+cohort+analysis+as+modified+primary+outcome+in+a+phase+III+clinical+trial&doi=10.3233%2FJAD-170560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial</span></div><div class="casAuthors">Wilcock, Gordon K.; Gauthier, Serge; Frisoni, Giovanni B.; Jia, Jianping; Hardlund, Jiri H.; Moebius, Hans J.; Bentham, Peter; Kook, Karin A.; Schelter, Bjoern O.; Wischik, Damon J.; Davis, Charles S.; Staff, Roger T.; Vuksanovic, Vesna; Ahearn, Trevor; Bracoud, Luc; Shamsi, Kohkan; Marek, Ken; Seibyl, John; Riedel, Gernot; Storey, John M. D.; Harrington, Charles R.; Wischik, Claude M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">435-457</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: : LMTM is being developed as a treatment for AD based on inhibition of tau aggregation.  Objectives: : To examine the efficacy of LMTM as monotherapy in non-randomized cohort analyses as modified primary outcomes in an 18-mo Phase III trial in mild AD.  Methods: : Mild AD patients (n=800) were randomly assigned to 100mg twice a day or 4mg twice a day.  Prior to unblinding, the Statistical Anal. Plan was revised to compare the 100mg twice a day as monotherapy subgroup (n=79) vs. 4mg twice a day as randomized (n=396), and 4mg twice a day as monotherapy (n=76) vs. 4mg twice a day as add-on therapy (n=297), with strong control of family-wise type I error.  Results: : The revised analyses were statistically significant at the required threshold of p<0.025 in both comparisons for change in ADAS-cog, ADCS-ADL, MRI atrophy, and glucose uptake.  The brain atrophy rate was initially typical of mild AD in both add-on and monotherapy groups, but after 9 mo of treatment, the rate in monotherapy patients declined significantly to that reported for normal elderly controls.  Differences in severity or diagnosis at baseline between monotherapy and add-on patients did not account for significant differences in favor of monotherapy.  Conclusions: : The results are consistent with earlier studies in supporting the hypothesis that LMTM might be effective as monotherapy and that 4mg twice a day may serve as well as higher doses.  A further suitably randomized trial is required to test this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjEsIfpVnYOLVg90H21EOLACvtfcHk0lgRVH58_UkRGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbjK&md5=54d8ecadd37e7628bf0bf21d22067378</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3233%2FJAD-170560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170560%26sid%3Dliteratum%253Aachs%26aulast%3DWilcock%26aufirst%3DG.%2BK.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DFrisoni%26aufirst%3DG.%2BB.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DHardlund%26aufirst%3DJ.%2BH.%26aulast%3DMoebius%26aufirst%3DH.%2BJ.%26aulast%3DBentham%26aufirst%3DP.%26aulast%3DKook%26aufirst%3DK.%2BA.%26aulast%3DSchelter%26aufirst%3DB.%2BO.%26aulast%3DWischik%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DC.%2BS.%26aulast%3DStaff%26aufirst%3DR.%2BT.%26aulast%3DVuksanovic%26aufirst%3DV.%26aulast%3DAhearn%26aufirst%3DT.%26aulast%3DBracoud%26aufirst%3DL.%26aulast%3DShamsi%26aufirst%3DK.%26aulast%3DMarek%26aufirst%3DK.%26aulast%3DSeibyl%26aufirst%3DJ.%26aulast%3DRiedel%26aufirst%3DG.%26aulast%3DStorey%26aufirst%3DJ.%2BM.%2BD.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26aulast%3DWischik%26aufirst%3DC.%2BM.%26atitle%3DPotential%2520of%2520low%2520dose%2520leuco-methylthioninium%2520bis%2528hydromethanesulphonate%2529%2520%2528LMTM%2529%2520monotherapy%2520for%2520treatment%2520of%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520cohort%2520analysis%2520as%2520modified%2520primary%2520outcome%2520in%2520a%2520phase%2520III%2520clinical%2520trial%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D61%26spage%3D435%26epage%3D457%26doi%3D10.3233%2FJAD-170560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korcsmáros, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szalay, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovács, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csermely, P.</span></span> <span> </span><span class="NLM_article-title">How to design multi-target drugs</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.1517/17460441.2.6.799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1517%2F17460441.2.6.799" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=799-808&author=T.+Korcsm%C3%A1rosauthor=M.+S.+Szalayauthor=C.+B%C3%B6deauthor=I.+A.+Kov%C3%A1csauthor=P.+Csermely&title=How+to+design+multi-target+drugs&doi=10.1517%2F17460441.2.6.799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.6.799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.6.799%26sid%3Dliteratum%253Aachs%26aulast%3DKorcsm%25C3%25A1ros%26aufirst%3DT.%26aulast%3DSzalay%26aufirst%3DM.%2BS.%26aulast%3DB%25C3%25B6de%26aufirst%3DC.%26aulast%3DKov%25C3%25A1cs%26aufirst%3DI.%2BA.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DHow%2520to%2520design%2520multi-target%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D799%26epage%3D808%26doi%3D10.1517%2F17460441.2.6.799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisignano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massenzio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favia, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">Multitarget drug discovery for Alzheimer’s disease: triazinones as BACE-1 and GSK-3beta inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1578</span>– <span class="NLM_lpage">1582</span>, <span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+triazinones+as+BACE-1+and+GSK-3beta+inhibitors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520triazinones%2520as%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
los Ríos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gálvez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5129</span>– <span class="NLM_lpage">5143</span>, <span class="refDoi"> DOI: 10.1021/jm901902w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901902w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5129-5143&author=C.+de%0Alos+R%C3%ADosauthor=J.+Egeaauthor=J.+Marco-Contellesauthor=R.+Le%C3%B3nauthor=A.+Samadiauthor=I.+Iriepaauthor=I.+Moraledaauthor=E.+G%C3%A1lvezauthor=A.+G.+Garc%C3%ADaauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+Romero&title=Synthesis%2C+inhibitory+activity+of+cholinesterases%2C+and+neuroprotective+profile+of+novel+1%2C8-naphthyridine+derivatives&doi=10.1021%2Fjm901902w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives</span></div><div class="casAuthors">de los Rios, Cristobal; Egea, Javier; Marco-Contelles, Jose; Leon, Rafael; Samadi, Abdelouahid; Iriepa, Isabel; Moraleda, Ignacio; Galvez, Enrique; Garcia, Antonio G.; Lopez, Manuela G.; Villarroya, Mercedes; Romero, Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5129-5143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,8-Naphthyridine derivs. related to neuroprotective compd. I (ITH4012) have been synthesized.  In general, they have shown better inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) than most related tacrine derivs.  The compds. presented an interesting neuroprotective profile in SH-SY5Y neuroblastoma cells stressed with rotenone/oligomycin A.  Moreover, compd. II also caused protection in cells stressed with okadaic acid (OA) or amyloid β 1-42 peptide (Aβ1-42).  Interestingly, compd. II prevented the OA-induced PP2A inhibition, one of the enzymes implicated in τ dephosphorylation.  This compd. also exhibited neuroprotection against neurotoxicity elicited by oxygen and glucose deprivation in hippocampal slices.  Because these stressors caused neuronal damage related to physiopathol. hallmarks found in the brain of Alzheimer's disease (AD) patients, we conclude that compd. II deserves further in vivo studies in AD models to test its therapeutic potential in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn990-FK7y87Vg90H21EOLACvtfcHk0lidHxHLhmqWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbg%253D&md5=92d0cf582eb9816f03c72a2f8344883f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901902w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901902w%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DE.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DRomero%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520inhibitory%2520activity%2520of%2520cholinesterases%252C%2520and%2520neuroprotective%2520profile%2520of%2520novel%25201%252C8-naphthyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5129%26epage%3D5143%26doi%3D10.1021%2Fjm901902w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorrio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lafuente, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajarin-Cuesta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Sanz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los
Rios, C.</span></span> <span> </span><span class="NLM_article-title">PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1021/cn400050p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400050p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Squr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1267-1277&author=S.+Lorrioauthor=A.+Romeroauthor=L.+Gonzalez-Lafuenteauthor=R.+Lajarin-Cuestaauthor=F.+J.+Martinez-Sanzauthor=M.+Estradaauthor=A.+Samadiauthor=J.+Marco-Contellesauthor=M.+I.+Rodriguez-Francoauthor=M.+Villarroyaauthor=M.+G.+Lopezauthor=C.+de+los%0ARios&title=PP2A+ligand+ITH12246+protects+against+memory+impairment+and+focal+cerebral+ischemia+in+mice&doi=10.1021%2Fcn400050p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">PP2A Ligand ITH12246 Protects against Memory Impairment and Focal Cerebral Ischemia in Mice</span></div><div class="casAuthors">Lorrio, Silvia; Romero, Alejandro; Gonzalez-Lafuente, Laura; Lajarin-Cuesta, Rocio; Martinez-Sanz, Francisco J.; Estrada, Martin; Samadi, Abdelouahid; Marco-Contelles, Jose; Rodriguez-Franco, Maria Isabel; Villarroya, Mercedes; Lopez, Manuela G.; de los Rios, Cristobal</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1267-1277</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ITH12246 (Et 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate) is a 1,8-naphthyridine described to feature an interesting neuroprotective profile in in vitro models of Alzheimer's disease.  These effects were proposed to be due in part to a regulatory action on protein phosphatase 2A inhibition, as it prevented binding of its inhibitor okadaic acid.  We decided to investigate the pharmacol. properties of ITH12246, evaluating its ability to counteract the memory impairment evoked by scopolamine, a muscarinic antagonist described to promote memory loss, as well as to reduce the infarct vol. in mice suffering phototrombosis.  Prior to conducting these expts., we confirmed its in vitro neuroprotective activity against both oxidative stress and Ca2+ overload-derived excitotoxicity, using SH-SY5Y neuroblastoma cells and rat hippocampal slices.  Using a predictive model of blood-brain barrier crossing, it seems that the passage of ITH12246 is not hindered.  Its potential hepatotoxicity was obsd. only at very high concns., from 0.1 mM.  ITH12246, at the concn. of 10 mg/kg i.p., was able to improve the memory index of mice treated with scopolamine, from 0.22 to 0.35, in a similar fashion to the well-known Alzheimer's disease drug galantamine 2.5 mg/kg.  On the other hand, ITH12246, at the concn. of 2.5 mg/kg, reduced the phototrombosis-triggered infarct vol. by 67%.  In the same exptl. conditions, 15 mg/kg melatonin, used as control std., reduced the infarct vol. by 30%.  All of these findings allow us to consider ITH12246 as a new potential drug for the treatment of neurodegenerative diseases, which would act as a multifactorial neuroprotectant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9HUSlFkRvi7Vg90H21EOLACvtfcHk0lidHxHLhmqWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Squr8%253D&md5=9dd83a239b75a0fbae55858881126e13</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcn400050p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400050p%26sid%3Dliteratum%253Aachs%26aulast%3DLorrio%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DGonzalez-Lafuente%26aufirst%3DL.%26aulast%3DLajarin-Cuesta%26aufirst%3DR.%26aulast%3DMartinez-Sanz%26aufirst%3DF.%2BJ.%26aulast%3DEstrada%26aufirst%3DM.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26atitle%3DPP2A%2520ligand%2520ITH12246%2520protects%2520against%2520memory%2520impairment%2520and%2520focal%2520cerebral%2520ischemia%2520in%2520mice%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1267%26epage%3D1277%26doi%3D10.1021%2Fcn400050p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallverdú-Queralt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragusa, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamuela-Raventós, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Shogaol–huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5307</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2014.07.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5298-5307&author=F.+J.+P%C3%A9rez-Arealesauthor=O.+Di+Pietroauthor=A.+Espargar%C3%B3author=A.+Vallverd%C3%BA-Queraltauthor=C.+Galdeanoauthor=I.+M.+Ragusaauthor=E.+Viaynaauthor=C.+Guillouauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Sabat%C3%A9author=R.+M.+Lamuela-Ravent%C3%B3sauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Shogaol%E2%80%93huprine+hybrids%3A+dual+antioxidant+and+anticholinesterase+agents+with+%CE%B2-amyloid+and+tau+anti-aggregating+properties&doi=10.1016%2Fj.bmc.2014.07.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DVallverd%25C3%25BA-Queralt%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRagusa%26aufirst%3DI.%2BM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DGuillou%26aufirst%3DC.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLamuela-Ravent%25C3%25B3s%26aufirst%3DR.%2BM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DShogaol%25E2%2580%2593huprine%2520hybrids%253A%2520dual%2520antioxidant%2520and%2520anticholinesterase%2520agents%2520with%2520%25CE%25B2-amyloid%2520and%2520tau%2520anti-aggregating%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5298%26epage%3D5307%26doi%3D10.1016%2Fj.bmc.2014.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralinaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">First selective dual inhibitors of tau phosphorylation and beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1198</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1021/cn5001815</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn5001815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyrsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1198-1202&author=M.+Marianoauthor=C.+Schmittauthor=P.+Miralinaghiauthor=M.+Cattoauthor=R.+W.+Hartmannauthor=A.+Carottiauthor=M.+Engel&title=First+selective+dual+inhibitors+of+tau+phosphorylation+and+beta-amyloid+aggregation%2C+two+major+pathogenic+mechanisms+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn5001815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">First Selective Dual Inhibitors of Tau Phosphorylation and Beta-Amyloid Aggregation, Two Major Pathogenic Mechanisms in Alzheimer's Disease</span></div><div class="casAuthors">Mariano, Marica; Schmitt, Christian; Miralinaghi, Parisa; Catto, Marco; Hartmann, Rolf W.; Carotti, Angelo; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1198-1202</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), multiple factors account for the accumulation of neurocellular changes, which may begin several years before symptoms appear.  The most important pathogenic brain changes that are contributing to the development of AD are the formation of the cytotoxic β-amyloid aggregates and of the neurofibrillary tangles, which originate from amyloid-β peptides and hyperphosphorylated tau protein, resp.  New therapeutic agents that target both major pathogenic mechanisms may be particularly efficient.  In this study, the authors introduce bis(hydroxyphenyl)-substituted thiophenes I [R1 = 3-Me, 3-MeO, 3-Me-4-MeO, 3-Et-4-MeO; R2 = 3-MeO, 4-MeO, 3-Me-4-MeO, 3-Et-4-MeO] as a novel class of selective, dual inhibitors of the tau kinase Dyrk1A and of the amyloid-β aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNgPu3VSQ64rVg90H21EOLACvtfcHk0lhMnlSOcMd5kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyrsL3K&md5=31754e003032609beeb9568418bc30d7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fcn5001815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn5001815%26sid%3Dliteratum%253Aachs%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DMiralinaghi%26aufirst%3DP.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DFirst%2520selective%2520dual%2520inhibitors%2520of%2520tau%2520phosphorylation%2520and%2520beta-amyloid%2520aggregation%252C%2520two%2520major%2520pathogenic%2520mechanisms%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D1198%26epage%3D1202%26doi%3D10.1021%2Fcn5001815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejmech.2014.07.095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=228-234&author=S.+Fuseauthor=K.+Matsumuraauthor=Y.+Fujitaauthor=H.+Sugimotoauthor=T.+Takahashi&title=Development+of+dual+targeting+inhibitors+against+aggregations+of+amyloid-%CE%B2+and+tau+protein&doi=10.1016%2Fj.ejmech.2014.07.095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.095%26sid%3Dliteratum%253Aachs%26aulast%3DFuse%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520dual%2520targeting%2520inhibitors%2520against%2520aggregations%2520of%2520amyloid-%25CE%25B2%2520and%2520tau%2520protein%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D228%26epage%3D234%26doi%3D10.1016%2Fj.ejmech.2014.07.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hijikuro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5024</span>– <span class="NLM_lpage">5028</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmcl.2016.08.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5024-5028&author=M.+Okudaauthor=I.+Hijikuroauthor=Y.+Fujitaauthor=T.+Teruyaauthor=H.+Kawakamiauthor=T.+Takahashiauthor=H.+Sugimoto&title=Design+and+synthesis+of+curcumin+derivatives+as+tau+and+amyloid+%CE%B2+dual+aggregation+inhibitors&doi=10.1016%2Fj.bmcl.2016.08.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.092%26sid%3Dliteratum%253Aachs%26aulast%3DOkuda%26aufirst%3DM.%26aulast%3DHijikuro%26aufirst%3DI.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DTeruya%26aufirst%3DT.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520curcumin%2520derivatives%2520as%2520tau%2520and%2520amyloid%2520%25CE%25B2%2520dual%2520aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5024%26epage%3D5028%26doi%3D10.1016%2Fj.bmcl.2016.08.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lajarín-Cuesta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanclares, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arranz-Tagarro, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Lafuente, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arribas, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo de Brito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandía, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Ríos, C.</span></span> <span> </span><span class="NLM_article-title">Gramine derivatives targeting Ca2+ channels and Ser/Thr phosphatases: a new dual strategy for the treatment of neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6265</span>– <span class="NLM_lpage">6280</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6265-6280&author=R.+Lajar%C3%ADn-Cuestaauthor=C.+Nanclaresauthor=J.-A.+Arranz-Tagarroauthor=L.+Gonz%C3%A1lez-Lafuenteauthor=R.+L.+Arribasauthor=M.+Araujo+de+Britoauthor=L.+Gand%C3%ADaauthor=C.+de+los+R%C3%ADos&title=Gramine+derivatives+targeting+Ca2%2B+channels+and+Ser%2FThr+phosphatases%3A+a+new+dual+strategy+for+the+treatment+of+neurodegenerative+diseases&doi=10.1021%2Facs.jmedchem.6b00478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00478%26sid%3Dliteratum%253Aachs%26aulast%3DLajar%25C3%25ADn-Cuesta%26aufirst%3DR.%26aulast%3DNanclares%26aufirst%3DC.%26aulast%3DArranz-Tagarro%26aufirst%3DJ.-A.%26aulast%3DGonz%25C3%25A1lez-Lafuente%26aufirst%3DL.%26aulast%3DArribas%26aufirst%3DR.%2BL.%26aulast%3DAraujo%2Bde%2BBrito%26aufirst%3DM.%26aulast%3DGand%25C3%25ADa%26aufirst%3DL.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26atitle%3DGramine%2520derivatives%2520targeting%2520Ca2%252B%2520channels%2520and%2520Ser%252FThr%2520phosphatases%253A%2520a%2520new%2520dual%2520strategy%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6265%26epage%3D6280%26doi%3D10.1021%2Facs.jmedchem.6b00478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Martino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisignano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belluti, F.</span></span> <span> </span><span class="NLM_article-title">Versatility of the curcumin scaffold: discovery of potent and balanced dual BACE-1 and GSK-3beta inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=531-544&author=R.+M.+Di%0AMartinoauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=P.+Bisignanoauthor=A.+Bisiauthor=S.+Gobbiauthor=A.+Rampaauthor=R.+Fatoauthor=C.+Bergaminiauthor=D.+I.+Perezauthor=A.+Martinezauthor=G.+Bottegoniauthor=A.+Cavalliauthor=F.+Belluti&title=Versatility+of+the+curcumin+scaffold%3A+discovery+of+potent+and+balanced+dual+BACE-1+and+GSK-3beta+inhibitors&doi=10.1021%2Facs.jmedchem.5b00894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors</span></div><div class="casAuthors">Di Martino, Rita Maria Concetta; De Simone, Angela; Andrisano, Vincenza; Bisignano, Paola; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Fato, Romana; Bergamini, Christian; Perez, Daniel I.; Martinez, Ana; Bottegoni, Giovanni; Cavalli, Andrea; Belluti, Federica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">531-544</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach has gained increasing acceptance as a useful tool to address complex and multifactorial maladies such as Alzheimer's disease (AD).  The concurrent inhibition of the validated AD targets β-secretase (BACE-1) and glycogen synthase kinase-3β (GSK-3β) by attacking both β-amyloid and tau protein cascades has been identified as a promising AD therapeutic strategy.  In our study, curcumin was identified as a lead compd. for the simultaneous inhibition of both targets; therefore, synthetic efforts were dedicated to obtaining a small library of novel curcumin-based analogs, and a no. of potent and balanced dual-target inhibitors were obtained.  In particular, 2, 6, and 7 emerged as promising drug candidates endowed with neuroprotective potential and brain permeability.  Notably, for some new compds. the sym. diketo and the β-keto-enol tautomeric forms were purposely isolated and tested in vitro, allowing us to gain insight into the key requirements for BACE-1 and GSK-3β inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw1HaZGRzvJbVg90H21EOLACvtfcHk0lgosPZXsY20hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ&md5=349916a940c9cc8d87ca817c689756f1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00894%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMartino%26aufirst%3DR.%2BM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26atitle%3DVersatility%2520of%2520the%2520curcumin%2520scaffold%253A%2520discovery%2520of%2520potent%2520and%2520balanced%2520dual%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D531%26epage%3D544%26doi%3D10.1021%2Facs.jmedchem.5b00894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornec, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayendran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukoloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Multitargeted imidazoles: potential therapeutic leads for Alzheimer’s and other neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5120</span>– <span class="NLM_lpage">5145</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00475</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00475" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFOks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5120-5145&author=A.+S.+Cornecauthor=L.+Montiauthor=J.+Kovalevichauthor=V.+Makaniauthor=M.+J.+Jamesauthor=K.+G.+Vijayendranauthor=K.+Oukoloffauthor=Y.+Yaoauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=A.+B.+Smithauthor=K.+R.+Brundenauthor=C.+Ballatore&title=Multitargeted+imidazoles%3A+potential+therapeutic+leads+for+Alzheimer%E2%80%99s+and+other+neurodegenerative+diseases&doi=10.1021%2Facs.jmedchem.7b00475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases</span></div><div class="casAuthors">Cornec, Anne-Sophie; Monti, Ludovica; Kovalevich, Jane; Makani, Vishruti; James, Michael J.; Vijayendran, Krishna G.; Oukoloff, Killian; Yao, Yuemang; Lee, Virginia M.-Y.; Trojanowski, John Q.; Smith, Amos B.; Brunden, Kurt R.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5120-5145</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a complex, multifactorial disease in which different neuropathol. mechanisms are likely involved, including those assocd. with pathol. tau and Aβ species, as well as neuroinflammation.  In this context, the development of single multi-targeted therapeutics directed against two or more disease mechanisms could be advantageous.  Starting from a series of 1,5-diarylimidazoles with microtubule (MT)-stabilizing activity and structural similarities with known NSAIDs, the authors conducted structure-activity relationship studies that led to the identification of multi-targeted prototypes with activities as MT-stabilizing agents and/or inhibitors of the cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) pathways.  Several examples are brain-penetrant and exhibit balanced multi-targeted in vitro activity in the low μM range.  As brain-penetrant MT-stabilizing agents have proven effective against tau-mediated neurodegeneration in animal models, and because COX- and 5-LOX-derived eicosanoids are thought to contribute to Aβ plaque deposition, these 1,5-diarylimidazoles provide tools to explore novel multi-targeted strategies for AD and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnld-8Gn6PrVg90H21EOLACvtfcHk0lgosPZXsY20hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFOks7w%253D&md5=f0e874f8f6c63d3aa9ff70ca479e09b2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00475%26sid%3Dliteratum%253Aachs%26aulast%3DCornec%26aufirst%3DA.%2BS.%26aulast%3DMonti%26aufirst%3DL.%26aulast%3DKovalevich%26aufirst%3DJ.%26aulast%3DMakani%26aufirst%3DV.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DOukoloff%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DMultitargeted%2520imidazoles%253A%2520potential%2520therapeutic%2520leads%2520for%2520Alzheimer%25E2%2580%2599s%2520and%2520other%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5120%26epage%3D5145%26doi%3D10.1021%2Facs.jmedchem.7b00475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieckowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasieka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pislar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer’s agents</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1094</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00461</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00461" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2nur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1074-1094&author=D.+Panekauthor=A.+Wieckowskaauthor=J.+Jonczykauthor=J.+Godynauthor=M.+Bajdaauthor=T.+Wichurauthor=A.+Pasiekaauthor=D.+Knezauthor=A.+Pislarauthor=J.+Korabecnyauthor=O.+Soukupauthor=V.+Sepsovaauthor=R.+Sabateauthor=J.+Kosauthor=S.+Gobecauthor=B.+Malawska&title=Design%2C+synthesis%2C+and+biological+evaluation+of+1-benzylamino-2-hydroxyalkyl+derivatives+as+new+potential+disease-modifying+multifunctional+anti-Alzheimer%E2%80%99s+agents&doi=10.1021%2Facschemneuro.7b00461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents</span></div><div class="casAuthors">Panek, Dawid; Wieckowska, Anna; Jonczyk, Jakub; Godyn, Justyna; Bajda, Marek; Wichur, Tomasz; Pasieka, Anna; Knez, Damijan; Pislar, Anja; Korabecny, Jan; Soukup, Ondrej; Sepsova, Vendula; Sabate, Raimon; Kos, Janko; Gobec, Stanislav; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1074-1094</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach is a promising paradigm in drug discovery, potentially leading to new treatment options for complex disorders, such as Alzheimer's disease.  Herein, we present the discovery of a unique series of 1-benzylamino-2-hydroxyalkyl derivs. combining inhibitory activity against butyrylcholinesterase, β-secretase, β-amyloid, and tau protein aggregation, all related to mechanisms which underpin Alzheimer's disease.  Notably, diphenylpropylamine deriv. 10 showed balanced activity against both disease-modifying targets, inhibition of β-secretase (IC50 hBACE-1 = 41.60 μM), inhibition of amyloid β aggregation (IC50 Aβ = 3.09 μM), inhibition of tau aggregation (55% at 10 μM); as well as against symptomatic targets, butyrylcholinesterase inhibition (IC50 hBuChE = 7.22 μM).  It might represent an encouraging starting point for development of multifunctional disease-modifying anti-Alzheimer's agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6nGriFfBF7Vg90H21EOLACvtfcHk0lh5Dyhfzgpalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2nur4%253D&md5=766d57590941aa6de4008e7430bae815</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00461%26sid%3Dliteratum%253Aachs%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DJonczyk%26aufirst%3DJ.%26aulast%3DGodyn%26aufirst%3DJ.%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DWichur%26aufirst%3DT.%26aulast%3DPasieka%26aufirst%3DA.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DPislar%26aufirst%3DA.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25201-benzylamino-2-hydroxyalkyl%2520derivatives%2520as%2520new%2520potential%2520disease-modifying%2520multifunctional%2520anti-Alzheimer%25E2%2580%2599s%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D1074%26epage%3D1094%26doi%3D10.1021%2Facschemneuro.7b00461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duran-Frigola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siragusa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aloy, P.</span></span> <span> </span><span class="NLM_article-title">Detecting similar binding pockets to enable systems polypharmacology</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e1005522</span>, <span class="refDoi"> DOI: 10.1371/journal.pcbi.1005522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1371%2Fjournal.pcbi.1005522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28662117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1agurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=e1005522&author=M.+Duran-Frigolaauthor=L.+Siragusaauthor=E.+Ruppinauthor=X.+Barrilauthor=G.+Crucianiauthor=P.+Aloy&title=Detecting+similar+binding+pockets+to+enable+systems+polypharmacology&doi=10.1371%2Fjournal.pcbi.1005522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Detecting similar binding pockets to enable systems polypharmacology</span></div><div class="casAuthors">Duran-Frigola, Miquel; Siragusa, Lydia; Ruppin, Eytan; Barril, Xavier; Cruciani, Gabriele; Aloy, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1005522/1-e1005522/18</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In the era of systems biol., multi-target pharmacol. strategies hold promise for tackling disease-related networks.  In this regard, drug promiscuity may be leveraged to interfere with multiple receptors: the so-called polypharmacol. of drugs can be anticipated by analyzing the similarity of binding sites across the proteome.  Here, we perform a pairwise comparison of 90,000 putative binding pockets detected in 3,700 proteins, and find that 23,000 pairs of proteins have at least one similar cavity that could, in principle, accommodate similar ligands.  By inspecting these pairs, we demonstrate how the detection of similar binding sites expands the space of opportunities for the rational design of drug polypharmacol.  Finally, we illustrate how to leverage these opportunities in protein-protein interaction networks related to several therapeutic classes and tumor types, and in a genome-scale metabolic model of leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrncR4y_CryxbVg90H21EOLACvtfcHk0lh5Dyhfzgpalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1agurnE&md5=568e97aa21976360c76610cdfd4dbfd7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1005522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1005522%26sid%3Dliteratum%253Aachs%26aulast%3DDuran-Frigola%26aufirst%3DM.%26aulast%3DSiragusa%26aufirst%3DL.%26aulast%3DRuppin%26aufirst%3DE.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DAloy%26aufirst%3DP.%26atitle%3DDetecting%2520similar%2520binding%2520pockets%2520to%2520enable%2520systems%2520polypharmacology%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3De1005522%26doi%3D10.1371%2Fjournal.pcbi.1005522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanfar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaddoumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Sayed, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel GSK-3beta inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8534</span>– <span class="NLM_lpage">8545</span>, <span class="refDoi"> DOI: 10.1021/jm100941j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100941j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8534-8545&author=M.+A.+Khanfarauthor=R.+A.+Hillauthor=A.+Kaddoumiauthor=K.+A.+El+Sayed&title=Discovery+of+novel+GSK-3beta+inhibitors+with+potent+in+vitro+and+in+vivo+activities+and+excellent+brain+permeability+using+combined+ligand-+and+structure-based+virtual+screening&doi=10.1021%2Fjm100941j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm100941j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100941j%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BA.%26aulast%3DKaddoumi%26aufirst%3DA.%26aulast%3DEl%2BSayed%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520novel%2520GSK-3beta%2520inhibitors%2520with%2520potent%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%2520and%2520excellent%2520brain%2520permeability%2520using%2520combined%2520ligand-%2520and%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8534%26epage%3D8545%26doi%3D10.1021%2Fjm100941j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arfeen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborti, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharatam, P. V.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3beta inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejmech.2016.04.075" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=727-736&author=M.+Arfeenauthor=S.+Bhagatauthor=R.+Patelauthor=S.+Prasadauthor=I.+Royauthor=A.+K.+Chakrabortiauthor=P.+V.+Bharatam&title=Design%2C+synthesis+and+biological+evaluation+of+5-benzylidene-2-iminothiazolidin-4-ones+as+selective+GSK-3beta+inhibitors&doi=10.1016%2Fj.ejmech.2016.04.075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.075%26sid%3Dliteratum%253Aachs%26aulast%3DArfeen%26aufirst%3DM.%26aulast%3DBhagat%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DI.%26aulast%3DChakraborti%26aufirst%3DA.%2BK.%26aulast%3DBharatam%26aufirst%3DP.%2BV.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25205-benzylidene-2-iminothiazolidin-4-ones%2520as%2520selective%2520GSK-3beta%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D727%26epage%3D736%26doi%3D10.1016%2Fj.ejmech.2016.04.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, F. J.</span></span> <span> </span><span class="NLM_article-title">First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1292</span>– <span class="NLM_lpage">1299</span>, <span class="refDoi"> DOI: 10.1021/jm011020u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011020u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFCgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1292-1299&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=C.+Perezauthor=F.+J.+Moreno&title=First+non-ATP+competitive+glycogen+synthase+kinase+3+beta+%28GSK-3beta%29+inhibitors%3A+thiadiazolidinones+%28TDZD%29+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm011020u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">First Non-ATP Competitive Glycogen Synthase Kinase 3β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Martinez, Ana; Alonso, Mercedes; Castro, Ana; Perez, Concepcion; Moreno, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1292-1299</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3β (GSK-3β) has a central role in Alzheimer's disease (AD).  Selective inhibitors which avoid τ hyperphosphorylation may represent an effective therapeutic approach to the pharmacotherapy of AD and other neurodegenerative disorders.  The synthesis, biol. evaluation, and SAR of some thiadiazolidinones (TDZD) as the first non-ATP competitive inhibitor of GSK-3β.  Their synthesis is based on the reactivity of sulfenyl chlorides.  In GSK-3β assays, TDZD derivs. showed IC50 values in the micromolar range, whereas in other protein kinase assays they were devoid of any inhibitory activity.  SAR studies allowed the identification of the key structural features.  Finally, a possible enzymic binding mode is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofQZkRe2BHh7Vg90H21EOLACvtfcHk0lh3T8qQDki1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFCgu70%253D&md5=a364133d1035bee183c58ad30ac140f8</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm011020u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011020u%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DFirst%2520non-ATP%2520competitive%2520glycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK-3beta%2529%2520inhibitors%253A%2520thiadiazolidinones%2520%2528TDZD%2529%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1292%26epage%3D1299%26doi%3D10.1021%2Fjm011020u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlistunova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">9215</span>– <span class="NLM_lpage">9219</span>, <span class="refDoi"> DOI: 10.1002/anie.200704051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.200704051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BD2sjjtlSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9215-9219&author=B.+Bulicauthor=M.+Pickhardtauthor=I.+Khlistunovaauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=H.+Waldmann&title=Rhodanine-based+tau+aggregation+inhibitors+in+cell+models+of+tauopathy&doi=10.1002%2Fanie.200704051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span></div><div class="casAuthors">Bulic Bruno; Pickhardt Marcus; Khlistunova Inna; Biernat Jacek; Mandelkow Eva-Maria; Mandelkow Eckhard; Waldmann Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">9215-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScsfK7C2PCgf6xYuD7tu2XfW6udTcc2ebcGAh6wQcX2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjjtlSltg%253D%253D&md5=9948b3054bae5ce9e52d0ce3d4635788</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fanie.200704051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200704051%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DRhodanine-based%2520tau%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D9215%26epage%3D9219%26doi%3D10.1002%2Fanie.200704051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saji, H.</span></span> <span> </span><span class="NLM_article-title">Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer’s brains</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1021/cn200002t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200002t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269-275&author=M.+Onoauthor=S.+Hayashiauthor=K.+Matsumuraauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Rhodanine+and+thiohydantoin+derivatives+for+detecting+tau+pathology+in+Alzheimer%E2%80%99s+brains&doi=10.1021%2Fcn200002t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains</span></div><div class="casAuthors">Ono, Masahiro; Hayashi, Shun; Matsumura, Kenji; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Mori, Hiroshi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of rhodanine (RH) and thiohydantoin (TH) derivs. were designed and synthesized for detecting tau pathol. in the brains of patients with Alzheimer's disease (AD).  In expts. in vitro using tau and β-amyloid (Aβ) aggregates, the TH deriv., TH2, showed high specific binding to tau aggregates.  In hippocampal sections obtained from AD patients, TH2 intensely stained neurofibrillary tangles.  In expts. using normal mice, [125I]TH2 showed good uptake (1.54%ID/g, 2 min postinjection) into and a rapid washout (0.25%ID/g, 60 min postinjection) from the brain. [123I]TH2 should be further investigated as a potential imaging agent for detecting tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvU2DzEOu6ubVg90H21EOLACvtfcHk0lh3T8qQDki1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D&md5=6f4924eaa828e075a59d9ead25ed3c36</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fcn200002t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200002t%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRhodanine%2520and%2520thiohydantoin%2520derivatives%2520for%2520detecting%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520brains%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D269%26epage%3D275%26doi%3D10.1021%2Fcn200002t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendgen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C. D.</span></span> <span> </span><span class="NLM_article-title">Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1021/jm201243p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201243p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=743-753&author=T.+Mendgenauthor=C.+Steuerauthor=C.+D.+Klein&title=Privileged+scaffolds+or+promiscuous+binders%3A+a+comparative+study+on+rhodanines+and+related+heterocycles+in+medicinal+chemistry&doi=10.1021%2Fjm201243p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry</span></div><div class="casAuthors">Mendgen, Thomas; Steuer, Christian; Klein, Christian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">743-753</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rhodanines and related five-membered heterocycles with multiple heteroatoms have recently gained a reputation of being unselective compds. that appear as "frequent hitters" in screening campaigns and therefore have little value in drug discovery.  However, this judgment appears to be based mostly on anecdotal evidence.  Having identified various rhodanines and related compds. in screening campaigns, we decided to perform a systematic study on their promiscuity.  An amt. of 163 rhodanines, hydantoins, thiohydantoins, and thiazolidinediones were synthesized and tested against several targets.  The compds. were also characterized with respect to aggregation and electrophilic reactivity, and the binding modes of rhodanines and related compds. in published x-ray cocrystal structures were analyzed.  The results indicate that the exocyclic, double bonded sulfur atom in rhodanines and thiohydantoins, in addn. to other structural features, offers a particularly high d. of interaction sites for polar interactions and hydrogen bonds.  This causes a promiscuous behavior at concns. in the "screening range" but should not be regarded as a general knockout criterion that excludes such screening hits from further development.  It is suggested that special criteria for target affinity and selectivity are applied to these classes of compds. and that their exceptional and potentially valuable biomol. binding properties are consequently exploited in a useful way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLzna8Pcz1iLVg90H21EOLACvtfcHk0lgnRmZny0barw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7nN&md5=6a94d097f44bdbaaec9a56fd6b371521</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm201243p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201243p%26sid%3Dliteratum%253Aachs%26aulast%3DMendgen%26aufirst%3DT.%26aulast%3DSteuer%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%2BD.%26atitle%3DPrivileged%2520scaffolds%2520or%2520promiscuous%2520binders%253A%2520a%2520comparative%2520study%2520on%2520rhodanines%2520and%2520related%2520heterocycles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D743%26epage%3D753%26doi%3D10.1021%2Fjm201243p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muratov, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropsha, A.</span></span> <span> </span><span class="NLM_article-title">Phantom PAINS: problems with the utility of alerts for pan-assay interference compounds</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00465</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00465" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFCgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=417-427&author=S.+J.+Capuzziauthor=E.+N.+Muratovauthor=A.+Tropsha&title=Phantom+PAINS%3A+problems+with+the+utility+of+alerts+for+pan-assay+interference+compounds&doi=10.1021%2Facs.jcim.6b00465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS</span></div><div class="casAuthors">Capuzzi, Stephen J.; Muratov, Eugene N.; Tropsha, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-427</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of substructural alerts to identify Pan-Assay INterference compds. (PAINS) has become a common component of the triage process in biol. screening campaigns.  These alerts, however, were originally derived from a proprietary library tested in just six assays measuring protein-protein interaction (PPI) inhibition using the AlphaScreen detection technol. only; moreover, 68% (328 out of the 480 alerts) were derived from four or fewer compds.  In an effort to assess the reliability of these alerts as indicators of pan-assay interference, the authors performed a large-scale anal. of the impact of PAINS alerts on compd. promiscuity in bioassays using publicly available data in PubChem.  The authors found that the majority (97%) of all compds. contg. PAINS alerts were actually infrequent hitters in AlphaScreen assays measuring PPI inhibition.  The authors also found that the presence of PAINS alerts, contrary to expectations, did not reflect any heightened assay activity trends across all assays in PubChem including AlphaScreen, luciferase, β-lactamase, or fluorescence-based assays.  In addn., 109 PAINS alerts were present in 3570 extensively assayed, but consistently inactive compds. Dark Chem. Matter.  Finally, the authors obsd. that 87 small mol. FDA-approved drugs contained PAINS alerts and profiled their bioassay activity.  Based on this detailed anal. of PAINS alerts in nonproprietary compd. libraries, the authors caution against the blind use of PAINS filters to detect and triage compds. with possible PAINS liabilities and recommend that such conclusions should be drawn only by conducting orthogonal expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczoSnfEJzUrVg90H21EOLACvtfcHk0lgnRmZny0barw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFCgtbw%253D&md5=206e1d1f24df12644527ddbaa03b24b0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00465%26sid%3Dliteratum%253Aachs%26aulast%3DCapuzzi%26aufirst%3DS.%2BJ.%26aulast%3DMuratov%26aufirst%3DE.%2BN.%26aulast%3DTropsha%26aufirst%3DA.%26atitle%3DPhantom%2520PAINS%253A%2520problems%2520with%2520the%2520utility%2520of%2520alerts%2520for%2520pan-assay%2520interference%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2017%26volume%3D57%26spage%3D417%26epage%3D427%26doi%3D10.1021%2Facs.jcim.6b00465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jasial, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">How frequently are pan-assay interference compounds active? Large-scale analysis of screening data reveals diverse activity profiles, low global hit frequency, and many consistently inactive compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3879</span>– <span class="NLM_lpage">3886</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1amtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3879-3886&author=S.+Jasialauthor=Y.+Huauthor=J.+Bajorath&title=How+frequently+are+pan-assay+interference+compounds+active%3F+Large-scale+analysis+of+screening+data+reveals+diverse+activity+profiles%2C+low+global+hit+frequency%2C+and+many+consistently+inactive+compounds&doi=10.1021%2Facs.jmedchem.7b00154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds</span></div><div class="casAuthors">Jasial, Swarit; Hu, Ye; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3879-3886</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Undetected pan-assay interference compds. (PAINS) with false-pos. activities in assays often propagate through medicinal chem. programs and compromise their outcomes.  Although a large no. of PAINS have been classified, often on the basis of individual studies or chem. experience, little has been done so far to systematically assess their activity profiles.  Herein we report a large-scale anal. of the behavior of PAINS in biol. screening assays.  More than 23,000 extensively tested compds. contg. PAINS substructures were detected, and their hit rates were detd.  Many consistently inactive compds. were identified.  The hit frequency was low overall, with median values of two to five hits for PAINS tested in hundreds of assays.  Only confined subsets of PAINS produced abundant hits.  The same PAINS substructure was often found in consistently inactive and frequently active compds., indicating that the structural context in which PAINS occur modulates their effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMc4n-Xo9Fn7Vg90H21EOLACvtfcHk0lgnRmZny0barw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1amtL8%253D&md5=893dad99e5717f8e59b9adb4f675beb0</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00154%26sid%3Dliteratum%253Aachs%26aulast%3DJasial%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DHow%2520frequently%2520are%2520pan-assay%2520interference%2520compounds%2520active%253F%2520Large-scale%2520analysis%2520of%2520screening%2520data%2520reveals%2520diverse%2520activity%2520profiles%252C%2520low%2520global%2520hit%2520frequency%252C%2520and%2520many%2520consistently%2520inactive%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3879%26epage%3D3886%26doi%3D10.1021%2Facs.jmedchem.7b00154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00903</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=36-44&author=J.+B.+Baellauthor=J.+W.+M.+Nissink&title=Seven+year+itch%3A+pan-assay+interference+compounds+%28PAINS%29+in+2017-utility+and+limitations&doi=10.1021%2Facschembio.7b00903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations</span></div><div class="casAuthors">Baell, Jonathan B.; Nissink, J. Willem M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on all necessary considerations for the appropriate use of PAINs filters formulated to process hundreds and thousands of compds. in seconds, and identify PAINS in order to exclude them from further anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocZ7E_j7zxfbVg90H21EOLACvtfcHk0lieWRrj2LD_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK&md5=051115704137d6a91b8271702c619682</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00903%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DSeven%2520year%2520itch%253A%2520pan-assay%2520interference%2520compounds%2520%2528PAINS%2529%2520in%25202017-utility%2520and%2520limitations%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D36%26epage%3D44%26doi%3D10.1021%2Facschembio.7b00903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanmart, S.</span></span> <span> </span><span class="NLM_article-title">Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00361</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00361" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=497-503&author=M.+Pouliotauthor=S.+Jeanmart&title=Pan+assay+interference+compounds+%28PAINS%29+and+other+promiscuous+compounds+in+antifungal+research&doi=10.1021%2Facs.jmedchem.5b00361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research</span></div><div class="casAuthors">Pouliot, Martin; Jeanmart, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">497-503</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Every week, articles disclosing new antifungal leads reported as promising starting points for optimization projects are published.  In many cases, the mechanism that accounts for their antifungal activity has not been fully elucidated.  More significantly, the detrimental impact that could result from certain embedded chem. features has been underestimated or even overlooked.  In the course of the authors' research in the agrochem. area, the authors have concluded that in many cases such leads are actually nonoptimizable because they either contain what are now recognized as pan assay interference compds. (PAINS) or other promiscuous groups.  This article is aimed at highlighting the pitfalls the authors have encountered and hopefully to steer other research groups away from them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqURFxdfKNQIbVg90H21EOLACvtfcHk0lieWRrj2LD_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE&md5=af11fcafd47de435fcc5fdf05080023a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00361%26sid%3Dliteratum%253Aachs%26aulast%3DPouliot%26aufirst%3DM.%26aulast%3DJeanmart%26aufirst%3DS.%26atitle%3DPan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520and%2520other%2520promiscuous%2520compounds%2520in%2520antifungal%2520research%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D497%26epage%3D503%26doi%3D10.1021%2Facs.jmedchem.5b00361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Observations on screening-based research and some concerning trends in the literature</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1546</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.4155%2Ffmc.10.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=21426147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1529-1546&author=J.+B.+Baell&title=Observations+on+screening-based+research+and+some+concerning+trends+in+the+literature&doi=10.4155%2Ffmc.10.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Observations on screening-based research and some concerning trends in the literature</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1529-1546</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Academic drug discovery is being accompanied by a plethora of publications that report screening hits as good starting points for drug discovery or as useful tool compds., whereas in many cases this is not so.  These compds. may be protein-reactive but can also interfere in bioassays via a no. of other means, and it can be very hard to prove early on that they represent false starts.  This, for instance, makes it difficult for journals in their assessment of manuscripts submitted for publication.  Wider awareness and recognition of these problematic compds. will help the academic drug-discovery community focus on and publish genuinely optimizable screening hits.  This will be of general benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob88J0NH5Mx7Vg90H21EOLACvtfcHk0lieWRrj2LD_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI&md5=14f916535540fc04e37c2eb21cfe7876</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.237%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DObservations%2520on%2520screening-based%2520research%2520and%2520some%2520concerning%2520trends%2520in%2520the%2520literature%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D1529%26epage%3D1546%26doi%3D10.4155%2Ffmc.10.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span> <span> </span><span class="NLM_article-title">PAINS: relevance to tool compound discovery and fragment-based screening</span>. <i>Aust. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1494</span>, <span class="refDoi"> DOI: 10.1071/CH13551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1071%2FCH13551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=1483-1494&author=J.+B.+Baellauthor=L.+Ferrinsauthor=H.+Falkauthor=G.+Nikolakopoulos&title=PAINS%3A+relevance+to+tool+compound+discovery+and+fragment-based+screening&doi=10.1071%2FCH13551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening</span></div><div class="casAuthors">Baell, Jonathan B.; Ferrins, Lori; Falk, Hendrik; Nikolakopoulos, George</div><div class="citationInfo"><span class="NLM_cas:title">Australian Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1483-1494</span>CODEN:
                <span class="NLM_cas:coden">AJCHAS</span>;
        ISSN:<span class="NLM_cas:issn">0004-9425</span>.
    
            (<span class="NLM_cas:orgname">CSIRO Publishing</span>)
        </div><div class="casAbstract">Pan assay interference compds. (PAINS) are readily discovered in any bioassay and can appear to give selective and optimizable hits.  The most common PAINS can be readily recognized by their structure.  However, there are compds. that closely resemble PAINS that are not specifically recognized by the PAINS filters.  In addn., highly reactive compds. are not encoded for in the PAINS filters because they were excluded from the high-throughput screening (HTS) library used to develop the filters and so were never present to provide indicting data.  A compounding complication in the area is that very occasionally a PAINS compd. may serve as a viable starting point for progression.  Despite such an occasional example, the literature is littered with an overwhelming no. of examples of compds. that fail to progress and were probably not optimizable in the first place, nor useful tool compds.  Thus it is with great caution and diligence that compds. possessing a known PAINS core should be progressed through to medicinal chem. optimization, if at all, as the chances are very high that the hits will be found to be non-progressable, often after a significant waste of resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUnBCDXW-TbVg90H21EOLACvtfcHk0lieWRrj2LD_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLzF&md5=cc4c7966a48f7cf9a7520591d0dcfd14</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1071%2FCH13551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FCH13551%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DFalk%26aufirst%3DH.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26atitle%3DPAINS%253A%2520relevance%2520to%2520tool%2520compound%2520discovery%2520and%2520fragment-based%2520screening%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D1483%26epage%3D1494%26doi%3D10.1071%2FCH13551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span> </span><span class="NLM_article-title">Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI)
Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation
of Pioglitazone in Delaying Its Onset (TOMMORROW)</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National Institutes
of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2013</span>; <a href="https://www.clinicaltrials.gov/ct2/show/NCT01931566?term=pioglitazone%2C+alzheimer&amp;rank=1" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT01931566?term=pioglitazone%2C+alzheimer&rank=1</a> (accessed July 12, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Biomarker+Qualification+for+Risk+of+Mild+Cognitive+Impairment+%28MCI%29%0ADue+to+Alzheimer%27s+Disease+%28AD%29+and+Safety+and+Efficacy+Evaluation%0Aof+Pioglitazone+in+Delaying+Its+Onset+%28TOMMORROW%29.+ClinicalTrials.gov%3B+U.S.+National+Institutes%0Aof+Health%3A+Bethesda%2C+MD%2C+2013%3B+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01931566%3Fterm%3Dpioglitazone%252C%2Balzheimer%26rank%3D1+%28accessed+July+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DBiomarker%2520Qualification%2520for%2520Risk%2520of%2520Mild%2520Cognitive%2520Impairment%2520%2528MCI%2529%250ADue%2520to%2520Alzheimer%2527s%2520Disease%2520%2528AD%2529%2520and%2520Safety%2520and%2520Efficacy%2520Evaluation%250Aof%2520Pioglitazone%2520in%2520Delaying%2520Its%2520Onset%2520%2528TOMMORROW%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%2520Institutes%250Aof%2520Health%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuret, J.</span></span> <span> </span><span class="NLM_article-title">Structure and mechanism of action of tau aggregation inhibitors</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.2174/1567205011666141107150331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F1567205011666141107150331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=25387336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=918-927&author=K.+Cisekauthor=G.+L.+Cooperauthor=C.+J.+Husebyauthor=J.+Kuret&title=Structure+and+mechanism+of+action+of+tau+aggregation+inhibitors&doi=10.2174%2F1567205011666141107150331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Mechanism of Action of Tau Aggregation Inhibitors</span></div><div class="casAuthors">Cisek, Katryna; Cooper, Grace L.; Huseby, Carol J.; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">918-927</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Since the discovery of phenothiazines as tau protein aggregation inhibitors, many addnl. small mol. inhibitors of diverse chemotype have been discovered and characterized in biol. model systems.  Although direct inhibition of tau aggregation has shown promise as a potential treatment strategy for depressing neurofibrillary lesion formation in Alzheimer's disease, the mechanism of action of these compds. has been unclear.  However, recent studies have found that tau aggregation antagonists exert their effects through both covalent and non-covalent means, and have identified assocd. potency and selectivity driving features.  Here we review small-mol. tau aggregation inhibitors with a focus on compd. structure and inhibitory mechanism.  The elucidation of inhibitory mechanism has implications for maximizing on-target efficacy while minimizing off-target side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXuPjf844LQbVg90H21EOLACvtfcHk0liYHC2jFf5t4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFygsw%253D%253D&md5=15e0da5cf285e4aa460d6902920cfa98</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F1567205011666141107150331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666141107150331%26sid%3Dliteratum%253Aachs%26aulast%3DCisek%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DG.%2BL.%26aulast%3DHuseby%26aufirst%3DC.%2BJ.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520action%2520of%2520tau%2520aggregation%2520inhibitors%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D918%26epage%3D927%26doi%3D10.2174%2F1567205011666141107150331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinke, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestwicki, J. E.</span></span> <span> </span><span class="NLM_article-title">Insight into amyloid structure using chemical probes</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01110.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1111%2Fj.1747-0285.2011.01110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=21457473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=399-411&author=A.+A.+Reinkeauthor=J.+E.+Gestwicki&title=Insight+into+amyloid+structure+using+chemical+probes&doi=10.1111%2Fj.1747-0285.2011.01110.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into amyloid structure using chemical probes</span></div><div class="casAuthors">Reinke, Ashley A.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">399-411</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by the deposition of amyloids in the brain.  One prominent form of amyloid is composed of repeating units of the amyloid-β (Aβ) peptide.  Over the past decade, it has become clear that these Aβ amyloids are not homogeneous; rather, they are composed of a series of structures varying in their overall size and shape and the no. of Aβ peptides they contain.  Recent theories suggest that these different amyloid conformations may play distinct roles in disease, although their relative contributions are still being discovered.  Here, we review how chem. probes, such as Congo red, thioflavin T and their derivs., have been powerful tools for the better understanding of amyloid structure and function.  Moreover, we discuss how design and deployment of conformationally selective probes might be used to test emerging models of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1MeycFDiwGLVg90H21EOLACvtfcHk0liYHC2jFf5t4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D&md5=52a8815e569523bd2b05e7a5e7c70d00</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01110.x%26sid%3Dliteratum%253Aachs%26aulast%3DReinke%26aufirst%3DA.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DInsight%2520into%2520amyloid%2520structure%2520using%2520chemical%2520probes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D399%26epage%3D411%26doi%3D10.1111%2Fj.1747-0285.2011.01110.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antihyperglycemic activity profiles of novel thiazolidinedione derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5857</span>– <span class="NLM_lpage">5864</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2004.08.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5857-5864&author=B.+A.+Bhatauthor=S.+Ponnalaauthor=D.+P.+Sahuauthor=P.+Tiwariauthor=B.+K.+Tripathiauthor=A.+K.+Srivastava&title=Synthesis+and+antihyperglycemic+activity+profiles+of+novel+thiazolidinedione+derivatives&doi=10.1016%2Fj.bmc.2004.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DB.%2BA.%26aulast%3DPonnala%26aufirst%3DS.%26aulast%3DSahu%26aufirst%3DD.%2BP.%26aulast%3DTiwari%26aufirst%3DP.%26aulast%3DTripathi%26aufirst%3DB.%2BK.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520and%2520antihyperglycemic%2520activity%2520profiles%2520of%2520novel%2520thiazolidinedione%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5857%26epage%3D5864%26doi%3D10.1016%2Fj.bmc.2004.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span> <span> </span><span class="NLM_article-title">A solvent-free protocol for the green synthesis of 5-arylidene-2,4-thiazolidinediones using ethylenediamine diacetate as catalyst</span>. <i>Org. Chem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">194784</span>, <span class="refDoi"> DOI: 10.1155/2012/194784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1155%2F2012%2F194784" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=194784&author=Y.+Zhangauthor=Z.+Zhou&title=A+solvent-free+protocol+for+the+green+synthesis+of+5-arylidene-2%2C4-thiazolidinediones+using+ethylenediamine+diacetate+as+catalyst&doi=10.1155%2F2012%2F194784"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1155%2F2012%2F194784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F194784%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DZ.%26atitle%3DA%2520solvent-free%2520protocol%2520for%2520the%2520green%2520synthesis%2520of%25205-arylidene-2%252C4-thiazolidinediones%2520using%2520ethylenediamine%2520diacetate%2520as%2520catalyst%26jtitle%3DOrg.%2520Chem.%2520Int.%26date%3D2012%26volume%3D2012%26spage%3D194784%26doi%3D10.1155%2F2012%2F194784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">O-hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-beta aggregation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5884</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2012.07.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5884-5892&author=F.+Maoauthor=L.+Huangauthor=Z.+Luoauthor=A.+Liuauthor=C.+Luauthor=Z.+Xieauthor=X.+Li&title=O-hydroxyl-+or+o-amino+benzylamine-tacrine+hybrids%3A+multifunctional+biometals+chelators%2C+antioxidants%2C+and+inhibitors+of+cholinesterase+activity+and+amyloid-beta+aggregation&doi=10.1016%2Fj.bmc.2012.07.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DO-hydroxyl-%2520or%2520o-amino%2520benzylamine-tacrine%2520hybrids%253A%2520multifunctional%2520biometals%2520chelators%252C%2520antioxidants%252C%2520and%2520inhibitors%2520of%2520cholinesterase%2520activity%2520and%2520amyloid-beta%2520aggregation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5884%26epage%3D5892%26doi%3D10.1016%2Fj.bmc.2012.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qabaja, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. B.</span></span> <span> </span><span class="NLM_article-title">Annulation strategies for benzo[b]fluorene synthesis: efficient routes to the kinafluorenone and WS-5995 antibiotics</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">7187</span>– <span class="NLM_lpage">7194</span>, <span class="refDoi"> DOI: 10.1021/jo0056186</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0056186" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=7187-7194&author=G.+Qabajaauthor=G.+B.+Jones&title=Annulation+strategies+for+benzo%5Bb%5Dfluorene+synthesis%3A+efficient+routes+to+the+kinafluorenone+and+WS-5995+antibiotics&doi=10.1021%2Fjo0056186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjo0056186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0056186%26sid%3Dliteratum%253Aachs%26aulast%3DQabaja%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DG.%2BB.%26atitle%3DAnnulation%2520strategies%2520for%2520benzo%255Bb%255Dfluorene%2520synthesis%253A%2520efficient%2520routes%2520to%2520the%2520kinafluorenone%2520and%2520WS-5995%2520antibiotics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D7187%26epage%3D7194%26doi%3D10.1021%2Fjo0056186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szendrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1089/adt.2006.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1089%2Fadt.2006.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=17355201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislCktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=75-83&author=A.+Bakiauthor=A.+Bielikauthor=L.+Molnarauthor=G.+Szendreiauthor=G.+M.+Keseru&title=A+high+throughput+luminescent+assay+for+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1089%2Fadt.2006.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A High Throughput Luminescent Assay for Glycogen Synthase Kinase-3β Inhibitors</span></div><div class="casAuthors">Baki, Andrea; Bielik, Attila; Molnar, Laszlo; Szendrei, Gyoergyi; Keserue, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-84</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A high throughput luminescent assay based on the Kinase-Glo system (Promega, Madison, WI) has been developed for screening against glycogen synthase kinase-3β (GSK-3β).  Careful optimization of assay parameters allowed us to develop a robust, reproducible, and sensitive assay.  Its usefulness has been demonstrated in a high throughput screening run when screening 55,000 compds.  This campaign yielded five chem. classes of hits, including several highly potent GSK-3β inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYXSuULTtzHLVg90H21EOLACvtfcHk0lhO27diwrRWiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislCktbg%253D&md5=d9e594ab3d34af353b12b53eb41e43cb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1089%2Fadt.2006.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2006.029%26sid%3Dliteratum%253Aachs%26aulast%3DBaki%26aufirst%3DA.%26aulast%3DBielik%26aufirst%3DA.%26aulast%3DMolnar%26aufirst%3DL.%26aulast%3DSzendrei%26aufirst%3DG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DA%2520high%2520throughput%2520luminescent%2520assay%2520for%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2007%26volume%3D5%26spage%3D75%26epage%3D83%26doi%3D10.1089%2Fadt.2006.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dans, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4042</span>– <span class="NLM_lpage">4056</span>, <span class="refDoi"> DOI: 10.1021/jm1016279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1016279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmt1Gnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4042-4056&author=D.+I.+Perezauthor=V.+Palomoauthor=C.+Perezauthor=C.+Gilauthor=P.+D.+Dansauthor=F.+J.+Luqueauthor=S.+Condeauthor=A.+Martinez&title=Switching+reversibility+to+irreversibility+in+glycogen+synthase+kinase+3+inhibitors%3A+clues+for+specific+design+of+new+compounds&doi=10.1021%2Fjm1016279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds</span></div><div class="casAuthors">Perez, Daniel I.; Palomo, Valle; Perez, Concepcion; Gil, Carmen; Dans, Pablo D.; Luque, F. Javier; Conde, Santiago; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4042-4056</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge.  Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clin. trials for different tauopathies.  Following our hypothesis based on the enhanced reactivity of residue Cys199 in the binding site of GSK-3, we examine here the suitability of phenylhalomethylketones as irreversible inhibitors.  Our data confirm that the halomethylketone unit is essential for the inhibitory activity.  Moreover, addn. of the halomethylketone moiety to reversible inhibitors turned them into irreversible inhibitors with IC50 values in the nanomolar range.  Overall, the results point out that these compds. might be useful pharmacol. tools to explore physiol. and pathol. processes related to signaling pathways regulated by GSK-3 opening new avenues for the discovery of novel GSK-3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodOmaptYUQ77Vg90H21EOLACvtfcHk0liWwYenea68Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmt1Gnsr8%253D&md5=9b5be4c124364e028d5fbaf5043d72ce</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm1016279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1016279%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DDans%26aufirst%3DP.%2BD.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DSwitching%2520reversibility%2520to%2520irreversibility%2520in%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%253A%2520clues%2520for%2520specific%2520design%2520of%2520new%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4042%26epage%3D4056%26doi%3D10.1021%2Fjm1016279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0liWwYenea68Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0ljBk2VxSUxoFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crivori, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span> <span> </span><span class="NLM_article-title">Predicting blood-brain barrier permeation from three-dimensional molecular structure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2204</span>– <span class="NLM_lpage">2216</span>, <span class="refDoi"> DOI: 10.1021/jm990968+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990968%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2204-2216&author=P.+Crivoriauthor=G.+Crucianiauthor=P.+A.+Carruptauthor=B.+Testa&title=Predicting+blood-brain+barrier+permeation+from+three-dimensional+molecular+structure&doi=10.1021%2Fjm990968%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting blood-brain barrier permeation from three-dimensional molecular structure</span></div><div class="casAuthors">Crivori, Patrizia; Cruciani, Gabriele; Carrupt, Pierre-Alain; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2204-2216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Predicting blood-brain barrier (BBB) permeation remains a challenge in drug design.  Since it is impossible to det. exptl. the BBB partitioning of large nos. of preclin. candidates, alternative evaluation methods based on computerized models are desirable.  The present study was conducted to demonstrate the value of descriptors derived from 3D mol. fields in estg. the BBB permeation of a large set of compds. and to produce a simple math. model suitable for external prediction.  The method used (VolSurf) transforms 3D fields into descriptors and correlates them to the exptl. permeation by a discriminant partial least squares procedure.  The model obtained here correctly predicts more than 90% of the BBB permeation data.  By quantifying the favorable and unfavorable contributions of physicochem. and structural properties, it also offers valuable insights for drug design, pharmacol. profiling, and screening.  The computational procedure is fully automated and quite fast.  The method thus appears as a valuable new tool in virtual screening where selection or prioritization of candidates is required from large collections of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURsaBTpmsObVg90H21EOLACvtfcHk0ljBk2VxSUxoFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D&md5=569f3500268859660bb9e5206da270fe</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm990968%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990968%252B%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DPredicting%2520blood-brain%2520barrier%2520permeation%2520from%2520three-dimensional%2520molecular%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2204%26epage%3D2216%26doi%3D10.1021%2Fjm990968%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro</span>. <i>Cerebellum</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1080/147342202753203087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1080%2F147342202753203087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=41-55&author=A.+Contestabile&title=Cerebellar+granule+cells+as+a+model+to+study+mechanisms+of+neuronal+apoptosis+or+survival+in+vivo+and+in+vitro&doi=10.1080%2F147342202753203087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1080%2F147342202753203087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F147342202753203087%26sid%3Dliteratum%253Aachs%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DCerebellar%2520granule%2520cells%2520as%2520a%2520model%2520to%2520study%2520mechanisms%2520of%2520neuronal%2520apoptosis%2520or%2520survival%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DCerebellum%26date%3D2002%26volume%3D1%26spage%3D41%26epage%3D55%26doi%3D10.1080%2F147342202753203087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, B. R.</span></span> <span> </span><span class="NLM_article-title">The PPARs: from orphan receptors to drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/jm990554g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990554g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=527-550&author=T.+M.+Willsonauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=B.+R.+Henke&title=The+PPARs%3A+from+orphan+receptors+to+drug+discovery&doi=10.1021%2Fjm990554g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARs: From orphan receptors to drug discovery</span></div><div class="casAuthors">Willson, Timothy M.; Brown, Peter J.; Sternbach, Daniel D.; Henke, Brad R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-550</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 326 refs. is given on peroxisome proliferator-activated receptors (PPARs).  The structural and functional anal. of the different PPAR subtypes is summarized and their function as hormone receptors for dietary fatty acids and certain eicosanoids in different species and in many metabolically active tissues is described.  Progress is reported in the development of drugs, which use PPARs as mol. targets, for the treatment of human metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocp31Cq_kgebVg90H21EOLACvtfcHk0lgUBIGjETwZXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D&md5=003b19fe3fdf813411d6a2ac5aefdc01</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm990554g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990554g%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DThe%2520PPARs%253A%2520from%2520orphan%2520receptors%2520to%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D527%26epage%3D550%26doi%3D10.1021%2Fjm990554g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, A. W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murzin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garringer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowther, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheres, S. H. W.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM structures of tau filaments from Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>547</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature23002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnature23002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28678775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2017&pages=185-190&author=A.+W.+P.+Fitzpatrickauthor=B.+Falconauthor=S.+Heauthor=A.+G.+Murzinauthor=G.+Murshudovauthor=H.+J.+Garringerauthor=R.+A.+Crowtherauthor=B.+Ghettiauthor=M.+Goedertauthor=S.+H.+W.+Scheres&title=Cryo-EM+structures+of+tau+filaments+from+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature23002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structures of tau filaments from Alzheimer's disease</span></div><div class="casAuthors">Fitzpatrick, Anthony W. P.; Falcon, Benjamin; He, Shaoda; Murzin, Alexey G.; Murshudov, Garib; Garringer, Holly J.; Crowther, R. Anthony; Ghetti, Bernardino; Goedert, Michel; Scheres, Sjors H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">7662</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most common neurodegenerative disease, and there are no mechanism-based therapies.  The disease is defined by the presence of abundant neurofibrillary lesions and neuritic plaques in the cerebral cortex.  Neurofibrillary lesions comprise paired helical and straight tau filaments, whereas tau filaments with different morphologies characterize other neurodegenerative diseases.  No high-resoln. structures of tau filaments are available.  Here we present cryo-electron microscopy (cryo-EM) maps at 3.4-3.5 Å resoln. and corresponding at. models of paired helical and straight filaments from the brain of an individual with Alzheimer's disease.  Filament cores are made of two identical protofilaments comprising residues 306-378 of tau protein, which adopt a combined cross-β/β-helix structure and define the seed for tau aggregation.  Paired helical and straight filaments differ in their inter-protofilament packing, showing that they are ultrastructural polymorphs.  These findings demonstrate that cryo-EM allows at. characterization of amyloid filaments from patient-derived material, and pave the way for investigation of a range of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZxSJoSzqlEbVg90H21EOLACvtfcHk0lgUBIGjETwZXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73F&md5=05d201bf16a383e96421b6969f3c1419</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature23002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23002%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DA.%2BW.%2BP.%26aulast%3DFalcon%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DMurzin%26aufirst%3DA.%2BG.%26aulast%3DMurshudov%26aufirst%3DG.%26aulast%3DGarringer%26aufirst%3DH.%2BJ.%26aulast%3DCrowther%26aufirst%3DR.%2BA.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DScheres%26aufirst%3DS.%2BH.%2BW.%26atitle%3DCryo-EM%2520structures%2520of%2520tau%2520filaments%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2017%26volume%3D547%26spage%3D185%26epage%3D190%26doi%3D10.1038%2Fnature23002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1351</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.06224.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1111%2Fj.1471-4159.2009.06224.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=19549281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFOls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=1339-1351&author=W.+Liauthor=J.+B.+Sperryauthor=A.+Croweauthor=J.+Q.+Trojanowskiauthor=A.+B.+Smithauthor=V.+M.+Lee&title=Inhibition+of+tau+fibrillization+by+oleocanthal+via+reaction+with+the+amino+groups+of+tau&doi=10.1111%2Fj.1471-4159.2009.06224.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau</span></div><div class="casAuthors">Li, Wenkai; Sperry, Jeffrey B.; Crowe, Alex; Trojanowski, John Q.; Smith, Amos B., III; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1339-1351</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tau is a microtubule-assocd. protein that promotes microtubule assembly and stability.  In Alzheimer's disease and related tauopathies, tau fibrillizes and aggregates into neurofibrillary tangles.  Recently, oleocanthal isolated from extra virgin olive oil was found to display non-steroidal anti-inflammatory activity similar to ibuprofen.  As our unpublished data indicates an inhibitory effect of oleocanthal on amyloid β peptide fibrillization, we reasoned that it might inhibit tau fibrillization as well.  Herein, we demonstrate that oleocanthal abrogates fibrillization of tau by locking tau into the naturally unfolded state.  Using PHF6 consisting of the amino acid residues VQIVYK, a hexapeptide within the third repeat of tau that is essential for fibrillization, we show that oleocanthal forms an adduct with the lysine via initial Schiff base formation.  Structure and function studies demonstrate that the two aldehyde groups of oleocanthal are required for the inhibitory activity.  These two aldehyde groups show certain specificity when titrated with free lysine and oleocanthal does not significantly affect the normal function of tau.  These findings provide a potential scheme for the development of novel therapies for neurodegenerative tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKQPzimquC4LVg90H21EOLACvtfcHk0lgT38jF6TSaSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFOls78%253D&md5=9456d2b98217e3f60f80d1aa0fba8218</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06224.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06224.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSperry%26aufirst%3DJ.%2BB.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DInhibition%2520of%2520tau%2520fibrillization%2520by%2520oleocanthal%2520via%2520reaction%2520with%2520the%2520amino%2520groups%2520of%2520tau%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D110%26spage%3D1339%26epage%3D1351%26doi%3D10.1111%2Fj.1471-4159.2009.06224.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawaya, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goux, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic beta-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">3144</span>– <span class="NLM_lpage">3157</span>, <span class="refDoi"> DOI: 10.1021/ja110545h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja110545h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=3144-3157&author=J.+Zhengauthor=C.+Liuauthor=M.+R.+Sawayaauthor=B.+Vadlaauthor=S.+Khanauthor=R.+J.+Woodsauthor=D.+Eisenbergauthor=W.+J.+Gouxauthor=J.+S.+Nowick&title=Macrocyclic+beta-sheet+peptides+that+inhibit+the+aggregation+of+a+tau-protein-derived+hexapeptide&doi=10.1021%2Fja110545h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic β-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span></div><div class="casAuthors">Zheng, Jing; Liu, Cong; Sawaya, Michael R.; Vadla, Balraju; Khan, Shafiullah; Woods, R. Jeremy; Eisenberg, David; Goux, Warren J.; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3144-3157</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes studies of a series of macrocyclic β-sheet peptides 1 that inhibit the aggregation of a tau-protein-derived peptide.  The macrocyclic β-sheet peptides comprise a pentapeptide "upper" strand, two δ-linked ornithine turn units, and a "lower" strand comprising two addnl. residues and the β-sheet peptidomimetic template "Hao".  The tau-derived peptide Ac-VQIVYK-NH2 (AcPHF6) aggregates in soln. through β-sheet interactions to form straight and twisted filaments similar to those formed by tau protein in Alzheimer's neurofibrillary tangles.  Macrocycles 1 contg. the pentapeptide VQIVY in the "upper" strand delay and suppress the onset of aggregation of the AcPHF6 peptide.  Inhibition is particularly pronounced in other macrocycles in which the two residues in the "lower" strand provide a pattern of hydrophobicity and hydrophilicity that matches that of the pentapeptide "upper" strand.  Inhibition varies strongly with the concn. of these macrocycles, suggesting that it is cooperative.  Another macrocycle contg. the pentapeptide QIVYK shows little inhibition, suggesting the possibility of a preferred direction of growth of AcPHF6 β-sheets.  On the basis of these studies, a model is proposed in which the AcPHF6 amyloid grows as a layered pair of β-sheets and in which growth is blocked by a pair of macrocycles that cap the growing paired hydrogen-bonding edges.  This model provides a provocative and appealing target for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUUxfY1h_AurVg90H21EOLACvtfcHk0lgT38jF6TSaSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D&md5=47c5d5dd0864b5e4613bf00baa445ef1</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fja110545h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja110545h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DVadla%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DR.%2BJ.%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DGoux%26aufirst%3DW.%2BJ.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DMacrocyclic%2520beta-sheet%2520peptides%2520that%2520inhibit%2520the%2520aggregation%2520of%2520a%2520tau-protein-derived%2520hexapeptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D3144%26epage%3D3157%26doi%3D10.1021%2Fja110545h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelokhani-Niaraki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P. P.</span></span> <span> </span><span class="NLM_article-title">Tau-derived-hexapeptide 306VQIVYK311 aggregation inhibitors: nitrocatechol moiety as a pharmacophore in drug design</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1021/cn400151a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400151a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1559-1570&author=T.+Mohamedauthor=T.+Hoangauthor=M.+Jelokhani-Niarakiauthor=P.+P.+Rao&title=Tau-derived-hexapeptide+306VQIVYK311+aggregation+inhibitors%3A+nitrocatechol+moiety+as+a+pharmacophore+in+drug+design&doi=10.1021%2Fcn400151a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-Derived-Hexapeptide 306VQIVYK311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design</span></div><div class="casAuthors">Mohamed, Tarek; Hoang, Tuan; Jelokhani-Niaraki, Masoud; Rao, Praveen P. N.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1559-1570</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nitrocatechol derivs. tolcapone (1) and entacapone (2), used as adjunctive therapy in the treatment of Parkinson's disease, were investigated for their potential to inhibit the tau-derived-hexapeptide 306VQIVYK311.  They were compared to small mols. that contain similar pharmacophores including the catechol derivs. (dopamine 3 and epinephrine 4), nitroderivatives (nifedipine 5 and chloramphenicol 6), nitrocatechol isomers (7 and 8), and a tolcapone deriv. (13) lacking the nitrocatechol moiety.  The aggregation kinetics by thioflavin S fluorescence assay indicates that both tolcapone (1) and entacapone (2) exhibit antiaggregation properties.  These findings were supported by transmission electron microscopy (TEM) and CD (CD) spectroscopy measurements which suggest that the nitrocatechol (3,4-dihydroxy-5-nitrophenyl) moiety is a suitable pharmacophore in the design of new tau-aggregation inhibitors.  Furthermore, tolcapone (1) was identified as most active compd. with antiaggregation activity (46% inhibition of fluorescence intensity at 50 μM), which was supported by TEM data.  The in silico steric zipper model of the tau-derived-hexapeptide 306VQIVYK311 indicates that the 3,4-dihydroxy-substituent present in tolcapone (1) and entacapone (2) underwent polar contacts with lysine side chains (VQIVYK), whereas the charged 5-nitrosubstituent was in close contact with lysine side chain present in the steric zipper region suggesting the crit. role of a nitrocatechol (3,4-dihydroxy-5-nitrophenyl) pharmacophore present in tolcapone (1) and entacapone (2) in tau-hexapeptide binding and prevention of β-sheet assembly.  Our results have significant implications in the design and development of tau-aggregation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoynOhTr4WtArVg90H21EOLACvtfcHk0lgT38jF6TSaSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtLfI&md5=263e2ba311d2a21e197c7c6b1f242416</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fcn400151a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400151a%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DJelokhani-Niaraki%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DP.%2BP.%26atitle%3DTau-derived-hexapeptide%2520306VQIVYK311%2520aggregation%2520inhibitors%253A%2520nitrocatechol%2520moiety%2520as%2520a%2520pharmacophore%2520in%2520drug%2520design%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1559%26epage%3D1570%26doi%3D10.1021%2Fcn400151a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel-Pinter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherzer-Attali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Hussien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alyagor, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbaum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span> <span> </span><span class="NLM_article-title">Naphthoquinone-tryptophan hybrid inhibits aggregation of the tau-derived peptide PHF6 and reduces neurotoxicity</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.3233/JAD-150927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.3233%2FJAD-150927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=26836184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2016&pages=165-178&author=M.+Frenkel-Pinterauthor=S.+Talauthor=R.+Scherzer-Attaliauthor=M.+Abu-Hussienauthor=I.+Alyagorauthor=T.+Eisenbaumauthor=E.+Gazitauthor=D.+Segal&title=Naphthoquinone-tryptophan+hybrid+inhibits+aggregation+of+the+tau-derived+peptide+PHF6+and+reduces+neurotoxicity&doi=10.3233%2FJAD-150927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity</span></div><div class="casAuthors">Frenkel-Pinter, Moran; Tal, Sharon; Scherzer-Attali, Roni; Abu-Hussien, Malak; Alyagor, Idan; Eisenbaum, Tal; Gazit, Ehud; Segal, Daniel; Lichtenthaler, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-178</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Tauopathies, such as Alzheimer's disease (AD), are a group of disorders characterized neuropathol. by intracellular toxic accumulations of abnormal protein aggregates formed by misfolding of the microtubule-assocd. protein tau.  Since protein self-assembly appears to be an initial key step in the pathol. of this group of diseases, intervening in this process can be both a prophylactic measure and a means for modifying the course of the disease for therapeutic purposes.  We and others have shown that arom. small mols. can be effective inhibitors of aggregation of various protein assemblies, by binding to the arom. core in aggregation-prone motifs and preventing their self-assembly.  Specifically, we have designed a series of small arom. naphthoquinone-tryptophan hybrid mols. as candidate aggregation inhibitors of β -sheet based assembly and demonstrated their efficacy toward inhibiting aggregation of the amyloid-β peptide, another culprit of AD, as well as of various other aggregative proteins involved in other protein misfolding diseases.  Here we tested whether a leading naphthoquinone-tryptophan hybrid mol., namely NQTrp, can be repurposed as an inhibitor of the aggregation of the tau protein in vitro and in vivo.  We show that the mol. inhibits the in vitro assembly of PHF6, the aggregation-prone fragment of tau protein, reduces hyperphosphorylated tau deposits and ameliorates tauopathy-related behavioral defect in an established transgenic Drosophila model expressing human tau.  We suggest that NQTrp, or optimized versions of it, could act as novel disease modifying drugs for AD and other tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ-1eBVk7cz7Vg90H21EOLACvtfcHk0linIeBGuI5KDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCgsrY%253D&md5=792bf76e1b8b8d787dc4b06fc895b9f1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3233%2FJAD-150927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150927%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel-Pinter%26aufirst%3DM.%26aulast%3DTal%26aufirst%3DS.%26aulast%3DScherzer-Attali%26aufirst%3DR.%26aulast%3DAbu-Hussien%26aufirst%3DM.%26aulast%3DAlyagor%26aufirst%3DI.%26aulast%3DEisenbaum%26aufirst%3DT.%26aulast%3DGazit%26aufirst%3DE.%26aulast%3DSegal%26aufirst%3DD.%26atitle%3DNaphthoquinone-tryptophan%2520hybrid%2520inhibits%2520aggregation%2520of%2520the%2520tau-derived%2520peptide%2520PHF6%2520and%2520reduces%2520neurotoxicity%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2016%26volume%3D51%26spage%3D165%26epage%3D178%26doi%3D10.3233%2FJAD-150927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunven, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Costa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peuchmaur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumendjel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chierici, S.</span></span> <span> </span><span class="NLM_article-title">Disruption of fibers from the tau model AcPHF6 by naturally occurring aurones and synthetic analogues</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=995-1003&author=L.+Lunvenauthor=H.+Bonnetauthor=S.+Yahiaouiauthor=W.+Yiauthor=L.+Da+Costaauthor=M.+Peuchmaurauthor=A.+Boumendjelauthor=S.+Chierici&title=Disruption+of+fibers+from+the+tau+model+AcPHF6+by+naturally+occurring+aurones+and+synthetic+analogues&doi=10.1021%2Facschemneuro.6b00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of Fibers from the Tau Model AcPHF6 by Naturally Occurring Aurones and Synthetic Analogues</span></div><div class="casAuthors">Lunven, Laurent; Bonnet, Hugues; Yahiaoui, Samir; Yi, Wei; Da Costa, Laurene; Peuchmaur, Marine; Boumendjel, Ahcene; Chierici, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-1003</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of tau aggregates is strongly linked to the neurodegenerative process in tauopathies such as Alzheimer's disease (AD).  Yet only a few mols. have shown to efficiently prevent the in vitro formation of those aggregates, and the identification of such mols. is still an ongoing interest in a therapeutic context.  Herein, we report the in vitro evaluation of a series of aurones against the fibrillation of the tau-derived hexapeptide AcPHF6 model.  Using thioflavin T-based fluorescence assays, CD and at. force microscopy, we showed that aurones are capable of efficiently interacting with the tau-derived hexapeptide.  Importantly, this work reveals a significant activity obsd. for polyhydroxylated aurones.  In particular, aurone 23 displayed an almost complete inhibition of fibers formation as shown by AFM at a peptide/inhibitor 1:1 ratio.  It is similar to that obsd. for myricetin, a polyphenolic compd., well-known to prevent the in vitro elongation of tau fibers.  Moreover, a tetrahydroxylated isomer, compd. 24, was shown as a chem. probe of fibers rather than an inhibitor.  Consequently, these results highlight aurones as a new promising scaffold to interfere with tau aggregation for both treatment and diagnosis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp27DT3ZYXjTrVg90H21EOLACvtfcHk0linIeBGuI5KDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFaktb0%253D&md5=cbb78251ada2a8f400624b724fd4da26</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00102%26sid%3Dliteratum%253Aachs%26aulast%3DLunven%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DH.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DW.%26aulast%3DDa%2BCosta%26aufirst%3DL.%26aulast%3DPeuchmaur%26aufirst%3DM.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DChierici%26aufirst%3DS.%26atitle%3DDisruption%2520of%2520fibers%2520from%2520the%2520tau%2520model%2520AcPHF6%2520by%2520naturally%2520occurring%2520aurones%2520and%2520synthetic%2520analogues%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D995%26epage%3D1003%26doi%3D10.1021%2Facschemneuro.6b00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejmech.2016.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=26807864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2ntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2016&pages=342-349&author=C.+K.+Wangauthor=S.+E.+Northfieldauthor=Y.+H.+Huangauthor=M.+C.+Ramosauthor=D.+J.+Craik&title=Inhibition+of+tau+aggregation+using+a+naturally-occurring+cyclic+peptide+scaffold&doi=10.1016%2Fj.ejmech.2016.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold</span></div><div class="casAuthors">Wang, Conan K.; Northfield, Susan E.; Huang, Yen-Hua; Ramos, Mariana C.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">342-349</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Disulfide-rich macrocyclic peptides are emerging as versatile scaffolds for the development of stable biochem. tools.  This potential is due to the combination of their structural stability and range of bioactivities.  Here, we explored the activity of these peptides on fibril growth of the hexapeptide Ac-VQIVYK-NH2 (AcPHF6), which is a tau-derived peptide that has been widely used to understand the pathol. mechanism of numerous tauopathies, including Alzheimer's disease.  Of the cyclic peptides tested, SFTI-1 and kB1 showed an inherent ability to inhibit AcPHF6 fibril formation.  Using an end-capping strategy and combining it with a mol. grafting approach, we demonstrated that SFTI-1 could be used as a starting point to design more potent fibril inhibitors.  We further identified chem. and structural features of SFTI-1 and its analogs that underpin their inhibitory activity.  The ability to inhibit fibril growth using the strategy employed herein supports the 'steric zipper' model of AcPHF6 fibril formation and shows that naturally-occurring cyclic peptides have potential as drug leads or mol. probes for understanding fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8EceNHBR-sbVg90H21EOLACvtfcHk0ljbVMPqnmw01w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2ntLk%253D&md5=3e649c3437e072ab206fc739d3d95bd2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BK.%26aulast%3DNorthfield%26aufirst%3DS.%2BE.%26aulast%3DHuang%26aufirst%3DY.%2BH.%26aulast%3DRamos%26aufirst%3DM.%2BC.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520tau%2520aggregation%2520using%2520a%2520naturally-occurring%2520cyclic%2520peptide%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D109%26spage%3D342%26epage%3D349%26doi%3D10.1016%2Fj.ejmech.2016.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biancalana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, S.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of Thioflavin-T binding to amyloid fibrils</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1412</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2010.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bbapap.2010.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20399286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVGlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=1405-1412&author=M.+Biancalanaauthor=S.+Koide&title=Molecular+mechanism+of+Thioflavin-T+binding+to+amyloid+fibrils&doi=10.1016%2Fj.bbapap.2010.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of thioflavin-T binding to amyloid fibrils</span></div><div class="casAuthors">Biancalana, Matthew; Koide, Shohei</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1405-1412</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Intense efforts to detect, diagnose, and analyze the kinetic and structural properties of amyloid fibrils have generated a powerful toolkit of amyloid-specific mol. probes.  Since its 1st description in 1959, the fluorescent dye, thioflavin-T (ThT), has become among the most widely used "gold stds." for selectively staining and identifying amyloid fibrils both in vivo and in vitro.  The large enhancement of its fluorescence emission upon its binding to fibrils makes ThT a particularly powerful and convenient tool.  Despite its widespread use in clin. and basic science applications, the mol. mechanism for the ability of ThT to recognize diverse types of amyloid fibrils and for the dye's characteristic fluorescence has only begun to be elucidated.  Here, the authors review recent progress in the understanding of ThT-fibril interactions at at. resoln.  These studies have yielded important insights into amyloid structures and the processes of fibril formation, and they also offer guidance for designing the next generation of amyloid assembly diagnostics, inhibitors, and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5H7hkh8MvL7Vg90H21EOLACvtfcHk0ljbVMPqnmw01w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVGlsbs%253D&md5=81e2da6940732c11dd04e4ae078c5741</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2010.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2010.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DBiancalana%26aufirst%3DM.%26aulast%3DKoide%26aufirst%3DS.%26atitle%3DMolecular%2520mechanism%2520of%2520Thioflavin-T%2520binding%2520to%2520amyloid%2520fibrils%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D1405%26epage%3D1412%26doi%3D10.1016%2Fj.bbapap.2010.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisanaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">7614</span>– <span class="NLM_lpage">7623</span>, <span class="refDoi"> DOI: 10.1074/jbc.M408714200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1074%2Fjbc.M408714200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=15611092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1yisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=7614-7623&author=S.+Taniguchiauthor=N.+Suzukiauthor=M.+Masudaauthor=S.+Hisanagaauthor=T.+Iwatsuboauthor=M.+Goedertauthor=M.+Hasegawa&title=Inhibition+of+heparin-induced+tau+filament+formation+by+phenothiazines%2C+polyphenols%2C+and+porphyrins&doi=10.1074%2Fjbc.M408714200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins</span></div><div class="casAuthors">Taniguchi, Sayuri; Suzuki, Nobuyuki; Masuda, Masami; Hisanaga, Shin-ichi; Iwatsubo, Takeshi; Goedert, Michel; Hasegawa, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7614-7623</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tau protein is the major component of the intraneuronal filamentous inclusions that constitute defining neuropathol. characteristics of Alzheimer's disease and other tauopathies.  The discovery of tau gene mutations in familial forms of frontotemporal dementia has established that dysfunction of the tau protein is sufficient to cause neurodegeneration and dementia.  Here we have tested 42 compds. belonging to nine different chem. classes for their ability to inhibit heparin-induced assembly of tau into filaments in vitro.  Several phenothiazines (methylene blue, azure A, azure B, and quinacrine mustard), polyphenols (myricetin, epicatechin 5-gallate, gossypetin, and 2,3,4,2',4'-pentahydroxybenzophenone), and the porphyrin ferric deuteroporphyrin IX inhibited tau filament formation with IC50 values in the low micromolar range as assessed by thioflavin S fluorescence, electron microscopy, and Sarkosyl insoly.  Disassembly of tau filaments was obsd. in the presence of the porphyrin phthalocyanine.  Compds. that inhibited tau filament assembly were also found to inhibit the formation of Aβ fibrils.  Biochem. anal. revealed the formation of sol. oligomeric tau in the presence of the inhibitory compds., suggesting that this may be the mechanism by which tau filament formation is inhibited.  The compds. investigated did not affect the ability of tau to interact with microtubules.  Identification of small mol. inhibitors of heparin-induced assembly of tau will form a starting point for the development of mechanism-based therapies for the tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGredfcb9NBJVLVg90H21EOLACvtfcHk0lhvH3l5iKJ53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1yisL8%253D&md5=cc8f16759387a4de44a2657bc0430190</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M408714200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M408714200%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DHisanaga%26aufirst%3DS.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520heparin-induced%2520tau%2520filament%2520formation%2520by%2520phenothiazines%252C%2520polyphenols%252C%2520and%2520porphyrins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D7614%26epage%3D7623%26doi%3D10.1074%2Fjbc.M408714200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wille, H. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1083/jcb.118.3.573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1083%2Fjcb.118.3.573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1639844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK38XltV2gsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1992&pages=573-584&author=H.+D.+G.+Willeauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Alzheimer-like+paired+helical+filaments+and+antiparallel+dimers+formed+from+microtubule-associated+protein+tau+in+vitro&doi=10.1083%2Fjcb.118.3.573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro</span></div><div class="casAuthors">Wille, Holger; Drewes, Gerard; Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">573-84</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Recent evidence from several labs. shows that the paired helical filaments of Alzheimer's disease brains consist mainly of the protein tau in an abnormally phosphorylated form, but the mode of assembly is not understood.  The authors used electron microscopy to study several constructs derived from human brain tau and expressed in Escherichia coli.  All constructs or tau isoforms were rodlike mols. with a high tendency to dimerize in an antiparallel fashion, as shown by antibody labeling and chem. crosslinking.  The length of the rods was largely detd. by the region of internal repeats that was also responsible for microtubule binding.  One unit length of the repeat domain (three or four repeats) was around 22-25 nm, comparable to the cross-section of Alzheimer PHF cores.  Constructs corresponding roughly to the repeat region of tau could form synthetic paired helical filaments resembling those from Alzheimer brain tissue.  A similar self-assembly occurred with the chem. crosslinked dimers.  In both cases there was no need for phosphorylation of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0edAcipxrRbVg90H21EOLACvtfcHk0lhvH3l5iKJ53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltV2gsLo%253D&md5=a6cb9e9daa49b1e9cad1ecabdd03c060</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1083%2Fjcb.118.3.573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.118.3.573%26sid%3Dliteratum%253Aachs%26aulast%3DWille%26aufirst%3DH.%2BD.%2BG.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAlzheimer-like%2520paired%2520helical%2520filaments%2520and%2520antiparallel%2520dimers%2520formed%2520from%2520microtubule-associated%2520protein%2520tau%2520in%2520vitro%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1992%26volume%3D118%26spage%3D573%26epage%3D584%26doi%3D10.1083%2Fjcb.118.3.573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">8029</span>– <span class="NLM_lpage">8038</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.12.8029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1074%2Fjbc.274.12.8029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10075702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK1MXitFSku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=8029-8038&author=H.+K.+Paudelauthor=W.+Li&title=Heparin-induced+conformational+change+in+microtubule-associated+protein+Tau+as+detected+by+chemical+cross-linking+and+phosphopeptide+mapping&doi=10.1074%2Fjbc.274.12.8029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical crosslinking and phosphopeptide mapping</span></div><div class="casAuthors">Paudel, Hemant K.; Li, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8029-8038</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">In Alzheimer's disease, microtubule-assocd. protein tau becomes abnormally phosphorylated and aggregates into paired helical filaments.  Sulfated glycosaminoglycans such as heparin and heparan sulfate were shown to accumulate in pretangle neurons, stimulate in vitro tau phosphorylation, and cause tau aggregation into paired helical filament-like filaments.  The sulfated glycosaminoglycan-tau interaction was suggested to be the central event in the development of neuropathol. in Alzheimer's disease brain (Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Nature 383, 550-553).  The biochem. mechanism by which sulfated glycosaminoglycans stimulate tau phosphorylation and cause tau aggregation remains unclear.  In this study, disuccinimidyl suberate (DSS), a bifunctional chem. cross-linker, cross-linked tau dimers, tetramers, high mol. size aggregates, and two tau species of sizes 72 and 83 kDa in the presence of heparin.  In the absence of heparin only dimeric tau was cross-linked by DSS.  Fast protein liq. chromatog. gel filtration revealed that 72- and 83-kDa species were formed by intramol. crosslinking of tau by DSS.  These observations indicate that heparin, in addn. to causing aggregation, also induces a conformational change in tau in which reactive groups are unmasked or move closer leading to the DSS crosslinking of 72- and 83-kDa species.  Heparin-induced structural changes in tau mol. depended on time of heparin exposure.  Dimerization and tetramerization peaked at 48 h, whereas conformational change was completed within 30 min of heparin exposure.  Heparin exposure beyond 48 h caused an abrupt aggregation of tau into high mol. size species.  Heparin stimulated tau phosphorylation by neuronal cdc2-like kinase (NCLK) and cAMP-dependent protein kinase.  Phosphopeptide mapping and phosphopeptide sequencing revealed that tau is phosphorylated by NCLK on Thr212 and Thr231 and by cAMP-dependent protein kinase on Ser262 only in the presence of heparin.  Heparin stimulation of tau phosphorylation by NCLK showed dependence on time of heparin exposure and correlated with the heparin-induced conformational change of tau.  Our data suggest that heparin-induced conformational change exposes new sites for phosphorylation within tau mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKHPNytgwfv7Vg90H21EOLACvtfcHk0lhvH3l5iKJ53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFSku7k%253D&md5=9061e517bbaa0d8baccdec1022dbeaa6</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.12.8029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.12.8029%26sid%3Dliteratum%253Aachs%26aulast%3DPaudel%26aufirst%3DH.%2BK.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DHeparin-induced%2520conformational%2520change%2520in%2520microtubule-associated%2520protein%2520Tau%2520as%2520detected%2520by%2520chemical%2520cross-linking%2520and%2520phosphopeptide%2520mapping%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D8029%26epage%3D8038%26doi%3D10.1074%2Fjbc.274.12.8029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilham, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrú, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessen, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atarashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Race, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meade-White, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubner, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, B.</span></span> <span> </span><span class="NLM_article-title">Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1001217</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1001217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1371%2Fjournal.ppat.1001217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=e1001217&author=J.+M.+Wilhamauthor=C.+D.+Orr%C3%BAauthor=R.+A.+Bessenauthor=R.+Atarashiauthor=K.+Sanoauthor=B.+Raceauthor=K.+D.+Meade-Whiteauthor=L.+M.+Taubnerauthor=A.+Timmesauthor=B.+Caughey&title=Rapid+end-point+quantitation+of+prion+seeding+activity+with+sensitivity+comparable+to+bioassays&doi=10.1371%2Fjournal.ppat.1001217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1001217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1001217%26sid%3Dliteratum%253Aachs%26aulast%3DWilham%26aufirst%3DJ.%2BM.%26aulast%3DOrr%25C3%25BA%26aufirst%3DC.%2BD.%26aulast%3DBessen%26aufirst%3DR.%2BA.%26aulast%3DAtarashi%26aufirst%3DR.%26aulast%3DSano%26aufirst%3DK.%26aulast%3DRace%26aufirst%3DB.%26aulast%3DMeade-White%26aufirst%3DK.%2BD.%26aulast%3DTaubner%26aufirst%3DL.%2BM.%26aulast%3DTimmes%26aufirst%3DA.%26aulast%3DCaughey%26aufirst%3DB.%26atitle%3DRapid%2520end-point%2520quantitation%2520of%2520prion%2520seeding%2520activity%2520with%2520sensitivity%2520comparable%2520to%2520bioassays%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26spage%3De1001217%26doi%3D10.1371%2Fjournal.ppat.1001217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span> <span> </span><span class="NLM_article-title">Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(01)02944-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS0014-5793%2801%2902944-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2001&pages=81-87&author=J.+Wangauthor=Y.+C.+Tungauthor=Y.+Wangauthor=X.+T.+Liauthor=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Hyperphosphorylation+and+accumulation+of+neurofilament+proteins+in+Alzheimer+disease+brain+and+in+okadaic+acid-treated+SY5Y+cells&doi=10.1016%2FS0014-5793%2801%2902944-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2902944-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252902944-1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BT.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DHyperphosphorylation%2520and%2520accumulation%2520of%2520neurofilament%2520proteins%2520in%2520Alzheimer%2520disease%2520brain%2520and%2520in%2520okadaic%2520acid-treated%2520SY5Y%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D507%26spage%3D81%26epage%3D87%26doi%3D10.1016%2FS0014-5793%2801%2902944-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. X.</span></span> <span> </span><span class="NLM_article-title">Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model</span>. <i>Int. J. Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/j.ijdevneu.2012.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ijdevneu.2012.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=411-419&author=Z.+Chenauthor=B.+Chenauthor=W.+F.+Xuauthor=R.+F.+Liuauthor=J.+Yangauthor=C.+X.+Yu&title=Effects+of+PTEN+inhibition+on+regulation+of+tau+phosphorylation+in+an+okadaic+acid-induced+neurodegeneration+model&doi=10.1016%2Fj.ijdevneu.2012.08.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2012.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DW.%2BF.%26aulast%3DLiu%26aufirst%3DR.%2BF.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%2BX.%26atitle%3DEffects%2520of%2520PTEN%2520inhibition%2520on%2520regulation%2520of%2520tau%2520phosphorylation%2520in%2520an%2520okadaic%2520acid-induced%2520neurodegeneration%2520model%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2012%26volume%3D30%26spage%3D411%26epage%3D419%26doi%3D10.1016%2Fj.ijdevneu.2012.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, J. W.</span></span> <span> </span><span class="NLM_article-title">An okadaic acid-induced model of tauopathy and cognitive deficiency</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1359</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2010.08.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.brainres.2010.08.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20807517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSgt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1359&publication_year=2010&pages=233-246&author=Z.+Zhangauthor=J.+W.+Simpkins&title=An+okadaic+acid-induced+model+of+tauopathy+and+cognitive+deficiency&doi=10.1016%2Fj.brainres.2010.08.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">An okadaic acid-induced model of tauopathy and cognitive deficiency</span></div><div class="casAuthors">Zhang, Zhang; Simpkins, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1359</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-246</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes cognitive and behavioral deterioration in the elderly.  Neurofibrillary tangles (NFTs) are one of the pathol. hallmarks of AD that has been shown to correlate pos. with the severity of dementia in the neocortex of AD patients.  In an attempt to characterize an in vivo AD tauopathy model, okadaic acid (OA), a protein phosphatase inhibitor, was microinfused into the right lateral dorsal hippocampus area of ovariectomized adult rat.  Cognitive deficiency was seen in OA-treated rats without a change in motor function.  Both silver staining and immunohistochem. staining revealed that OA treatment induces NFTs-like conformational changes in both the cortex and hippocampus.  Phosphorylated tau as well as cyclin-dependent kinase 5 (cdk5) and its coactivator, p25, were significantly increased in these regions of the brain.  Oxidative stress was also increased with OA treatment as measured by protein carbonylation and lipid peroxidn.  These data suggest that the unilateral microinfusion of OA into the dorsal hippocampus causes cognitive deficiency, NFTs-like pathol. changes, and oxidative stress as seen in AD pathol. via tau hyperphosphorylation caused by inhibition of protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUqOG8p8fBHbVg90H21EOLACvtfcHk0lhhxiw5EuFsGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSgt7rM&md5=fa24cf9dae25d308ba0effa930992597</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2010.08.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2010.08.077%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSimpkins%26aufirst%3DJ.%2BW.%26atitle%3DAn%2520okadaic%2520acid-induced%2520model%2520of%2520tauopathy%2520and%2520cognitive%2520deficiency%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1359%26spage%3D233%26epage%3D246%26doi%3D10.1016%2Fj.brainres.2010.08.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lhhxiw5EuFsGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dwyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santocanale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carew, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F.</span></span> <span> </span><span class="NLM_article-title">Cdc7 kinase - a new target for drug development</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2009.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejca.2009.09.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=33-40&author=R.+Swordsauthor=D.+Mahalingamauthor=M.+O%E2%80%99Dwyerauthor=C.+Santocanaleauthor=K.+Kellyauthor=J.+Carewauthor=F.+Giles&title=Cdc7+kinase+-+a+new+target+for+drug+development&doi=10.1016%2Fj.ejca.2009.09.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2009.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2009.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DSwords%26aufirst%3DR.%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DM.%26aulast%3DSantocanale%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DK.%26aulast%3DCarew%26aufirst%3DJ.%26aulast%3DGiles%26aufirst%3DF.%26atitle%3DCdc7%2520kinase%2520-%2520a%2520new%2520target%2520for%2520drug%2520development%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D33%26epage%3D40%26doi%3D10.1016%2Fj.ejca.2009.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1423</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1995.64031420.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1046%2Fj.1471-4159.1995.64031420.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=7532213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1995&pages=1420-1423&author=T.+J.+Singhauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Phosphorylation+of+tau+protein+by+casein+kinase-1+converts+it+to+an+abnormal+Alzheimer-like+state&doi=10.1046%2Fj.1471-4159.1995.64031420.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of τ protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span></div><div class="casAuthors">Singh, Toolsee; Grundke-Iqbal, Inge; Iqbal, Khalid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1420-3</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Microtubule-assocd. protein τ is abnormally hyperphosphorylated in Alzheimer's disease.  Both proline-dependent protein kinases (PDPKs) and non-PDPKs are involved in this hyperphosphorylation of τ.  Several PDPKs can phosphorylate τ in vitro and induce Alzheimer-like epitopes to many phosphorylation-dependent antibodies.  A similar induction has not been reported with non-PDPKs.  Here, the authors evaluated 6 non-PDPKs [cAMP-dependent (A-kinase), Ca2+/phospholipid-dependent (C-kinase), casein kinase-1 (CK-1), casein kinase-2 (CK-2), Ca2+/calmodulin-dependent protein kinase II, and Ca2+/calmodulin-dependent protein kinase from rat cerebellum] for their abilities to induce Alzheimer-like epitopes on τ.  Such epitopes were induced by A-kinase, C-kinase, CK-1, and CK-2, but the degree of induction achieved by CK-1 was much greater than with the other kinases.  These results suggest that CK-1 may play an important role in the conversion of τ from the normal to the abnormal phosphorylation state in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiaaD_uS92HrVg90H21EOLACvtfcHk0lj_NtAbmJA53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D&md5=3827ab9e85b4dc25ab1e3e02dd614a4d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.64031420.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.64031420.x%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%2BJ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DPhosphorylation%2520of%2520tau%2520protein%2520by%2520casein%2520kinase-1%2520converts%2520it%2520to%2520an%2520abnormal%2520Alzheimer-like%2520state%26jtitle%3DJ.%2520Neurochem.%26date%3D1995%26volume%3D64%26spage%3D1420%26epage%3D1423%26doi%3D10.1046%2Fj.1471-4159.1995.64031420.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maccari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottana, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curinga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigorita, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakowitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steindl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2809</span>– <span class="NLM_lpage">2823</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2005.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2809-2823&author=R.+Maccariauthor=R.+Ottanaauthor=C.+Curingaauthor=M.+G.+Vigoritaauthor=D.+Rakowitzauthor=T.+Steindlauthor=T.+Langer&title=Structure-activity+relationships+and+molecular+modelling+of+5-arylidene-2%2C4-thiazolidinediones+active+as+aldose+reductase+inhibitors&doi=10.1016%2Fj.bmc.2005.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttana%26aufirst%3DR.%26aulast%3DCuringa%26aufirst%3DC.%26aulast%3DVigorita%26aufirst%3DM.%2BG.%26aulast%3DRakowitz%26aufirst%3DD.%26aulast%3DSteindl%26aufirst%3DT.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DStructure-activity%2520relationships%2520and%2520molecular%2520modelling%2520of%25205-arylidene-2%252C4-thiazolidinediones%2520active%2520as%2520aldose%2520reductase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2809%26epage%3D2823%26doi%3D10.1016%2Fj.bmc.2005.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepartz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2168</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2165-2168&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facs.jmedchem.7b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis; Merz, Kenneth M.; Schepartz, Alanna; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2165-2168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecstasy of discovering a new hit from screening can lead to a highly productive research effort to discover new bioactive compds.  However, in too many cases this ecstasy is followed by the agony of realizing that the compds. are not active against the desired target.  Many of these false hits are Pan Assay INterference compds. (PAINS) 1 or colloidal aggregators.  Whether the screen is conducted in silico or in the lab. and whether screening libraries, natural products, or drugs are used, all discovery efforts that rely on some form of screening to identify bioactivity are susceptible to this phenomenon.  Studies that omit crit. controls against exptl. artifacts caused by PAINS may waste years of research effort as useless compds. are progressed.  The American Chem. Society (ACS) is eager to alert the scientific community to this problem and to recommend protocols that will eliminate the publication of research articles based on compds. with artificial activity.  This editorial aims to summarize relevant concepts and to set the framework by which relevant ACS journals will address this issue going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUf5u51VEpbVg90H21EOLACvtfcHk0lj_NtAbmJA53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D&md5=64bf087659a47fe7769208217ef8c989</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00229%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2165%26epage%3D2168%26doi%3D10.1021%2Facs.jmedchem.7b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Drug–target residence time</span>. In  <i>Evaluation of Enzyme Inhibitors in Drug Discovery</i>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2F9781118540398.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=318-325&author=R.+A.+Copelandauthor=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2F9781118540398.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DDrug%25E2%2580%2593target%2520residence%2520time%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26pub%3DWiley%26date%3D2013%26spage%3D318%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avonto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taglialatela-Scafati, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span> <span> </span><span class="NLM_article-title">An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of Michael acceptors for drug discovery?</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1002/anie.201005959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.201005959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=467-471&author=C.+Avontoauthor=O.+Taglialatela-Scafatiauthor=F.+Pollastroauthor=A.+Minassiauthor=V.+Di+Marzoauthor=L.+De+Petrocellisauthor=G.+Appendino&title=An+NMR+spectroscopic+method+to+identify+and+classify+thiol-trapping+agents%3A+revival+of+Michael+acceptors+for+drug+discovery%3F&doi=10.1002%2Fanie.201005959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">An NMR Spectroscopic Method to Identify and Classify Thiol-Trapping Agents: Revival of Michael Acceptors for Drug Discovery?</span></div><div class="casAuthors">Avonto, Cristina; Taglialatela-Scafati, Orazio; Pollastro, Federica; Minassi, Alberto; Di Marzo, Vincenzo; De Petrocellis, Luciano; Appendino, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">467-471, S467/1-S467/30</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a simple and quick NMR spectroscopic method to identify Michael acceptor sites in complex multifunctional compds.  The method sorts them out in reversible and irreversible thiol sinks, and predicts their potential to modify proteins, as validated by the identification of several new chemotypes of TRPA1 activators.  These include well-known anti-inflammatory agents, such as curcumin and parthenolide, which had been overlooked as ligands for this druggable end point of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt8t1J015hqbVg90H21EOLACvtfcHk0liQJOme1cRrmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D&md5=8fd61bce5e0dfeb9209a6572516fd583</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2Fanie.201005959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201005959%26sid%3Dliteratum%253Aachs%26aulast%3DAvonto%26aufirst%3DC.%26aulast%3DTaglialatela-Scafati%26aufirst%3DO.%26aulast%3DPollastro%26aufirst%3DF.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DAn%2520NMR%2520spectroscopic%2520method%2520to%2520identify%2520and%2520classify%2520thiol-trapping%2520agents%253A%2520revival%2520of%2520Michael%2520acceptors%2520for%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D467%26epage%3D471%26doi%3D10.1002%2Fanie.201005959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julià, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Baeza, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anglada, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centelles, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascante, M.</span></span> <span> </span><span class="NLM_article-title">Cysteinyl-flavan-3-ol conjugates from grape procyanidins. Antioxidant and antiproliferative properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2509</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00127-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS0968-0896%2802%2900127-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2497-2509&author=J.+L.+Torresauthor=C.+Lozanoauthor=L.+Juli%C3%A0author=F.+J.+S%C3%A1nchez-Baezaauthor=J.+M.+Angladaauthor=J.+J.+Centellesauthor=M.+Cascante&title=Cysteinyl-flavan-3-ol+conjugates+from+grape+procyanidins.+Antioxidant+and+antiproliferative+properties&doi=10.1016%2FS0968-0896%2802%2900127-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900127-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900127-X%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DJ.%2BL.%26aulast%3DLozano%26aufirst%3DC.%26aulast%3DJuli%25C3%25A0%26aufirst%3DL.%26aulast%3DS%25C3%25A1nchez-Baeza%26aufirst%3DF.%2BJ.%26aulast%3DAnglada%26aufirst%3DJ.%2BM.%26aulast%3DCentelles%26aufirst%3DJ.%2BJ.%26aulast%3DCascante%26aufirst%3DM.%26atitle%3DCysteinyl-flavan-3-ol%2520conjugates%2520from%2520grape%2520procyanidins.%2520Antioxidant%2520and%2520antiproliferative%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2497%26epage%3D2509%26doi%3D10.1016%2FS0968-0896%2802%2900127-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arsovska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trontelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zidar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masic, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plavec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zega, A.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Michael-type acceptor reactivity of 5-benzylidenebarbiturates, 5-benzylidenerhodanines, and related heterocycles using NMR</span>. <i>Acta Chim. Slov.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=637-644&author=E.+Arsovskaauthor=J.+Tronteljauthor=N.+Zidarauthor=T.+Tomasicauthor=L.+P.+Masicauthor=D.+Kikeljauthor=J.+Plavecauthor=A.+Zega&title=Evaluation+of+Michael-type+acceptor+reactivity+of+5-benzylidenebarbiturates%2C+5-benzylidenerhodanines%2C+and+related+heterocycles+using+NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArsovska%26aufirst%3DE.%26aulast%3DTrontelj%26aufirst%3DJ.%26aulast%3DZidar%26aufirst%3DN.%26aulast%3DTomasic%26aufirst%3DT.%26aulast%3DMasic%26aufirst%3DL.%2BP.%26aulast%3DKikelj%26aufirst%3DD.%26aulast%3DPlavec%26aufirst%3DJ.%26aulast%3DZega%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520Michael-type%2520acceptor%2520reactivity%2520of%25205-benzylidenebarbiturates%252C%25205-benzylidenerhodanines%252C%2520and%2520related%2520heterocycles%2520using%2520NMR%26jtitle%3DActa%2520Chim.%2520Slov.%26date%3D2014%26volume%3D61%26spage%3D637%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polazzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengoni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caprini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Altamira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtys, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span> <span> </span><span class="NLM_article-title">Copper-zinc superoxide dismutase (SOD1) is released by microglial cells and confers neuroprotection against 6-OHDA neurotoxicity</span>. <i>Neurosignals</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1159/000337115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1159%2F000337115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=22572742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Gmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=112-128&author=E.+Polazziauthor=I.+Mengoniauthor=M.+Capriniauthor=E.+Pena-Altamiraauthor=E.+Kurtysauthor=B.+Monti&title=Copper-zinc+superoxide+dismutase+%28SOD1%29+is+released+by+microglial+cells+and+confers+neuroprotection+against+6-OHDA+neurotoxicity&doi=10.1159%2F000337115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity</span></div><div class="casAuthors">Polazzi, Elisabetta; Mengoni, Ilaria; Caprini, Marco; Pena-Altamira, Emiliano; Kurtys, Ewelina; Monti, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">112-128</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Microglial-neuronal interactions are essential for brain physiopathol.  In this framework, recent data have changed the concept of microglia from essentially macrophagic cells to crucial elements in maintaining neuronal homeostasis and function through the release of neuroprotective mols.  Using proteomic anal., here we identify copper-zinc superoxide dismutase (SOD1) as a protein produced and released by cultured rat primary microglia.  Evidence for a neuroprotective role of microglia-derived SOD1 resulted from expts. in which primary cerebellar granule neurons (CGNs) were exposed to the dopaminergic toxin 6-hydroxydopamine (6-OHDA).  Microglial conditioned medium, in which SOD1 had accumulated, protected CGNs from degeneration, and neuroprotection was abrogated by SOD1 inhibitors.  These effects were replicated when exogenous SOD1 was added to a nonconditioned medium.  SOD1 neuroprotective action was mediated by increased cell calcium from an external source.  Further expts. demonstrated the specificity of SOD1 neuroprotection against 6-OHDA compared to other types of neurotoxic challenges.  SOD1, constitutively produced and released by microglia through a lysosomal secretory pathway, is identified here for the first time as an essential component of neuroprotection mediated by microglia.  This novel information is relevant to stimulating further studies of microglia-mediated neuroprotection in in vivo models of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFBV29S5907Vg90H21EOLACvtfcHk0ljUz252p9e84Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Gmuro%253D&md5=06d4d02f8d6bc8b5a32127e9dc18cdc8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1159%2F000337115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000337115%26sid%3Dliteratum%253Aachs%26aulast%3DPolazzi%26aufirst%3DE.%26aulast%3DMengoni%26aufirst%3DI.%26aulast%3DCaprini%26aufirst%3DM.%26aulast%3DPena-Altamira%26aufirst%3DE.%26aulast%3DKurtys%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26atitle%3DCopper-zinc%2520superoxide%2520dismutase%2520%2528SOD1%2529%2520is%2520released%2520by%2520microglial%2520cells%2520and%2520confers%2520neuroprotection%2520against%25206-OHDA%2520neurotoxicity%26jtitle%3DNeurosignals%26date%3D2013%26volume%3D21%26spage%3D112%26epage%3D128%26doi%3D10.1159%2F000337115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Altamira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polazzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauriola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span> <span> </span><span class="NLM_article-title">The transcription factor CCAAT enhancer-binding protein beta protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1111/ejn.12407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1111%2Fejn.12407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=24438488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BC2czmvV2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=176-185&author=E.+Pena-Altamiraauthor=E.+Polazziauthor=E.+Morettoauthor=M.+Lauriolaauthor=B.+Monti&title=The+transcription+factor+CCAAT+enhancer-binding+protein+beta+protects+rat+cerebellar+granule+neurons+from+apoptosis+through+its+transcription-activating+isoforms&doi=10.1111%2Fejn.12407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms</span></div><div class="casAuthors">Pena-Altamira Emiliano; Polazzi Elisabetta; Moretto Edoardo; Lauriola Mattia; Monti Barbara</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CCAAT enhancer-binding protein β is a transcription factor that is involved in many brain processes, although its role in neuronal survival/death remains unclear.  By using primary cultures of rat cerebellar granule neurons, we have shown here that CCAAT enhancer-binding protein β is present as all of its isoforms: the transcriptional activators liver activator proteins 1 and 2, and the transcriptional inhibitor liver inhibitory protein.  We have also shown that liver activator protein 1 undergoes post-translational modifications, such as phosphorylation and sumoylation.  These isoforms have different subcellular localizations, liver activator protein 2 being found in the cytosolic fraction only, liver inhibitory protein in the nucleus only, and liver activator protein 1 in both fractions.  Through neuronal apoptosis induction by shifting mature cerebellar granule neurons to low-potassium medium, we have demonstrated that nuclear liver activator protein 1 expression decreases and its phosphorylation disappears, whereas liver inhibitory protein levels increase in the nuclear fraction, suggesting a pro-survival role for liver activator protein transcriptional activation and a pro-apoptotic role for liver inhibitory protein transcriptional inhibition.  To confirm this, we transfected cerebellar granule neurons with plasmids expressing liver activator protein 1, liver activator protein 2, or liver inhibitory protein respectively, and observed that both liver activator proteins, which increase CCAAT-dependent transcription, but not liver inhibitory protein, counteracted apoptosis, thus demonstrating the pro-survival role of liver activator proteins.  These data significantly improve our current understanding of the role of CCAAT enhancer-binding protein β in neuronal survival/apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSX_bKS03xe8DC850By6mxpfW6udTcc2eYpAwdGI3XBi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czmvV2gsQ%253D%253D&md5=8e23229a38098f74c6b7f769f18ab982</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fejn.12407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.12407%26sid%3Dliteratum%253Aachs%26aulast%3DPena-Altamira%26aufirst%3DE.%26aulast%3DPolazzi%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DE.%26aulast%3DLauriola%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DB.%26atitle%3DThe%2520transcription%2520factor%2520CCAAT%2520enhancer-binding%2520protein%2520beta%2520protects%2520rat%2520cerebellar%2520granule%2520neurons%2520from%2520apoptosis%2520through%2520its%2520transcription-activating%2520isoforms%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2014%26volume%3D39%26spage%3D176%26epage%3D185%26doi%3D10.1111%2Fejn.12407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Prabitha P, Antony Justin, T. Durai Ananda Kumar, Mithuna Chinaswamy, <span class="NLM_string-name hlFld-ContribAuthor">B. R. Prashantha Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (13)
                                     , 2261-2272. <a href="https://doi.org/10.1021/acschemneuro.1c00085" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00085%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DGlitazones%252BActivate%252BPGC-1%2525CE%2525B1%252BSignaling%252Bvia%252BPPAR-%2525CE%2525B3%25253A%252BA%252BPromising%252BStrategy%252Bfor%252BAntiparkinsonism%252BTherapeutics%26aulast%3DP%26aufirst%3DPrabitha%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12022021%26date%3D01062021%26date%3D14062021%26volume%3D12%26issue%3D13%26spage%3D2261%26epage%3D2272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lukas Gorecki, Elisa Uliassi, Manuela Bartolini, Jana Janockova, Martina Hrabinova, Vendula Hepnarova, Lukas Prchal, Lubica Muckova, Jaroslav Pejchal, Jana Z. Karasova, Eva Mezeiova, Marketa Benkova, Tereza Kobrlova, Ondrej Soukup, Sabrina Petralla, Barbara Monti, Jan Korabecny, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (9)
                                     , 1698-1715. <a href="https://doi.org/10.1021/acschemneuro.1c00184" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00184%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPhenothiazine-Tacrine%252BHeterodimers%25253A%252BPursuing%252BMultitarget%252BDirected%252BApproach%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGorecki%26aufirst%3DLukas%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26032021%26date%3D07042021%26date%3D14042021%26volume%3D12%26issue%3D9%26spage%3D1698%26epage%3D1715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lhassane Ismaili, Julie Monnin, Adeline Etievant, Raquel L. Arribas, Lucía Viejo, Bernard Refouvelet, Ondrej Soukup, Jana Janockova, Vendula Hepnarova, Jan Korabecny, Tomas Kucera, Daniel Jun, Rudolf Andrys, Kamil Musilek, Aurelie Baguet, Eva M. García-Frutos, Angela De Simone, Vincenza Andrisano, Manuela Bartolini, Cristóbal de los Ríos, José Marco-Contelles, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel Haffen</span>. </span><span class="cited-content_cbyCitation_article-title">(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (8)
                                     , 1328-1342. <a href="https://doi.org/10.1021/acschemneuro.0c00803" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00803%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D%252528%2525C2%2525B1%252529-BIGI-3h%25253A%252BPentatarget-Directed%252BLigand%252Bcombining%252BCholinesterase%25252C%252BMonoamine%252BOxidase%25252C%252Band%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252BInhibition%252Bwith%252BCalcium%252BChannel%252BAntagonism%252Band%252BAntiaggregating%252BProperties%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DIsmaili%26aufirst%3DLhassane%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19122020%26date%3D22032021%26date%3D02042021%26volume%3D12%26issue%3D8%26spage%3D1328%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Milelli</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 26-41. <a href="https://doi.org/10.1021/acs.jmedchem.0c00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%25253A%252BA%252BNew%252BGold%252BRush%252Bin%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BMultitarget%252BDrug%252BDiscovery%25253F%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D21122020%26volume%3D64%26issue%3D1%26spage%3D26%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinhua Zhao, Fucheng Yin, Limei Ji, Cheng Wang, Cunjian Shi, Xingchen Liu, Huali Yang, Xiaobing Wang, <span class="NLM_string-name hlFld-ContribAuthor">Lingyi Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal–Organic Framework for Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2020,</strong> <em>12 </em>
                                    (40)
                                     , 44447-44458. <a href="https://doi.org/10.1021/acsami.0c11064" title="DOI URL">https://doi.org/10.1021/acsami.0c11064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.0c11064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.0c11064%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DDevelopment%252Bof%252Ba%252BTau-Targeted%252BDrug%252BDelivery%252BSystem%252BUsing%252Ba%252BMultifunctional%252BNanoscale%252BMetal%2525E2%252580%252593Organic%252BFramework%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DZhao%26aufirst%3DJinhua%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D08092020%26date%3D16092020%26date%3D08092020%26volume%3D12%26issue%3D40%26spage%3D44447%26epage%3D44458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">F. Javier Pérez-Areales, María Garrido, Ester Aso, Manuela Bartolini, Angela De Simone, Alba Espargaró, Tiziana Ginex, Raimon Sabate, Belén Pérez, Vincenza Andrisano, Dolors Puigoriol-Illamola, Mercè Pallàs, F. Javier Luque, María Isabel Loza, José Brea, Isidro Ferrer, Francisco Ciruela, Angel Messeguer, <span class="NLM_string-name hlFld-ContribAuthor">Diego Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9360-9390. <a href="https://doi.org/10.1021/acs.jmedchem.0c00528" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00528%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCentrally%252BActive%252BMultitarget%252BAnti-Alzheimer%252BAgents%252BDerived%252Bfrom%252Bthe%252BAntioxidant%252BLead%252BCR-6%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31032020%26date%3D11082020%26date%3D24072020%26volume%3D63%26issue%3D17%26spage%3D9360%26epage%3D9390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rim Malek, Raquel L. Arribas, Alejandra Palomino-Antolin, Perle Totoson, Celine Demougeot, Tereza Kobrlova, Ondrej Soukup, Isabel Iriepa, Ignacio Moraleda, Daniel Diez-Iriepa, Justyna Godyń, Dawid Panek, Barbara Malawska, Monika Głuch-Lutwin, Barbara Mordyl, Agata Siwek, Fakher Chabchoub, José Marco-Contelles, Katarzyna Kiec-Kononowicz, Javier Egea, Cristóbal de los Ríos, <span class="NLM_string-name hlFld-ContribAuthor">Lhassane Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11416-11422. <a href="https://doi.org/10.1021/acs.jmedchem.9b00937" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00937%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BDual%252BSmall%252BMolecules%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%252BCombining%252BHistamine%252BH3%252BReceptor%252B%252528H3R%252529%252BAntagonism%252Band%252BCalcium%252BChannels%252BBlockade%252Bwith%252BAdditional%252BCholinesterase%252BInhibition%26aulast%3DMalek%26aufirst%3DRim%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D05122019%26date%3D14112019%26volume%3D62%26issue%3D24%26spage%3D11416%26epage%3D11422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexei N.  Izmest'ev</span>, <span class="hlFld-ContribAuthor ">Galina A.  Gazieva</span>, <span class="hlFld-ContribAuthor ">Lada V.  Anikina</span>, <span class="hlFld-ContribAuthor ">Sergey A.  Pukhov</span>, <span class="hlFld-ContribAuthor ">Valentina A.  Karnoukhova</span>, <span class="hlFld-ContribAuthor ">Natalya G.  Kolotyrkina</span>, <span class="hlFld-ContribAuthor ">Angelina N.  Kravchenko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of the antiproliferative activity of new heterylmethylidene derivatives of imidazothiazolotriazinones. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (27)
                                     , 12271-12285. <a href="https://doi.org/10.1039/D1NJ02163J" title="DOI URL">https://doi.org/10.1039/D1NJ02163J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NJ02163J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NJ02163J%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthe%252Bantiproliferative%252Bactivity%252Bof%252Bnew%252Bheterylmethylidene%252Bderivatives%252Bof%252Bimidazothiazolotriazinones%26aulast%3DIzmest%2527ev%26aufirst%3DAlexei%2BN.%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D27%26spage%3D12271%26epage%3D12285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teeba  Athar</span>, <span class="hlFld-ContribAuthor ">K.  Al Balushi</span>, <span class="hlFld-ContribAuthor ">Shah Alam  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology Reports</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.1007/s11033-021-06512-9" title="DOI URL">https://doi.org/10.1007/s11033-021-06512-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11033-021-06512-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11033-021-06512-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520Reports%26atitle%3DRecent%252Badvances%252Bon%252Bdrug%252Bdevelopment%252Band%252Bemerging%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DAthar%26aufirst%3DTeeba%26date%3D2021%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ángel  Cores</span>, <span class="hlFld-ContribAuthor ">Sheila  Abril</span>, <span class="hlFld-ContribAuthor ">Patrycja  Michalska</span>, <span class="hlFld-ContribAuthor ">Pablo  Duarte</span>, <span class="hlFld-ContribAuthor ">Ana I.  Olives</span>, <span class="hlFld-ContribAuthor ">M. Antonia  Martín</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villacampa</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">J. Carlos  Menéndez</span>. </span><span class="cited-content_cbyCitation_article-title">Bisavenathramide Analogues as Nrf2 Inductors and Neuroprotectors in In Vitro Models of Oxidative Stress and Hyperphosphorylation. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 941. <a href="https://doi.org/10.3390/antiox10060941" title="DOI URL">https://doi.org/10.3390/antiox10060941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10060941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10060941%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DBisavenathramide%252BAnalogues%252Bas%252BNrf2%252BInductors%252Band%252BNeuroprotectors%252Bin%252BIn%252BVitro%252BModels%252Bof%252BOxidative%252BStress%252Band%252BHyperphosphorylation%26aulast%3DCores%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Julia  Tabor</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Fabien  Chantegreil</span>, <span class="hlFld-ContribAuthor ">José  Dias</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Junfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Georg  Höfner</span>, <span class="hlFld-ContribAuthor ">Klaus  Wanner</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113397. <a href="https://doi.org/10.1016/j.ejmech.2021.113397" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113397%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bmultifunctional%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%252Bwith%252Ba%252Bunique%252Bmechanism%252Bof%252Baction%252Bincluding%252Binhibition%252Bof%252Bthe%252Benzyme%252Bbutyrylcholinesterase%252Band%252B%2525CE%2525B3-aminobutyric%252Bacid%252Btransporters%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2021%26volume%3D218%26spage%3D113397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Slavka  Hamulakova</span>, <span class="hlFld-ContribAuthor ">Zuzana  Kudlickova</span>, <span class="hlFld-ContribAuthor ">Ladislav  Janovec</span>, <span class="hlFld-ContribAuthor ">Roman  Mezencev</span>, <span class="hlFld-ContribAuthor ">Zachery J  Deckner</span>, <span class="hlFld-ContribAuthor ">Yury O  Chernoff</span>, <span class="hlFld-ContribAuthor ">Jana  Janockova</span>, <span class="hlFld-ContribAuthor ">Veronika  Ihnatova</span>, <span class="hlFld-ContribAuthor ">Petr  Bzonek</span>, <span class="hlFld-ContribAuthor ">Nikola  Novakova</span>, <span class="hlFld-ContribAuthor ">Vendula  Hepnarova</span>, <span class="hlFld-ContribAuthor ">Martina  Hrabinova</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel tacrine–indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (9)
                                     , 785-804. <a href="https://doi.org/10.4155/fmc-2020-0184" title="DOI URL">https://doi.org/10.4155/fmc-2020-0184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0184%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Btacrine%2525E2%252580%252593indole%252Bhybrids%252Bas%252Bpotential%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DHamulakova%26aufirst%3DSlavka%26date%3D2021%26volume%3D13%26issue%3D9%26spage%3D785%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazmiye  SABANCI</span>. </span><span class="cited-content_cbyCitation_article-title">Antinörodejeneratif 5-sübstitüe 2,4-tiyazolidindion Türevlerinin Kuantum Kimyasal İncelemesi. </span><span class="cited-content_cbyCitation_journal-name">Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.18185/erzifbed.856269" title="DOI URL">https://doi.org/10.18185/erzifbed.856269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18185/erzifbed.856269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18185%2Ferzifbed.856269%26sid%3Dliteratum%253Aachs%26jtitle%3DErzincan%2520%25C3%259Cniversitesi%2520Fen%2520Bilimleri%2520Enstit%25C3%25BCs%25C3%25BC%2520Dergisi%26atitle%3DAntin%2525C3%2525B6rodejeneratif%252B5-s%2525C3%2525BCbstit%2525C3%2525BCe%252B2%25252C4-tiyazolidindion%252BT%2525C3%2525BCrevlerinin%252BKuantum%252BKimyasal%252B%2525C4%2525B0ncelemesi%26aulast%3DSABANCI%26aufirst%3DNazmiye%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiao  Luo</span>, <span class="hlFld-ContribAuthor ">Shuju  Guo</span>, <span class="hlFld-ContribAuthor ">Lijun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104648. <a href="https://doi.org/10.1016/j.bioorg.2021.104648" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104648%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5-%2525283-bromo-2-%2525282%25252C3-dibromo-4%25252C5-dimethoxybenzyl%252529-4%25252C5-dimethoxybenzylidene%252529thiazolidine-2%25252C4-dione%252Bas%252Ba%252Bnovel%252Bpotent%252Bprotein%252Btyrosine%252Bphosphatase%252B1B%252Binhibitor%252Bwith%252Bantidiabetic%252Bproperties%26aulast%3DJiang%26aufirst%3DBo%26date%3D2021%26volume%3D108%26spage%3D104648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Bremner</span>. </span><span class="cited-content_cbyCitation_article-title">Single Molecule Non-cleavable Multiply Active Antibacterials. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 51-119. <a href="https://doi.org/10.1007/978-981-16-0999-2_3" title="DOI URL">https://doi.org/10.1007/978-981-16-0999-2_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0999-2_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0999-2_3%26sid%3Dliteratum%253Aachs%26atitle%3DSingle%252BMolecule%252BNon-cleavable%252BMultiply%252BActive%252BAntibacterials%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26date%3D2021%26spage%3D51%26epage%3D119%26pub%3DSpringer%2520Singapore%26atitle%3DMultiple%252BAction-Based%252BDesign%252BApproaches%252Bto%252BAntibacterials%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, , <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, , <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Ligand Approach: Search for Effective Therapy Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-203. <a href="https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11" title="DOI URL">https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.36255/exonpublications.alzheimersdisease.2020.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.36255%2Fexonpublications.alzheimersdisease.2020.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DMultifunctional%252BLigand%252BApproach%25253A%252BSearch%252Bfor%252BEffective%252BTherapy%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26spage%3D181%26epage%3D203%26pub%3DExon%2520Publications%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDrug%252BDiscovery%26aulast%3DHuang%26aufirst%3DXudong%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arramshetti  Venkanna</span>, <span class="hlFld-ContribAuthor ">Lalita  Subedi</span>, <span class="hlFld-ContribAuthor ">Mahesh K.  Teli</span>, <span class="hlFld-ContribAuthor ">Prema Dhorma  Lama</span>, <span class="hlFld-ContribAuthor ">Bhargav Gupta  Nangunuri</span>, <span class="hlFld-ContribAuthor ">Sang-Yoon  Lee</span>, <span class="hlFld-ContribAuthor ">Sun Yeou  Kim</span>, <span class="hlFld-ContribAuthor ">Mi-hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Positioning of an unprecedented spiro[5.5]undeca ring system into kinase inhibitor space. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-78158-9" title="DOI URL">https://doi.org/10.1038/s41598-020-78158-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-78158-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-78158-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPositioning%252Bof%252Ban%252Bunprecedented%252Bspiro%25255B5.5%25255Dundeca%252Bring%252Bsystem%252Binto%252Bkinase%252Binhibitor%252Bspace%26aulast%3DVenkanna%26aufirst%3DArramshetti%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Pedro de S. M.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Fernanda S.  Sagrillo</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2177-2211. <a href="https://doi.org/10.1002/med.21701" title="DOI URL">https://doi.org/10.1002/med.21701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21701%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistone%252Bdeacetylases%252Bas%252Btargets%252Bfor%252Bthe%252Btreatment%252Bof%252Bneurodegenerative%252Bdisorders%25253A%252BChallenges%252Band%252Bfuture%252Bopportunities%26aulast%3DRodrigues%26aufirst%3DDaniel%2BA.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2177%26epage%3D2211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katerina  Sobolova</span>, <span class="hlFld-ContribAuthor ">Martina  Hrabinova</span>, <span class="hlFld-ContribAuthor ">Vendula  Hepnarova</span>, <span class="hlFld-ContribAuthor ">Tomas  Kucera</span>, <span class="hlFld-ContribAuthor ">Tereza  Kobrlova</span>, <span class="hlFld-ContribAuthor ">Marketa  Benkova</span>, <span class="hlFld-ContribAuthor ">Jana  Janockova</span>, <span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>, <span class="hlFld-ContribAuthor ">Lukas  Prchal</span>, <span class="hlFld-ContribAuthor ">Ondrej  Benek</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112593. <a href="https://doi.org/10.1016/j.ejmech.2020.112593" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112593%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bberberine%252Bderivatives%252Bwith%252Bbalanced%252Bcholinesterase%252Band%252Bprolyl%252Boligopeptidase%252Binhibition%252Bprofile%26aulast%3DSobolova%26aufirst%3DKaterina%26date%3D2020%26volume%3D203%26spage%3D112593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Pachón Angona</span>, <span class="hlFld-ContribAuthor ">Helene  Martin</span>, <span class="hlFld-ContribAuthor ">Solene  Daniel</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Alexandre  Bonet</span>, <span class="hlFld-ContribAuthor ">Artur  Wnorowski</span>, <span class="hlFld-ContribAuthor ">Maciej  Maj</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jozwiak</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Bernard  Refouvelet</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7652. <a href="https://doi.org/10.3390/ijms21207652" title="DOI URL">https://doi.org/10.3390/ijms21207652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207652%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%252Bof%252BHantzsch%252BAdducts%252Bas%252BCholinesterases%252Band%252BCalcium%252BFlux%252Binhibitors%25252C%252BAntioxidants%252Band%252BNeuroprotectives%26aulast%3DPach%25C3%25B3n%2BAngona%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J  Scanlon</span>, <span class="hlFld-ContribAuthor ">Stephen P  Wren</span>. </span><span class="cited-content_cbyCitation_article-title">Unearthing novel thiazolidinone building blocks as carboxylic acid bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (20)
                                     , 1855-1864. <a href="https://doi.org/10.4155/fmc-2020-0192" title="DOI URL">https://doi.org/10.4155/fmc-2020-0192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0192%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DUnearthing%252Bnovel%252Bthiazolidinone%252Bbuilding%252Bblocks%252Bas%252Bcarboxylic%252Bacid%252Bbioisosteres%26aulast%3DScanlon%26aufirst%3DJames%2BJ%26date%3D2020%26volume%3D12%26issue%3D20%26spage%3D1855%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa T.  Gabr</span>, <span class="hlFld-ContribAuthor ">Florent  Barbault</span>. </span><span class="cited-content_cbyCitation_article-title">First dual binder of microRNA-146a and monomeric tau: a novel approach for multitargeted therapeutics for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (67)
                                     , 9695-9698. <a href="https://doi.org/10.1039/D0CC04249H" title="DOI URL">https://doi.org/10.1039/D0CC04249H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC04249H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC04249H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DFirst%252Bdual%252Bbinder%252Bof%252BmicroRNA-146a%252Band%252Bmonomeric%252Btau%25253A%252Ba%252Bnovel%252Bapproach%252Bfor%252Bmultitargeted%252Btherapeutics%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DGabr%26aufirst%3DMoustafa%2BT.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D67%26spage%3D9695%26epage%3D9698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrycja  Michalska</span>, <span class="hlFld-ContribAuthor ">Paloma  Mayo</span>, <span class="hlFld-ContribAuthor ">Cristina  Fernández-Mendívil</span>, <span class="hlFld-ContribAuthor ">Giammarco  Tenti</span>, <span class="hlFld-ContribAuthor ">Pablo  Duarte</span>, <span class="hlFld-ContribAuthor ">Izaskun  Buendia</span>, <span class="hlFld-ContribAuthor ">María Teresa  Ramos</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">J. Carlos  Menéndez</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>. </span><span class="cited-content_cbyCitation_article-title">Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1,4-Dihydropyridine Derivatives for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (8)
                                     , 650. <a href="https://doi.org/10.3390/antiox9080650" title="DOI URL">https://doi.org/10.3390/antiox9080650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9080650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9080650%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DAntioxidant%25252C%252BAnti-inflammatory%252Band%252BNeuroprotective%252BProfiles%252Bof%252BNovel%252B1%25252C4-Dihydropyridine%252BDerivatives%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMichalska%26aufirst%3DPatrycja%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D8%26spage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yash Pal  Singh</span>, <span class="hlFld-ContribAuthor ">Gullanki Naga Venkata Charan  Tej</span>, <span class="hlFld-ContribAuthor ">Amruta  Pandey</span>, <span class="hlFld-ContribAuthor ">Khushbu  Priya</span>, <span class="hlFld-ContribAuthor ">Pankaj  Pandey</span>, <span class="hlFld-ContribAuthor ">Gauri  Shankar</span>, <span class="hlFld-ContribAuthor ">Prasanta Kumar  Nayak</span>, <span class="hlFld-ContribAuthor ">Geeta  Rai</span>, <span class="hlFld-ContribAuthor ">Amar G.  Chittiboyina</span>, <span class="hlFld-ContribAuthor ">Robert J.  Doerksen</span>, <span class="hlFld-ContribAuthor ">Swati  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Gyan  Modi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112257. <a href="https://doi.org/10.1016/j.ejmech.2020.112257" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112257%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bnaturally-inspired%252Bmultifunctional%252Bmolecules%252Bfor%252Bthe%252Bmanagement%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSingh%26aufirst%3DYash%2BPal%26date%3D2020%26volume%3D198%26spage%3D112257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harapriya  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Yaojun  Ju</span>, <span class="hlFld-ContribAuthor ">Wen‐Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Kin Y.  Tam</span>. </span><span class="cited-content_cbyCitation_article-title">Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2020,</strong> <em>81 </em>
                                    (2)
                                     , 242-255. <a href="https://doi.org/10.1002/ddr.21631" title="DOI URL">https://doi.org/10.1002/ddr.21631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21631%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DDual%252Btargeting%252Bof%252Bcholinesterase%252Band%252Bamyloid%252Bbeta%252Bwith%252Bpyridinium%25252Fisoquinolium%252Bderivatives%26aulast%3DChakravarty%26aufirst%3DHarapriya%26date%3D2020%26volume%3D81%26issue%3D2%26spage%3D242%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>, <span class="hlFld-ContribAuthor ">Xinfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Gaofeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yiling  Wang</span>, <span class="hlFld-ContribAuthor ">Yiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhanpin  Qiao</span>, <span class="hlFld-ContribAuthor ">Anguo  Wu</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112180. <a href="https://doi.org/10.1016/j.ejmech.2020.112180" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112180%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Badvanced%252Bstructural%252Bframework%252Bas%252Bmulti-target-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2020%26volume%3D192%26spage%3D112180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurul  Husna Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mohamad Fairuz  Yahaya</span>, <span class="hlFld-ContribAuthor ">Wael  Mohamed</span>, <span class="hlFld-ContribAuthor ">Seong Lin  Teoh</span>, <span class="hlFld-ContribAuthor ">Chua Kien  Hui</span>, <span class="hlFld-ContribAuthor ">Jaya  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00261" title="DOI URL">https://doi.org/10.3389/fphar.2020.00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00261%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPharmacotherapy%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BSeeking%252BClarity%252Bin%252Ba%252BTime%252Bof%252BUncertainty%26aulast%3DHusna%2BIbrahim%26aufirst%3DNurul%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Pachòn Angona</span>, <span class="hlFld-ContribAuthor ">Solene  Daniel</span>, <span class="hlFld-ContribAuthor ">Helene  Martin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Bonet</span>, <span class="hlFld-ContribAuthor ">Artur  Wnorowski</span>, <span class="hlFld-ContribAuthor ">Maciej  Maj</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jóźwiak</span>, <span class="hlFld-ContribAuthor ">Tiago Barros  Silva</span>, <span class="hlFld-ContribAuthor ">Bernard  Refouvelet</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1329. <a href="https://doi.org/10.3390/molecules25061329" title="DOI URL">https://doi.org/10.3390/molecules25061329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25061329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25061329%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252BAntioxidant%252Band%252BNeuroprotective%252BMultitarget%252BDirected%252BLigands%252BAble%252Bto%252BBlock%252BCalcium%252BChannels%26aulast%3DPach%25C3%25B2n%2BAngona%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipei  Sang</span>, <span class="hlFld-ContribAuthor ">Keren  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Xinfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Gaofeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Rongrui  Wei</span>, <span class="hlFld-ContribAuthor ">Qinge  Ma</span>, <span class="hlFld-ContribAuthor ">Lintao  Yu</span>, <span class="hlFld-ContribAuthor ">Yiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Wenmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111958. <a href="https://doi.org/10.1016/j.ejmech.2019.111958" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111958%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApigenin-rivastigmine%252Bhybrids%252Bas%252Bmulti-target-directed%252Bliagnds%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSang%26aufirst%3DZhipei%26date%3D2020%26volume%3D187%26spage%3D111958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayang  Xie</span>, <span class="hlFld-ContribAuthor ">Ruirui  Liang</span>, <span class="hlFld-ContribAuthor ">Yajiang  Wang</span>, <span class="hlFld-ContribAuthor ">Junyi  Huang</span>, <span class="hlFld-ContribAuthor ">Xin  Cao</span>, <span class="hlFld-ContribAuthor ">Bing  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Target Drug Molecules for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     , 4-36. <a href="https://doi.org/10.2174/1568026619666191203113745" title="DOI URL">https://doi.org/10.2174/1568026619666191203113745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191203113745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191203113745%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252BTarget%252BDrug%252BMolecules%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DXie%26aufirst%3DJiayang%26date%3D2020%26volume%3D20%26issue%3D1%26spage%3D4%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Chavarria</span>, <span class="hlFld-ContribAuthor ">Carlos  Fernandes</span>, <span class="hlFld-ContribAuthor ">Vera  Silva</span>, <span class="hlFld-ContribAuthor ">Catia  Silva</span>, <span class="hlFld-ContribAuthor ">Eva  Gil-Martins</span>, <span class="hlFld-ContribAuthor ">Pedro  Soares</span>, <span class="hlFld-ContribAuthor ">Tiago  Silva</span>, <span class="hlFld-ContribAuthor ">Renata  Silva</span>, <span class="hlFld-ContribAuthor ">Fernando  Remião</span>, <span class="hlFld-ContribAuthor ">Paulo J.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111770. <a href="https://doi.org/10.1016/j.ejmech.2019.111770" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111770%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Bnovel%252Bmonoamine%252Boxidase-B%252Binhibitors%252Bbased%252Bon%252Bpiperine%252Bscaffold%25253A%252BStructure-activity-toxicity%25252C%252Bdrug-likeness%252Band%252Befflux%252Btransport%252Bstudies%26aulast%3DChavarria%26aufirst%3DDaniel%26date%3D2020%26volume%3D185%26spage%3D111770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Daniele  Tedesco</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Lara  Davani</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced analytical methodologies in Alzheimer’s disease drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>178 </em>, 112899. <a href="https://doi.org/10.1016/j.jpba.2019.112899" title="DOI URL">https://doi.org/10.1016/j.jpba.2019.112899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2019.112899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2019.112899%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DAdvanced%252Banalytical%252Bmethodologies%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bdrug%252Bdiscovery%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2020%26volume%3D178%26spage%3D112899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh  Jadhav</span>, <span class="hlFld-ContribAuthor ">Jesus  Avila</span>, <span class="hlFld-ContribAuthor ">Michael  Schöll</span>, <span class="hlFld-ContribAuthor ">Gabor G.  Kovacs</span>, <span class="hlFld-ContribAuthor ">Enikö  Kövari</span>, <span class="hlFld-ContribAuthor ">Rostislav  Skrabana</span>, <span class="hlFld-ContribAuthor ">Lewis D  Evans</span>, <span class="hlFld-ContribAuthor ">Eva  Kontsekova</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, <span class="hlFld-ContribAuthor ">Rohan  de Silva</span>, <span class="hlFld-ContribAuthor ">Luc  Buee</span>, <span class="hlFld-ContribAuthor ">Norbert  Zilka</span>. </span><span class="cited-content_cbyCitation_article-title">A walk through tau therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2019,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-019-0664-z" title="DOI URL">https://doi.org/10.1186/s40478-019-0664-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-019-0664-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-019-0664-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DA%252Bwalk%252Bthrough%252Btau%252Btherapeutic%252Bstrategies%26aulast%3DJadhav%26aufirst%3DSantosh%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel  Morales-Navarro</span>, <span class="hlFld-ContribAuthor ">Luis  Prent-Peñaloza</span>, <span class="hlFld-ContribAuthor ">Yeray A.  Rodríguez Núñez</span>, <span class="hlFld-ContribAuthor ">Laura  Sánchez-Aros</span>, <span class="hlFld-ContribAuthor ">Oscar  Forero-Doria</span>, <span class="hlFld-ContribAuthor ">Wendy  González</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campilllo</span>, <span class="hlFld-ContribAuthor ">Miguel  Reyes-Parada</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">David  Ramírez</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2019,</strong> <em>7 </em>
                                    (12)
                                     , 940. <a href="https://doi.org/10.3390/pr7120940" title="DOI URL">https://doi.org/10.3390/pr7120940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr7120940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr7120940%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DTheoretical%252Band%252BExperimental%252BApproaches%252BAimed%252Bat%252BDrug%252BDesign%252BTargeting%252BNeurodegenerative%252BDiseases%26aulast%3DMorales-Navarro%26aufirst%3DSamuel%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D12%26spage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Andreea L.  Turcu</span>, <span class="hlFld-ContribAuthor ">Marta  Barniol-Xicota</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Deborah  Pivetta</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Francesc X.  Sureda</span>, <span class="hlFld-ContribAuthor ">Santiago  Vázquez</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>180 </em>, 613-626. <a href="https://doi.org/10.1016/j.ejmech.2019.07.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Bmultitarget%252Banti-Alzheimer%252Bbenzohomoadamantane%2525E2%252580%252592chlorotacrine%252Bhybrids%252Bmodulating%252Bcholinesterases%252Band%252Bglutamate%252BNMDA%252Breceptors%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan F.  González</span>, <span class="hlFld-ContribAuthor ">Andrés R.  Alcántara</span>, <span class="hlFld-ContribAuthor ">Antonio L.  Doadrio</span>, <span class="hlFld-ContribAuthor ">Jose María  Sánchez-Montero</span>. </span><span class="cited-content_cbyCitation_article-title">Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 879-891. <a href="https://doi.org/10.1080/17460441.2019.1623201" title="DOI URL">https://doi.org/10.1080/17460441.2019.1623201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1623201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1623201%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DDevelopments%252Bwith%252Bmulti-target%252Bdrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Ban%252Boverview%252Bof%252Bthe%252Bcurrent%252Bdiscovery%252Bapproaches%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DJuan%2BF.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D879%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan J.  Danon</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities in Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Chemistry</span><span> <strong>2019,</strong> <em>1 </em>
                                    (6)
                                     , 612-624. <a href="https://doi.org/10.1016/j.trechm.2019.04.009" title="DOI URL">https://doi.org/10.1016/j.trechm.2019.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trechm.2019.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trechm.2019.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Chemistry%26atitle%3DChallenges%252Band%252BOpportunities%252Bin%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DDanon%26aufirst%3DJonathan%2BJ.%26date%3D2019%26volume%3D1%26issue%3D6%26spage%3D612%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanxing  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Dou</span>, <span class="hlFld-ContribAuthor ">Lan  Jiang</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 221-234. <a href="https://doi.org/10.1016/j.ejmech.2019.03.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B1%252Binhibitors%25253A%252BStructure-based%252Bvirtual%252Bscreening%25252C%252Bpreliminary%252BSAR%252Band%252Bbiological%252Bevaluation%252Bfor%252Btreatment%252Bof%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DWang%26aufirst%3DYanxing%26date%3D2019%26volume%3D171%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Martinelli</span>, <span class="hlFld-ContribAuthor ">Fernanda  Lopes</span>, <span class="hlFld-ContribAuthor ">Elisa  John</span>, <span class="hlFld-ContribAuthor ">Célia  Carlini</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Ligabue-Braun</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     , 1322. <a href="https://doi.org/10.3390/ijms20061322" title="DOI URL">https://doi.org/10.3390/ijms20061322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20061322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20061322%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DModulation%252Bof%252BDisordered%252BProteins%252Bwith%252Ba%252BFocus%252Bon%252BNeurodegenerative%252BDiseases%252Band%252BOther%252BPathologies%26aulast%3DMartinelli%26aufirst%3DAnne%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Sun</span>, <span class="hlFld-ContribAuthor ">Mohammad Fawad  Ansari</span>, <span class="hlFld-ContribAuthor ">Narsaiah  Battini</span>, <span class="hlFld-ContribAuthor ">Rammohan R. Yadav  Bheemanaboina</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Novel potential artificial MRSA DNA intercalators: synthesis and biological evaluation of berberine-derived thiazolidinediones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (3)
                                     , 319-334. <a href="https://doi.org/10.1039/C8QO01180J" title="DOI URL">https://doi.org/10.1039/C8QO01180J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8QO01180J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8QO01180J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DNovel%252Bpotential%252Bartificial%252BMRSA%252BDNA%252Bintercalators%25253A%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bberberine-derived%252Bthiazolidinediones%26aulast%3DSun%26aufirst%3DHang%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D3%26spage%3D319%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic depiction of tau cascade, tau structure, and points of pharmacological intervention.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of tau-directed AD investigational drugs <b>1</b>–<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General chemical structures of TDZD, 2-iminothiazolidin-4-one, hydantoin, rhodanine, thiohydantoin, and TZD-derivatives <b>4</b>–<b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Optimized Knoevenagel Reaction for the Synthesis of TZD Derivatives <b>4</b>–<b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0017.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Procedure for the Synthesis of Aldehydes <b>14a</b> and <b>15a</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response curves of GSK-3β activity in the presence of <b>28</b> and <b>30</b>. Values are the means ± SD determined for at least two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinetic data for the TZD derivatives <b>28</b> and <b>30</b>. ATP concentration in the reaction mixture varied from 1 to 50 μM. Compounds concentrations used are depicted in the plot, and the concentration of GS-2 was kept constant at 25 μM. Each point is the mean of two different experiments, both analyzed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Neurotoxicity on primary rat cerebellar granule neurons (CGNs) after 24 h treatment. (B) Hepatotoxicity on human hepatoma cells (HepG2) after 24 h treatment. Results are expressed as percentage of controls and are the mean ± SE of at least three different experiments, each run in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Inhibition of AcPHF6 peptide (50 μM) aggregation in the presence of selected derivatives (10 μM) after 80 min incubation. The data are the mean of at least three repeats. (B) Kinetics of the AcPHF6 aggregation in the absence and in the presence of compounds <b>28</b> and <b>30</b> monitored by ThT fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. CD spectra of AcPHF6 (100 μM) in the absence (blue solid line) and in the presence of <b>28</b> (20 μM, green dashed line) or <b>30</b> (20 μM, red dotted line), measured after 2 h incubation. Solvent: phosphate buffer (50 mM pH 7.4)/water/methanol/DMSO 89:10:0.95:0.05 (v/v/v/v). Pathlength: 1 mm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. AFM micrographs of amyloid fibers obtained from the aggregation of 50 μM AcPHF6 peptide in phosphate buffer in the absence (A) and in the presence of 10 μM compound <b>28</b> (B) and compound <b>30</b> (C). The height of fibers on the mica substrate is coded according to the common included color table (ranging from 0 to 50 nm of heights) as to allow visual comparison of the different size of the adsorbed structures. Insets of B and C: the rectangular portions of B and C situated at the inset location in the micrograph (and of the size of the inset) are displayed according to the reported magnified 0–5 nm color look-up table in order to better show the smaller and thinner adsorbed structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. RT-QuIC analysis of <b>30</b> activity on tau K18 self-aggregation monitored by ThT fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. RT-QuIC analysis of <b>30</b> activity on full-length tau self-aggregation monitored by ThT fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. OA-induced neurodegeneration cell model. Effects of treatment with <b>28</b> and <b>30</b>. Results are mean value ± SEM, represented as relatives to control value (= 100), of six replicates from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Inhibitory activity profile of <b>28</b> (blue) and <b>30</b> (purple) toward human CK1δ, CK1ε, Cdc7, and GSK-3β kinases, at a fixed concentration of 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/medium/jm-2018-00610f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0015.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Thiol trapping assay. <sup>1</sup>H NMR spectrum of <b>28</b> (A) and <b>30</b> (B) in DMSO-<i>d</i><sub>6</sub> and in DMSO-<i>d</i><sub>6</sub> with cysteamine (1:2). In the squares, the olefin signal is highlighted. No reaction occurs, even after 30 min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00610/20180907/images/large/jm-2018-00610f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00610&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 99 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morstorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eb1t5cbG5cdDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uliassi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perone, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer’s disease drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.4155%2Ffmc-2017-0038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28632448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=995-1013&author=E.+Uliassiauthor=A.+Gandiniauthor=R.+C.+Peroneauthor=M.+L.+Bolognesi&title=Neuroregeneration+versus+neurodegeneration%3A+toward+a+paradigm+shift+in+Alzheimer%E2%80%99s+disease+drug+discovery&doi=10.4155%2Ffmc-2017-0038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery</span></div><div class="casAuthors">Uliassi, Elisa; Gandini, Annachiara; Perone, Rosaria Carmela; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">995-1013</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease represents an enormous global burden in terms of human suffering and economic cost.  To tackle the current lack of effective drugs and the continuous clin. trial failures might require a shift from the prevailing paradigm targeting pathogenesis to the one targeting neural stem cells (NSCs) regeneration.  In this context, small mols. have come to the forefront for their potential to manipulate NSCs, provide therapeutic tools and unveil NSCs biol.  Classically, these mols. have been generated either by target-based or phenotypic approaches.  To circumvent specific liabilities, nanomedicines emerge as a feasible alternative.  However, this review is not intended to be comprehensive.  Its purpose is to focus on recent examples that could accelerate development of neuroregenerative drugs against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6M7MV2M7NbVg90H21EOLACvtfcHk0lijRh_Mzqytfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCkt7nN&md5=bbbe7af9d8f6b0e7ad76e9c9a2561b5a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0038%26sid%3Dliteratum%253Aachs%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DPerone%26aufirst%3DR.%2BC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DNeuroregeneration%2520versus%2520neurodegeneration%253A%2520toward%2520a%2520paradigm%2520shift%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D995%26epage%3D1013%26doi%3D10.4155%2Ffmc-2017-0038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolsten, M.</span></span> <i>Learn more about our neuroscience R&D decision</i>; <span class="NLM_publisher-name">Pfizer Worldwide Research and Development</span>, January 11, <span class="NLM_year">2018</span>; <a href="https://www.pfizer.com/news/featured_stories/featured_stories_detail/learn_more_about_our_neuroscience_r_d_decision" class="extLink">https://www.pfizer.com/news/featured_stories/featured_stories_detail/learn_more_about_our_neuroscience_r_d_decision</a> (accessed July 12, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Dolsten&title=Learn+more+about+our+neuroscience+R%26D+decision"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DDolsten%26aufirst%3DM.%26jtitle%3DLearn%2520more%2520about%2520our%2520neuroscience%2520R%2526D%2520decision%26pub%3DPfizer%2520Worldwide%2520Research%2520and%2520Development%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M.
P.</span></span> <span> </span><span class="NLM_article-title">Pathways towards and away from Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">631</span>, <span class="refDoi"> DOI: 10.1038/nature02621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnature02621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=15295589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=631&author=M.%0AP.+Mattson&title=Pathways+towards+and+away+from+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature02621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways towards and away from Alzheimer's disease</span></div><div class="casAuthors">Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7000</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Slowly but surely, Alzheimer's disease (AD) patients lose their memory and their cognitive abilities, and even their personalities may change dramatically.  These changes are due to the progressive dysfunction and death of nerve cells that are responsible for the storage and processing of information.  Although drugs can temporarily improve memory, at present there are no treatments that can stop or reverse the inexorable neurodegenerative process.  But rapid progress towards understanding the cellular and mol. alterations that are responsible for the neuron's demise may soon help in developing effective preventative and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQHWKtbjr0cLVg90H21EOLACvtfcHk0lgliBMErKcjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D&md5=796c7f13ce37cf041c62266bad2f7218</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature02621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02621%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DPathways%2520towards%2520and%2520away%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D631%26doi%3D10.1038%2Fnature02621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span> <span> </span><span class="NLM_article-title">Alzheimer disease, a multifactorial disorder seeking multi-therapies</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">424</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2010.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.jalz.2010.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20813343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqtrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=420-424&author=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Alzheimer+disease%2C+a+multifactorial+disorder+seeking+multi-therapies&doi=10.1016%2Fj.jalz.2010.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease, a multifactorial disorder seeking multitherapies</span></div><div class="casAuthors">Iqbal, Khalid; Grundke-Iqbal, Inge</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">420-424</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is multifactorial and apparently involves several different etiopathogenic mechanisms.  There are at least five subgroups of AD based on cerebrospinal fluid levels of Aβ1-42, a marker of beta-amyloid (Aβ) plaques, and tau and ubiquitin, two markers of neurofibrillary tangles.  These different AD subgroups may respond differently to a given disease-modifying drug, and hence, different therapeutic drugs for different disease subgroups might be required.  Stratification of AD patients by disease subgroups in clin. trials is crit. to the successful development of potent disease-modifying drugs.  Levels of disease markers in the cerebrospinal fluid are promising, both in identifying various subgroups of AD and in monitoring the response to therapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfMb_FH8t4rVg90H21EOLACvtfcHk0lgliBMErKcjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqtrnN&md5=fe74812223b2952b3a63bc9a703a2903</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DAlzheimer%2520disease%252C%2520a%2520multifactorial%2520disorder%2520seeking%2520multi-therapies%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3D420%26epage%3D424%26doi%3D10.1016%2Fj.jalz.2010.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Human disease and drug pharmacology, complex as real life</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.2174/0929867311320130002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F0929867311320130002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=23410162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1623-1634&author=E.+Viaynaauthor=I.+Solaauthor=O.+Di+Pietroauthor=D.+Munoz-Torrero&title=Human+disease+and+drug+pharmacology%2C+complex+as+real+life&doi=10.2174%2F0929867311320130002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Human disease and drug pharmacology, complex as real life</span></div><div class="casAuthors">Viayna, E.; Sola, I.; Di Pietro, O.; Munoz-Torrero, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1623-1634</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past decades drug discovery practice has escaped from the complexity of the formerly used phenotypic screening in animals to focus on assessing drug effects on isolated protein targets in the search for drugs that exclusively and potently hit one selected target, thought to be crit. for a given disease, while not affecting at all any other target to avoid the occurrence of side-effects.  However, reality does not conform to these expectations, and, conversely, this approach has been concurrent with increased attrition figures in late-stage clin. trials, precisely due to lack of efficacy and safety.  In this context, a network biol. perspective of human disease and treatment has burst into the drug discovery scenario to bring it back to the consideration of the complexity of living organisms and particularly of the (patho)physiol. environment where protein targets are (mal)functioning and where drugs have to exert their restoring action.  Under this perspective, it has been found that usually there is not one but several disease-causing genes and, therefore, not one but several relevant protein targets to be hit, which do not work on isolation but in a highly interconnected manner, and that most known drugs are inherently promiscuous.  In this light, the rationale behind the currently prevailing single-target-based drug discovery approach might even seem a Utopia, while, conversely, the notion that the complexity of human disease must be tackled with complex polypharmacol. therapeutic interventions constitutes a difficult-to-refuse argument that is spurring the development of multitarget therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBt1iV-z6TT7Vg90H21EOLACvtfcHk0lgliBMErKcjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jtLo%253D&md5=6f57be001cdbd82e7b57d09149759022</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F0929867311320130002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320130002%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DHuman%2520disease%2520and%2520drug%2520pharmacology%252C%2520complex%2520as%2520real%2520life%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1623%26epage%3D1634%26doi%3D10.2174%2F0929867311320130002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buccafusco, J. J.</span></span> <span> </span><span class="NLM_article-title">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.tips.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=15629202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktV2m" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=27-35&author=M.+B.+Youdimauthor=J.+J.+Buccafusco&title=Multi-functional+drugs+for+various+CNS+targets+in+the+treatment+of+neurodegenerative+disorders&doi=10.1016%2Fj.tips.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span></div><div class="casAuthors">Youdim, Moussa B. H.; Buccafusco, Jerry J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-35</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Individuals with neurodegenerative diseases such as Parkinson's disease or Alzheimer's disease are benefiting from drugs developed to act on a single mol. target.  However, current pharmacol. approaches are limited in their ability to modify significantly the course of the disease, and offer incomplete and transient benefit to patients.  New therapeutic strategies comprise drug candidates designed specifically to act on multiple neural and biochem. targets for the treatment of cognition impairment, motor dysfunction, depression and neurodegeneration.  Examples include the development of single mol. entities that combine 2 or more of the following properties: (i) cholinesterase inhibition; (ii) activation or inhibition of specific subtypes of acetylcholine receptors or α-adrenoceptors; (iii) anti-inflammatory activity; (iv) monoamine oxidase inhibition; (v) catechol-O-Me transferase inhibition; (vi) nitric oxide prodn.; (vii) neuroprotection; (viii) anti-apoptotic activity; and (ix) activation of mitochondrial-dependent cell-survival genes and proteins.  These bi- or multi-functional compds. might provide greater symptomatic efficacy, and better utility as potential neuroprotective disease-modifying drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreBPSKLWPfGLVg90H21EOLACvtfcHk0lj5Kvu5xVUsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktV2m&md5=0f2bd02614627d98b7e17a7a49905d1a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DMulti-functional%2520drugs%2520for%2520various%2520CNS%2520targets%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D27%26epage%3D35%26doi%3D10.1016%2Fj.tips.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Network pharmacology: the next paradigm in drug discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1038/nchembio.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnchembio.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=18936753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=682-690&author=A.+L.+Hopkins&title=Network+pharmacology%3A+the+next+paradigm+in+drug+discovery&doi=10.1038%2Fnchembio.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology: the next paradigm in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets.  However, many effective drugs act via modulation of multiple proteins rather than single targets.  Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy.  This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity.  Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets.  However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties.  Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHy4FqkK-h7Vg90H21EOLACvtfcHk0lj5Kvu5xVUsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.118%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520pharmacology%253A%2520the%2520next%2520paradigm%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D682%26epage%3D690%26doi%3D10.1038%2Fnchembio.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lj5Kvu5xVUsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzior, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignasik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands in Alzheimer’s disease treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4949</span>– <span class="NLM_lpage">4975</span>, <span class="refDoi"> DOI: 10.2174/092986711797535245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F092986711797535245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=22050745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4949-4975&author=M.+Bajdaauthor=N.+Guziorauthor=M.+Ignasikauthor=B.+Malawska&title=Multi-target-directed+ligands+in+Alzheimer%E2%80%99s+disease+treatment&doi=10.2174%2F092986711797535245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed ligands in Alzheimer's disease treatment</span></div><div class="casAuthors">Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4949-4975</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs).  This methodol. has been specifically developed for treatment of disorders with complex pathol. mechanisms.  One such disorder is Alzheimer's disease (AD), currently the most common multifactorial neurodegenerative disease.  AD is related to increased levels of the amyloid β peptide (Aβ) and the hyperphosphorylated tau protein, along with loss of neurons and synapses.  Moreover, there is some evidence pointing to the role of oxidative stress, metal ion deregulation, inflammation and cell cycle regulatory failure in its pathogenesis.  There are many attractive targets for the development of anti-AD drugs, and the multi-factor nature of this disease calls for multi-target-directed compds. which can be beneficial for AD treatment.  This review presents the discovery of dual- and multi-acting anti-AD drug candidates, focusing on the novel design strategy and the compds. it yields - particularly hybrids obtained by linking structurally active moieties interacting with different targets.  The first group of compds. includes cholinesterase inhibitors acting as dual binding site inhibitors and/or inhibitors with addnl. properties.  These compds. are characterized by increased potency against acetylcholinesterase (AChE) and Aβ plaque formation with addnl. properties such as antioxidant activity, neuroprotective, and metal-complexing property, voltage-dependent calcium channel antagonistic activity, inhibitory activity against glutamate-induced excitotoxicity, histamine H3 receptor antagonism, cannabinoid CB1 receptor antagonism and β-secretase (BACE1) inhibition.  A novel class of compds. represents the combination of dual BACE1 inhibitors with metal chelators, and dual modulators of γ-secretase with peroxisome proliferator-activated receptor γ (PPARγ).  We have reviewed the latest reports (2008-2011) presenting new multi-target-directed compds. in Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZHSluHvxy4bVg90H21EOLACvtfcHk0liPpORQtP6iAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F&md5=c8f35f849c399d43c90570f71ca10e13</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F092986711797535245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535245%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DIgnasik%26aufirst%3DM.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DMulti-target-directed%2520ligands%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4949%26epage%3D4975%26doi%3D10.2174%2F092986711797535245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0liPpORQtP6iAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tranches
Dias, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Multi-target directed drugs: a modern approach for design of new drugs for the treatment of Alzheimer’s disease</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2174/1570159X1203140511153200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F1570159X1203140511153200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=24851088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Whtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=239-255&author=K.+S.+Tranches%0ADiasauthor=C.+Viegas&title=Multi-target+directed+drugs%3A+a+modern+approach+for+design+of+new+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1570159X1203140511153200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimerμs Disease</span></div><div class="casAuthors">Tranches Dias, Kris Simone; Viegas, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-255</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multi-faceted pathogenesis.  So far, the therapeutic paradigm "one-compd.-one-target" has failed and despite enormous efforts to elucidate the pathophysiol. of AD, the disease is still incurable. ; The multiple factors involved in AD include amyloid aggregation to form insol. neurotoxic plaques of A, hyperphosphorylation of tau protein, oxidative stress, calcium imbalance, mitochondrial dysfunction and deterioration of synaptic transmission.  These factors together, accentuate changes in the CNS homeostasis, starting a complex process of interconnected physiol. damage, leading to cognitive and memory impairment and neuronal death. ; A recent approach for the rational design of new drug candidates, also called multitarget-directed ligand (MTDL) approach, has gained increasing attention by many research groups, which have developed a variety of hybrid compds. acting simultaneously on diverse biol. targets.  This review aims to show some recent advances and examples of the exploitation of MTDL approach in the rational design of novel drug candidate prototypes for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm9_SZfQyuGLVg90H21EOLACvtfcHk0liPpORQtP6iAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Whtrc%253D&md5=98863e70218492e508d306284e93da4c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1570159X1203140511153200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X1203140511153200%26sid%3Dliteratum%253Aachs%26aulast%3DTranches%2BDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMulti-target%2520directed%2520drugs%253A%2520a%2520modern%2520approach%2520for%2520design%2520of%2520new%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2014%26volume%3D12%26spage%3D239%26epage%3D255%26doi%3D10.2174%2F1570159X1203140511153200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer’s disease</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">466</span>, <span class="refDoi"> DOI: 10.3390/molecules21040466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.3390%2Fmolecules21040466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=27070562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=466&author=F.+Pratiauthor=A.+Cavalliauthor=M.+L.+Bolognesi&title=Navigating+the+chemical+space+of+multitarget-directed+ligands%3A+from+hybrids+to+fragments+in+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules21040466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease</span></div><div class="casAuthors">Prati, Federica; Cavalli, Andrea; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466/1-466/12</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Multitarget drug discovery is one of the hottest topics and most active fields in the search for new mols. against Alzheimer's disease (AD).  Over the last 20 years, many promising multitarget-directed ligands (MTDLs) have been identified and developed at a pre-clin. level.  However, how to design them in a rational way remains the most fundamental challenge of medicinal chemists.  This is related to the foundational question of achieving an optimized activity towards multiple targets of interest, while preserving drug-like properties.  In this respect, large hybrid mols. and small fragments are poles apart.  In this review article, our aim is to appraise what we have accomplished in the development of both hybrid- and fragment-like mols. directed to diverse AD targets (i.e., acetylcholinesterase, NMDA receptors, metal chelation, BACE-1 and GSK-3β).  In addn., we attempt to highlight what are the persistent needs that deserve to be improved and cared for, with the ultimate goal of moving an MTDL to AD clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAXsoof4raqbVg90H21EOLACvtfcHk0liPpORQtP6iAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWktLjI&md5=3653a0ef6b41711663e8d2f2d4ae74f6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21040466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21040466%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DNavigating%2520the%2520chemical%2520space%2520of%2520multitarget-directed%2520ligands%253A%2520from%2520hybrids%2520to%2520fragments%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D466%26doi%3D10.3390%2Fmolecules21040466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lhfV3BZTQWUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, M. S.</span></span> <span> </span><span class="NLM_article-title">Introduction to special issue on Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8977</span>– <span class="NLM_lpage">8978</span>, <span class="refDoi"> DOI: 10.1021/jm301426y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301426y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKmtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8977-8978&author=M.+S.+Wolfe&title=Introduction+to+special+issue+on+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301426y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction to Special Issue on Alzheimer's Disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8977-8978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtrVvr47zTWrVg90H21EOLACvtfcHk0lhfV3BZTQWUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKmtbjN&md5=d89975521800c43d5621f0a69690845b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301426y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301426y%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3DIntroduction%2520to%2520special%2520issue%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8977%26epage%3D8978%26doi%3D10.1021%2Fjm301426y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0lhfV3BZTQWUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">637</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=619-637&author=F.+Pratiauthor=G.+Bottegoniauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=BACE-1+inhibitors%3A+from+recent+single-target+molecules+to+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Prati, Federica; Bottegoni, Giovanni; Bolognesi, Maria Laura; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer's disease (AD), leading to many small-mol. and biol. drug candidates.  One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors.  The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment.  It also suggests new possibilities for discovering BACE-1-targeted compds. with more complex mechanisms of actions and improved efficacy.  Herein, the authors review the major advances in BACE-1 drug discovery, from single-target small mol. inhibitors to multitarget compds.  The authors discuss these compds. as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqIKti01PzWrVg90H21EOLACvtfcHk0liC_Fyf5NWd1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eks7nO&md5=a30fe7a54f34206355c6380eb9eacbe4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DBACE-1%2520inhibitors%253A%2520from%2520recent%2520single-target%2520molecules%2520to%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D619%26epage%3D637%26doi%3D10.1021%2Facs.jmedchem.7b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, A.</span></span> <span> </span><span class="NLM_article-title">Neuroscience: the plaque plan</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>456</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1038/456161a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2F456161a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=19005527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=456&publication_year=2008&pages=161-164&author=A.+Abbott&title=Neuroscience%3A+the+plaque+plan&doi=10.1038%2F456161a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroscience: The plaque plan</span></div><div class="casAuthors">Abbott, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">456</span>
        (<span class="NLM_cas:issue">7219</span>),
    <span class="NLM_cas:pages">161-164</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroscientists are pretty sure they know what causes Alzheimer's disease, but their theory has not yet given rise to effective drugs.  Alison Abbott asks what's wrong.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBBdgBQowASrVg90H21EOLACvtfcHk0liC_Fyf5NWd1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlKmtLzL&md5=58988985203c90e130a2b6f451e0a165</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F456161a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F456161a%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DA.%26atitle%3DNeuroscience%253A%2520the%2520plaque%2520plan%26jtitle%3DNature%26date%3D2008%26volume%3D456%26spage%3D161%26epage%3D164%26doi%3D10.1038%2F456161a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, D. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">γ-secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1021/jm101168r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.+C.+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs&doi=10.1021%2Fjm101168r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer's Drugs</span></div><div class="casAuthors">Oehlrich, Daniel; Berthelot, Didier J.-C.; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvn89jnxR8U7Vg90H21EOLACvtfcHk0liC_Fyf5NWd1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCltbfO&md5=91dfeb6984c718e941635e7b3f60f59f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2BC.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698%26doi%3D10.1021%2Fjm101168r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrup, K.</span></span> <span> </span><span class="NLM_article-title">The case for rejecting the amyloid cascade hypothesis</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">794</span>– <span class="NLM_lpage">799</span>, <span class="refDoi"> DOI: 10.1038/nn.4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnn.4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=26007212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=794-799&author=K.+Herrup&title=The+case+for+rejecting+the+amyloid+cascade+hypothesis&doi=10.1038%2Fnn.4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The case for rejecting the amyloid cascade hypothesis</span></div><div class="casAuthors">Herrup, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">794-799</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a biol. complex neurodegenerative dementia.  Nearly 20 years ago, with the combination of observations from biochem., neuropathol. and genetics, a compelling hypothesis known as the amyloid cascade hypothesis was formulated.  The core of this hypothesis is that it is pathol. accumulations of amyloid-β, a peptide fragment of a membrane protein called amyloid precursor protein, that act as the root cause of AD and initiate its pathogenesis.  Yet, with the passage of time, growing amts. of data have accumulated that are inconsistent with the basically linear structure of this hypothesis.  And while there is fear in the field over the consequences of rejecting it outright, clinging to an inaccurate disease model is the option we should fear most.  This Perspective explores the proposition that we are over-reliant on amyloid to define and diagnose AD and that the time has come to face our fears and reject the amyloid cascade hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIDjilDJZlrVg90H21EOLACvtfcHk0liC_Fyf5NWd1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN&md5=e7513943fd2fa3fe7c6d9e1cb3f859b2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnn.4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4017%26sid%3Dliteratum%253Aachs%26aulast%3DHerrup%26aufirst%3DK.%26atitle%3DThe%2520case%2520for%2520rejecting%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D794%26epage%3D799%26doi%3D10.1038%2Fnn.4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkes, N.</span></span> <span> </span><span class="NLM_article-title">Merck ends trial of potential Alzheimer’s drug verubecestat</span>. <i>BMJ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">j845</span>, <span class="refDoi"> DOI: 10.1136/bmj.j845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1136%2Fbmj.j845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28202490" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2017&pages=j845&author=N.+Hawkes&title=Merck+ends+trial+of+potential+Alzheimer%E2%80%99s+drug+verubecestat&doi=10.1136%2Fbmj.j845"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fbmj.j845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.j845%26sid%3Dliteratum%253Aachs%26aulast%3DHawkes%26aufirst%3DN.%26atitle%3DMerck%2520ends%2520trial%2520of%2520potential%2520Alzheimer%25E2%2580%2599s%2520drug%2520verubecestat%26jtitle%3DBMJ.%26date%3D2017%26volume%3D356%26spage%3Dj845%26doi%3D10.1136%2Fbmj.j845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Castillo-Frias, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthoumieu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasica-Labouze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterpone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derreumaux, P.</span></span> <span> </span><span class="NLM_article-title">Why is research on amyloid-beta failing to give new drugs for Alzheimer’s disease?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1437</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1435-1437&author=A.+J.+Doigauthor=M.+P.+Del+Castillo-Friasauthor=O.+Berthoumieuauthor=B.+Tarusauthor=J.+Nasica-Labouzeauthor=F.+Sterponeauthor=P.+H.+Nguyenauthor=N.+M.+Hooperauthor=P.+Fallerauthor=P.+Derreumaux&title=Why+is+research+on+amyloid-beta+failing+to+give+new+drugs+for+Alzheimer%E2%80%99s+disease%3F&doi=10.1021%2Facschemneuro.7b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?</span></div><div class="casAuthors">Doig, Andrew J.; del Castillo-Frias, Maria P.; Berthoumieu, Olivia; Tarus, Bogdan; Nasica-Labouze, Jessica; Sterpone, Fabio; Nguyen, Phuong H.; Hooper, Nigel M.; Faller, Peter; Derreumaux, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1435-1437</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The two hallmarks of Alzheimer's disease (AD) are the presence of neurofibrillary tangles (NFT) made of aggregates of the hyperphosphorylated tau protein and of amyloid plaques composed of amyloid-β (Aβ) peptides, primarily Aβ1-40 and Aβ1-42.  Targeting the prodn., aggregation, and toxicity of Aβ with small mol. drugs or antibodies is an active area of AD research due to the general acceptance of the amyloid cascade hypothesis, but thus far all drugs targeting Aβ have failed.  From a review of the recent literature and our own experience based on in vitro, in silico, and in vivo studies, we present some reasons to explain this repetitive failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrimFSfyVV9VrVg90H21EOLACvtfcHk0lh4WE3WYIQrYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1CmsLo%253D&md5=26bc5126993b4d8df4eaf9ddf81e981a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00188%26sid%3Dliteratum%253Aachs%26aulast%3DDoig%26aufirst%3DA.%2BJ.%26aulast%3DDel%2BCastillo-Frias%26aufirst%3DM.%2BP.%26aulast%3DBerthoumieu%26aufirst%3DO.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DNasica-Labouze%26aufirst%3DJ.%26aulast%3DSterpone%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DDerreumaux%26aufirst%3DP.%26atitle%3DWhy%2520is%2520research%2520on%2520amyloid-beta%2520failing%2520to%2520give%2520new%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1435%26epage%3D1437%26doi%3D10.1021%2Facschemneuro.7b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodero-Tavoletti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span> <span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(14)70252-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions&doi=10.1016%2FS1474-4422%2814%2970252-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2eZSaF0maGcsKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124%26doi%3D10.1016%2FS1474-4422%2814%2970252-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, J.</span></span> <span> </span><span class="NLM_article-title">Tau-based therapies in neurodegeneration: opportunities and challenges</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnrd.2017.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28983098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Sqt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=863-883&author=C.+Liauthor=J.+G%C3%B6tz&title=Tau-based+therapies+in+neurodegeneration%3A+opportunities+and+challenges&doi=10.1038%2Fnrd.2017.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-based therapies in neurodegeneration: opportunities and challenges</span></div><div class="casAuthors">Li, Chuanzhou; Gotz, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">863-883</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Aggregates of the microtubule-assocd. protein tau are a defining feature of several neurodegenerative diseases that are collectively known as tauopathies, and constitute one of the hallmark lesions of Alzheimer disease (AD).  Given the lack of efficacy to date of amyloid-β-targeted therapies for AD, interest is growing in tau as a potential alternative target.  Several drug candidates, which are now in clin. trials, aim to reduce tau levels or to prevent the aggregation or pathol. post-translation modifications of this protein.  In this Review, we discuss preclin. and clin. studies in light of an increased understanding of the physiol. and pathol. roles of tau, advances in animal models of tauopathy, the identification of novel targets and the availability of novel tracers to track tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSC7Md8i-637Vg90H21EOLACvtfcHk0lh4WE3WYIQrYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Sqt7jF&md5=389b4be6419498344b5e53ca1be9c22e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.155%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DG%25C3%25B6tz%26aufirst%3DJ.%26atitle%3DTau-based%2520therapies%2520in%2520neurodegeneration%253A%2520opportunities%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D863%26epage%3D883%26doi%3D10.1038%2Fnrd.2017.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span> <span> </span><span class="NLM_article-title">Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1038/nrn2194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnrn2194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=17684513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Crt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=663-672&author=C.+Ballatoreauthor=V.+M.+Y.+Leeauthor=J.+Q.+Trojanowski&title=Tau-mediated+neurodegeneration+in+Alzheimer%E2%80%99s+disease+and+related+disorders&doi=10.1038%2Fnrn2194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-mediated neurodegeneration in Alzheimer's disease and related disorders</span></div><div class="casAuthors">Ballatore, Carlo; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">663-672</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Advances in the understanding of the mechanisms of tau-mediated neurodegeneration in Alzheimer's disease (AD) and related tauopathies, which are characterized by prominent CNS accumulations of fibrillar tau inclusions, are rapidly moving this previously underexplored disease pathway to center stage for disease-modifying drug discovery efforts.  However, controversies abound concerning whether or not the deleterious effects of tau pathologies result from toxic gains-of-function by pathol. tau or from crit. losses of normal tau function in the disease state.  This review summarizes the most recent advances in the authors' knowledge of the mechanisms of tau-mediated neurodegeneration to forge an integrated concept of those tau-linked disease processes that drive the onset and progression of AD and related tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8-k_a3SnV7bVg90H21EOLACvtfcHk0lgzthXzdKxBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Crt78%253D&md5=eef3cc99033075b3215b739521d672f6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrn2194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2194%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTau-mediated%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2007%26volume%3D8%26spage%3D663%26epage%3D672%26doi%3D10.1038%2Fnrn2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spillantini, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span> <span> </span><span class="NLM_article-title">Tau pathology and neurodegeneration</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70090-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS1474-4422%2813%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=23684085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=609-622&author=M.+G.+Spillantiniauthor=M.+Goedert&title=Tau+pathology+and+neurodegeneration&doi=10.1016%2FS1474-4422%2813%2970090-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Tau pathology and neurodegeneration</span></div><div class="casAuthors">Spillantini, Maria Grazia; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-622</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathway leading from sol. and monomeric to hyperphosphorylated, insol. and filamentous tau protein is at the center of many human neurodegenerative diseases, collectively referred to as tauopathies.  Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia.  However, most cases of tauopathy are not inherited in a dominant manner.  The first tau aggregates form in a few nerve cells in discrete brain areas.  These become self propagating and spread to distant brain regions in a prion-like manner.  The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-Mr15hi3grVg90H21EOLACvtfcHk0lgzthXzdKxBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D&md5=532220e2bfffdb228277e80868bdde65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DTau%2520pathology%2520and%2520neurodegeneration%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D609%26epage%3D622%26doi%3D10.1016%2FS1474-4422%2813%2970090-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huryn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span> <span> </span><span class="NLM_article-title">Microtubule stabilizing agents as potential treatment for Alzheimer’s disease and related neurodegenerative tauopathies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8979</span>– <span class="NLM_lpage">8996</span>, <span class="refDoi"> DOI: 10.1021/jm301079z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301079z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8979-8996&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=D.+M.+Hurynauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Leeauthor=A.+B.+Smith&title=Microtubule+stabilizing+agents+as+potential+treatment+for+Alzheimer%E2%80%99s+disease+and+related+neurodegenerative+tauopathies&doi=10.1021%2Fjm301079z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule Stabilizing Agents as Potential Treatment for Alzheimer's Disease and Related Neurodegenerative Tauopathies</span></div><div class="casAuthors">Ballatore, Carlo; Brunden, Kurt R.; Huryn, Donna M.; Trojanowski, John Q.; Lee, Virginia M.-Y.; Smith, Amos B., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8979-8996</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The microtubule (MT) assocd. protein tau, which is highly expressed in the axons of neurons, is an endogenous MT-stabilizing agent that plays an important role in axonal transport.  Loss of MT-stabilizing tau function, caused by misfolding, hyperphosphorylation, and sequestration of tau into insol. aggregates, leads to axonal transport deficits with neuropathol. consequences.  Several in vitro and preclin. in vivo studies have shown that MT-stabilizing drugs can be utilized to compensate for the loss of tau function and to maintain/restore effective axonal transport.  These findings indicate that MT-stabilizing compds. hold considerable promise for the treatment of Alzheimer disease and related tauopathies.  The present article provides a synopsis of the key findings demonstrating the therapeutic potential of MT-stabilizing drugs in the context of neurodegenerative tauopathies, as well as an overview of the different classes of MT-stabilizing compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB8zgmxRqAj7Vg90H21EOLACvtfcHk0lgzthXzdKxBJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVagtLfE&md5=f995701a74a9d4b6d831ef208891177a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301079z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301079z%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DMicrotubule%2520stabilizing%2520agents%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520neurodegenerative%2520tauopathies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8979%26epage%3D8996%26doi%3D10.1021%2Fjm301079z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Progress and developments in tau aggregation inhibitors for Alzheimer disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4135</span>– <span class="NLM_lpage">4155</span>, <span class="refDoi"> DOI: 10.1021/jm3017317</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3017317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVCks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4135-4155&author=B.+Bulicauthor=M.+Pickhardtauthor=E.+Mandelkow&title=Progress+and+developments+in+tau+aggregation+inhibitors+for+Alzheimer+disease&doi=10.1021%2Fjm3017317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease</span></div><div class="casAuthors">Bulic, Bruno; Pickhardt, Marcus; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4135-4155</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacol. approaches directed toward Alzheimer disease are diversifying in parallel with a growing no. of promising targets.  Investigations on the microtubule-assocd. protein tau yielded innovative targets backed by recent findings about the central role of tau in numerous neurodegenerative diseases.  In this review, we summarize the recent evolution in the development of nonpeptidic small mols. tau aggregation inhibitors (TAGIs) and their advancement toward clin. trials.  The compds. are classified according to their chem. structures, providing correlative insights into their pharmacol.  Overall, shared structure-activity traits are emerging, as well as specific binding modes related to their ability to engage in hydrogen bonding.  Medicinal chem. efforts on TAGIs together with encouraging in vivo data argue for successful translation to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-MCCWng61lLVg90H21EOLACvtfcHk0lg7e12xJhdUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVCks7w%253D&md5=35aa968d078ff044e0d353fca4f13e42</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3017317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3017317%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProgress%2520and%2520developments%2520in%2520tau%2520aggregation%2520inhibitors%2520for%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4135%26epage%3D4155%26doi%3D10.1021%2Fjm3017317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1259412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1080%2F13543776.2017.1259412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=27828716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFegtbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=657-666&author=V.+Palomoauthor=A.+Martinez&title=Glycogen+synthase+kinase+3+%28GSK-3%29+inhibitors%3A+a+patent+update+%282014%E2%80%932015%29&doi=10.1080%2F13543776.2017.1259412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)</span></div><div class="casAuthors">Palomo, Valle; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-666</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Glycogen synthase kinase (GSK-3) is a serine/threonine kinase that phosphorylates more than one hundred different sequences within proteins in a variety of different pathways.  It is a key component of a remarkably large no. of cellular processes and diseases.  Imbalance of GSK-3 activity is involved in various prevalent pathol. diseases, such as diabetes, neurodegenerative diseases and cancer.  Understanding its role in different disorders has been central in the last several decades and there has been a significantly large development of GSK-3 inhibitors, some of which, show promising results for the treatment of these devastating diseases.:.  This review covers patent literature on GSK-3 inhibitors and their applications published and/or granted between 2014 and 2015.:.  GSK-3 inhibitors have gained a prominent role in regenerative medicine based in their ability to modulate stem cells.  Moreover, some allosteric modulators of GSK-3 emerge as safe compds. for chronic treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiR4jwEmZaLLVg90H21EOLACvtfcHk0lg7e12xJhdUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFegtbnP&md5=a919f64e1136af3b4901ff2929d1bf58</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1259412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1259412%26sid%3Dliteratum%253Aachs%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520%2528GSK-3%2529%2520inhibitors%253A%2520a%2520patent%2520update%2520%25282014%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D657%26epage%3D666%26doi%3D10.1080%2F13543776.2017.1259412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandosell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, F.</span></span> <span> </span><span class="NLM_article-title">Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1586/ern.10.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1586%2Fern.10.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20420491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=703-710&author=J.+Avilaauthor=F.+Wandosellauthor=F.+Hernandez&title=Role+of+glycogen+synthase+kinase-3+in+Alzheimer%E2%80%99s+disease+pathogenesis+and+glycogen+synthase+kinase-3+inhibitors&doi=10.1586%2Fern.10.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors</span></div><div class="casAuthors">Avila, Jesus; Wandosell, Francisco; Hernandez, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">703-710</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase (GSK)-3 has been proposed as the link between the two histopathol. hallmarks of Alzheimer's disease, the extracellular senile plaques composed of β-amyloid and the intracellular neurofibrillary tangles formed from hyperphosphorylated tau.  Thus, GSK-3 is one of the main tau kinases and it modifies several sites of the tau protein present in neurofibrillary tangles.  Furthermore, GSK-3 is able to modulate the generation of amyloid-β, as well as to respond to this peptide.  In several transgenic models, overexpression of GSK-3 has been assocd. with neuronal death, tau hyperphosphorylation and a decline in cognitive performance.  Lithium, a widely used drug for affective disorders, inhibits GSK-3 at therapeutically relevant concns. and it has been demonstrated that this is able to prevent tau phosphorylation.  In the present review, we summarize all these data and discuss the potential of GSK-3 inhibitors for Alzheimer's disease therapy, as well as some of their potential problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9AMLoLImff7Vg90H21EOLACvtfcHk0lg7e12xJhdUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWls7s%253D&md5=4add8e9d6a932f16b0209442033c3f61</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1586%2Fern.10.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.10.40%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DWandosell%26aufirst%3DF.%26aulast%3DHernandez%26aufirst%3DF.%26atitle%3DRole%2520of%2520glycogen%2520synthase%2520kinase-3%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathogenesis%2520and%2520glycogen%2520synthase%2520kinase-3%2520inhibitors%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2010%26volume%3D10%26spage%3D703%26epage%3D710%26doi%3D10.1586%2Fern.10.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Muela, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timchenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Subtly modulating glycogen synthase kinase 3 beta: allosteric inhibitor development and their potential for the treatment of chronic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4983</span>– <span class="NLM_lpage">5001</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00395</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00395" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4983-5001&author=V.+Palomoauthor=D.+I.+Perezauthor=C.+Rocaauthor=C.+Andersonauthor=N.+Rodriguez-Muelaauthor=C.+Perezauthor=J.+A.+Morales-Garciaauthor=J.+A.+Reyesauthor=N.+E.+Campilloauthor=A.+M.+Perez-Castilloauthor=L.+L.+Rubinauthor=L.+Timchenkoauthor=C.+Gilauthor=A.+Martinez&title=Subtly+modulating+glycogen+synthase+kinase+3+beta%3A+allosteric+inhibitor+development+and+their+potential+for+the+treatment+of+chronic+diseases&doi=10.1021%2Facs.jmedchem.7b00395"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00395%26sid%3Dliteratum%253Aachs%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DRoca%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DC.%26aulast%3DRodriguez-Muela%26aufirst%3DN.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DReyes%26aufirst%3DJ.%2BA.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DPerez-Castillo%26aufirst%3DA.%2BM.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DTimchenko%26aufirst%3DL.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DSubtly%2520modulating%2520glycogen%2520synthase%2520kinase%25203%2520beta%253A%2520allosteric%2520inhibitor%2520development%2520and%2520their%2520potential%2520for%2520the%2520treatment%2520of%2520chronic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4983%26epage%3D5001%26doi%3D10.1021%2Facs.jmedchem.7b00395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Development of tau aggregation inhibitors for Alzheimer’s disease</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1740</span>– <span class="NLM_lpage">1752</span>, <span class="refDoi"> DOI: 10.1002/anie.200802621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.200802621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlaltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1740-1752&author=B.+Bulicauthor=M.+Pickhardtauthor=B.+Schmidtauthor=E.+M.+Mandelkowauthor=H.+Waldmannauthor=E.+Mandelkow&title=Development+of+tau+aggregation+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fanie.200802621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Development of tau aggregation inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Bulic, Bruno; Pickhardt, Marcus; Schmidt, Boris; Mandelkow, Eva-Maria; Waldmann, Herbert; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1740-1752</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  A variety of human diseases are suspected to be directly linked to protein misfolding.  Highly organized protein aggregates, called amyloid fibrils, and aggregation intermediates are obsd.; these are considered to be mediators of cellular toxicity and thus attract a great deal of attention from investigators.  Neurodegenerative pathologies such as Alzheimer's disease account for a major part of these protein misfolding diseases.  The last decade has witnessed a renaissance of interest in inhibitors of tau aggregation as potential disease-modifying drugs for Alzheimer's disease and other "tautopathies".  The recent report of a phase II clin. trial with the tau aggregation inhibitor MTC could hold promise for the validation of the concept.  This review summarizes the available data concerning small-mol. inhibitors of tau aggregation from a medicinal chem. point of view.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotlDVfG5fTwrVg90H21EOLACvtfcHk0litVtxqvj61Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlaltb0%253D&md5=99fae786e20252e4139283ce4943e37c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.200802621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200802621%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DDevelopment%2520of%2520tau%2520aggregation%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D1740%26epage%3D1752%26doi%3D10.1002%2Fanie.200802621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span> </span><span class="NLM_article-title">Cognitive
and Functional Connectivity Effects of Methylene Blue in
Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
(MB2)</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2015</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT02380573" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02380573</a> (accessed July 12, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cognitive%0Aand+Functional+Connectivity+Effects+of+Methylene+Blue+in%0AHealthy+Aging%2C+Mild+Cognitive+Impairment+and+Alzheimer%27s+Disease%0A%28MB2%29.+ClinicalTrials.gov%3B+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02380573+%28accessed+July+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DCognitive%250Aand%2520Functional%2520Connectivity%2520Effects%2520of%2520Methylene%2520Blue%2520in%250AHealthy%2520Aging%252C%2520Mild%2520Cognitive%2520Impairment%2520and%2520Alzheimer%2527s%2520Disease%250A%2528MB2%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2015%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilcock, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisoni, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardlund, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moebius, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelter, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staff, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuksanovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahearn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracoud, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamsi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, J. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, C. M.</span></span> <span> </span><span class="NLM_article-title">Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer’s disease: cohort analysis as modified primary outcome in a phase III clinical trial</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.3233/JAD-170560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.3233%2FJAD-170560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=29154277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=435-457&author=G.+K.+Wilcockauthor=S.+Gauthierauthor=G.+B.+Frisoniauthor=J.+Jiaauthor=J.+H.+Hardlundauthor=H.+J.+Moebiusauthor=P.+Benthamauthor=K.+A.+Kookauthor=B.+O.+Schelterauthor=D.+J.+Wischikauthor=C.+S.+Davisauthor=R.+T.+Staffauthor=V.+Vuksanovicauthor=T.+Ahearnauthor=L.+Bracoudauthor=K.+Shamsiauthor=K.+Marekauthor=J.+Seibylauthor=G.+Riedelauthor=J.+M.+D.+Storeyauthor=C.+R.+Harringtonauthor=C.+M.+Wischik&title=Potential+of+low+dose+leuco-methylthioninium+bis%28hydromethanesulphonate%29+%28LMTM%29+monotherapy+for+treatment+of+mild+Alzheimer%E2%80%99s+disease%3A+cohort+analysis+as+modified+primary+outcome+in+a+phase+III+clinical+trial&doi=10.3233%2FJAD-170560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial</span></div><div class="casAuthors">Wilcock, Gordon K.; Gauthier, Serge; Frisoni, Giovanni B.; Jia, Jianping; Hardlund, Jiri H.; Moebius, Hans J.; Bentham, Peter; Kook, Karin A.; Schelter, Bjoern O.; Wischik, Damon J.; Davis, Charles S.; Staff, Roger T.; Vuksanovic, Vesna; Ahearn, Trevor; Bracoud, Luc; Shamsi, Kohkan; Marek, Ken; Seibyl, John; Riedel, Gernot; Storey, John M. D.; Harrington, Charles R.; Wischik, Claude M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">435-457</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: : LMTM is being developed as a treatment for AD based on inhibition of tau aggregation.  Objectives: : To examine the efficacy of LMTM as monotherapy in non-randomized cohort analyses as modified primary outcomes in an 18-mo Phase III trial in mild AD.  Methods: : Mild AD patients (n=800) were randomly assigned to 100mg twice a day or 4mg twice a day.  Prior to unblinding, the Statistical Anal. Plan was revised to compare the 100mg twice a day as monotherapy subgroup (n=79) vs. 4mg twice a day as randomized (n=396), and 4mg twice a day as monotherapy (n=76) vs. 4mg twice a day as add-on therapy (n=297), with strong control of family-wise type I error.  Results: : The revised analyses were statistically significant at the required threshold of p<0.025 in both comparisons for change in ADAS-cog, ADCS-ADL, MRI atrophy, and glucose uptake.  The brain atrophy rate was initially typical of mild AD in both add-on and monotherapy groups, but after 9 mo of treatment, the rate in monotherapy patients declined significantly to that reported for normal elderly controls.  Differences in severity or diagnosis at baseline between monotherapy and add-on patients did not account for significant differences in favor of monotherapy.  Conclusions: : The results are consistent with earlier studies in supporting the hypothesis that LMTM might be effective as monotherapy and that 4mg twice a day may serve as well as higher doses.  A further suitably randomized trial is required to test this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjEsIfpVnYOLVg90H21EOLACvtfcHk0litVtxqvj61Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbjK&md5=54d8ecadd37e7628bf0bf21d22067378</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3233%2FJAD-170560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170560%26sid%3Dliteratum%253Aachs%26aulast%3DWilcock%26aufirst%3DG.%2BK.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DFrisoni%26aufirst%3DG.%2BB.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DHardlund%26aufirst%3DJ.%2BH.%26aulast%3DMoebius%26aufirst%3DH.%2BJ.%26aulast%3DBentham%26aufirst%3DP.%26aulast%3DKook%26aufirst%3DK.%2BA.%26aulast%3DSchelter%26aufirst%3DB.%2BO.%26aulast%3DWischik%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DC.%2BS.%26aulast%3DStaff%26aufirst%3DR.%2BT.%26aulast%3DVuksanovic%26aufirst%3DV.%26aulast%3DAhearn%26aufirst%3DT.%26aulast%3DBracoud%26aufirst%3DL.%26aulast%3DShamsi%26aufirst%3DK.%26aulast%3DMarek%26aufirst%3DK.%26aulast%3DSeibyl%26aufirst%3DJ.%26aulast%3DRiedel%26aufirst%3DG.%26aulast%3DStorey%26aufirst%3DJ.%2BM.%2BD.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26aulast%3DWischik%26aufirst%3DC.%2BM.%26atitle%3DPotential%2520of%2520low%2520dose%2520leuco-methylthioninium%2520bis%2528hydromethanesulphonate%2529%2520%2528LMTM%2529%2520monotherapy%2520for%2520treatment%2520of%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520cohort%2520analysis%2520as%2520modified%2520primary%2520outcome%2520in%2520a%2520phase%2520III%2520clinical%2520trial%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D61%26spage%3D435%26epage%3D457%26doi%3D10.3233%2FJAD-170560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korcsmáros, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szalay, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovács, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csermely, P.</span></span> <span> </span><span class="NLM_article-title">How to design multi-target drugs</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.1517/17460441.2.6.799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1517%2F17460441.2.6.799" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=799-808&author=T.+Korcsm%C3%A1rosauthor=M.+S.+Szalayauthor=C.+B%C3%B6deauthor=I.+A.+Kov%C3%A1csauthor=P.+Csermely&title=How+to+design+multi-target+drugs&doi=10.1517%2F17460441.2.6.799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.6.799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.6.799%26sid%3Dliteratum%253Aachs%26aulast%3DKorcsm%25C3%25A1ros%26aufirst%3DT.%26aulast%3DSzalay%26aufirst%3DM.%2BS.%26aulast%3DB%25C3%25B6de%26aufirst%3DC.%26aulast%3DKov%25C3%25A1cs%26aufirst%3DI.%2BA.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DHow%2520to%2520design%2520multi-target%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D799%26epage%3D808%26doi%3D10.1517%2F17460441.2.6.799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisignano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massenzio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Racchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favia, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span> <span> </span><span class="NLM_article-title">Multitarget drug discovery for Alzheimer’s disease: triazinones as BACE-1 and GSK-3beta inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1578</span>– <span class="NLM_lpage">1582</span>, <span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+triazinones+as+BACE-1+and+GSK-3beta+inhibitors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520triazinones%2520as%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
los Ríos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gálvez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5129</span>– <span class="NLM_lpage">5143</span>, <span class="refDoi"> DOI: 10.1021/jm901902w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901902w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5129-5143&author=C.+de%0Alos+R%C3%ADosauthor=J.+Egeaauthor=J.+Marco-Contellesauthor=R.+Le%C3%B3nauthor=A.+Samadiauthor=I.+Iriepaauthor=I.+Moraledaauthor=E.+G%C3%A1lvezauthor=A.+G.+Garc%C3%ADaauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+Romero&title=Synthesis%2C+inhibitory+activity+of+cholinesterases%2C+and+neuroprotective+profile+of+novel+1%2C8-naphthyridine+derivatives&doi=10.1021%2Fjm901902w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives</span></div><div class="casAuthors">de los Rios, Cristobal; Egea, Javier; Marco-Contelles, Jose; Leon, Rafael; Samadi, Abdelouahid; Iriepa, Isabel; Moraleda, Ignacio; Galvez, Enrique; Garcia, Antonio G.; Lopez, Manuela G.; Villarroya, Mercedes; Romero, Alejandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5129-5143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,8-Naphthyridine derivs. related to neuroprotective compd. I (ITH4012) have been synthesized.  In general, they have shown better inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) than most related tacrine derivs.  The compds. presented an interesting neuroprotective profile in SH-SY5Y neuroblastoma cells stressed with rotenone/oligomycin A.  Moreover, compd. II also caused protection in cells stressed with okadaic acid (OA) or amyloid β 1-42 peptide (Aβ1-42).  Interestingly, compd. II prevented the OA-induced PP2A inhibition, one of the enzymes implicated in τ dephosphorylation.  This compd. also exhibited neuroprotection against neurotoxicity elicited by oxygen and glucose deprivation in hippocampal slices.  Because these stressors caused neuronal damage related to physiopathol. hallmarks found in the brain of Alzheimer's disease (AD) patients, we conclude that compd. II deserves further in vivo studies in AD models to test its therapeutic potential in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn990-FK7y87Vg90H21EOLACvtfcHk0lg1sz0f1gNAvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVKqsbg%253D&md5=92d0cf582eb9816f03c72a2f8344883f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901902w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901902w%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DE.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DRomero%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520inhibitory%2520activity%2520of%2520cholinesterases%252C%2520and%2520neuroprotective%2520profile%2520of%2520novel%25201%252C8-naphthyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5129%26epage%3D5143%26doi%3D10.1021%2Fjm901902w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorrio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lafuente, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajarin-Cuesta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Sanz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los
Rios, C.</span></span> <span> </span><span class="NLM_article-title">PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1021/cn400050p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400050p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Squr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1267-1277&author=S.+Lorrioauthor=A.+Romeroauthor=L.+Gonzalez-Lafuenteauthor=R.+Lajarin-Cuestaauthor=F.+J.+Martinez-Sanzauthor=M.+Estradaauthor=A.+Samadiauthor=J.+Marco-Contellesauthor=M.+I.+Rodriguez-Francoauthor=M.+Villarroyaauthor=M.+G.+Lopezauthor=C.+de+los%0ARios&title=PP2A+ligand+ITH12246+protects+against+memory+impairment+and+focal+cerebral+ischemia+in+mice&doi=10.1021%2Fcn400050p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">PP2A Ligand ITH12246 Protects against Memory Impairment and Focal Cerebral Ischemia in Mice</span></div><div class="casAuthors">Lorrio, Silvia; Romero, Alejandro; Gonzalez-Lafuente, Laura; Lajarin-Cuesta, Rocio; Martinez-Sanz, Francisco J.; Estrada, Martin; Samadi, Abdelouahid; Marco-Contelles, Jose; Rodriguez-Franco, Maria Isabel; Villarroya, Mercedes; Lopez, Manuela G.; de los Rios, Cristobal</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1267-1277</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ITH12246 (Et 5-amino-2-methyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate) is a 1,8-naphthyridine described to feature an interesting neuroprotective profile in in vitro models of Alzheimer's disease.  These effects were proposed to be due in part to a regulatory action on protein phosphatase 2A inhibition, as it prevented binding of its inhibitor okadaic acid.  We decided to investigate the pharmacol. properties of ITH12246, evaluating its ability to counteract the memory impairment evoked by scopolamine, a muscarinic antagonist described to promote memory loss, as well as to reduce the infarct vol. in mice suffering phototrombosis.  Prior to conducting these expts., we confirmed its in vitro neuroprotective activity against both oxidative stress and Ca2+ overload-derived excitotoxicity, using SH-SY5Y neuroblastoma cells and rat hippocampal slices.  Using a predictive model of blood-brain barrier crossing, it seems that the passage of ITH12246 is not hindered.  Its potential hepatotoxicity was obsd. only at very high concns., from 0.1 mM.  ITH12246, at the concn. of 10 mg/kg i.p., was able to improve the memory index of mice treated with scopolamine, from 0.22 to 0.35, in a similar fashion to the well-known Alzheimer's disease drug galantamine 2.5 mg/kg.  On the other hand, ITH12246, at the concn. of 2.5 mg/kg, reduced the phototrombosis-triggered infarct vol. by 67%.  In the same exptl. conditions, 15 mg/kg melatonin, used as control std., reduced the infarct vol. by 30%.  All of these findings allow us to consider ITH12246 as a new potential drug for the treatment of neurodegenerative diseases, which would act as a multifactorial neuroprotectant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9HUSlFkRvi7Vg90H21EOLACvtfcHk0lg1sz0f1gNAvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Squr8%253D&md5=9dd83a239b75a0fbae55858881126e13</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcn400050p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400050p%26sid%3Dliteratum%253Aachs%26aulast%3DLorrio%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DGonzalez-Lafuente%26aufirst%3DL.%26aulast%3DLajarin-Cuesta%26aufirst%3DR.%26aulast%3DMartinez-Sanz%26aufirst%3DF.%2BJ.%26aulast%3DEstrada%26aufirst%3DM.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26atitle%3DPP2A%2520ligand%2520ITH12246%2520protects%2520against%2520memory%2520impairment%2520and%2520focal%2520cerebral%2520ischemia%2520in%2520mice%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1267%26epage%3D1277%26doi%3D10.1021%2Fcn400050p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallverdú-Queralt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragusa, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamuela-Raventós, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Shogaol–huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5307</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2014.07.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5298-5307&author=F.+J.+P%C3%A9rez-Arealesauthor=O.+Di+Pietroauthor=A.+Espargar%C3%B3author=A.+Vallverd%C3%BA-Queraltauthor=C.+Galdeanoauthor=I.+M.+Ragusaauthor=E.+Viaynaauthor=C.+Guillouauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Sabat%C3%A9author=R.+M.+Lamuela-Ravent%C3%B3sauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Shogaol%E2%80%93huprine+hybrids%3A+dual+antioxidant+and+anticholinesterase+agents+with+%CE%B2-amyloid+and+tau+anti-aggregating+properties&doi=10.1016%2Fj.bmc.2014.07.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DVallverd%25C3%25BA-Queralt%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRagusa%26aufirst%3DI.%2BM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DGuillou%26aufirst%3DC.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLamuela-Ravent%25C3%25B3s%26aufirst%3DR.%2BM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DShogaol%25E2%2580%2593huprine%2520hybrids%253A%2520dual%2520antioxidant%2520and%2520anticholinesterase%2520agents%2520with%2520%25CE%25B2-amyloid%2520and%2520tau%2520anti-aggregating%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5298%26epage%3D5307%26doi%3D10.1016%2Fj.bmc.2014.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralinaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">First selective dual inhibitors of tau phosphorylation and beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1198</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1021/cn5001815</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn5001815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyrsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1198-1202&author=M.+Marianoauthor=C.+Schmittauthor=P.+Miralinaghiauthor=M.+Cattoauthor=R.+W.+Hartmannauthor=A.+Carottiauthor=M.+Engel&title=First+selective+dual+inhibitors+of+tau+phosphorylation+and+beta-amyloid+aggregation%2C+two+major+pathogenic+mechanisms+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn5001815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">First Selective Dual Inhibitors of Tau Phosphorylation and Beta-Amyloid Aggregation, Two Major Pathogenic Mechanisms in Alzheimer's Disease</span></div><div class="casAuthors">Mariano, Marica; Schmitt, Christian; Miralinaghi, Parisa; Catto, Marco; Hartmann, Rolf W.; Carotti, Angelo; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1198-1202</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), multiple factors account for the accumulation of neurocellular changes, which may begin several years before symptoms appear.  The most important pathogenic brain changes that are contributing to the development of AD are the formation of the cytotoxic β-amyloid aggregates and of the neurofibrillary tangles, which originate from amyloid-β peptides and hyperphosphorylated tau protein, resp.  New therapeutic agents that target both major pathogenic mechanisms may be particularly efficient.  In this study, the authors introduce bis(hydroxyphenyl)-substituted thiophenes I [R1 = 3-Me, 3-MeO, 3-Me-4-MeO, 3-Et-4-MeO; R2 = 3-MeO, 4-MeO, 3-Me-4-MeO, 3-Et-4-MeO] as a novel class of selective, dual inhibitors of the tau kinase Dyrk1A and of the amyloid-β aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNgPu3VSQ64rVg90H21EOLACvtfcHk0lhfv0FgeqHhow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyrsL3K&md5=31754e003032609beeb9568418bc30d7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fcn5001815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn5001815%26sid%3Dliteratum%253Aachs%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DMiralinaghi%26aufirst%3DP.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DFirst%2520selective%2520dual%2520inhibitors%2520of%2520tau%2520phosphorylation%2520and%2520beta-amyloid%2520aggregation%252C%2520two%2520major%2520pathogenic%2520mechanisms%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D1198%26epage%3D1202%26doi%3D10.1021%2Fcn5001815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejmech.2014.07.095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=228-234&author=S.+Fuseauthor=K.+Matsumuraauthor=Y.+Fujitaauthor=H.+Sugimotoauthor=T.+Takahashi&title=Development+of+dual+targeting+inhibitors+against+aggregations+of+amyloid-%CE%B2+and+tau+protein&doi=10.1016%2Fj.ejmech.2014.07.095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.095%26sid%3Dliteratum%253Aachs%26aulast%3DFuse%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520dual%2520targeting%2520inhibitors%2520against%2520aggregations%2520of%2520amyloid-%25CE%25B2%2520and%2520tau%2520protein%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D228%26epage%3D234%26doi%3D10.1016%2Fj.ejmech.2014.07.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hijikuro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teruya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5024</span>– <span class="NLM_lpage">5028</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmcl.2016.08.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5024-5028&author=M.+Okudaauthor=I.+Hijikuroauthor=Y.+Fujitaauthor=T.+Teruyaauthor=H.+Kawakamiauthor=T.+Takahashiauthor=H.+Sugimoto&title=Design+and+synthesis+of+curcumin+derivatives+as+tau+and+amyloid+%CE%B2+dual+aggregation+inhibitors&doi=10.1016%2Fj.bmcl.2016.08.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.092%26sid%3Dliteratum%253Aachs%26aulast%3DOkuda%26aufirst%3DM.%26aulast%3DHijikuro%26aufirst%3DI.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DTeruya%26aufirst%3DT.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520curcumin%2520derivatives%2520as%2520tau%2520and%2520amyloid%2520%25CE%25B2%2520dual%2520aggregation%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5024%26epage%3D5028%26doi%3D10.1016%2Fj.bmcl.2016.08.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lajarín-Cuesta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanclares, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arranz-Tagarro, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Lafuente, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arribas, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo de Brito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandía, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Ríos, C.</span></span> <span> </span><span class="NLM_article-title">Gramine derivatives targeting Ca2+ channels and Ser/Thr phosphatases: a new dual strategy for the treatment of neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6265</span>– <span class="NLM_lpage">6280</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6265-6280&author=R.+Lajar%C3%ADn-Cuestaauthor=C.+Nanclaresauthor=J.-A.+Arranz-Tagarroauthor=L.+Gonz%C3%A1lez-Lafuenteauthor=R.+L.+Arribasauthor=M.+Araujo+de+Britoauthor=L.+Gand%C3%ADaauthor=C.+de+los+R%C3%ADos&title=Gramine+derivatives+targeting+Ca2%2B+channels+and+Ser%2FThr+phosphatases%3A+a+new+dual+strategy+for+the+treatment+of+neurodegenerative+diseases&doi=10.1021%2Facs.jmedchem.6b00478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00478%26sid%3Dliteratum%253Aachs%26aulast%3DLajar%25C3%25ADn-Cuesta%26aufirst%3DR.%26aulast%3DNanclares%26aufirst%3DC.%26aulast%3DArranz-Tagarro%26aufirst%3DJ.-A.%26aulast%3DGonz%25C3%25A1lez-Lafuente%26aufirst%3DL.%26aulast%3DArribas%26aufirst%3DR.%2BL.%26aulast%3DAraujo%2Bde%2BBrito%26aufirst%3DM.%26aulast%3DGand%25C3%25ADa%26aufirst%3DL.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26atitle%3DGramine%2520derivatives%2520targeting%2520Ca2%252B%2520channels%2520and%2520Ser%252FThr%2520phosphatases%253A%2520a%2520new%2520dual%2520strategy%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6265%26epage%3D6280%26doi%3D10.1021%2Facs.jmedchem.6b00478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Martino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisignano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belluti, F.</span></span> <span> </span><span class="NLM_article-title">Versatility of the curcumin scaffold: discovery of potent and balanced dual BACE-1 and GSK-3beta inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=531-544&author=R.+M.+Di%0AMartinoauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=P.+Bisignanoauthor=A.+Bisiauthor=S.+Gobbiauthor=A.+Rampaauthor=R.+Fatoauthor=C.+Bergaminiauthor=D.+I.+Perezauthor=A.+Martinezauthor=G.+Bottegoniauthor=A.+Cavalliauthor=F.+Belluti&title=Versatility+of+the+curcumin+scaffold%3A+discovery+of+potent+and+balanced+dual+BACE-1+and+GSK-3beta+inhibitors&doi=10.1021%2Facs.jmedchem.5b00894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors</span></div><div class="casAuthors">Di Martino, Rita Maria Concetta; De Simone, Angela; Andrisano, Vincenza; Bisignano, Paola; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Fato, Romana; Bergamini, Christian; Perez, Daniel I.; Martinez, Ana; Bottegoni, Giovanni; Cavalli, Andrea; Belluti, Federica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">531-544</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach has gained increasing acceptance as a useful tool to address complex and multifactorial maladies such as Alzheimer's disease (AD).  The concurrent inhibition of the validated AD targets β-secretase (BACE-1) and glycogen synthase kinase-3β (GSK-3β) by attacking both β-amyloid and tau protein cascades has been identified as a promising AD therapeutic strategy.  In our study, curcumin was identified as a lead compd. for the simultaneous inhibition of both targets; therefore, synthetic efforts were dedicated to obtaining a small library of novel curcumin-based analogs, and a no. of potent and balanced dual-target inhibitors were obtained.  In particular, 2, 6, and 7 emerged as promising drug candidates endowed with neuroprotective potential and brain permeability.  Notably, for some new compds. the sym. diketo and the β-keto-enol tautomeric forms were purposely isolated and tested in vitro, allowing us to gain insight into the key requirements for BACE-1 and GSK-3β inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw1HaZGRzvJbVg90H21EOLACvtfcHk0lgKsEb02ghpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ&md5=349916a940c9cc8d87ca817c689756f1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00894%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMartino%26aufirst%3DR.%2BM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26atitle%3DVersatility%2520of%2520the%2520curcumin%2520scaffold%253A%2520discovery%2520of%2520potent%2520and%2520balanced%2520dual%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D531%26epage%3D544%26doi%3D10.1021%2Facs.jmedchem.5b00894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornec, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalevich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayendran, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukoloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunden, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballatore, C.</span></span> <span> </span><span class="NLM_article-title">Multitargeted imidazoles: potential therapeutic leads for Alzheimer’s and other neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5120</span>– <span class="NLM_lpage">5145</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00475</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00475" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFOks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5120-5145&author=A.+S.+Cornecauthor=L.+Montiauthor=J.+Kovalevichauthor=V.+Makaniauthor=M.+J.+Jamesauthor=K.+G.+Vijayendranauthor=K.+Oukoloffauthor=Y.+Yaoauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=A.+B.+Smithauthor=K.+R.+Brundenauthor=C.+Ballatore&title=Multitargeted+imidazoles%3A+potential+therapeutic+leads+for+Alzheimer%E2%80%99s+and+other+neurodegenerative+diseases&doi=10.1021%2Facs.jmedchem.7b00475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases</span></div><div class="casAuthors">Cornec, Anne-Sophie; Monti, Ludovica; Kovalevich, Jane; Makani, Vishruti; James, Michael J.; Vijayendran, Krishna G.; Oukoloff, Killian; Yao, Yuemang; Lee, Virginia M.-Y.; Trojanowski, John Q.; Smith, Amos B.; Brunden, Kurt R.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5120-5145</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a complex, multifactorial disease in which different neuropathol. mechanisms are likely involved, including those assocd. with pathol. tau and Aβ species, as well as neuroinflammation.  In this context, the development of single multi-targeted therapeutics directed against two or more disease mechanisms could be advantageous.  Starting from a series of 1,5-diarylimidazoles with microtubule (MT)-stabilizing activity and structural similarities with known NSAIDs, the authors conducted structure-activity relationship studies that led to the identification of multi-targeted prototypes with activities as MT-stabilizing agents and/or inhibitors of the cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) pathways.  Several examples are brain-penetrant and exhibit balanced multi-targeted in vitro activity in the low μM range.  As brain-penetrant MT-stabilizing agents have proven effective against tau-mediated neurodegeneration in animal models, and because COX- and 5-LOX-derived eicosanoids are thought to contribute to Aβ plaque deposition, these 1,5-diarylimidazoles provide tools to explore novel multi-targeted strategies for AD and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnld-8Gn6PrVg90H21EOLACvtfcHk0lgKsEb02ghpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFOks7w%253D&md5=f0e874f8f6c63d3aa9ff70ca479e09b2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00475%26sid%3Dliteratum%253Aachs%26aulast%3DCornec%26aufirst%3DA.%2BS.%26aulast%3DMonti%26aufirst%3DL.%26aulast%3DKovalevich%26aufirst%3DJ.%26aulast%3DMakani%26aufirst%3DV.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DOukoloff%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DMultitargeted%2520imidazoles%253A%2520potential%2520therapeutic%2520leads%2520for%2520Alzheimer%25E2%2580%2599s%2520and%2520other%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5120%26epage%3D5145%26doi%3D10.1021%2Facs.jmedchem.7b00475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieckowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasieka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pislar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer’s agents</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1094</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00461</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00461" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2nur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1074-1094&author=D.+Panekauthor=A.+Wieckowskaauthor=J.+Jonczykauthor=J.+Godynauthor=M.+Bajdaauthor=T.+Wichurauthor=A.+Pasiekaauthor=D.+Knezauthor=A.+Pislarauthor=J.+Korabecnyauthor=O.+Soukupauthor=V.+Sepsovaauthor=R.+Sabateauthor=J.+Kosauthor=S.+Gobecauthor=B.+Malawska&title=Design%2C+synthesis%2C+and+biological+evaluation+of+1-benzylamino-2-hydroxyalkyl+derivatives+as+new+potential+disease-modifying+multifunctional+anti-Alzheimer%E2%80%99s+agents&doi=10.1021%2Facschemneuro.7b00461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents</span></div><div class="casAuthors">Panek, Dawid; Wieckowska, Anna; Jonczyk, Jakub; Godyn, Justyna; Bajda, Marek; Wichur, Tomasz; Pasieka, Anna; Knez, Damijan; Pislar, Anja; Korabecny, Jan; Soukup, Ondrej; Sepsova, Vendula; Sabate, Raimon; Kos, Janko; Gobec, Stanislav; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1074-1094</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach is a promising paradigm in drug discovery, potentially leading to new treatment options for complex disorders, such as Alzheimer's disease.  Herein, we present the discovery of a unique series of 1-benzylamino-2-hydroxyalkyl derivs. combining inhibitory activity against butyrylcholinesterase, β-secretase, β-amyloid, and tau protein aggregation, all related to mechanisms which underpin Alzheimer's disease.  Notably, diphenylpropylamine deriv. 10 showed balanced activity against both disease-modifying targets, inhibition of β-secretase (IC50 hBACE-1 = 41.60 μM), inhibition of amyloid β aggregation (IC50 Aβ = 3.09 μM), inhibition of tau aggregation (55% at 10 μM); as well as against symptomatic targets, butyrylcholinesterase inhibition (IC50 hBuChE = 7.22 μM).  It might represent an encouraging starting point for development of multifunctional disease-modifying anti-Alzheimer's agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6nGriFfBF7Vg90H21EOLACvtfcHk0lhf8l9woB5v6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2nur4%253D&md5=766d57590941aa6de4008e7430bae815</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00461%26sid%3Dliteratum%253Aachs%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DJonczyk%26aufirst%3DJ.%26aulast%3DGodyn%26aufirst%3DJ.%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DWichur%26aufirst%3DT.%26aulast%3DPasieka%26aufirst%3DA.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DPislar%26aufirst%3DA.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25201-benzylamino-2-hydroxyalkyl%2520derivatives%2520as%2520new%2520potential%2520disease-modifying%2520multifunctional%2520anti-Alzheimer%25E2%2580%2599s%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D1074%26epage%3D1094%26doi%3D10.1021%2Facschemneuro.7b00461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duran-Frigola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siragusa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruppin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aloy, P.</span></span> <span> </span><span class="NLM_article-title">Detecting similar binding pockets to enable systems polypharmacology</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e1005522</span>, <span class="refDoi"> DOI: 10.1371/journal.pcbi.1005522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1371%2Fjournal.pcbi.1005522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28662117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1agurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=e1005522&author=M.+Duran-Frigolaauthor=L.+Siragusaauthor=E.+Ruppinauthor=X.+Barrilauthor=G.+Crucianiauthor=P.+Aloy&title=Detecting+similar+binding+pockets+to+enable+systems+polypharmacology&doi=10.1371%2Fjournal.pcbi.1005522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Detecting similar binding pockets to enable systems polypharmacology</span></div><div class="casAuthors">Duran-Frigola, Miquel; Siragusa, Lydia; Ruppin, Eytan; Barril, Xavier; Cruciani, Gabriele; Aloy, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1005522/1-e1005522/18</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In the era of systems biol., multi-target pharmacol. strategies hold promise for tackling disease-related networks.  In this regard, drug promiscuity may be leveraged to interfere with multiple receptors: the so-called polypharmacol. of drugs can be anticipated by analyzing the similarity of binding sites across the proteome.  Here, we perform a pairwise comparison of 90,000 putative binding pockets detected in 3,700 proteins, and find that 23,000 pairs of proteins have at least one similar cavity that could, in principle, accommodate similar ligands.  By inspecting these pairs, we demonstrate how the detection of similar binding sites expands the space of opportunities for the rational design of drug polypharmacol.  Finally, we illustrate how to leverage these opportunities in protein-protein interaction networks related to several therapeutic classes and tumor types, and in a genome-scale metabolic model of leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrncR4y_CryxbVg90H21EOLACvtfcHk0lhf8l9woB5v6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1agurnE&md5=568e97aa21976360c76610cdfd4dbfd7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1005522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1005522%26sid%3Dliteratum%253Aachs%26aulast%3DDuran-Frigola%26aufirst%3DM.%26aulast%3DSiragusa%26aufirst%3DL.%26aulast%3DRuppin%26aufirst%3DE.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DAloy%26aufirst%3DP.%26atitle%3DDetecting%2520similar%2520binding%2520pockets%2520to%2520enable%2520systems%2520polypharmacology%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3De1005522%26doi%3D10.1371%2Fjournal.pcbi.1005522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanfar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaddoumi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Sayed, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel GSK-3beta inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8534</span>– <span class="NLM_lpage">8545</span>, <span class="refDoi"> DOI: 10.1021/jm100941j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100941j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8534-8545&author=M.+A.+Khanfarauthor=R.+A.+Hillauthor=A.+Kaddoumiauthor=K.+A.+El+Sayed&title=Discovery+of+novel+GSK-3beta+inhibitors+with+potent+in+vitro+and+in+vivo+activities+and+excellent+brain+permeability+using+combined+ligand-+and+structure-based+virtual+screening&doi=10.1021%2Fjm100941j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm100941j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100941j%26sid%3Dliteratum%253Aachs%26aulast%3DKhanfar%26aufirst%3DM.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BA.%26aulast%3DKaddoumi%26aufirst%3DA.%26aulast%3DEl%2BSayed%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520novel%2520GSK-3beta%2520inhibitors%2520with%2520potent%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%2520and%2520excellent%2520brain%2520permeability%2520using%2520combined%2520ligand-%2520and%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8534%26epage%3D8545%26doi%3D10.1021%2Fjm100941j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arfeen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborti, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharatam, P. V.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3beta inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejmech.2016.04.075" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=727-736&author=M.+Arfeenauthor=S.+Bhagatauthor=R.+Patelauthor=S.+Prasadauthor=I.+Royauthor=A.+K.+Chakrabortiauthor=P.+V.+Bharatam&title=Design%2C+synthesis+and+biological+evaluation+of+5-benzylidene-2-iminothiazolidin-4-ones+as+selective+GSK-3beta+inhibitors&doi=10.1016%2Fj.ejmech.2016.04.075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.075%26sid%3Dliteratum%253Aachs%26aulast%3DArfeen%26aufirst%3DM.%26aulast%3DBhagat%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DI.%26aulast%3DChakraborti%26aufirst%3DA.%2BK.%26aulast%3DBharatam%26aufirst%3DP.%2BV.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25205-benzylidene-2-iminothiazolidin-4-ones%2520as%2520selective%2520GSK-3beta%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D727%26epage%3D736%26doi%3D10.1016%2Fj.ejmech.2016.04.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, F. J.</span></span> <span> </span><span class="NLM_article-title">First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1292</span>– <span class="NLM_lpage">1299</span>, <span class="refDoi"> DOI: 10.1021/jm011020u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011020u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFCgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1292-1299&author=A.+Martinezauthor=M.+Alonsoauthor=A.+Castroauthor=C.+Perezauthor=F.+J.+Moreno&title=First+non-ATP+competitive+glycogen+synthase+kinase+3+beta+%28GSK-3beta%29+inhibitors%3A+thiadiazolidinones+%28TDZD%29+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm011020u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">First Non-ATP Competitive Glycogen Synthase Kinase 3β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Martinez, Ana; Alonso, Mercedes; Castro, Ana; Perez, Concepcion; Moreno, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1292-1299</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3β (GSK-3β) has a central role in Alzheimer's disease (AD).  Selective inhibitors which avoid τ hyperphosphorylation may represent an effective therapeutic approach to the pharmacotherapy of AD and other neurodegenerative disorders.  The synthesis, biol. evaluation, and SAR of some thiadiazolidinones (TDZD) as the first non-ATP competitive inhibitor of GSK-3β.  Their synthesis is based on the reactivity of sulfenyl chlorides.  In GSK-3β assays, TDZD derivs. showed IC50 values in the micromolar range, whereas in other protein kinase assays they were devoid of any inhibitory activity.  SAR studies allowed the identification of the key structural features.  Finally, a possible enzymic binding mode is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofQZkRe2BHh7Vg90H21EOLACvtfcHk0likCjh7L-vlkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFCgu70%253D&md5=a364133d1035bee183c58ad30ac140f8</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm011020u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011020u%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAlonso%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMoreno%26aufirst%3DF.%2BJ.%26atitle%3DFirst%2520non-ATP%2520competitive%2520glycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK-3beta%2529%2520inhibitors%253A%2520thiadiazolidinones%2520%2528TDZD%2529%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1292%26epage%3D1299%26doi%3D10.1021%2Fjm011020u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlistunova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">9215</span>– <span class="NLM_lpage">9219</span>, <span class="refDoi"> DOI: 10.1002/anie.200704051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.200704051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BD2sjjtlSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9215-9219&author=B.+Bulicauthor=M.+Pickhardtauthor=I.+Khlistunovaauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=H.+Waldmann&title=Rhodanine-based+tau+aggregation+inhibitors+in+cell+models+of+tauopathy&doi=10.1002%2Fanie.200704051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span></div><div class="casAuthors">Bulic Bruno; Pickhardt Marcus; Khlistunova Inna; Biernat Jacek; Mandelkow Eva-Maria; Mandelkow Eckhard; Waldmann Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">9215-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScsfK7C2PCgf6xYuD7tu2XfW6udTcc2ebYrQR9XTCYnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjjtlSltg%253D%253D&md5=9948b3054bae5ce9e52d0ce3d4635788</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fanie.200704051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200704051%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DRhodanine-based%2520tau%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D9215%26epage%3D9219%26doi%3D10.1002%2Fanie.200704051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saji, H.</span></span> <span> </span><span class="NLM_article-title">Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer’s brains</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1021/cn200002t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200002t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269-275&author=M.+Onoauthor=S.+Hayashiauthor=K.+Matsumuraauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Rhodanine+and+thiohydantoin+derivatives+for+detecting+tau+pathology+in+Alzheimer%E2%80%99s+brains&doi=10.1021%2Fcn200002t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains</span></div><div class="casAuthors">Ono, Masahiro; Hayashi, Shun; Matsumura, Kenji; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Mori, Hiroshi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of rhodanine (RH) and thiohydantoin (TH) derivs. were designed and synthesized for detecting tau pathol. in the brains of patients with Alzheimer's disease (AD).  In expts. in vitro using tau and β-amyloid (Aβ) aggregates, the TH deriv., TH2, showed high specific binding to tau aggregates.  In hippocampal sections obtained from AD patients, TH2 intensely stained neurofibrillary tangles.  In expts. using normal mice, [125I]TH2 showed good uptake (1.54%ID/g, 2 min postinjection) into and a rapid washout (0.25%ID/g, 60 min postinjection) from the brain. [123I]TH2 should be further investigated as a potential imaging agent for detecting tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvU2DzEOu6ubVg90H21EOLACvtfcHk0likCjh7L-vlkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D&md5=6f4924eaa828e075a59d9ead25ed3c36</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fcn200002t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200002t%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRhodanine%2520and%2520thiohydantoin%2520derivatives%2520for%2520detecting%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520brains%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D269%26epage%3D275%26doi%3D10.1021%2Fcn200002t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendgen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C. D.</span></span> <span> </span><span class="NLM_article-title">Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1021/jm201243p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201243p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=743-753&author=T.+Mendgenauthor=C.+Steuerauthor=C.+D.+Klein&title=Privileged+scaffolds+or+promiscuous+binders%3A+a+comparative+study+on+rhodanines+and+related+heterocycles+in+medicinal+chemistry&doi=10.1021%2Fjm201243p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry</span></div><div class="casAuthors">Mendgen, Thomas; Steuer, Christian; Klein, Christian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">743-753</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rhodanines and related five-membered heterocycles with multiple heteroatoms have recently gained a reputation of being unselective compds. that appear as "frequent hitters" in screening campaigns and therefore have little value in drug discovery.  However, this judgment appears to be based mostly on anecdotal evidence.  Having identified various rhodanines and related compds. in screening campaigns, we decided to perform a systematic study on their promiscuity.  An amt. of 163 rhodanines, hydantoins, thiohydantoins, and thiazolidinediones were synthesized and tested against several targets.  The compds. were also characterized with respect to aggregation and electrophilic reactivity, and the binding modes of rhodanines and related compds. in published x-ray cocrystal structures were analyzed.  The results indicate that the exocyclic, double bonded sulfur atom in rhodanines and thiohydantoins, in addn. to other structural features, offers a particularly high d. of interaction sites for polar interactions and hydrogen bonds.  This causes a promiscuous behavior at concns. in the "screening range" but should not be regarded as a general knockout criterion that excludes such screening hits from further development.  It is suggested that special criteria for target affinity and selectivity are applied to these classes of compds. and that their exceptional and potentially valuable biomol. binding properties are consequently exploited in a useful way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLzna8Pcz1iLVg90H21EOLACvtfcHk0lisaHdEvZXAHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGkt7nN&md5=6a94d097f44bdbaaec9a56fd6b371521</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm201243p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201243p%26sid%3Dliteratum%253Aachs%26aulast%3DMendgen%26aufirst%3DT.%26aulast%3DSteuer%26aufirst%3DC.%26aulast%3DKlein%26aufirst%3DC.%2BD.%26atitle%3DPrivileged%2520scaffolds%2520or%2520promiscuous%2520binders%253A%2520a%2520comparative%2520study%2520on%2520rhodanines%2520and%2520related%2520heterocycles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D743%26epage%3D753%26doi%3D10.1021%2Fjm201243p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muratov, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropsha, A.</span></span> <span> </span><span class="NLM_article-title">Phantom PAINS: problems with the utility of alerts for pan-assay interference compounds</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00465</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00465" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFCgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=417-427&author=S.+J.+Capuzziauthor=E.+N.+Muratovauthor=A.+Tropsha&title=Phantom+PAINS%3A+problems+with+the+utility+of+alerts+for+pan-assay+interference+compounds&doi=10.1021%2Facs.jcim.6b00465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS</span></div><div class="casAuthors">Capuzzi, Stephen J.; Muratov, Eugene N.; Tropsha, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-427</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of substructural alerts to identify Pan-Assay INterference compds. (PAINS) has become a common component of the triage process in biol. screening campaigns.  These alerts, however, were originally derived from a proprietary library tested in just six assays measuring protein-protein interaction (PPI) inhibition using the AlphaScreen detection technol. only; moreover, 68% (328 out of the 480 alerts) were derived from four or fewer compds.  In an effort to assess the reliability of these alerts as indicators of pan-assay interference, the authors performed a large-scale anal. of the impact of PAINS alerts on compd. promiscuity in bioassays using publicly available data in PubChem.  The authors found that the majority (97%) of all compds. contg. PAINS alerts were actually infrequent hitters in AlphaScreen assays measuring PPI inhibition.  The authors also found that the presence of PAINS alerts, contrary to expectations, did not reflect any heightened assay activity trends across all assays in PubChem including AlphaScreen, luciferase, β-lactamase, or fluorescence-based assays.  In addn., 109 PAINS alerts were present in 3570 extensively assayed, but consistently inactive compds. Dark Chem. Matter.  Finally, the authors obsd. that 87 small mol. FDA-approved drugs contained PAINS alerts and profiled their bioassay activity.  Based on this detailed anal. of PAINS alerts in nonproprietary compd. libraries, the authors caution against the blind use of PAINS filters to detect and triage compds. with possible PAINS liabilities and recommend that such conclusions should be drawn only by conducting orthogonal expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczoSnfEJzUrVg90H21EOLACvtfcHk0lisaHdEvZXAHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFCgtbw%253D&md5=206e1d1f24df12644527ddbaa03b24b0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00465%26sid%3Dliteratum%253Aachs%26aulast%3DCapuzzi%26aufirst%3DS.%2BJ.%26aulast%3DMuratov%26aufirst%3DE.%2BN.%26aulast%3DTropsha%26aufirst%3DA.%26atitle%3DPhantom%2520PAINS%253A%2520problems%2520with%2520the%2520utility%2520of%2520alerts%2520for%2520pan-assay%2520interference%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2017%26volume%3D57%26spage%3D417%26epage%3D427%26doi%3D10.1021%2Facs.jcim.6b00465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jasial, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">How frequently are pan-assay interference compounds active? Large-scale analysis of screening data reveals diverse activity profiles, low global hit frequency, and many consistently inactive compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3879</span>– <span class="NLM_lpage">3886</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1amtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3879-3886&author=S.+Jasialauthor=Y.+Huauthor=J.+Bajorath&title=How+frequently+are+pan-assay+interference+compounds+active%3F+Large-scale+analysis+of+screening+data+reveals+diverse+activity+profiles%2C+low+global+hit+frequency%2C+and+many+consistently+inactive+compounds&doi=10.1021%2Facs.jmedchem.7b00154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds</span></div><div class="casAuthors">Jasial, Swarit; Hu, Ye; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3879-3886</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Undetected pan-assay interference compds. (PAINS) with false-pos. activities in assays often propagate through medicinal chem. programs and compromise their outcomes.  Although a large no. of PAINS have been classified, often on the basis of individual studies or chem. experience, little has been done so far to systematically assess their activity profiles.  Herein we report a large-scale anal. of the behavior of PAINS in biol. screening assays.  More than 23,000 extensively tested compds. contg. PAINS substructures were detected, and their hit rates were detd.  Many consistently inactive compds. were identified.  The hit frequency was low overall, with median values of two to five hits for PAINS tested in hundreds of assays.  Only confined subsets of PAINS produced abundant hits.  The same PAINS substructure was often found in consistently inactive and frequently active compds., indicating that the structural context in which PAINS occur modulates their effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMc4n-Xo9Fn7Vg90H21EOLACvtfcHk0lisaHdEvZXAHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1amtL8%253D&md5=893dad99e5717f8e59b9adb4f675beb0</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00154%26sid%3Dliteratum%253Aachs%26aulast%3DJasial%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DHow%2520frequently%2520are%2520pan-assay%2520interference%2520compounds%2520active%253F%2520Large-scale%2520analysis%2520of%2520screening%2520data%2520reveals%2520diverse%2520activity%2520profiles%252C%2520low%2520global%2520hit%2520frequency%252C%2520and%2520many%2520consistently%2520inactive%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3879%26epage%3D3886%26doi%3D10.1021%2Facs.jmedchem.7b00154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W. M.</span></span> <span> </span><span class="NLM_article-title">Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00903</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=36-44&author=J.+B.+Baellauthor=J.+W.+M.+Nissink&title=Seven+year+itch%3A+pan-assay+interference+compounds+%28PAINS%29+in+2017-utility+and+limitations&doi=10.1021%2Facschembio.7b00903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations</span></div><div class="casAuthors">Baell, Jonathan B.; Nissink, J. Willem M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on all necessary considerations for the appropriate use of PAINs filters formulated to process hundreds and thousands of compds. in seconds, and identify PAINS in order to exclude them from further anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocZ7E_j7zxfbVg90H21EOLACvtfcHk0lisaHdEvZXAHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSlu7bK&md5=051115704137d6a91b8271702c619682</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00903%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DSeven%2520year%2520itch%253A%2520pan-assay%2520interference%2520compounds%2520%2528PAINS%2529%2520in%25202017-utility%2520and%2520limitations%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D36%26epage%3D44%26doi%3D10.1021%2Facschembio.7b00903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pouliot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanmart, S.</span></span> <span> </span><span class="NLM_article-title">Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00361</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00361" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=497-503&author=M.+Pouliotauthor=S.+Jeanmart&title=Pan+assay+interference+compounds+%28PAINS%29+and+other+promiscuous+compounds+in+antifungal+research&doi=10.1021%2Facs.jmedchem.5b00361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research</span></div><div class="casAuthors">Pouliot, Martin; Jeanmart, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">497-503</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Every week, articles disclosing new antifungal leads reported as promising starting points for optimization projects are published.  In many cases, the mechanism that accounts for their antifungal activity has not been fully elucidated.  More significantly, the detrimental impact that could result from certain embedded chem. features has been underestimated or even overlooked.  In the course of the authors' research in the agrochem. area, the authors have concluded that in many cases such leads are actually nonoptimizable because they either contain what are now recognized as pan assay interference compds. (PAINS) or other promiscuous groups.  This article is aimed at highlighting the pitfalls the authors have encountered and hopefully to steer other research groups away from them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqURFxdfKNQIbVg90H21EOLACvtfcHk0liqsQQohvFfOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7rE&md5=af11fcafd47de435fcc5fdf05080023a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00361%26sid%3Dliteratum%253Aachs%26aulast%3DPouliot%26aufirst%3DM.%26aulast%3DJeanmart%26aufirst%3DS.%26atitle%3DPan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520and%2520other%2520promiscuous%2520compounds%2520in%2520antifungal%2520research%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D497%26epage%3D503%26doi%3D10.1021%2Facs.jmedchem.5b00361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Observations on screening-based research and some concerning trends in the literature</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1546</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.4155%2Ffmc.10.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=21426147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1529-1546&author=J.+B.+Baell&title=Observations+on+screening-based+research+and+some+concerning+trends+in+the+literature&doi=10.4155%2Ffmc.10.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Observations on screening-based research and some concerning trends in the literature</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1529-1546</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Academic drug discovery is being accompanied by a plethora of publications that report screening hits as good starting points for drug discovery or as useful tool compds., whereas in many cases this is not so.  These compds. may be protein-reactive but can also interfere in bioassays via a no. of other means, and it can be very hard to prove early on that they represent false starts.  This, for instance, makes it difficult for journals in their assessment of manuscripts submitted for publication.  Wider awareness and recognition of these problematic compds. will help the academic drug-discovery community focus on and publish genuinely optimizable screening hits.  This will be of general benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob88J0NH5Mx7Vg90H21EOLACvtfcHk0liqsQQohvFfOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yqsbjI&md5=14f916535540fc04e37c2eb21cfe7876</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.237%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DObservations%2520on%2520screening-based%2520research%2520and%2520some%2520concerning%2520trends%2520in%2520the%2520literature%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D1529%26epage%3D1546%26doi%3D10.4155%2Ffmc.10.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span> <span> </span><span class="NLM_article-title">PAINS: relevance to tool compound discovery and fragment-based screening</span>. <i>Aust. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1494</span>, <span class="refDoi"> DOI: 10.1071/CH13551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1071%2FCH13551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=1483-1494&author=J.+B.+Baellauthor=L.+Ferrinsauthor=H.+Falkauthor=G.+Nikolakopoulos&title=PAINS%3A+relevance+to+tool+compound+discovery+and+fragment-based+screening&doi=10.1071%2FCH13551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening</span></div><div class="casAuthors">Baell, Jonathan B.; Ferrins, Lori; Falk, Hendrik; Nikolakopoulos, George</div><div class="citationInfo"><span class="NLM_cas:title">Australian Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1483-1494</span>CODEN:
                <span class="NLM_cas:coden">AJCHAS</span>;
        ISSN:<span class="NLM_cas:issn">0004-9425</span>.
    
            (<span class="NLM_cas:orgname">CSIRO Publishing</span>)
        </div><div class="casAbstract">Pan assay interference compds. (PAINS) are readily discovered in any bioassay and can appear to give selective and optimizable hits.  The most common PAINS can be readily recognized by their structure.  However, there are compds. that closely resemble PAINS that are not specifically recognized by the PAINS filters.  In addn., highly reactive compds. are not encoded for in the PAINS filters because they were excluded from the high-throughput screening (HTS) library used to develop the filters and so were never present to provide indicting data.  A compounding complication in the area is that very occasionally a PAINS compd. may serve as a viable starting point for progression.  Despite such an occasional example, the literature is littered with an overwhelming no. of examples of compds. that fail to progress and were probably not optimizable in the first place, nor useful tool compds.  Thus it is with great caution and diligence that compds. possessing a known PAINS core should be progressed through to medicinal chem. optimization, if at all, as the chances are very high that the hits will be found to be non-progressable, often after a significant waste of resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUnBCDXW-TbVg90H21EOLACvtfcHk0liqsQQohvFfOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyqsLzF&md5=cc4c7966a48f7cf9a7520591d0dcfd14</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1071%2FCH13551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FCH13551%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DFalk%26aufirst%3DH.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26atitle%3DPAINS%253A%2520relevance%2520to%2520tool%2520compound%2520discovery%2520and%2520fragment-based%2520screening%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D1483%26epage%3D1494%26doi%3D10.1071%2FCH13551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span> </span><span class="NLM_article-title">Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI)
Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation
of Pioglitazone in Delaying Its Onset (TOMMORROW)</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National Institutes
of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2013</span>; <a href="https://www.clinicaltrials.gov/ct2/show/NCT01931566?term=pioglitazone%2C+alzheimer&amp;rank=1" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT01931566?term=pioglitazone%2C+alzheimer&rank=1</a> (accessed July 12, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Biomarker+Qualification+for+Risk+of+Mild+Cognitive+Impairment+%28MCI%29%0ADue+to+Alzheimer%27s+Disease+%28AD%29+and+Safety+and+Efficacy+Evaluation%0Aof+Pioglitazone+in+Delaying+Its+Onset+%28TOMMORROW%29.+ClinicalTrials.gov%3B+U.S.+National+Institutes%0Aof+Health%3A+Bethesda%2C+MD%2C+2013%3B+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01931566%3Fterm%3Dpioglitazone%252C%2Balzheimer%26rank%3D1+%28accessed+July+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DBiomarker%2520Qualification%2520for%2520Risk%2520of%2520Mild%2520Cognitive%2520Impairment%2520%2528MCI%2529%250ADue%2520to%2520Alzheimer%2527s%2520Disease%2520%2528AD%2529%2520and%2520Safety%2520and%2520Efficacy%2520Evaluation%250Aof%2520Pioglitazone%2520in%2520Delaying%2520Its%2520Onset%2520%2528TOMMORROW%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%2520Institutes%250Aof%2520Health%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuret, J.</span></span> <span> </span><span class="NLM_article-title">Structure and mechanism of action of tau aggregation inhibitors</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">918</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.2174/1567205011666141107150331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.2174%2F1567205011666141107150331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=25387336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=918-927&author=K.+Cisekauthor=G.+L.+Cooperauthor=C.+J.+Husebyauthor=J.+Kuret&title=Structure+and+mechanism+of+action+of+tau+aggregation+inhibitors&doi=10.2174%2F1567205011666141107150331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and Mechanism of Action of Tau Aggregation Inhibitors</span></div><div class="casAuthors">Cisek, Katryna; Cooper, Grace L.; Huseby, Carol J.; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">918-927</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Since the discovery of phenothiazines as tau protein aggregation inhibitors, many addnl. small mol. inhibitors of diverse chemotype have been discovered and characterized in biol. model systems.  Although direct inhibition of tau aggregation has shown promise as a potential treatment strategy for depressing neurofibrillary lesion formation in Alzheimer's disease, the mechanism of action of these compds. has been unclear.  However, recent studies have found that tau aggregation antagonists exert their effects through both covalent and non-covalent means, and have identified assocd. potency and selectivity driving features.  Here we review small-mol. tau aggregation inhibitors with a focus on compd. structure and inhibitory mechanism.  The elucidation of inhibitory mechanism has implications for maximizing on-target efficacy while minimizing off-target side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXuPjf844LQbVg90H21EOLACvtfcHk0lgqopT0x-x9ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFygsw%253D%253D&md5=15e0da5cf285e4aa460d6902920cfa98</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F1567205011666141107150331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666141107150331%26sid%3Dliteratum%253Aachs%26aulast%3DCisek%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DG.%2BL.%26aulast%3DHuseby%26aufirst%3DC.%2BJ.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DStructure%2520and%2520mechanism%2520of%2520action%2520of%2520tau%2520aggregation%2520inhibitors%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D918%26epage%3D927%26doi%3D10.2174%2F1567205011666141107150331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinke, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestwicki, J. E.</span></span> <span> </span><span class="NLM_article-title">Insight into amyloid structure using chemical probes</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01110.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1111%2Fj.1747-0285.2011.01110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=21457473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=399-411&author=A.+A.+Reinkeauthor=J.+E.+Gestwicki&title=Insight+into+amyloid+structure+using+chemical+probes&doi=10.1111%2Fj.1747-0285.2011.01110.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into amyloid structure using chemical probes</span></div><div class="casAuthors">Reinke, Ashley A.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">399-411</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by the deposition of amyloids in the brain.  One prominent form of amyloid is composed of repeating units of the amyloid-β (Aβ) peptide.  Over the past decade, it has become clear that these Aβ amyloids are not homogeneous; rather, they are composed of a series of structures varying in their overall size and shape and the no. of Aβ peptides they contain.  Recent theories suggest that these different amyloid conformations may play distinct roles in disease, although their relative contributions are still being discovered.  Here, we review how chem. probes, such as Congo red, thioflavin T and their derivs., have been powerful tools for the better understanding of amyloid structure and function.  Moreover, we discuss how design and deployment of conformationally selective probes might be used to test emerging models of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1MeycFDiwGLVg90H21EOLACvtfcHk0lgqopT0x-x9ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslWqsb0%253D&md5=52a8815e569523bd2b05e7a5e7c70d00</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01110.x%26sid%3Dliteratum%253Aachs%26aulast%3DReinke%26aufirst%3DA.%2BA.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DInsight%2520into%2520amyloid%2520structure%2520using%2520chemical%2520probes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D399%26epage%3D411%26doi%3D10.1111%2Fj.1747-0285.2011.01110.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antihyperglycemic activity profiles of novel thiazolidinedione derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5857</span>– <span class="NLM_lpage">5864</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2004.08.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5857-5864&author=B.+A.+Bhatauthor=S.+Ponnalaauthor=D.+P.+Sahuauthor=P.+Tiwariauthor=B.+K.+Tripathiauthor=A.+K.+Srivastava&title=Synthesis+and+antihyperglycemic+activity+profiles+of+novel+thiazolidinedione+derivatives&doi=10.1016%2Fj.bmc.2004.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DB.%2BA.%26aulast%3DPonnala%26aufirst%3DS.%26aulast%3DSahu%26aufirst%3DD.%2BP.%26aulast%3DTiwari%26aufirst%3DP.%26aulast%3DTripathi%26aufirst%3DB.%2BK.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520and%2520antihyperglycemic%2520activity%2520profiles%2520of%2520novel%2520thiazolidinedione%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5857%26epage%3D5864%26doi%3D10.1016%2Fj.bmc.2004.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span> <span> </span><span class="NLM_article-title">A solvent-free protocol for the green synthesis of 5-arylidene-2,4-thiazolidinediones using ethylenediamine diacetate as catalyst</span>. <i>Org. Chem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">194784</span>, <span class="refDoi"> DOI: 10.1155/2012/194784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1155%2F2012%2F194784" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=194784&author=Y.+Zhangauthor=Z.+Zhou&title=A+solvent-free+protocol+for+the+green+synthesis+of+5-arylidene-2%2C4-thiazolidinediones+using+ethylenediamine+diacetate+as+catalyst&doi=10.1155%2F2012%2F194784"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1155%2F2012%2F194784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F194784%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DZ.%26atitle%3DA%2520solvent-free%2520protocol%2520for%2520the%2520green%2520synthesis%2520of%25205-arylidene-2%252C4-thiazolidinediones%2520using%2520ethylenediamine%2520diacetate%2520as%2520catalyst%26jtitle%3DOrg.%2520Chem.%2520Int.%26date%3D2012%26volume%3D2012%26spage%3D194784%26doi%3D10.1155%2F2012%2F194784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">O-hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-beta aggregation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5884</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2012.07.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5884-5892&author=F.+Maoauthor=L.+Huangauthor=Z.+Luoauthor=A.+Liuauthor=C.+Luauthor=Z.+Xieauthor=X.+Li&title=O-hydroxyl-+or+o-amino+benzylamine-tacrine+hybrids%3A+multifunctional+biometals+chelators%2C+antioxidants%2C+and+inhibitors+of+cholinesterase+activity+and+amyloid-beta+aggregation&doi=10.1016%2Fj.bmc.2012.07.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DO-hydroxyl-%2520or%2520o-amino%2520benzylamine-tacrine%2520hybrids%253A%2520multifunctional%2520biometals%2520chelators%252C%2520antioxidants%252C%2520and%2520inhibitors%2520of%2520cholinesterase%2520activity%2520and%2520amyloid-beta%2520aggregation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5884%26epage%3D5892%26doi%3D10.1016%2Fj.bmc.2012.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qabaja, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. B.</span></span> <span> </span><span class="NLM_article-title">Annulation strategies for benzo[b]fluorene synthesis: efficient routes to the kinafluorenone and WS-5995 antibiotics</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">7187</span>– <span class="NLM_lpage">7194</span>, <span class="refDoi"> DOI: 10.1021/jo0056186</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0056186" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=7187-7194&author=G.+Qabajaauthor=G.+B.+Jones&title=Annulation+strategies+for+benzo%5Bb%5Dfluorene+synthesis%3A+efficient+routes+to+the+kinafluorenone+and+WS-5995+antibiotics&doi=10.1021%2Fjo0056186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjo0056186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0056186%26sid%3Dliteratum%253Aachs%26aulast%3DQabaja%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DG.%2BB.%26atitle%3DAnnulation%2520strategies%2520for%2520benzo%255Bb%255Dfluorene%2520synthesis%253A%2520efficient%2520routes%2520to%2520the%2520kinafluorenone%2520and%2520WS-5995%2520antibiotics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D7187%26epage%3D7194%26doi%3D10.1021%2Fjo0056186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szendrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1089/adt.2006.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1089%2Fadt.2006.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=17355201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislCktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=75-83&author=A.+Bakiauthor=A.+Bielikauthor=L.+Molnarauthor=G.+Szendreiauthor=G.+M.+Keseru&title=A+high+throughput+luminescent+assay+for+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1089%2Fadt.2006.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A High Throughput Luminescent Assay for Glycogen Synthase Kinase-3β Inhibitors</span></div><div class="casAuthors">Baki, Andrea; Bielik, Attila; Molnar, Laszlo; Szendrei, Gyoergyi; Keserue, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-84</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A high throughput luminescent assay based on the Kinase-Glo system (Promega, Madison, WI) has been developed for screening against glycogen synthase kinase-3β (GSK-3β).  Careful optimization of assay parameters allowed us to develop a robust, reproducible, and sensitive assay.  Its usefulness has been demonstrated in a high throughput screening run when screening 55,000 compds.  This campaign yielded five chem. classes of hits, including several highly potent GSK-3β inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYXSuULTtzHLVg90H21EOLACvtfcHk0lgp-6jNCGBAGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislCktbg%253D&md5=d9e594ab3d34af353b12b53eb41e43cb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1089%2Fadt.2006.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2006.029%26sid%3Dliteratum%253Aachs%26aulast%3DBaki%26aufirst%3DA.%26aulast%3DBielik%26aufirst%3DA.%26aulast%3DMolnar%26aufirst%3DL.%26aulast%3DSzendrei%26aufirst%3DG.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DA%2520high%2520throughput%2520luminescent%2520assay%2520for%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2007%26volume%3D5%26spage%3D75%26epage%3D83%26doi%3D10.1089%2Fadt.2006.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dans, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4042</span>– <span class="NLM_lpage">4056</span>, <span class="refDoi"> DOI: 10.1021/jm1016279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1016279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmt1Gnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4042-4056&author=D.+I.+Perezauthor=V.+Palomoauthor=C.+Perezauthor=C.+Gilauthor=P.+D.+Dansauthor=F.+J.+Luqueauthor=S.+Condeauthor=A.+Martinez&title=Switching+reversibility+to+irreversibility+in+glycogen+synthase+kinase+3+inhibitors%3A+clues+for+specific+design+of+new+compounds&doi=10.1021%2Fjm1016279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New Compounds</span></div><div class="casAuthors">Perez, Daniel I.; Palomo, Valle; Perez, Concepcion; Gil, Carmen; Dans, Pablo D.; Luque, F. Javier; Conde, Santiago; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4042-4056</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge.  Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clin. trials for different tauopathies.  Following our hypothesis based on the enhanced reactivity of residue Cys199 in the binding site of GSK-3, we examine here the suitability of phenylhalomethylketones as irreversible inhibitors.  Our data confirm that the halomethylketone unit is essential for the inhibitory activity.  Moreover, addn. of the halomethylketone moiety to reversible inhibitors turned them into irreversible inhibitors with IC50 values in the nanomolar range.  Overall, the results point out that these compds. might be useful pharmacol. tools to explore physiol. and pathol. processes related to signaling pathways regulated by GSK-3 opening new avenues for the discovery of novel GSK-3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodOmaptYUQ77Vg90H21EOLACvtfcHk0lgp-6jNCGBAGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmt1Gnsr8%253D&md5=9b5be4c124364e028d5fbaf5043d72ce</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm1016279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1016279%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DDans%26aufirst%3DP.%2BD.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DSwitching%2520reversibility%2520to%2520irreversibility%2520in%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%253A%2520clues%2520for%2520specific%2520design%2520of%2520new%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4042%26epage%3D4056%26doi%3D10.1021%2Fjm1016279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankovic, Z.</span></span> <span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2584</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0liVbGIxI4vuCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0liVbGIxI4vuCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crivori, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span> <span> </span><span class="NLM_article-title">Predicting blood-brain barrier permeation from three-dimensional molecular structure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2204</span>– <span class="NLM_lpage">2216</span>, <span class="refDoi"> DOI: 10.1021/jm990968+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990968%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2204-2216&author=P.+Crivoriauthor=G.+Crucianiauthor=P.+A.+Carruptauthor=B.+Testa&title=Predicting+blood-brain+barrier+permeation+from+three-dimensional+molecular+structure&doi=10.1021%2Fjm990968%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting blood-brain barrier permeation from three-dimensional molecular structure</span></div><div class="casAuthors">Crivori, Patrizia; Cruciani, Gabriele; Carrupt, Pierre-Alain; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2204-2216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Predicting blood-brain barrier (BBB) permeation remains a challenge in drug design.  Since it is impossible to det. exptl. the BBB partitioning of large nos. of preclin. candidates, alternative evaluation methods based on computerized models are desirable.  The present study was conducted to demonstrate the value of descriptors derived from 3D mol. fields in estg. the BBB permeation of a large set of compds. and to produce a simple math. model suitable for external prediction.  The method used (VolSurf) transforms 3D fields into descriptors and correlates them to the exptl. permeation by a discriminant partial least squares procedure.  The model obtained here correctly predicts more than 90% of the BBB permeation data.  By quantifying the favorable and unfavorable contributions of physicochem. and structural properties, it also offers valuable insights for drug design, pharmacol. profiling, and screening.  The computational procedure is fully automated and quite fast.  The method thus appears as a valuable new tool in virtual screening where selection or prioritization of candidates is required from large collections of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURsaBTpmsObVg90H21EOLACvtfcHk0liVbGIxI4vuCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFKhtLk%253D&md5=569f3500268859660bb9e5206da270fe</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm990968%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990968%252B%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DPredicting%2520blood-brain%2520barrier%2520permeation%2520from%2520three-dimensional%2520molecular%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2204%26epage%3D2216%26doi%3D10.1021%2Fjm990968%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro</span>. <i>Cerebellum</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1080/147342202753203087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1080%2F147342202753203087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=41-55&author=A.+Contestabile&title=Cerebellar+granule+cells+as+a+model+to+study+mechanisms+of+neuronal+apoptosis+or+survival+in+vivo+and+in+vitro&doi=10.1080%2F147342202753203087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1080%2F147342202753203087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F147342202753203087%26sid%3Dliteratum%253Aachs%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DCerebellar%2520granule%2520cells%2520as%2520a%2520model%2520to%2520study%2520mechanisms%2520of%2520neuronal%2520apoptosis%2520or%2520survival%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DCerebellum%26date%3D2002%26volume%3D1%26spage%3D41%26epage%3D55%26doi%3D10.1080%2F147342202753203087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henke, B. R.</span></span> <span> </span><span class="NLM_article-title">The PPARs: from orphan receptors to drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/jm990554g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990554g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=527-550&author=T.+M.+Willsonauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=B.+R.+Henke&title=The+PPARs%3A+from+orphan+receptors+to+drug+discovery&doi=10.1021%2Fjm990554g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The PPARs: From orphan receptors to drug discovery</span></div><div class="casAuthors">Willson, Timothy M.; Brown, Peter J.; Sternbach, Daniel D.; Henke, Brad R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-550</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 326 refs. is given on peroxisome proliferator-activated receptors (PPARs).  The structural and functional anal. of the different PPAR subtypes is summarized and their function as hormone receptors for dietary fatty acids and certain eicosanoids in different species and in many metabolically active tissues is described.  Progress is reported in the development of drugs, which use PPARs as mol. targets, for the treatment of human metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocp31Cq_kgebVg90H21EOLACvtfcHk0lhPFHeCCMiesw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1Churk%253D&md5=003b19fe3fdf813411d6a2ac5aefdc01</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm990554g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990554g%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26atitle%3DThe%2520PPARs%253A%2520from%2520orphan%2520receptors%2520to%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D527%26epage%3D550%26doi%3D10.1021%2Fjm990554g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, A. W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murzin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garringer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowther, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheres, S. H. W.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM structures of tau filaments from Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>547</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1038/nature23002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnature23002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=28678775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2017&pages=185-190&author=A.+W.+P.+Fitzpatrickauthor=B.+Falconauthor=S.+Heauthor=A.+G.+Murzinauthor=G.+Murshudovauthor=H.+J.+Garringerauthor=R.+A.+Crowtherauthor=B.+Ghettiauthor=M.+Goedertauthor=S.+H.+W.+Scheres&title=Cryo-EM+structures+of+tau+filaments+from+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature23002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structures of tau filaments from Alzheimer's disease</span></div><div class="casAuthors">Fitzpatrick, Anthony W. P.; Falcon, Benjamin; He, Shaoda; Murzin, Alexey G.; Murshudov, Garib; Garringer, Holly J.; Crowther, R. Anthony; Ghetti, Bernardino; Goedert, Michel; Scheres, Sjors H. W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">7662</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most common neurodegenerative disease, and there are no mechanism-based therapies.  The disease is defined by the presence of abundant neurofibrillary lesions and neuritic plaques in the cerebral cortex.  Neurofibrillary lesions comprise paired helical and straight tau filaments, whereas tau filaments with different morphologies characterize other neurodegenerative diseases.  No high-resoln. structures of tau filaments are available.  Here we present cryo-electron microscopy (cryo-EM) maps at 3.4-3.5 Å resoln. and corresponding at. models of paired helical and straight filaments from the brain of an individual with Alzheimer's disease.  Filament cores are made of two identical protofilaments comprising residues 306-378 of tau protein, which adopt a combined cross-β/β-helix structure and define the seed for tau aggregation.  Paired helical and straight filaments differ in their inter-protofilament packing, showing that they are ultrastructural polymorphs.  These findings demonstrate that cryo-EM allows at. characterization of amyloid filaments from patient-derived material, and pave the way for investigation of a range of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZxSJoSzqlEbVg90H21EOLACvtfcHk0lhPFHeCCMiesw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73F&md5=05d201bf16a383e96421b6969f3c1419</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature23002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23002%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DA.%2BW.%2BP.%26aulast%3DFalcon%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DMurzin%26aufirst%3DA.%2BG.%26aulast%3DMurshudov%26aufirst%3DG.%26aulast%3DGarringer%26aufirst%3DH.%2BJ.%26aulast%3DCrowther%26aufirst%3DR.%2BA.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DScheres%26aufirst%3DS.%2BH.%2BW.%26atitle%3DCryo-EM%2520structures%2520of%2520tau%2520filaments%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2017%26volume%3D547%26spage%3D185%26epage%3D190%26doi%3D10.1038%2Fnature23002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1351</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.06224.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1111%2Fj.1471-4159.2009.06224.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=19549281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFOls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2009&pages=1339-1351&author=W.+Liauthor=J.+B.+Sperryauthor=A.+Croweauthor=J.+Q.+Trojanowskiauthor=A.+B.+Smithauthor=V.+M.+Lee&title=Inhibition+of+tau+fibrillization+by+oleocanthal+via+reaction+with+the+amino+groups+of+tau&doi=10.1111%2Fj.1471-4159.2009.06224.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau</span></div><div class="casAuthors">Li, Wenkai; Sperry, Jeffrey B.; Crowe, Alex; Trojanowski, John Q.; Smith, Amos B., III; Lee, Virginia M.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1339-1351</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tau is a microtubule-assocd. protein that promotes microtubule assembly and stability.  In Alzheimer's disease and related tauopathies, tau fibrillizes and aggregates into neurofibrillary tangles.  Recently, oleocanthal isolated from extra virgin olive oil was found to display non-steroidal anti-inflammatory activity similar to ibuprofen.  As our unpublished data indicates an inhibitory effect of oleocanthal on amyloid β peptide fibrillization, we reasoned that it might inhibit tau fibrillization as well.  Herein, we demonstrate that oleocanthal abrogates fibrillization of tau by locking tau into the naturally unfolded state.  Using PHF6 consisting of the amino acid residues VQIVYK, a hexapeptide within the third repeat of tau that is essential for fibrillization, we show that oleocanthal forms an adduct with the lysine via initial Schiff base formation.  Structure and function studies demonstrate that the two aldehyde groups of oleocanthal are required for the inhibitory activity.  These two aldehyde groups show certain specificity when titrated with free lysine and oleocanthal does not significantly affect the normal function of tau.  These findings provide a potential scheme for the development of novel therapies for neurodegenerative tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKQPzimquC4LVg90H21EOLACvtfcHk0lhPFHeCCMiesw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFOls78%253D&md5=9456d2b98217e3f60f80d1aa0fba8218</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06224.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06224.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSperry%26aufirst%3DJ.%2BB.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DInhibition%2520of%2520tau%2520fibrillization%2520by%2520oleocanthal%2520via%2520reaction%2520with%2520the%2520amino%2520groups%2520of%2520tau%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D110%26spage%3D1339%26epage%3D1351%26doi%3D10.1111%2Fj.1471-4159.2009.06224.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawaya, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goux, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowick, J. S.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic beta-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">3144</span>– <span class="NLM_lpage">3157</span>, <span class="refDoi"> DOI: 10.1021/ja110545h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja110545h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=3144-3157&author=J.+Zhengauthor=C.+Liuauthor=M.+R.+Sawayaauthor=B.+Vadlaauthor=S.+Khanauthor=R.+J.+Woodsauthor=D.+Eisenbergauthor=W.+J.+Gouxauthor=J.+S.+Nowick&title=Macrocyclic+beta-sheet+peptides+that+inhibit+the+aggregation+of+a+tau-protein-derived+hexapeptide&doi=10.1021%2Fja110545h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic β-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide</span></div><div class="casAuthors">Zheng, Jing; Liu, Cong; Sawaya, Michael R.; Vadla, Balraju; Khan, Shafiullah; Woods, R. Jeremy; Eisenberg, David; Goux, Warren J.; Nowick, James S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3144-3157</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes studies of a series of macrocyclic β-sheet peptides 1 that inhibit the aggregation of a tau-protein-derived peptide.  The macrocyclic β-sheet peptides comprise a pentapeptide "upper" strand, two δ-linked ornithine turn units, and a "lower" strand comprising two addnl. residues and the β-sheet peptidomimetic template "Hao".  The tau-derived peptide Ac-VQIVYK-NH2 (AcPHF6) aggregates in soln. through β-sheet interactions to form straight and twisted filaments similar to those formed by tau protein in Alzheimer's neurofibrillary tangles.  Macrocycles 1 contg. the pentapeptide VQIVY in the "upper" strand delay and suppress the onset of aggregation of the AcPHF6 peptide.  Inhibition is particularly pronounced in other macrocycles in which the two residues in the "lower" strand provide a pattern of hydrophobicity and hydrophilicity that matches that of the pentapeptide "upper" strand.  Inhibition varies strongly with the concn. of these macrocycles, suggesting that it is cooperative.  Another macrocycle contg. the pentapeptide QIVYK shows little inhibition, suggesting the possibility of a preferred direction of growth of AcPHF6 β-sheets.  On the basis of these studies, a model is proposed in which the AcPHF6 amyloid grows as a layered pair of β-sheets and in which growth is blocked by a pair of macrocycles that cap the growing paired hydrogen-bonding edges.  This model provides a provocative and appealing target for future inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUUxfY1h_AurVg90H21EOLACvtfcHk0lgbJ5DnLNlxYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeis7k%253D&md5=47c5d5dd0864b5e4613bf00baa445ef1</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fja110545h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja110545h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DVadla%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DR.%2BJ.%26aulast%3DEisenberg%26aufirst%3DD.%26aulast%3DGoux%26aufirst%3DW.%2BJ.%26aulast%3DNowick%26aufirst%3DJ.%2BS.%26atitle%3DMacrocyclic%2520beta-sheet%2520peptides%2520that%2520inhibit%2520the%2520aggregation%2520of%2520a%2520tau-protein-derived%2520hexapeptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D3144%26epage%3D3157%26doi%3D10.1021%2Fja110545h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelokhani-Niaraki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P. P.</span></span> <span> </span><span class="NLM_article-title">Tau-derived-hexapeptide 306VQIVYK311 aggregation inhibitors: nitrocatechol moiety as a pharmacophore in drug design</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1570</span>, <span class="refDoi"> DOI: 10.1021/cn400151a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400151a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1559-1570&author=T.+Mohamedauthor=T.+Hoangauthor=M.+Jelokhani-Niarakiauthor=P.+P.+Rao&title=Tau-derived-hexapeptide+306VQIVYK311+aggregation+inhibitors%3A+nitrocatechol+moiety+as+a+pharmacophore+in+drug+design&doi=10.1021%2Fcn400151a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-Derived-Hexapeptide 306VQIVYK311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design</span></div><div class="casAuthors">Mohamed, Tarek; Hoang, Tuan; Jelokhani-Niaraki, Masoud; Rao, Praveen P. N.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1559-1570</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nitrocatechol derivs. tolcapone (1) and entacapone (2), used as adjunctive therapy in the treatment of Parkinson's disease, were investigated for their potential to inhibit the tau-derived-hexapeptide 306VQIVYK311.  They were compared to small mols. that contain similar pharmacophores including the catechol derivs. (dopamine 3 and epinephrine 4), nitroderivatives (nifedipine 5 and chloramphenicol 6), nitrocatechol isomers (7 and 8), and a tolcapone deriv. (13) lacking the nitrocatechol moiety.  The aggregation kinetics by thioflavin S fluorescence assay indicates that both tolcapone (1) and entacapone (2) exhibit antiaggregation properties.  These findings were supported by transmission electron microscopy (TEM) and CD (CD) spectroscopy measurements which suggest that the nitrocatechol (3,4-dihydroxy-5-nitrophenyl) moiety is a suitable pharmacophore in the design of new tau-aggregation inhibitors.  Furthermore, tolcapone (1) was identified as most active compd. with antiaggregation activity (46% inhibition of fluorescence intensity at 50 μM), which was supported by TEM data.  The in silico steric zipper model of the tau-derived-hexapeptide 306VQIVYK311 indicates that the 3,4-dihydroxy-substituent present in tolcapone (1) and entacapone (2) underwent polar contacts with lysine side chains (VQIVYK), whereas the charged 5-nitrosubstituent was in close contact with lysine side chain present in the steric zipper region suggesting the crit. role of a nitrocatechol (3,4-dihydroxy-5-nitrophenyl) pharmacophore present in tolcapone (1) and entacapone (2) in tau-hexapeptide binding and prevention of β-sheet assembly.  Our results have significant implications in the design and development of tau-aggregation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoynOhTr4WtArVg90H21EOLACvtfcHk0lgbJ5DnLNlxYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2rtLfI&md5=263e2ba311d2a21e197c7c6b1f242416</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fcn400151a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400151a%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DJelokhani-Niaraki%26aufirst%3DM.%26aulast%3DRao%26aufirst%3DP.%2BP.%26atitle%3DTau-derived-hexapeptide%2520306VQIVYK311%2520aggregation%2520inhibitors%253A%2520nitrocatechol%2520moiety%2520as%2520a%2520pharmacophore%2520in%2520drug%2520design%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1559%26epage%3D1570%26doi%3D10.1021%2Fcn400151a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel-Pinter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherzer-Attali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Hussien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alyagor, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbaum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span> <span> </span><span class="NLM_article-title">Naphthoquinone-tryptophan hybrid inhibits aggregation of the tau-derived peptide PHF6 and reduces neurotoxicity</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.3233/JAD-150927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.3233%2FJAD-150927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=26836184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2016&pages=165-178&author=M.+Frenkel-Pinterauthor=S.+Talauthor=R.+Scherzer-Attaliauthor=M.+Abu-Hussienauthor=I.+Alyagorauthor=T.+Eisenbaumauthor=E.+Gazitauthor=D.+Segal&title=Naphthoquinone-tryptophan+hybrid+inhibits+aggregation+of+the+tau-derived+peptide+PHF6+and+reduces+neurotoxicity&doi=10.3233%2FJAD-150927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity</span></div><div class="casAuthors">Frenkel-Pinter, Moran; Tal, Sharon; Scherzer-Attali, Roni; Abu-Hussien, Malak; Alyagor, Idan; Eisenbaum, Tal; Gazit, Ehud; Segal, Daniel; Lichtenthaler, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-178</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Tauopathies, such as Alzheimer's disease (AD), are a group of disorders characterized neuropathol. by intracellular toxic accumulations of abnormal protein aggregates formed by misfolding of the microtubule-assocd. protein tau.  Since protein self-assembly appears to be an initial key step in the pathol. of this group of diseases, intervening in this process can be both a prophylactic measure and a means for modifying the course of the disease for therapeutic purposes.  We and others have shown that arom. small mols. can be effective inhibitors of aggregation of various protein assemblies, by binding to the arom. core in aggregation-prone motifs and preventing their self-assembly.  Specifically, we have designed a series of small arom. naphthoquinone-tryptophan hybrid mols. as candidate aggregation inhibitors of β -sheet based assembly and demonstrated their efficacy toward inhibiting aggregation of the amyloid-β peptide, another culprit of AD, as well as of various other aggregative proteins involved in other protein misfolding diseases.  Here we tested whether a leading naphthoquinone-tryptophan hybrid mol., namely NQTrp, can be repurposed as an inhibitor of the aggregation of the tau protein in vitro and in vivo.  We show that the mol. inhibits the in vitro assembly of PHF6, the aggregation-prone fragment of tau protein, reduces hyperphosphorylated tau deposits and ameliorates tauopathy-related behavioral defect in an established transgenic Drosophila model expressing human tau.  We suggest that NQTrp, or optimized versions of it, could act as novel disease modifying drugs for AD and other tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ-1eBVk7cz7Vg90H21EOLACvtfcHk0lgbJ5DnLNlxYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCgsrY%253D&md5=792bf76e1b8b8d787dc4b06fc895b9f1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3233%2FJAD-150927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150927%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel-Pinter%26aufirst%3DM.%26aulast%3DTal%26aufirst%3DS.%26aulast%3DScherzer-Attali%26aufirst%3DR.%26aulast%3DAbu-Hussien%26aufirst%3DM.%26aulast%3DAlyagor%26aufirst%3DI.%26aulast%3DEisenbaum%26aufirst%3DT.%26aulast%3DGazit%26aufirst%3DE.%26aulast%3DSegal%26aufirst%3DD.%26atitle%3DNaphthoquinone-tryptophan%2520hybrid%2520inhibits%2520aggregation%2520of%2520the%2520tau-derived%2520peptide%2520PHF6%2520and%2520reduces%2520neurotoxicity%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2016%26volume%3D51%26spage%3D165%26epage%3D178%26doi%3D10.3233%2FJAD-150927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunven, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Costa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peuchmaur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumendjel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chierici, S.</span></span> <span> </span><span class="NLM_article-title">Disruption of fibers from the tau model AcPHF6 by naturally occurring aurones and synthetic analogues</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=995-1003&author=L.+Lunvenauthor=H.+Bonnetauthor=S.+Yahiaouiauthor=W.+Yiauthor=L.+Da+Costaauthor=M.+Peuchmaurauthor=A.+Boumendjelauthor=S.+Chierici&title=Disruption+of+fibers+from+the+tau+model+AcPHF6+by+naturally+occurring+aurones+and+synthetic+analogues&doi=10.1021%2Facschemneuro.6b00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of Fibers from the Tau Model AcPHF6 by Naturally Occurring Aurones and Synthetic Analogues</span></div><div class="casAuthors">Lunven, Laurent; Bonnet, Hugues; Yahiaoui, Samir; Yi, Wei; Da Costa, Laurene; Peuchmaur, Marine; Boumendjel, Ahcene; Chierici, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-1003</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of tau aggregates is strongly linked to the neurodegenerative process in tauopathies such as Alzheimer's disease (AD).  Yet only a few mols. have shown to efficiently prevent the in vitro formation of those aggregates, and the identification of such mols. is still an ongoing interest in a therapeutic context.  Herein, we report the in vitro evaluation of a series of aurones against the fibrillation of the tau-derived hexapeptide AcPHF6 model.  Using thioflavin T-based fluorescence assays, CD and at. force microscopy, we showed that aurones are capable of efficiently interacting with the tau-derived hexapeptide.  Importantly, this work reveals a significant activity obsd. for polyhydroxylated aurones.  In particular, aurone 23 displayed an almost complete inhibition of fibers formation as shown by AFM at a peptide/inhibitor 1:1 ratio.  It is similar to that obsd. for myricetin, a polyphenolic compd., well-known to prevent the in vitro elongation of tau fibers.  Moreover, a tetrahydroxylated isomer, compd. 24, was shown as a chem. probe of fibers rather than an inhibitor.  Consequently, these results highlight aurones as a new promising scaffold to interfere with tau aggregation for both treatment and diagnosis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp27DT3ZYXjTrVg90H21EOLACvtfcHk0lghJ-kISQukWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFaktb0%253D&md5=cbb78251ada2a8f400624b724fd4da26</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00102%26sid%3Dliteratum%253Aachs%26aulast%3DLunven%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DH.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DW.%26aulast%3DDa%2BCosta%26aufirst%3DL.%26aulast%3DPeuchmaur%26aufirst%3DM.%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DChierici%26aufirst%3DS.%26atitle%3DDisruption%2520of%2520fibers%2520from%2520the%2520tau%2520model%2520AcPHF6%2520by%2520naturally%2520occurring%2520aurones%2520and%2520synthetic%2520analogues%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D995%26epage%3D1003%26doi%3D10.1021%2Facschemneuro.6b00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejmech.2016.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=26807864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2ntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2016&pages=342-349&author=C.+K.+Wangauthor=S.+E.+Northfieldauthor=Y.+H.+Huangauthor=M.+C.+Ramosauthor=D.+J.+Craik&title=Inhibition+of+tau+aggregation+using+a+naturally-occurring+cyclic+peptide+scaffold&doi=10.1016%2Fj.ejmech.2016.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold</span></div><div class="casAuthors">Wang, Conan K.; Northfield, Susan E.; Huang, Yen-Hua; Ramos, Mariana C.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">342-349</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Disulfide-rich macrocyclic peptides are emerging as versatile scaffolds for the development of stable biochem. tools.  This potential is due to the combination of their structural stability and range of bioactivities.  Here, we explored the activity of these peptides on fibril growth of the hexapeptide Ac-VQIVYK-NH2 (AcPHF6), which is a tau-derived peptide that has been widely used to understand the pathol. mechanism of numerous tauopathies, including Alzheimer's disease.  Of the cyclic peptides tested, SFTI-1 and kB1 showed an inherent ability to inhibit AcPHF6 fibril formation.  Using an end-capping strategy and combining it with a mol. grafting approach, we demonstrated that SFTI-1 could be used as a starting point to design more potent fibril inhibitors.  We further identified chem. and structural features of SFTI-1 and its analogs that underpin their inhibitory activity.  The ability to inhibit fibril growth using the strategy employed herein supports the 'steric zipper' model of AcPHF6 fibril formation and shows that naturally-occurring cyclic peptides have potential as drug leads or mol. probes for understanding fibril formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8EceNHBR-sbVg90H21EOLACvtfcHk0lg-n7BJTHyynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2ntLk%253D&md5=3e649c3437e072ab206fc739d3d95bd2</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BK.%26aulast%3DNorthfield%26aufirst%3DS.%2BE.%26aulast%3DHuang%26aufirst%3DY.%2BH.%26aulast%3DRamos%26aufirst%3DM.%2BC.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520tau%2520aggregation%2520using%2520a%2520naturally-occurring%2520cyclic%2520peptide%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D109%26spage%3D342%26epage%3D349%26doi%3D10.1016%2Fj.ejmech.2016.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biancalana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, S.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of Thioflavin-T binding to amyloid fibrils</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1412</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2010.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bbapap.2010.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20399286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVGlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=1405-1412&author=M.+Biancalanaauthor=S.+Koide&title=Molecular+mechanism+of+Thioflavin-T+binding+to+amyloid+fibrils&doi=10.1016%2Fj.bbapap.2010.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of thioflavin-T binding to amyloid fibrils</span></div><div class="casAuthors">Biancalana, Matthew; Koide, Shohei</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1405-1412</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Intense efforts to detect, diagnose, and analyze the kinetic and structural properties of amyloid fibrils have generated a powerful toolkit of amyloid-specific mol. probes.  Since its 1st description in 1959, the fluorescent dye, thioflavin-T (ThT), has become among the most widely used "gold stds." for selectively staining and identifying amyloid fibrils both in vivo and in vitro.  The large enhancement of its fluorescence emission upon its binding to fibrils makes ThT a particularly powerful and convenient tool.  Despite its widespread use in clin. and basic science applications, the mol. mechanism for the ability of ThT to recognize diverse types of amyloid fibrils and for the dye's characteristic fluorescence has only begun to be elucidated.  Here, the authors review recent progress in the understanding of ThT-fibril interactions at at. resoln.  These studies have yielded important insights into amyloid structures and the processes of fibril formation, and they also offer guidance for designing the next generation of amyloid assembly diagnostics, inhibitors, and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5H7hkh8MvL7Vg90H21EOLACvtfcHk0lg-n7BJTHyynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVGlsbs%253D&md5=81e2da6940732c11dd04e4ae078c5741</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2010.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2010.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DBiancalana%26aufirst%3DM.%26aulast%3DKoide%26aufirst%3DS.%26atitle%3DMolecular%2520mechanism%2520of%2520Thioflavin-T%2520binding%2520to%2520amyloid%2520fibrils%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D1405%26epage%3D1412%26doi%3D10.1016%2Fj.bbapap.2010.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisanaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">7614</span>– <span class="NLM_lpage">7623</span>, <span class="refDoi"> DOI: 10.1074/jbc.M408714200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1074%2Fjbc.M408714200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=15611092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1yisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=7614-7623&author=S.+Taniguchiauthor=N.+Suzukiauthor=M.+Masudaauthor=S.+Hisanagaauthor=T.+Iwatsuboauthor=M.+Goedertauthor=M.+Hasegawa&title=Inhibition+of+heparin-induced+tau+filament+formation+by+phenothiazines%2C+polyphenols%2C+and+porphyrins&doi=10.1074%2Fjbc.M408714200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins</span></div><div class="casAuthors">Taniguchi, Sayuri; Suzuki, Nobuyuki; Masuda, Masami; Hisanaga, Shin-ichi; Iwatsubo, Takeshi; Goedert, Michel; Hasegawa, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7614-7623</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tau protein is the major component of the intraneuronal filamentous inclusions that constitute defining neuropathol. characteristics of Alzheimer's disease and other tauopathies.  The discovery of tau gene mutations in familial forms of frontotemporal dementia has established that dysfunction of the tau protein is sufficient to cause neurodegeneration and dementia.  Here we have tested 42 compds. belonging to nine different chem. classes for their ability to inhibit heparin-induced assembly of tau into filaments in vitro.  Several phenothiazines (methylene blue, azure A, azure B, and quinacrine mustard), polyphenols (myricetin, epicatechin 5-gallate, gossypetin, and 2,3,4,2',4'-pentahydroxybenzophenone), and the porphyrin ferric deuteroporphyrin IX inhibited tau filament formation with IC50 values in the low micromolar range as assessed by thioflavin S fluorescence, electron microscopy, and Sarkosyl insoly.  Disassembly of tau filaments was obsd. in the presence of the porphyrin phthalocyanine.  Compds. that inhibited tau filament assembly were also found to inhibit the formation of Aβ fibrils.  Biochem. anal. revealed the formation of sol. oligomeric tau in the presence of the inhibitory compds., suggesting that this may be the mechanism by which tau filament formation is inhibited.  The compds. investigated did not affect the ability of tau to interact with microtubules.  Identification of small mol. inhibitors of heparin-induced assembly of tau will form a starting point for the development of mechanism-based therapies for the tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGredfcb9NBJVLVg90H21EOLACvtfcHk0lg-n7BJTHyynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1yisL8%253D&md5=cc8f16759387a4de44a2657bc0430190</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M408714200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M408714200%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMasuda%26aufirst%3DM.%26aulast%3DHisanaga%26aufirst%3DS.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520heparin-induced%2520tau%2520filament%2520formation%2520by%2520phenothiazines%252C%2520polyphenols%252C%2520and%2520porphyrins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D7614%26epage%3D7623%26doi%3D10.1074%2Fjbc.M408714200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wille, H. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1083/jcb.118.3.573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1083%2Fjcb.118.3.573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1639844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK38XltV2gsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1992&pages=573-584&author=H.+D.+G.+Willeauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Alzheimer-like+paired+helical+filaments+and+antiparallel+dimers+formed+from+microtubule-associated+protein+tau+in+vitro&doi=10.1083%2Fjcb.118.3.573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro</span></div><div class="casAuthors">Wille, Holger; Drewes, Gerard; Biernat, Jacek; Mandelkow, Eva Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">573-84</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">Recent evidence from several labs. shows that the paired helical filaments of Alzheimer's disease brains consist mainly of the protein tau in an abnormally phosphorylated form, but the mode of assembly is not understood.  The authors used electron microscopy to study several constructs derived from human brain tau and expressed in Escherichia coli.  All constructs or tau isoforms were rodlike mols. with a high tendency to dimerize in an antiparallel fashion, as shown by antibody labeling and chem. crosslinking.  The length of the rods was largely detd. by the region of internal repeats that was also responsible for microtubule binding.  One unit length of the repeat domain (three or four repeats) was around 22-25 nm, comparable to the cross-section of Alzheimer PHF cores.  Constructs corresponding roughly to the repeat region of tau could form synthetic paired helical filaments resembling those from Alzheimer brain tissue.  A similar self-assembly occurred with the chem. crosslinked dimers.  In both cases there was no need for phosphorylation of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0edAcipxrRbVg90H21EOLACvtfcHk0lg-n7BJTHyynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltV2gsLo%253D&md5=a6cb9e9daa49b1e9cad1ecabdd03c060</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1083%2Fjcb.118.3.573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.118.3.573%26sid%3Dliteratum%253Aachs%26aulast%3DWille%26aufirst%3DH.%2BD.%2BG.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAlzheimer-like%2520paired%2520helical%2520filaments%2520and%2520antiparallel%2520dimers%2520formed%2520from%2520microtubule-associated%2520protein%2520tau%2520in%2520vitro%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1992%26volume%3D118%26spage%3D573%26epage%3D584%26doi%3D10.1083%2Fjcb.118.3.573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">8029</span>– <span class="NLM_lpage">8038</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.12.8029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1074%2Fjbc.274.12.8029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10075702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK1MXitFSku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=8029-8038&author=H.+K.+Paudelauthor=W.+Li&title=Heparin-induced+conformational+change+in+microtubule-associated+protein+Tau+as+detected+by+chemical+cross-linking+and+phosphopeptide+mapping&doi=10.1074%2Fjbc.274.12.8029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical crosslinking and phosphopeptide mapping</span></div><div class="casAuthors">Paudel, Hemant K.; Li, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8029-8038</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">In Alzheimer's disease, microtubule-assocd. protein tau becomes abnormally phosphorylated and aggregates into paired helical filaments.  Sulfated glycosaminoglycans such as heparin and heparan sulfate were shown to accumulate in pretangle neurons, stimulate in vitro tau phosphorylation, and cause tau aggregation into paired helical filament-like filaments.  The sulfated glycosaminoglycan-tau interaction was suggested to be the central event in the development of neuropathol. in Alzheimer's disease brain (Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Nature 383, 550-553).  The biochem. mechanism by which sulfated glycosaminoglycans stimulate tau phosphorylation and cause tau aggregation remains unclear.  In this study, disuccinimidyl suberate (DSS), a bifunctional chem. cross-linker, cross-linked tau dimers, tetramers, high mol. size aggregates, and two tau species of sizes 72 and 83 kDa in the presence of heparin.  In the absence of heparin only dimeric tau was cross-linked by DSS.  Fast protein liq. chromatog. gel filtration revealed that 72- and 83-kDa species were formed by intramol. crosslinking of tau by DSS.  These observations indicate that heparin, in addn. to causing aggregation, also induces a conformational change in tau in which reactive groups are unmasked or move closer leading to the DSS crosslinking of 72- and 83-kDa species.  Heparin-induced structural changes in tau mol. depended on time of heparin exposure.  Dimerization and tetramerization peaked at 48 h, whereas conformational change was completed within 30 min of heparin exposure.  Heparin exposure beyond 48 h caused an abrupt aggregation of tau into high mol. size species.  Heparin stimulated tau phosphorylation by neuronal cdc2-like kinase (NCLK) and cAMP-dependent protein kinase.  Phosphopeptide mapping and phosphopeptide sequencing revealed that tau is phosphorylated by NCLK on Thr212 and Thr231 and by cAMP-dependent protein kinase on Ser262 only in the presence of heparin.  Heparin stimulation of tau phosphorylation by NCLK showed dependence on time of heparin exposure and correlated with the heparin-induced conformational change of tau.  Our data suggest that heparin-induced conformational change exposes new sites for phosphorylation within tau mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKHPNytgwfv7Vg90H21EOLACvtfcHk0lhp8k96rVKxqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFSku7k%253D&md5=9061e517bbaa0d8baccdec1022dbeaa6</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.12.8029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.12.8029%26sid%3Dliteratum%253Aachs%26aulast%3DPaudel%26aufirst%3DH.%2BK.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DHeparin-induced%2520conformational%2520change%2520in%2520microtubule-associated%2520protein%2520Tau%2520as%2520detected%2520by%2520chemical%2520cross-linking%2520and%2520phosphopeptide%2520mapping%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D8029%26epage%3D8038%26doi%3D10.1074%2Fjbc.274.12.8029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilham, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrú, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessen, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atarashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Race, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meade-White, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubner, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, B.</span></span> <span> </span><span class="NLM_article-title">Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1001217</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1001217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1371%2Fjournal.ppat.1001217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=e1001217&author=J.+M.+Wilhamauthor=C.+D.+Orr%C3%BAauthor=R.+A.+Bessenauthor=R.+Atarashiauthor=K.+Sanoauthor=B.+Raceauthor=K.+D.+Meade-Whiteauthor=L.+M.+Taubnerauthor=A.+Timmesauthor=B.+Caughey&title=Rapid+end-point+quantitation+of+prion+seeding+activity+with+sensitivity+comparable+to+bioassays&doi=10.1371%2Fjournal.ppat.1001217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1001217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1001217%26sid%3Dliteratum%253Aachs%26aulast%3DWilham%26aufirst%3DJ.%2BM.%26aulast%3DOrr%25C3%25BA%26aufirst%3DC.%2BD.%26aulast%3DBessen%26aufirst%3DR.%2BA.%26aulast%3DAtarashi%26aufirst%3DR.%26aulast%3DSano%26aufirst%3DK.%26aulast%3DRace%26aufirst%3DB.%26aulast%3DMeade-White%26aufirst%3DK.%2BD.%26aulast%3DTaubner%26aufirst%3DL.%2BM.%26aulast%3DTimmes%26aufirst%3DA.%26aulast%3DCaughey%26aufirst%3DB.%26atitle%3DRapid%2520end-point%2520quantitation%2520of%2520prion%2520seeding%2520activity%2520with%2520sensitivity%2520comparable%2520to%2520bioassays%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26spage%3De1001217%26doi%3D10.1371%2Fjournal.ppat.1001217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span> <span> </span><span class="NLM_article-title">Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(01)02944-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS0014-5793%2801%2902944-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2001&pages=81-87&author=J.+Wangauthor=Y.+C.+Tungauthor=Y.+Wangauthor=X.+T.+Liauthor=K.+Iqbalauthor=I.+Grundke-Iqbal&title=Hyperphosphorylation+and+accumulation+of+neurofilament+proteins+in+Alzheimer+disease+brain+and+in+okadaic+acid-treated+SY5Y+cells&doi=10.1016%2FS0014-5793%2801%2902944-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2902944-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252902944-1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTung%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BT.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DHyperphosphorylation%2520and%2520accumulation%2520of%2520neurofilament%2520proteins%2520in%2520Alzheimer%2520disease%2520brain%2520and%2520in%2520okadaic%2520acid-treated%2520SY5Y%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D507%26spage%3D81%26epage%3D87%26doi%3D10.1016%2FS0014-5793%2801%2902944-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. X.</span></span> <span> </span><span class="NLM_article-title">Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model</span>. <i>Int. J. Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/j.ijdevneu.2012.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ijdevneu.2012.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=411-419&author=Z.+Chenauthor=B.+Chenauthor=W.+F.+Xuauthor=R.+F.+Liuauthor=J.+Yangauthor=C.+X.+Yu&title=Effects+of+PTEN+inhibition+on+regulation+of+tau+phosphorylation+in+an+okadaic+acid-induced+neurodegeneration+model&doi=10.1016%2Fj.ijdevneu.2012.08.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2012.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DW.%2BF.%26aulast%3DLiu%26aufirst%3DR.%2BF.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%2BX.%26atitle%3DEffects%2520of%2520PTEN%2520inhibition%2520on%2520regulation%2520of%2520tau%2520phosphorylation%2520in%2520an%2520okadaic%2520acid-induced%2520neurodegeneration%2520model%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2012%26volume%3D30%26spage%3D411%26epage%3D419%26doi%3D10.1016%2Fj.ijdevneu.2012.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, J. W.</span></span> <span> </span><span class="NLM_article-title">An okadaic acid-induced model of tauopathy and cognitive deficiency</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1359</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2010.08.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.brainres.2010.08.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=20807517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSgt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1359&publication_year=2010&pages=233-246&author=Z.+Zhangauthor=J.+W.+Simpkins&title=An+okadaic+acid-induced+model+of+tauopathy+and+cognitive+deficiency&doi=10.1016%2Fj.brainres.2010.08.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">An okadaic acid-induced model of tauopathy and cognitive deficiency</span></div><div class="casAuthors">Zhang, Zhang; Simpkins, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1359</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-246</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes cognitive and behavioral deterioration in the elderly.  Neurofibrillary tangles (NFTs) are one of the pathol. hallmarks of AD that has been shown to correlate pos. with the severity of dementia in the neocortex of AD patients.  In an attempt to characterize an in vivo AD tauopathy model, okadaic acid (OA), a protein phosphatase inhibitor, was microinfused into the right lateral dorsal hippocampus area of ovariectomized adult rat.  Cognitive deficiency was seen in OA-treated rats without a change in motor function.  Both silver staining and immunohistochem. staining revealed that OA treatment induces NFTs-like conformational changes in both the cortex and hippocampus.  Phosphorylated tau as well as cyclin-dependent kinase 5 (cdk5) and its coactivator, p25, were significantly increased in these regions of the brain.  Oxidative stress was also increased with OA treatment as measured by protein carbonylation and lipid peroxidn.  These data suggest that the unilateral microinfusion of OA into the dorsal hippocampus causes cognitive deficiency, NFTs-like pathol. changes, and oxidative stress as seen in AD pathol. via tau hyperphosphorylation caused by inhibition of protein phosphatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUqOG8p8fBHbVg90H21EOLACvtfcHk0li-V89GvGnGHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSgt7rM&md5=fa24cf9dae25d308ba0effa930992597</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2010.08.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2010.08.077%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSimpkins%26aufirst%3DJ.%2BW.%26atitle%3DAn%2520okadaic%2520acid-induced%2520model%2520of%2520tauopathy%2520and%2520cognitive%2520deficiency%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1359%26spage%3D233%26epage%3D246%26doi%3D10.1016%2Fj.brainres.2010.08.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0li-V89GvGnGHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swords, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dwyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santocanale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carew, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, F.</span></span> <span> </span><span class="NLM_article-title">Cdc7 kinase - a new target for drug development</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2009.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.ejca.2009.09.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=33-40&author=R.+Swordsauthor=D.+Mahalingamauthor=M.+O%E2%80%99Dwyerauthor=C.+Santocanaleauthor=K.+Kellyauthor=J.+Carewauthor=F.+Giles&title=Cdc7+kinase+-+a+new+target+for+drug+development&doi=10.1016%2Fj.ejca.2009.09.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2009.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2009.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DSwords%26aufirst%3DR.%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DM.%26aulast%3DSantocanale%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DK.%26aulast%3DCarew%26aufirst%3DJ.%26aulast%3DGiles%26aufirst%3DF.%26atitle%3DCdc7%2520kinase%2520-%2520a%2520new%2520target%2520for%2520drug%2520development%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D33%26epage%3D40%26doi%3D10.1016%2Fj.ejca.2009.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1423</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1995.64031420.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1046%2Fj.1471-4159.1995.64031420.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=7532213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1995&pages=1420-1423&author=T.+J.+Singhauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Phosphorylation+of+tau+protein+by+casein+kinase-1+converts+it+to+an+abnormal+Alzheimer-like+state&doi=10.1046%2Fj.1471-4159.1995.64031420.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of τ protein by casein kinase-1 converts it to an abnormal Alzheimer-like state</span></div><div class="casAuthors">Singh, Toolsee; Grundke-Iqbal, Inge; Iqbal, Khalid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1420-3</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">Microtubule-assocd. protein τ is abnormally hyperphosphorylated in Alzheimer's disease.  Both proline-dependent protein kinases (PDPKs) and non-PDPKs are involved in this hyperphosphorylation of τ.  Several PDPKs can phosphorylate τ in vitro and induce Alzheimer-like epitopes to many phosphorylation-dependent antibodies.  A similar induction has not been reported with non-PDPKs.  Here, the authors evaluated 6 non-PDPKs [cAMP-dependent (A-kinase), Ca2+/phospholipid-dependent (C-kinase), casein kinase-1 (CK-1), casein kinase-2 (CK-2), Ca2+/calmodulin-dependent protein kinase II, and Ca2+/calmodulin-dependent protein kinase from rat cerebellum] for their abilities to induce Alzheimer-like epitopes on τ.  Such epitopes were induced by A-kinase, C-kinase, CK-1, and CK-2, but the degree of induction achieved by CK-1 was much greater than with the other kinases.  These results suggest that CK-1 may play an important role in the conversion of τ from the normal to the abnormal phosphorylation state in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiaaD_uS92HrVg90H21EOLACvtfcHk0li-V89GvGnGHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvVyns78%253D&md5=3827ab9e85b4dc25ab1e3e02dd614a4d</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1995.64031420.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1995.64031420.x%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%2BJ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DPhosphorylation%2520of%2520tau%2520protein%2520by%2520casein%2520kinase-1%2520converts%2520it%2520to%2520an%2520abnormal%2520Alzheimer-like%2520state%26jtitle%3DJ.%2520Neurochem.%26date%3D1995%26volume%3D64%26spage%3D1420%26epage%3D1423%26doi%3D10.1046%2Fj.1471-4159.1995.64031420.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maccari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottana, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curinga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigorita, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakowitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steindl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2809</span>– <span class="NLM_lpage">2823</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2Fj.bmc.2005.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2809-2823&author=R.+Maccariauthor=R.+Ottanaauthor=C.+Curingaauthor=M.+G.+Vigoritaauthor=D.+Rakowitzauthor=T.+Steindlauthor=T.+Langer&title=Structure-activity+relationships+and+molecular+modelling+of+5-arylidene-2%2C4-thiazolidinediones+active+as+aldose+reductase+inhibitors&doi=10.1016%2Fj.bmc.2005.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttana%26aufirst%3DR.%26aulast%3DCuringa%26aufirst%3DC.%26aulast%3DVigorita%26aufirst%3DM.%2BG.%26aulast%3DRakowitz%26aufirst%3DD.%26aulast%3DSteindl%26aufirst%3DT.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DStructure-activity%2520relationships%2520and%2520molecular%2520modelling%2520of%25205-arylidene-2%252C4-thiazolidinediones%2520active%2520as%2520aldose%2520reductase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2809%26epage%3D2823%26doi%3D10.1016%2Fj.bmc.2005.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepartz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2168</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2165-2168&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facs.jmedchem.7b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis; Merz, Kenneth M.; Schepartz, Alanna; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2165-2168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecstasy of discovering a new hit from screening can lead to a highly productive research effort to discover new bioactive compds.  However, in too many cases this ecstasy is followed by the agony of realizing that the compds. are not active against the desired target.  Many of these false hits are Pan Assay INterference compds. (PAINS) 1 or colloidal aggregators.  Whether the screen is conducted in silico or in the lab. and whether screening libraries, natural products, or drugs are used, all discovery efforts that rely on some form of screening to identify bioactivity are susceptible to this phenomenon.  Studies that omit crit. controls against exptl. artifacts caused by PAINS may waste years of research effort as useless compds. are progressed.  The American Chem. Society (ACS) is eager to alert the scientific community to this problem and to recommend protocols that will eliminate the publication of research articles based on compds. with artificial activity.  This editorial aims to summarize relevant concepts and to set the framework by which relevant ACS journals will address this issue going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUf5u51VEpbVg90H21EOLACvtfcHk0lh7fAmj4oPEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D&md5=64bf087659a47fe7769208217ef8c989</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00229%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2165%26epage%3D2168%26doi%3D10.1021%2Facs.jmedchem.7b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Drug–target residence time</span>. In  <i>Evaluation of Enzyme Inhibitors in Drug Discovery</i>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2F9781118540398.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=318-325&author=R.+A.+Copelandauthor=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2F9781118540398.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DDrug%25E2%2580%2593target%2520residence%2520time%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26pub%3DWiley%26date%3D2013%26spage%3D318%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avonto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taglialatela-Scafati, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollastro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Petrocellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appendino, G.</span></span> <span> </span><span class="NLM_article-title">An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of Michael acceptors for drug discovery?</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1002/anie.201005959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1002%2Fanie.201005959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=467-471&author=C.+Avontoauthor=O.+Taglialatela-Scafatiauthor=F.+Pollastroauthor=A.+Minassiauthor=V.+Di+Marzoauthor=L.+De+Petrocellisauthor=G.+Appendino&title=An+NMR+spectroscopic+method+to+identify+and+classify+thiol-trapping+agents%3A+revival+of+Michael+acceptors+for+drug+discovery%3F&doi=10.1002%2Fanie.201005959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">An NMR Spectroscopic Method to Identify and Classify Thiol-Trapping Agents: Revival of Michael Acceptors for Drug Discovery?</span></div><div class="casAuthors">Avonto, Cristina; Taglialatela-Scafati, Orazio; Pollastro, Federica; Minassi, Alberto; Di Marzo, Vincenzo; De Petrocellis, Luciano; Appendino, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">467-471, S467/1-S467/30</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a simple and quick NMR spectroscopic method to identify Michael acceptor sites in complex multifunctional compds.  The method sorts them out in reversible and irreversible thiol sinks, and predicts their potential to modify proteins, as validated by the identification of several new chemotypes of TRPA1 activators.  These include well-known anti-inflammatory agents, such as curcumin and parthenolide, which had been overlooked as ligands for this druggable end point of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt8t1J015hqbVg90H21EOLACvtfcHk0lh7fAmj4oPEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlGiuw%253D%253D&md5=8fd61bce5e0dfeb9209a6572516fd583</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2Fanie.201005959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201005959%26sid%3Dliteratum%253Aachs%26aulast%3DAvonto%26aufirst%3DC.%26aulast%3DTaglialatela-Scafati%26aufirst%3DO.%26aulast%3DPollastro%26aufirst%3DF.%26aulast%3DMinassi%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DDe%2BPetrocellis%26aufirst%3DL.%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DAn%2520NMR%2520spectroscopic%2520method%2520to%2520identify%2520and%2520classify%2520thiol-trapping%2520agents%253A%2520revival%2520of%2520Michael%2520acceptors%2520for%2520drug%2520discovery%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D467%26epage%3D471%26doi%3D10.1002%2Fanie.201005959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julià, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Baeza, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anglada, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centelles, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascante, M.</span></span> <span> </span><span class="NLM_article-title">Cysteinyl-flavan-3-ol conjugates from grape procyanidins. Antioxidant and antiproliferative properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2509</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(02)00127-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1016%2FS0968-0896%2802%2900127-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2497-2509&author=J.+L.+Torresauthor=C.+Lozanoauthor=L.+Juli%C3%A0author=F.+J.+S%C3%A1nchez-Baezaauthor=J.+M.+Angladaauthor=J.+J.+Centellesauthor=M.+Cascante&title=Cysteinyl-flavan-3-ol+conjugates+from+grape+procyanidins.+Antioxidant+and+antiproliferative+properties&doi=10.1016%2FS0968-0896%2802%2900127-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900127-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900127-X%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DJ.%2BL.%26aulast%3DLozano%26aufirst%3DC.%26aulast%3DJuli%25C3%25A0%26aufirst%3DL.%26aulast%3DS%25C3%25A1nchez-Baeza%26aufirst%3DF.%2BJ.%26aulast%3DAnglada%26aufirst%3DJ.%2BM.%26aulast%3DCentelles%26aufirst%3DJ.%2BJ.%26aulast%3DCascante%26aufirst%3DM.%26atitle%3DCysteinyl-flavan-3-ol%2520conjugates%2520from%2520grape%2520procyanidins.%2520Antioxidant%2520and%2520antiproliferative%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2497%26epage%3D2509%26doi%3D10.1016%2FS0968-0896%2802%2900127-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arsovska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trontelj, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zidar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masic, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plavec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zega, A.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Michael-type acceptor reactivity of 5-benzylidenebarbiturates, 5-benzylidenerhodanines, and related heterocycles using NMR</span>. <i>Acta Chim. Slov.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=637-644&author=E.+Arsovskaauthor=J.+Tronteljauthor=N.+Zidarauthor=T.+Tomasicauthor=L.+P.+Masicauthor=D.+Kikeljauthor=J.+Plavecauthor=A.+Zega&title=Evaluation+of+Michael-type+acceptor+reactivity+of+5-benzylidenebarbiturates%2C+5-benzylidenerhodanines%2C+and+related+heterocycles+using+NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArsovska%26aufirst%3DE.%26aulast%3DTrontelj%26aufirst%3DJ.%26aulast%3DZidar%26aufirst%3DN.%26aulast%3DTomasic%26aufirst%3DT.%26aulast%3DMasic%26aufirst%3DL.%2BP.%26aulast%3DKikelj%26aufirst%3DD.%26aulast%3DPlavec%26aufirst%3DJ.%26aulast%3DZega%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520Michael-type%2520acceptor%2520reactivity%2520of%25205-benzylidenebarbiturates%252C%25205-benzylidenerhodanines%252C%2520and%2520related%2520heterocycles%2520using%2520NMR%26jtitle%3DActa%2520Chim.%2520Slov.%26date%3D2014%26volume%3D61%26spage%3D637%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polazzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengoni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caprini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Altamira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtys, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span> <span> </span><span class="NLM_article-title">Copper-zinc superoxide dismutase (SOD1) is released by microglial cells and confers neuroprotection against 6-OHDA neurotoxicity</span>. <i>Neurosignals</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1159/000337115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1159%2F000337115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=22572742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Gmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=112-128&author=E.+Polazziauthor=I.+Mengoniauthor=M.+Capriniauthor=E.+Pena-Altamiraauthor=E.+Kurtysauthor=B.+Monti&title=Copper-zinc+superoxide+dismutase+%28SOD1%29+is+released+by+microglial+cells+and+confers+neuroprotection+against+6-OHDA+neurotoxicity&doi=10.1159%2F000337115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity</span></div><div class="casAuthors">Polazzi, Elisabetta; Mengoni, Ilaria; Caprini, Marco; Pena-Altamira, Emiliano; Kurtys, Ewelina; Monti, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">112-128</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Microglial-neuronal interactions are essential for brain physiopathol.  In this framework, recent data have changed the concept of microglia from essentially macrophagic cells to crucial elements in maintaining neuronal homeostasis and function through the release of neuroprotective mols.  Using proteomic anal., here we identify copper-zinc superoxide dismutase (SOD1) as a protein produced and released by cultured rat primary microglia.  Evidence for a neuroprotective role of microglia-derived SOD1 resulted from expts. in which primary cerebellar granule neurons (CGNs) were exposed to the dopaminergic toxin 6-hydroxydopamine (6-OHDA).  Microglial conditioned medium, in which SOD1 had accumulated, protected CGNs from degeneration, and neuroprotection was abrogated by SOD1 inhibitors.  These effects were replicated when exogenous SOD1 was added to a nonconditioned medium.  SOD1 neuroprotective action was mediated by increased cell calcium from an external source.  Further expts. demonstrated the specificity of SOD1 neuroprotection against 6-OHDA compared to other types of neurotoxic challenges.  SOD1, constitutively produced and released by microglia through a lysosomal secretory pathway, is identified here for the first time as an essential component of neuroprotection mediated by microglia.  This novel information is relevant to stimulating further studies of microglia-mediated neuroprotection in in vivo models of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFBV29S5907Vg90H21EOLACvtfcHk0lhe2XAt27J1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Gmuro%253D&md5=06d4d02f8d6bc8b5a32127e9dc18cdc8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1159%2F000337115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000337115%26sid%3Dliteratum%253Aachs%26aulast%3DPolazzi%26aufirst%3DE.%26aulast%3DMengoni%26aufirst%3DI.%26aulast%3DCaprini%26aufirst%3DM.%26aulast%3DPena-Altamira%26aufirst%3DE.%26aulast%3DKurtys%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26atitle%3DCopper-zinc%2520superoxide%2520dismutase%2520%2528SOD1%2529%2520is%2520released%2520by%2520microglial%2520cells%2520and%2520confers%2520neuroprotection%2520against%25206-OHDA%2520neurotoxicity%26jtitle%3DNeurosignals%26date%3D2013%26volume%3D21%26spage%3D112%26epage%3D128%26doi%3D10.1159%2F000337115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Altamira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polazzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauriola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span> <span> </span><span class="NLM_article-title">The transcription factor CCAAT enhancer-binding protein beta protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1111/ejn.12407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=10.1111%2Fejn.12407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=24438488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;key=1%3ACAS%3A280%3ADC%252BC2czmvV2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=176-185&author=E.+Pena-Altamiraauthor=E.+Polazziauthor=E.+Morettoauthor=M.+Lauriolaauthor=B.+Monti&title=The+transcription+factor+CCAAT+enhancer-binding+protein+beta+protects+rat+cerebellar+granule+neurons+from+apoptosis+through+its+transcription-activating+isoforms&doi=10.1111%2Fejn.12407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms</span></div><div class="casAuthors">Pena-Altamira Emiliano; Polazzi Elisabetta; Moretto Edoardo; Lauriola Mattia; Monti Barbara</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">176-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CCAAT enhancer-binding protein β is a transcription factor that is involved in many brain processes, although its role in neuronal survival/death remains unclear.  By using primary cultures of rat cerebellar granule neurons, we have shown here that CCAAT enhancer-binding protein β is present as all of its isoforms: the transcriptional activators liver activator proteins 1 and 2, and the transcriptional inhibitor liver inhibitory protein.  We have also shown that liver activator protein 1 undergoes post-translational modifications, such as phosphorylation and sumoylation.  These isoforms have different subcellular localizations, liver activator protein 2 being found in the cytosolic fraction only, liver inhibitory protein in the nucleus only, and liver activator protein 1 in both fractions.  Through neuronal apoptosis induction by shifting mature cerebellar granule neurons to low-potassium medium, we have demonstrated that nuclear liver activator protein 1 expression decreases and its phosphorylation disappears, whereas liver inhibitory protein levels increase in the nuclear fraction, suggesting a pro-survival role for liver activator protein transcriptional activation and a pro-apoptotic role for liver inhibitory protein transcriptional inhibition.  To confirm this, we transfected cerebellar granule neurons with plasmids expressing liver activator protein 1, liver activator protein 2, or liver inhibitory protein respectively, and observed that both liver activator proteins, which increase CCAAT-dependent transcription, but not liver inhibitory protein, counteracted apoptosis, thus demonstrating the pro-survival role of liver activator proteins.  These data significantly improve our current understanding of the role of CCAAT enhancer-binding protein β in neuronal survival/apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSX_bKS03xe8DC850By6mxpfW6udTcc2eYQcpPluewZ8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czmvV2gsQ%253D%253D&md5=8e23229a38098f74c6b7f769f18ab982</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fejn.12407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.12407%26sid%3Dliteratum%253Aachs%26aulast%3DPena-Altamira%26aufirst%3DE.%26aulast%3DPolazzi%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DE.%26aulast%3DLauriola%26aufirst%3DM.%26aulast%3DMonti%26aufirst%3DB.%26atitle%3DThe%2520transcription%2520factor%2520CCAAT%2520enhancer-binding%2520protein%2520beta%2520protects%2520rat%2520cerebellar%2520granule%2520neurons%2520from%2520apoptosis%2520through%2520its%2520transcription-activating%2520isoforms%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2014%26volume%3D39%26spage%3D176%26epage%3D185%26doi%3D10.1111%2Fejn.12407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00610">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11771"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00610">10.1021/acs.jmedchem.8b00610</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Retrospective computational studies; PAMPA-BBB assay data; jump dilution assay; synthetic details for compounds <b>14a</b> and <b>15a</b>; compounds purity by HPLC; <sup>1</sup>H and <sup>13</sup>C NMR spectra of all synthesized compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and GSK-3β data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_001.pdf">jm8b00610_si_001.pdf (4.35 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00610/suppl_file/jm8b00610_si_002.csv">jm8b00610_si_002.csv (1.73 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00610%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00610" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e8de39a832d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
